{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Natural Language Processing on Heat shock protein A4 related publications sourced from PubMed"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 468,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import re\n",
    "import nltk\n",
    "from nltk.tokenize import sent_tokenize\n",
    "import medspacy\n",
    "from transformers import pipeline\n",
    "from datetime import datetime"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Step 1: Loading and cleaning the scraped Pubmed data"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 469,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>title</th>\n",
       "      <th>pmid</th>\n",
       "      <th>url</th>\n",
       "      <th>abstract</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Tumor-educated B cells selectively promote breast cancer lymph node metastasis by HSPA4-targeting IgG</td>\n",
       "      <td>30643287</td>\n",
       "      <td>https://pubmed.ncbi.nlm.nih.gov/30643287</td>\n",
       "      <td>Primary tumors may create the premetastatic niche in secondary organs for subsequent metastasis. Humoral immunity contributes to the progression of certain cancers, but the roles of B cells and their derived antibodies in premetastatic niche formation are poorly defined. Using a mouse model of spontaneous lymph node metastasis of breast cancer, we show that primary tumors induced B cell accumulation in draining lymph nodes. These B cells selectively promoted lymph node metastasis by producing pathogenic IgG that targeted glycosylated membrane protein HSPA4, and activated the HSPA4-binding protein ITGB5 and the downstream Src/NF-κB pathway in tumor cells for CXCR4/SDF1α-axis-mediated metastasis. High serum anti-HSPA4 IgG was correlated with high tumor HSPA4 expression and poor prognosis of breast cancer subjects. Our findings identify a key role for tumor-educated B cells and their derived antibodies in lymph node premetastatic niche formation, providing potential targets for cancer intervention.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>HSPA4 upregulation induces immune evasion via ALKBH5/CD58 axis in gastric cancer</td>\n",
       "      <td>38589927</td>\n",
       "      <td>https://pubmed.ncbi.nlm.nih.gov/38589927</td>\n",
       "      <td>Introduction:\\n        \\n\\n      \\n      Gastric cancer (GC) is one of the leading causes of cancer-related death worldwide. Recently, targeted therapies including PD1 (programmed cell death 1) antibodies have been used in advanced GC patients. However, identifying new biomarker for immunotherapy is still urgently needed. The objective of this study is to unveil the immune evasion mechanism of GC cells and identify new biomarkers for immune checkpoint blockade therapy in patients with GC.\\n    \\n\\n\\n\\n\\n\\n          Methods:\\n        \\n\\n      \\n      Coimmunoprecipitation and meRIP were performed to investigate the mechanism of immune evasion of GC cells. Cocuture system was established to evaluate the cytotoxicity of cocultured CD8\\n+\\n T cells. The clinical significance of HSPA4 upregulation was analyzed by multiplex fluorescent immunohistochemistry staining in GC tumor tissues.\\n    \\n\\n\\n\\n\\n\\n          Results:\\n        \\n\\n      \\n      Histone acetylation causes HSPA4 upregulation in GC tumor tissues. HSPA4 upregulation increases the protein stability of m\\n6\\nA demethylase ALKBH5. ALKBH5 decreases CD58 in GC cells through m\\n6\\nA methylation regulation. The cytotoxicity of CD8\\n+\\n T cells are impaired and PD1/PDL1 axis is activated when CD8\\n+\\n T cells are cocultured with HSPA4 overexpressed GC cells. HSPA4 upregulation is associated with worse 5-year overall survival of GC patients receiving only surgery. It is an independent prognosis factor for worse survival of GC patients. In GC patients receiving the combined chemotherapy with anti-PD1 immunotherapy, HSPA4 upregulation is observed in responders compared with non-responders.\\n    \\n\\n\\n\\n\\n\\n          Conclusion:\\n        \\n\\n      \\n      HSPA4 upregulation causes the decrease of CD58 in GC cells via HSPA4/ALKBH5/CD58 axis, followed by PD1/PDL1 activation and impairment of CD8\\n+\\n T cell's cytotoxicity, finally induces immune evasion of GC cells. HSPA4 upregulation is associated with worse overall survival of GC patients with only surgery. Meanwhile, HSPA4 upregulation predicts for better response in GC patients receiving the combined immunotherapy.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>HSPA4 Knockdown Retarded Progression and Development of Colorectal Cancer</td>\n",
       "      <td>34163243</td>\n",
       "      <td>https://pubmed.ncbi.nlm.nih.gov/34163243</td>\n",
       "      <td>Purpose:\\n        \\n\\n      \\n      Colorectal cancer (CRC) is a common malignancy associated with high morbidity and mortality. Heat shock 70 kDa protein 4 (HSPA4) has been shown to exert regulatory roles during tumor progression in different cancer types. Here, we investigated the expression and cellular functions of HSPA4 in CRC.\\n    \\n\\n\\n\\n\\n\\n          Materials and methods:\\n        \\n\\n      \\n      Expression of HSPA4 in CRC tissues and paracancerous tissues was analyzed by RT-qPCR and immunohistochemistry IHC staining. The functional roles of HSPA4 were explored using shRNA-mediated knockdown in HCT116 and RKO CRC cell lines, both in vitro and in tumor xenograft studies.\\n    \\n\\n\\n\\n\\n\\n          Results:\\n        \\n\\n      \\n      HSPA4 expression was significantly increased at the RNA and protein levels in CRC tissues compared with noncancerous tissues. Moreover, HSPA4 expression was positively associated with tumor stage and its high expression of HSPA4 indicated poor patient prognosis. In vitro studies established that HSPA4 knockdown inhibited proliferation and migration, causing arrest in the G2-phase of the cell cycle along with increased levels of apoptosis. This phenotype was recapitulated in vivo where HSPA4 knockdown suppressed xenograft growth. Mechanistic investigations showed silencing of HSPA4 reduced activation of the PI3K, Akt signaling axis while also downregulating the cell cycle progression markers, CCND1 and CDK6. Similarly, there was altered expression of apoptosis-related proteins consistent with the increase in apoptosis.\\n    \\n\\n\\n\\n\\n\\n          Conclusion:\\n        \\n\\n      \\n      Our findings demonstrate clinical significance for HSPA4 in CRC, further showing that HSPA4 contributes to CRC tumorigenesis through effects on proliferation, migration and survival. Thus, HSPA4 represents a novel prognostic indicator as well as a promising therapeutic target in CRC.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>HSPA4, the \"Evil Chaperone\" of the HSP Family, Delays Gastric Ulcer Healing</td>\n",
       "      <td>25732714</td>\n",
       "      <td>https://pubmed.ncbi.nlm.nih.gov/25732714</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Significant correlation between HSPA4 and prognosis and immune regulation in hepatocellular carcinoma</td>\n",
       "      <td>34754620</td>\n",
       "      <td>https://pubmed.ncbi.nlm.nih.gov/34754620</td>\n",
       "      <td>Background:\\n        \\n\\n      \\n      Hepatocellular carcinoma (HCC) is an inflammation-associated tumor involved in immune tolerance and evasion in the immune microenvironment. Heat shock proteins (HSPs) are involved in the occurrence, progression, and immune regulation of tumors. Therefore, HSPs have been considered potential therapeutic targets. Here, we aimed to elucidate the value of HSP family A (Hsp70) member 4 (HSPA4) in the diagnosis and predicting prognosis of HCC, and its relationship with immune cell infiltration, immune cell biomarkers, and immune checkpoints. Gene mutation, DNA methylation, and the pathway involved in HCC were also analyzed.\\n    \\n\\n\\n\\n\\n\\n          Methods:\\n        \\n\\n      \\n      The gene expression omnibus (GEO) and The Cancer Genome Atlas (TCGA) databases were used to compare HSPA4 expression, and the results were confirmed by immunohistochemical staining of clinical samples. R package was used to analyze the correlation between HSPA4 and cancer stage, and to establish receiver operating characteristic (ROC) curve of diagnosis, time-dependent survival ROC curve, and a nomogram model. cBioPortal and MethSurv were used to identify genetic alterations and DNA methylation, and their effect on prognosis. The Tumor Immune Estimation Resource (TIMER) was used to analyze immune cell infiltration, immune cell biomarkers, and immune checkpoints. The STRING database was used to analyze protein-protein interaction network information. Gene Ontology (GO) analysis and the Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were performed to investigate the functions of HSPA4 and its functional partner genes.\\n    \\n\\n\\n\\n\\n\\n          Results:\\n        \\n\\n      \\n      Overexpression of HSPA4 was identified in 25 cancers. Overexpression of HSPA4 considerably correlated with cancer stage and alpha-fetoprotein (AFP) level in HCC. Patients with higher HSPA4 expression showed poorer prognosis. HSPA4 expression can accurately identify tumor from normal tissue (AUC = 0.957). The area under 1-, 3-, and 5-year survival ROCs were above 0.6. The HSPA4 genetic alteration rate was 1.3%. Among the 14 DNA methylation CpG sites, seven were related to the prognosis of HCC. HSPA4 was positively related to immune cell infiltration and immune checkpoints (PD-1 and CTLA-4) in HCC. The KEGG pathway enrichment analysis revealed HSPA4 enrichment in antigen processing and presentation together with HSPA8 and HSP90AA1. We verified the value of HSPA4 in the diagnosis and predicting prognosis of HCC. HSPA4 may not only participate in the occurrence and progression but also the immune regulation of HCC. Therefore, HSPA4 can be a potential diagnostic and prognostic biomarker and a therapeutic target for HCC.</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                                                                   title  \\\n",
       "0  Tumor-educated B cells selectively promote breast cancer lymph node metastasis by HSPA4-targeting IgG   \n",
       "1                       HSPA4 upregulation induces immune evasion via ALKBH5/CD58 axis in gastric cancer   \n",
       "2                              HSPA4 Knockdown Retarded Progression and Development of Colorectal Cancer   \n",
       "3                            HSPA4, the \"Evil Chaperone\" of the HSP Family, Delays Gastric Ulcer Healing   \n",
       "4  Significant correlation between HSPA4 and prognosis and immune regulation in hepatocellular carcinoma   \n",
       "\n",
       "       pmid                                       url  \\\n",
       "0  30643287  https://pubmed.ncbi.nlm.nih.gov/30643287   \n",
       "1  38589927  https://pubmed.ncbi.nlm.nih.gov/38589927   \n",
       "2  34163243  https://pubmed.ncbi.nlm.nih.gov/34163243   \n",
       "3  25732714  https://pubmed.ncbi.nlm.nih.gov/25732714   \n",
       "4  34754620  https://pubmed.ncbi.nlm.nih.gov/34754620   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   abstract  \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Primary tumors may create the premetastatic niche in secondary organs for subsequent metastasis. Humoral immunity contributes to the progression of certain cancers, but the roles of B cells and their derived antibodies in premetastatic niche formation are poorly defined. Using a mouse model of spontaneous lymph node metastasis of breast cancer, we show that primary tumors induced B cell accumulation in draining lymph nodes. These B cells selectively promoted lymph node metastasis by producing pathogenic IgG that targeted glycosylated membrane protein HSPA4, and activated the HSPA4-binding protein ITGB5 and the downstream Src/NF-κB pathway in tumor cells for CXCR4/SDF1α-axis-mediated metastasis. High serum anti-HSPA4 IgG was correlated with high tumor HSPA4 expression and poor prognosis of breast cancer subjects. Our findings identify a key role for tumor-educated B cells and their derived antibodies in lymph node premetastatic niche formation, providing potential targets for cancer intervention.  \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Introduction:\\n        \\n\\n      \\n      Gastric cancer (GC) is one of the leading causes of cancer-related death worldwide. Recently, targeted therapies including PD1 (programmed cell death 1) antibodies have been used in advanced GC patients. However, identifying new biomarker for immunotherapy is still urgently needed. The objective of this study is to unveil the immune evasion mechanism of GC cells and identify new biomarkers for immune checkpoint blockade therapy in patients with GC.\\n    \\n\\n\\n\\n\\n\\n          Methods:\\n        \\n\\n      \\n      Coimmunoprecipitation and meRIP were performed to investigate the mechanism of immune evasion of GC cells. Cocuture system was established to evaluate the cytotoxicity of cocultured CD8\\n+\\n T cells. The clinical significance of HSPA4 upregulation was analyzed by multiplex fluorescent immunohistochemistry staining in GC tumor tissues.\\n    \\n\\n\\n\\n\\n\\n          Results:\\n        \\n\\n      \\n      Histone acetylation causes HSPA4 upregulation in GC tumor tissues. HSPA4 upregulation increases the protein stability of m\\n6\\nA demethylase ALKBH5. ALKBH5 decreases CD58 in GC cells through m\\n6\\nA methylation regulation. The cytotoxicity of CD8\\n+\\n T cells are impaired and PD1/PDL1 axis is activated when CD8\\n+\\n T cells are cocultured with HSPA4 overexpressed GC cells. HSPA4 upregulation is associated with worse 5-year overall survival of GC patients receiving only surgery. It is an independent prognosis factor for worse survival of GC patients. In GC patients receiving the combined chemotherapy with anti-PD1 immunotherapy, HSPA4 upregulation is observed in responders compared with non-responders.\\n    \\n\\n\\n\\n\\n\\n          Conclusion:\\n        \\n\\n      \\n      HSPA4 upregulation causes the decrease of CD58 in GC cells via HSPA4/ALKBH5/CD58 axis, followed by PD1/PDL1 activation and impairment of CD8\\n+\\n T cell's cytotoxicity, finally induces immune evasion of GC cells. HSPA4 upregulation is associated with worse overall survival of GC patients with only surgery. Meanwhile, HSPA4 upregulation predicts for better response in GC patients receiving the combined immunotherapy.  \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Purpose:\\n        \\n\\n      \\n      Colorectal cancer (CRC) is a common malignancy associated with high morbidity and mortality. Heat shock 70 kDa protein 4 (HSPA4) has been shown to exert regulatory roles during tumor progression in different cancer types. Here, we investigated the expression and cellular functions of HSPA4 in CRC.\\n    \\n\\n\\n\\n\\n\\n          Materials and methods:\\n        \\n\\n      \\n      Expression of HSPA4 in CRC tissues and paracancerous tissues was analyzed by RT-qPCR and immunohistochemistry IHC staining. The functional roles of HSPA4 were explored using shRNA-mediated knockdown in HCT116 and RKO CRC cell lines, both in vitro and in tumor xenograft studies.\\n    \\n\\n\\n\\n\\n\\n          Results:\\n        \\n\\n      \\n      HSPA4 expression was significantly increased at the RNA and protein levels in CRC tissues compared with noncancerous tissues. Moreover, HSPA4 expression was positively associated with tumor stage and its high expression of HSPA4 indicated poor patient prognosis. In vitro studies established that HSPA4 knockdown inhibited proliferation and migration, causing arrest in the G2-phase of the cell cycle along with increased levels of apoptosis. This phenotype was recapitulated in vivo where HSPA4 knockdown suppressed xenograft growth. Mechanistic investigations showed silencing of HSPA4 reduced activation of the PI3K, Akt signaling axis while also downregulating the cell cycle progression markers, CCND1 and CDK6. Similarly, there was altered expression of apoptosis-related proteins consistent with the increase in apoptosis.\\n    \\n\\n\\n\\n\\n\\n          Conclusion:\\n        \\n\\n      \\n      Our findings demonstrate clinical significance for HSPA4 in CRC, further showing that HSPA4 contributes to CRC tumorigenesis through effects on proliferation, migration and survival. Thus, HSPA4 represents a novel prognostic indicator as well as a promising therapeutic target in CRC.  \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       NaN  \n",
       "4  Background:\\n        \\n\\n      \\n      Hepatocellular carcinoma (HCC) is an inflammation-associated tumor involved in immune tolerance and evasion in the immune microenvironment. Heat shock proteins (HSPs) are involved in the occurrence, progression, and immune regulation of tumors. Therefore, HSPs have been considered potential therapeutic targets. Here, we aimed to elucidate the value of HSP family A (Hsp70) member 4 (HSPA4) in the diagnosis and predicting prognosis of HCC, and its relationship with immune cell infiltration, immune cell biomarkers, and immune checkpoints. Gene mutation, DNA methylation, and the pathway involved in HCC were also analyzed.\\n    \\n\\n\\n\\n\\n\\n          Methods:\\n        \\n\\n      \\n      The gene expression omnibus (GEO) and The Cancer Genome Atlas (TCGA) databases were used to compare HSPA4 expression, and the results were confirmed by immunohistochemical staining of clinical samples. R package was used to analyze the correlation between HSPA4 and cancer stage, and to establish receiver operating characteristic (ROC) curve of diagnosis, time-dependent survival ROC curve, and a nomogram model. cBioPortal and MethSurv were used to identify genetic alterations and DNA methylation, and their effect on prognosis. The Tumor Immune Estimation Resource (TIMER) was used to analyze immune cell infiltration, immune cell biomarkers, and immune checkpoints. The STRING database was used to analyze protein-protein interaction network information. Gene Ontology (GO) analysis and the Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were performed to investigate the functions of HSPA4 and its functional partner genes.\\n    \\n\\n\\n\\n\\n\\n          Results:\\n        \\n\\n      \\n      Overexpression of HSPA4 was identified in 25 cancers. Overexpression of HSPA4 considerably correlated with cancer stage and alpha-fetoprotein (AFP) level in HCC. Patients with higher HSPA4 expression showed poorer prognosis. HSPA4 expression can accurately identify tumor from normal tissue (AUC = 0.957). The area under 1-, 3-, and 5-year survival ROCs were above 0.6. The HSPA4 genetic alteration rate was 1.3%. Among the 14 DNA methylation CpG sites, seven were related to the prognosis of HCC. HSPA4 was positively related to immune cell infiltration and immune checkpoints (PD-1 and CTLA-4) in HCC. The KEGG pathway enrichment analysis revealed HSPA4 enrichment in antigen processing and presentation together with HSPA8 and HSP90AA1. We verified the value of HSPA4 in the diagnosis and predicting prognosis of HCC. HSPA4 may not only participate in the occurrence and progression but also the immune regulation of HCC. Therefore, HSPA4 can be a potential diagnostic and prognostic biomarker and a therapeutic target for HCC.  "
      ]
     },
     "execution_count": 469,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df = pd.read_csv(\"pubmed_scraped_data_hspa4.csv\")\n",
    "df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 470,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "title       0\n",
       "pmid        0\n",
       "url         0\n",
       "abstract    2\n",
       "dtype: int64"
      ]
     },
     "execution_count": 470,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#check for missing values\n",
    "df.isnull().sum()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 471,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "title       0\n",
       "pmid        0\n",
       "url         0\n",
       "abstract    0\n",
       "dtype: int64"
      ]
     },
     "execution_count": 471,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.dropna(inplace=True) # Drop missing values\n",
    "\n",
    "#check for missing values\n",
    "df.isnull().sum()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 472,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>title</th>\n",
       "      <th>pmid</th>\n",
       "      <th>url</th>\n",
       "      <th>abstract</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Tumor-educated B cells selectively promote breast cancer lymph node metastasis by HSPA4-targeting IgG</td>\n",
       "      <td>30643287</td>\n",
       "      <td>https://pubmed.ncbi.nlm.nih.gov/30643287</td>\n",
       "      <td>Primary tumors may create the premetastatic niche in secondary organs for subsequent metastasis. Humoral immunity contributes to the progression of certain cancers, but the roles of B cells and their derived antibodies in premetastatic niche formation are poorly defined. Using a mouse model of spontaneous lymph node metastasis of breast cancer, we show that primary tumors induced B cell accumulation in draining lymph nodes. These B cells selectively promoted lymph node metastasis by producing pathogenic IgG that targeted glycosylated membrane protein HSPA4, and activated the HSPA4-binding protein ITGB5 and the downstream Src/NF-κB pathway in tumor cells for CXCR4/SDF1α-axis-mediated metastasis. High serum anti-HSPA4 IgG was correlated with high tumor HSPA4 expression and poor prognosis of breast cancer subjects. Our findings identify a key role for tumor-educated B cells and their derived antibodies in lymph node premetastatic niche formation, providing potential targets for cancer intervention.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>HSPA4 upregulation induces immune evasion via ALKBH5/CD58 axis in gastric cancer</td>\n",
       "      <td>38589927</td>\n",
       "      <td>https://pubmed.ncbi.nlm.nih.gov/38589927</td>\n",
       "      <td>Introduction:\\n        \\n\\n      \\n      Gastric cancer (GC) is one of the leading causes of cancer-related death worldwide. Recently, targeted therapies including PD1 (programmed cell death 1) antibodies have been used in advanced GC patients. However, identifying new biomarker for immunotherapy is still urgently needed. The objective of this study is to unveil the immune evasion mechanism of GC cells and identify new biomarkers for immune checkpoint blockade therapy in patients with GC.\\n    \\n\\n\\n\\n\\n\\n          Methods:\\n        \\n\\n      \\n      Coimmunoprecipitation and meRIP were performed to investigate the mechanism of immune evasion of GC cells. Cocuture system was established to evaluate the cytotoxicity of cocultured CD8\\n+\\n T cells. The clinical significance of HSPA4 upregulation was analyzed by multiplex fluorescent immunohistochemistry staining in GC tumor tissues.\\n    \\n\\n\\n\\n\\n\\n          Results:\\n        \\n\\n      \\n      Histone acetylation causes HSPA4 upregulation in GC tumor tissues. HSPA4 upregulation increases the protein stability of m\\n6\\nA demethylase ALKBH5. ALKBH5 decreases CD58 in GC cells through m\\n6\\nA methylation regulation. The cytotoxicity of CD8\\n+\\n T cells are impaired and PD1/PDL1 axis is activated when CD8\\n+\\n T cells are cocultured with HSPA4 overexpressed GC cells. HSPA4 upregulation is associated with worse 5-year overall survival of GC patients receiving only surgery. It is an independent prognosis factor for worse survival of GC patients. In GC patients receiving the combined chemotherapy with anti-PD1 immunotherapy, HSPA4 upregulation is observed in responders compared with non-responders.\\n    \\n\\n\\n\\n\\n\\n          Conclusion:\\n        \\n\\n      \\n      HSPA4 upregulation causes the decrease of CD58 in GC cells via HSPA4/ALKBH5/CD58 axis, followed by PD1/PDL1 activation and impairment of CD8\\n+\\n T cell's cytotoxicity, finally induces immune evasion of GC cells. HSPA4 upregulation is associated with worse overall survival of GC patients with only surgery. Meanwhile, HSPA4 upregulation predicts for better response in GC patients receiving the combined immunotherapy.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>HSPA4 Knockdown Retarded Progression and Development of Colorectal Cancer</td>\n",
       "      <td>34163243</td>\n",
       "      <td>https://pubmed.ncbi.nlm.nih.gov/34163243</td>\n",
       "      <td>Purpose:\\n        \\n\\n      \\n      Colorectal cancer (CRC) is a common malignancy associated with high morbidity and mortality. Heat shock 70 kDa protein 4 (HSPA4) has been shown to exert regulatory roles during tumor progression in different cancer types. Here, we investigated the expression and cellular functions of HSPA4 in CRC.\\n    \\n\\n\\n\\n\\n\\n          Materials and methods:\\n        \\n\\n      \\n      Expression of HSPA4 in CRC tissues and paracancerous tissues was analyzed by RT-qPCR and immunohistochemistry IHC staining. The functional roles of HSPA4 were explored using shRNA-mediated knockdown in HCT116 and RKO CRC cell lines, both in vitro and in tumor xenograft studies.\\n    \\n\\n\\n\\n\\n\\n          Results:\\n        \\n\\n      \\n      HSPA4 expression was significantly increased at the RNA and protein levels in CRC tissues compared with noncancerous tissues. Moreover, HSPA4 expression was positively associated with tumor stage and its high expression of HSPA4 indicated poor patient prognosis. In vitro studies established that HSPA4 knockdown inhibited proliferation and migration, causing arrest in the G2-phase of the cell cycle along with increased levels of apoptosis. This phenotype was recapitulated in vivo where HSPA4 knockdown suppressed xenograft growth. Mechanistic investigations showed silencing of HSPA4 reduced activation of the PI3K, Akt signaling axis while also downregulating the cell cycle progression markers, CCND1 and CDK6. Similarly, there was altered expression of apoptosis-related proteins consistent with the increase in apoptosis.\\n    \\n\\n\\n\\n\\n\\n          Conclusion:\\n        \\n\\n      \\n      Our findings demonstrate clinical significance for HSPA4 in CRC, further showing that HSPA4 contributes to CRC tumorigenesis through effects on proliferation, migration and survival. Thus, HSPA4 represents a novel prognostic indicator as well as a promising therapeutic target in CRC.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Significant correlation between HSPA4 and prognosis and immune regulation in hepatocellular carcinoma</td>\n",
       "      <td>34754620</td>\n",
       "      <td>https://pubmed.ncbi.nlm.nih.gov/34754620</td>\n",
       "      <td>Background:\\n        \\n\\n      \\n      Hepatocellular carcinoma (HCC) is an inflammation-associated tumor involved in immune tolerance and evasion in the immune microenvironment. Heat shock proteins (HSPs) are involved in the occurrence, progression, and immune regulation of tumors. Therefore, HSPs have been considered potential therapeutic targets. Here, we aimed to elucidate the value of HSP family A (Hsp70) member 4 (HSPA4) in the diagnosis and predicting prognosis of HCC, and its relationship with immune cell infiltration, immune cell biomarkers, and immune checkpoints. Gene mutation, DNA methylation, and the pathway involved in HCC were also analyzed.\\n    \\n\\n\\n\\n\\n\\n          Methods:\\n        \\n\\n      \\n      The gene expression omnibus (GEO) and The Cancer Genome Atlas (TCGA) databases were used to compare HSPA4 expression, and the results were confirmed by immunohistochemical staining of clinical samples. R package was used to analyze the correlation between HSPA4 and cancer stage, and to establish receiver operating characteristic (ROC) curve of diagnosis, time-dependent survival ROC curve, and a nomogram model. cBioPortal and MethSurv were used to identify genetic alterations and DNA methylation, and their effect on prognosis. The Tumor Immune Estimation Resource (TIMER) was used to analyze immune cell infiltration, immune cell biomarkers, and immune checkpoints. The STRING database was used to analyze protein-protein interaction network information. Gene Ontology (GO) analysis and the Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were performed to investigate the functions of HSPA4 and its functional partner genes.\\n    \\n\\n\\n\\n\\n\\n          Results:\\n        \\n\\n      \\n      Overexpression of HSPA4 was identified in 25 cancers. Overexpression of HSPA4 considerably correlated with cancer stage and alpha-fetoprotein (AFP) level in HCC. Patients with higher HSPA4 expression showed poorer prognosis. HSPA4 expression can accurately identify tumor from normal tissue (AUC = 0.957). The area under 1-, 3-, and 5-year survival ROCs were above 0.6. The HSPA4 genetic alteration rate was 1.3%. Among the 14 DNA methylation CpG sites, seven were related to the prognosis of HCC. HSPA4 was positively related to immune cell infiltration and immune checkpoints (PD-1 and CTLA-4) in HCC. The KEGG pathway enrichment analysis revealed HSPA4 enrichment in antigen processing and presentation together with HSPA8 and HSP90AA1. We verified the value of HSPA4 in the diagnosis and predicting prognosis of HCC. HSPA4 may not only participate in the occurrence and progression but also the immune regulation of HCC. Therefore, HSPA4 can be a potential diagnostic and prognostic biomarker and a therapeutic target for HCC.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>HSPA4 regulated glioma progression via activation of AKT signaling pathway</td>\n",
       "      <td>37339521</td>\n",
       "      <td>https://pubmed.ncbi.nlm.nih.gov/37339521</td>\n",
       "      <td>Glioma is still an incurable disease with high invasiveness. Heat shock 70 kDa protein 4 (HSPA4) is a member of the HSP110 family, and is associated with the development and progression of various cancers. In the current study, we assessed the expression of HSPA4 in clinical samples, and found that HSPA4 was up-regulated in glioma tissues and correlated with tumor recurrence and grade. Survival analyses demonstrated that glioma patients with high HSPA4 expression had lower overall survival and disease-free survival times. In vitro knockdown of HSPA4 inhibited glioma cell proliferation, mediated cell cycle arrest at G2 phase and apoptosis, and reduced the migration ability. In vivo, the growth of HSPA4-knockdown xenografts was markedly suppressed compared to the tumors formed by HSPA4-positive control cells. Additionally, Gene set enrichment analyses disclosed that HSPA4 was associated with the PI3K/Akt signaling pathway. The regulatory effect of the AKT activator SC79 on cell proliferation and apoptosis was suppressed by HSPA4 knockdown, indicating that HSPA4 is capable of promoting glioma development. In summary, these data showed that HSPA4 is likely to play a pivotal role in the progression of glioma, and consequently may be a promising therapeutic target for glioma therapy.</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                                                                   title  \\\n",
       "0  Tumor-educated B cells selectively promote breast cancer lymph node metastasis by HSPA4-targeting IgG   \n",
       "1                       HSPA4 upregulation induces immune evasion via ALKBH5/CD58 axis in gastric cancer   \n",
       "2                              HSPA4 Knockdown Retarded Progression and Development of Colorectal Cancer   \n",
       "4  Significant correlation between HSPA4 and prognosis and immune regulation in hepatocellular carcinoma   \n",
       "5                             HSPA4 regulated glioma progression via activation of AKT signaling pathway   \n",
       "\n",
       "       pmid                                       url  \\\n",
       "0  30643287  https://pubmed.ncbi.nlm.nih.gov/30643287   \n",
       "1  38589927  https://pubmed.ncbi.nlm.nih.gov/38589927   \n",
       "2  34163243  https://pubmed.ncbi.nlm.nih.gov/34163243   \n",
       "4  34754620  https://pubmed.ncbi.nlm.nih.gov/34754620   \n",
       "5  37339521  https://pubmed.ncbi.nlm.nih.gov/37339521   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   abstract  \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Primary tumors may create the premetastatic niche in secondary organs for subsequent metastasis. Humoral immunity contributes to the progression of certain cancers, but the roles of B cells and their derived antibodies in premetastatic niche formation are poorly defined. Using a mouse model of spontaneous lymph node metastasis of breast cancer, we show that primary tumors induced B cell accumulation in draining lymph nodes. These B cells selectively promoted lymph node metastasis by producing pathogenic IgG that targeted glycosylated membrane protein HSPA4, and activated the HSPA4-binding protein ITGB5 and the downstream Src/NF-κB pathway in tumor cells for CXCR4/SDF1α-axis-mediated metastasis. High serum anti-HSPA4 IgG was correlated with high tumor HSPA4 expression and poor prognosis of breast cancer subjects. Our findings identify a key role for tumor-educated B cells and their derived antibodies in lymph node premetastatic niche formation, providing potential targets for cancer intervention.  \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Introduction:\\n        \\n\\n      \\n      Gastric cancer (GC) is one of the leading causes of cancer-related death worldwide. Recently, targeted therapies including PD1 (programmed cell death 1) antibodies have been used in advanced GC patients. However, identifying new biomarker for immunotherapy is still urgently needed. The objective of this study is to unveil the immune evasion mechanism of GC cells and identify new biomarkers for immune checkpoint blockade therapy in patients with GC.\\n    \\n\\n\\n\\n\\n\\n          Methods:\\n        \\n\\n      \\n      Coimmunoprecipitation and meRIP were performed to investigate the mechanism of immune evasion of GC cells. Cocuture system was established to evaluate the cytotoxicity of cocultured CD8\\n+\\n T cells. The clinical significance of HSPA4 upregulation was analyzed by multiplex fluorescent immunohistochemistry staining in GC tumor tissues.\\n    \\n\\n\\n\\n\\n\\n          Results:\\n        \\n\\n      \\n      Histone acetylation causes HSPA4 upregulation in GC tumor tissues. HSPA4 upregulation increases the protein stability of m\\n6\\nA demethylase ALKBH5. ALKBH5 decreases CD58 in GC cells through m\\n6\\nA methylation regulation. The cytotoxicity of CD8\\n+\\n T cells are impaired and PD1/PDL1 axis is activated when CD8\\n+\\n T cells are cocultured with HSPA4 overexpressed GC cells. HSPA4 upregulation is associated with worse 5-year overall survival of GC patients receiving only surgery. It is an independent prognosis factor for worse survival of GC patients. In GC patients receiving the combined chemotherapy with anti-PD1 immunotherapy, HSPA4 upregulation is observed in responders compared with non-responders.\\n    \\n\\n\\n\\n\\n\\n          Conclusion:\\n        \\n\\n      \\n      HSPA4 upregulation causes the decrease of CD58 in GC cells via HSPA4/ALKBH5/CD58 axis, followed by PD1/PDL1 activation and impairment of CD8\\n+\\n T cell's cytotoxicity, finally induces immune evasion of GC cells. HSPA4 upregulation is associated with worse overall survival of GC patients with only surgery. Meanwhile, HSPA4 upregulation predicts for better response in GC patients receiving the combined immunotherapy.  \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Purpose:\\n        \\n\\n      \\n      Colorectal cancer (CRC) is a common malignancy associated with high morbidity and mortality. Heat shock 70 kDa protein 4 (HSPA4) has been shown to exert regulatory roles during tumor progression in different cancer types. Here, we investigated the expression and cellular functions of HSPA4 in CRC.\\n    \\n\\n\\n\\n\\n\\n          Materials and methods:\\n        \\n\\n      \\n      Expression of HSPA4 in CRC tissues and paracancerous tissues was analyzed by RT-qPCR and immunohistochemistry IHC staining. The functional roles of HSPA4 were explored using shRNA-mediated knockdown in HCT116 and RKO CRC cell lines, both in vitro and in tumor xenograft studies.\\n    \\n\\n\\n\\n\\n\\n          Results:\\n        \\n\\n      \\n      HSPA4 expression was significantly increased at the RNA and protein levels in CRC tissues compared with noncancerous tissues. Moreover, HSPA4 expression was positively associated with tumor stage and its high expression of HSPA4 indicated poor patient prognosis. In vitro studies established that HSPA4 knockdown inhibited proliferation and migration, causing arrest in the G2-phase of the cell cycle along with increased levels of apoptosis. This phenotype was recapitulated in vivo where HSPA4 knockdown suppressed xenograft growth. Mechanistic investigations showed silencing of HSPA4 reduced activation of the PI3K, Akt signaling axis while also downregulating the cell cycle progression markers, CCND1 and CDK6. Similarly, there was altered expression of apoptosis-related proteins consistent with the increase in apoptosis.\\n    \\n\\n\\n\\n\\n\\n          Conclusion:\\n        \\n\\n      \\n      Our findings demonstrate clinical significance for HSPA4 in CRC, further showing that HSPA4 contributes to CRC tumorigenesis through effects on proliferation, migration and survival. Thus, HSPA4 represents a novel prognostic indicator as well as a promising therapeutic target in CRC.  \n",
       "4  Background:\\n        \\n\\n      \\n      Hepatocellular carcinoma (HCC) is an inflammation-associated tumor involved in immune tolerance and evasion in the immune microenvironment. Heat shock proteins (HSPs) are involved in the occurrence, progression, and immune regulation of tumors. Therefore, HSPs have been considered potential therapeutic targets. Here, we aimed to elucidate the value of HSP family A (Hsp70) member 4 (HSPA4) in the diagnosis and predicting prognosis of HCC, and its relationship with immune cell infiltration, immune cell biomarkers, and immune checkpoints. Gene mutation, DNA methylation, and the pathway involved in HCC were also analyzed.\\n    \\n\\n\\n\\n\\n\\n          Methods:\\n        \\n\\n      \\n      The gene expression omnibus (GEO) and The Cancer Genome Atlas (TCGA) databases were used to compare HSPA4 expression, and the results were confirmed by immunohistochemical staining of clinical samples. R package was used to analyze the correlation between HSPA4 and cancer stage, and to establish receiver operating characteristic (ROC) curve of diagnosis, time-dependent survival ROC curve, and a nomogram model. cBioPortal and MethSurv were used to identify genetic alterations and DNA methylation, and their effect on prognosis. The Tumor Immune Estimation Resource (TIMER) was used to analyze immune cell infiltration, immune cell biomarkers, and immune checkpoints. The STRING database was used to analyze protein-protein interaction network information. Gene Ontology (GO) analysis and the Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were performed to investigate the functions of HSPA4 and its functional partner genes.\\n    \\n\\n\\n\\n\\n\\n          Results:\\n        \\n\\n      \\n      Overexpression of HSPA4 was identified in 25 cancers. Overexpression of HSPA4 considerably correlated with cancer stage and alpha-fetoprotein (AFP) level in HCC. Patients with higher HSPA4 expression showed poorer prognosis. HSPA4 expression can accurately identify tumor from normal tissue (AUC = 0.957). The area under 1-, 3-, and 5-year survival ROCs were above 0.6. The HSPA4 genetic alteration rate was 1.3%. Among the 14 DNA methylation CpG sites, seven were related to the prognosis of HCC. HSPA4 was positively related to immune cell infiltration and immune checkpoints (PD-1 and CTLA-4) in HCC. The KEGG pathway enrichment analysis revealed HSPA4 enrichment in antigen processing and presentation together with HSPA8 and HSP90AA1. We verified the value of HSPA4 in the diagnosis and predicting prognosis of HCC. HSPA4 may not only participate in the occurrence and progression but also the immune regulation of HCC. Therefore, HSPA4 can be a potential diagnostic and prognostic biomarker and a therapeutic target for HCC.  \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Glioma is still an incurable disease with high invasiveness. Heat shock 70 kDa protein 4 (HSPA4) is a member of the HSP110 family, and is associated with the development and progression of various cancers. In the current study, we assessed the expression of HSPA4 in clinical samples, and found that HSPA4 was up-regulated in glioma tissues and correlated with tumor recurrence and grade. Survival analyses demonstrated that glioma patients with high HSPA4 expression had lower overall survival and disease-free survival times. In vitro knockdown of HSPA4 inhibited glioma cell proliferation, mediated cell cycle arrest at G2 phase and apoptosis, and reduced the migration ability. In vivo, the growth of HSPA4-knockdown xenografts was markedly suppressed compared to the tumors formed by HSPA4-positive control cells. Additionally, Gene set enrichment analyses disclosed that HSPA4 was associated with the PI3K/Akt signaling pathway. The regulatory effect of the AKT activator SC79 on cell proliferation and apoptosis was suppressed by HSPA4 knockdown, indicating that HSPA4 is capable of promoting glioma development. In summary, these data showed that HSPA4 is likely to play a pivotal role in the progression of glioma, and consequently may be a promising therapeutic target for glioma therapy.  "
      ]
     },
     "execution_count": 472,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df['abstract'] = df['abstract'].astype(str) # Convert abstract to string\n",
    "df.head()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Step 2: Data Preprocessing"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 473,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Define a custom preprocessing component\n",
    "def custom_preprocessor(text):\n",
    "    text = re.sub(r'<[^>]+>', '', text)  # Remove HTML tags\n",
    "    text = re.sub(r'[^a-zA-Z0-9\\s]', '', text)  # Remove special characters\n",
    "    text = text.lower()  # Lowercase\n",
    "    text = re.sub(r'\\n', '', text) # Remove newline character\n",
    "    sentences = sent_tokenize(text)  # Sentence tokenization\n",
    "    return sentences"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 474,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>title</th>\n",
       "      <th>pmid</th>\n",
       "      <th>url</th>\n",
       "      <th>abstract</th>\n",
       "      <th>Title_Sentences</th>\n",
       "      <th>Abstract_Sentences</th>\n",
       "      <th>Combined_Sentences</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Tumor-educated B cells selectively promote breast cancer lymph node metastasis by HSPA4-targeting IgG</td>\n",
       "      <td>30643287</td>\n",
       "      <td>https://pubmed.ncbi.nlm.nih.gov/30643287</td>\n",
       "      <td>Primary tumors may create the premetastatic niche in secondary organs for subsequent metastasis. Humoral immunity contributes to the progression of certain cancers, but the roles of B cells and their derived antibodies in premetastatic niche formation are poorly defined. Using a mouse model of spontaneous lymph node metastasis of breast cancer, we show that primary tumors induced B cell accumulation in draining lymph nodes. These B cells selectively promoted lymph node metastasis by producing pathogenic IgG that targeted glycosylated membrane protein HSPA4, and activated the HSPA4-binding protein ITGB5 and the downstream Src/NF-κB pathway in tumor cells for CXCR4/SDF1α-axis-mediated metastasis. High serum anti-HSPA4 IgG was correlated with high tumor HSPA4 expression and poor prognosis of breast cancer subjects. Our findings identify a key role for tumor-educated B cells and their derived antibodies in lymph node premetastatic niche formation, providing potential targets for cancer intervention.</td>\n",
       "      <td>[tumoreducated b cells selectively promote breast cancer lymph node metastasis by hspa4targeting igg]</td>\n",
       "      <td>[primary tumors may create the premetastatic niche in secondary organs for subsequent metastasis humoral immunity contributes to the progression of certain cancers but the roles of b cells and their derived antibodies in premetastatic niche formation are poorly defined using a mouse model of spontaneous lymph node metastasis of breast cancer we show that primary tumors induced b cell accumulation in draining lymph nodes these b cells selectively promoted lymph node metastasis by producing pathogenic igg that targeted glycosylated membrane protein hspa4 and activated the hspa4binding protein itgb5 and the downstream srcnfb pathway in tumor cells for cxcr4sdf1axismediated metastasis high serum antihspa4 igg was correlated with high tumor hspa4 expression and poor prognosis of breast cancer subjects our findings identify a key role for tumoreducated b cells and their derived antibodies in lymph node premetastatic niche formation providing potential targets for cancer intervention]</td>\n",
       "      <td>tumoreducated b cells selectively promote breast cancer lymph node metastasis by hspa4targeting igg primary tumors may create the premetastatic niche in secondary organs for subsequent metastasis humoral immunity contributes to the progression of certain cancers but the roles of b cells and their derived antibodies in premetastatic niche formation are poorly defined using a mouse model of spontaneous lymph node metastasis of breast cancer we show that primary tumors induced b cell accumulation in draining lymph nodes these b cells selectively promoted lymph node metastasis by producing pathogenic igg that targeted glycosylated membrane protein hspa4 and activated the hspa4binding protein itgb5 and the downstream srcnfb pathway in tumor cells for cxcr4sdf1axismediated metastasis high serum antihspa4 igg was correlated with high tumor hspa4 expression and poor prognosis of breast cancer subjects our findings identify a key role for tumoreducated b cells and their derived antibodies in lymph node premetastatic niche formation providing potential targets for cancer intervention</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>HSPA4 upregulation induces immune evasion via ALKBH5/CD58 axis in gastric cancer</td>\n",
       "      <td>38589927</td>\n",
       "      <td>https://pubmed.ncbi.nlm.nih.gov/38589927</td>\n",
       "      <td>Introduction:\\n        \\n\\n      \\n      Gastric cancer (GC) is one of the leading causes of cancer-related death worldwide. Recently, targeted therapies including PD1 (programmed cell death 1) antibodies have been used in advanced GC patients. However, identifying new biomarker for immunotherapy is still urgently needed. The objective of this study is to unveil the immune evasion mechanism of GC cells and identify new biomarkers for immune checkpoint blockade therapy in patients with GC.\\n    \\n\\n\\n\\n\\n\\n          Methods:\\n        \\n\\n      \\n      Coimmunoprecipitation and meRIP were performed to investigate the mechanism of immune evasion of GC cells. Cocuture system was established to evaluate the cytotoxicity of cocultured CD8\\n+\\n T cells. The clinical significance of HSPA4 upregulation was analyzed by multiplex fluorescent immunohistochemistry staining in GC tumor tissues.\\n    \\n\\n\\n\\n\\n\\n          Results:\\n        \\n\\n      \\n      Histone acetylation causes HSPA4 upregulation in GC tumor tissues. HSPA4 upregulation increases the protein stability of m\\n6\\nA demethylase ALKBH5. ALKBH5 decreases CD58 in GC cells through m\\n6\\nA methylation regulation. The cytotoxicity of CD8\\n+\\n T cells are impaired and PD1/PDL1 axis is activated when CD8\\n+\\n T cells are cocultured with HSPA4 overexpressed GC cells. HSPA4 upregulation is associated with worse 5-year overall survival of GC patients receiving only surgery. It is an independent prognosis factor for worse survival of GC patients. In GC patients receiving the combined chemotherapy with anti-PD1 immunotherapy, HSPA4 upregulation is observed in responders compared with non-responders.\\n    \\n\\n\\n\\n\\n\\n          Conclusion:\\n        \\n\\n      \\n      HSPA4 upregulation causes the decrease of CD58 in GC cells via HSPA4/ALKBH5/CD58 axis, followed by PD1/PDL1 activation and impairment of CD8\\n+\\n T cell's cytotoxicity, finally induces immune evasion of GC cells. HSPA4 upregulation is associated with worse overall survival of GC patients with only surgery. Meanwhile, HSPA4 upregulation predicts for better response in GC patients receiving the combined immunotherapy.</td>\n",
       "      <td>[hspa4 upregulation induces immune evasion via alkbh5cd58 axis in gastric cancer]</td>\n",
       "      <td>[introduction                    gastric cancer gc is one of the leading causes of cancerrelated death worldwide recently targeted therapies including pd1 programmed cell death 1 antibodies have been used in advanced gc patients however identifying new biomarker for immunotherapy is still urgently needed the objective of this study is to unveil the immune evasion mechanism of gc cells and identify new biomarkers for immune checkpoint blockade therapy in patients with gc              methods                    coimmunoprecipitation and merip were performed to investigate the mechanism of immune evasion of gc cells cocuture system was established to evaluate the cytotoxicity of cocultured cd8 t cells the clinical significance of hspa4 upregulation was analyzed by multiplex fluorescent immunohistochemistry staining in gc tumor tissues              results                    histone acetylation causes hspa4 upregulation in gc tumor tissues hspa4 upregulation increases the protein stability of m6a demethylase alkbh5 alkbh5 decreases cd58 in gc cells through m6a methylation regulation the cytotoxicity of cd8 t cells are impaired and pd1pdl1 axis is activated when cd8 t cells are cocultured with hspa4 overexpressed gc cells hspa4 upregulation is associated with worse 5year overall survival of gc patients receiving only surgery it is an independent prognosis factor for worse survival of gc patients in gc patients receiving the combined chemotherapy with antipd1 immunotherapy hspa4 upregulation is observed in responders compared with nonresponders              conclusion                    hspa4 upregulation causes the decrease of cd58 in gc cells via hspa4alkbh5cd58 axis followed by pd1pdl1 activation and impairment of cd8 t cells cytotoxicity finally induces immune evasion of gc cells hspa4 upregulation is associated with worse overall survival of gc patients with only surgery meanwhile hspa4 upregulation predicts for better response in gc patients receiving the combined immunotherapy]</td>\n",
       "      <td>hspa4 upregulation induces immune evasion via alkbh5cd58 axis in gastric cancer introduction                    gastric cancer gc is one of the leading causes of cancerrelated death worldwide recently targeted therapies including pd1 programmed cell death 1 antibodies have been used in advanced gc patients however identifying new biomarker for immunotherapy is still urgently needed the objective of this study is to unveil the immune evasion mechanism of gc cells and identify new biomarkers for immune checkpoint blockade therapy in patients with gc              methods                    coimmunoprecipitation and merip were performed to investigate the mechanism of immune evasion of gc cells cocuture system was established to evaluate the cytotoxicity of cocultured cd8 t cells the clinical significance of hspa4 upregulation was analyzed by multiplex fluorescent immunohistochemistry staining in gc tumor tissues              results                    histone acetylation causes hspa4 upregulation in gc tumor tissues hspa4 upregulation increases the protein stability of m6a demethylase alkbh5 alkbh5 decreases cd58 in gc cells through m6a methylation regulation the cytotoxicity of cd8 t cells are impaired and pd1pdl1 axis is activated when cd8 t cells are cocultured with hspa4 overexpressed gc cells hspa4 upregulation is associated with worse 5year overall survival of gc patients receiving only surgery it is an independent prognosis factor for worse survival of gc patients in gc patients receiving the combined chemotherapy with antipd1 immunotherapy hspa4 upregulation is observed in responders compared with nonresponders              conclusion                    hspa4 upregulation causes the decrease of cd58 in gc cells via hspa4alkbh5cd58 axis followed by pd1pdl1 activation and impairment of cd8 t cells cytotoxicity finally induces immune evasion of gc cells hspa4 upregulation is associated with worse overall survival of gc patients with only surgery meanwhile hspa4 upregulation predicts for better response in gc patients receiving the combined immunotherapy</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>HSPA4 Knockdown Retarded Progression and Development of Colorectal Cancer</td>\n",
       "      <td>34163243</td>\n",
       "      <td>https://pubmed.ncbi.nlm.nih.gov/34163243</td>\n",
       "      <td>Purpose:\\n        \\n\\n      \\n      Colorectal cancer (CRC) is a common malignancy associated with high morbidity and mortality. Heat shock 70 kDa protein 4 (HSPA4) has been shown to exert regulatory roles during tumor progression in different cancer types. Here, we investigated the expression and cellular functions of HSPA4 in CRC.\\n    \\n\\n\\n\\n\\n\\n          Materials and methods:\\n        \\n\\n      \\n      Expression of HSPA4 in CRC tissues and paracancerous tissues was analyzed by RT-qPCR and immunohistochemistry IHC staining. The functional roles of HSPA4 were explored using shRNA-mediated knockdown in HCT116 and RKO CRC cell lines, both in vitro and in tumor xenograft studies.\\n    \\n\\n\\n\\n\\n\\n          Results:\\n        \\n\\n      \\n      HSPA4 expression was significantly increased at the RNA and protein levels in CRC tissues compared with noncancerous tissues. Moreover, HSPA4 expression was positively associated with tumor stage and its high expression of HSPA4 indicated poor patient prognosis. In vitro studies established that HSPA4 knockdown inhibited proliferation and migration, causing arrest in the G2-phase of the cell cycle along with increased levels of apoptosis. This phenotype was recapitulated in vivo where HSPA4 knockdown suppressed xenograft growth. Mechanistic investigations showed silencing of HSPA4 reduced activation of the PI3K, Akt signaling axis while also downregulating the cell cycle progression markers, CCND1 and CDK6. Similarly, there was altered expression of apoptosis-related proteins consistent with the increase in apoptosis.\\n    \\n\\n\\n\\n\\n\\n          Conclusion:\\n        \\n\\n      \\n      Our findings demonstrate clinical significance for HSPA4 in CRC, further showing that HSPA4 contributes to CRC tumorigenesis through effects on proliferation, migration and survival. Thus, HSPA4 represents a novel prognostic indicator as well as a promising therapeutic target in CRC.</td>\n",
       "      <td>[hspa4 knockdown retarded progression and development of colorectal cancer]</td>\n",
       "      <td>[purpose                    colorectal cancer crc is a common malignancy associated with high morbidity and mortality heat shock 70 kda protein 4 hspa4 has been shown to exert regulatory roles during tumor progression in different cancer types here we investigated the expression and cellular functions of hspa4 in crc              materials and methods                    expression of hspa4 in crc tissues and paracancerous tissues was analyzed by rtqpcr and immunohistochemistry ihc staining the functional roles of hspa4 were explored using shrnamediated knockdown in hct116 and rko crc cell lines both in vitro and in tumor xenograft studies              results                    hspa4 expression was significantly increased at the rna and protein levels in crc tissues compared with noncancerous tissues moreover hspa4 expression was positively associated with tumor stage and its high expression of hspa4 indicated poor patient prognosis in vitro studies established that hspa4 knockdown inhibited proliferation and migration causing arrest in the g2phase of the cell cycle along with increased levels of apoptosis this phenotype was recapitulated in vivo where hspa4 knockdown suppressed xenograft growth mechanistic investigations showed silencing of hspa4 reduced activation of the pi3k akt signaling axis while also downregulating the cell cycle progression markers ccnd1 and cdk6 similarly there was altered expression of apoptosisrelated proteins consistent with the increase in apoptosis              conclusion                    our findings demonstrate clinical significance for hspa4 in crc further showing that hspa4 contributes to crc tumorigenesis through effects on proliferation migration and survival thus hspa4 represents a novel prognostic indicator as well as a promising therapeutic target in crc]</td>\n",
       "      <td>hspa4 knockdown retarded progression and development of colorectal cancer purpose                    colorectal cancer crc is a common malignancy associated with high morbidity and mortality heat shock 70 kda protein 4 hspa4 has been shown to exert regulatory roles during tumor progression in different cancer types here we investigated the expression and cellular functions of hspa4 in crc              materials and methods                    expression of hspa4 in crc tissues and paracancerous tissues was analyzed by rtqpcr and immunohistochemistry ihc staining the functional roles of hspa4 were explored using shrnamediated knockdown in hct116 and rko crc cell lines both in vitro and in tumor xenograft studies              results                    hspa4 expression was significantly increased at the rna and protein levels in crc tissues compared with noncancerous tissues moreover hspa4 expression was positively associated with tumor stage and its high expression of hspa4 indicated poor patient prognosis in vitro studies established that hspa4 knockdown inhibited proliferation and migration causing arrest in the g2phase of the cell cycle along with increased levels of apoptosis this phenotype was recapitulated in vivo where hspa4 knockdown suppressed xenograft growth mechanistic investigations showed silencing of hspa4 reduced activation of the pi3k akt signaling axis while also downregulating the cell cycle progression markers ccnd1 and cdk6 similarly there was altered expression of apoptosisrelated proteins consistent with the increase in apoptosis              conclusion                    our findings demonstrate clinical significance for hspa4 in crc further showing that hspa4 contributes to crc tumorigenesis through effects on proliferation migration and survival thus hspa4 represents a novel prognostic indicator as well as a promising therapeutic target in crc</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Significant correlation between HSPA4 and prognosis and immune regulation in hepatocellular carcinoma</td>\n",
       "      <td>34754620</td>\n",
       "      <td>https://pubmed.ncbi.nlm.nih.gov/34754620</td>\n",
       "      <td>Background:\\n        \\n\\n      \\n      Hepatocellular carcinoma (HCC) is an inflammation-associated tumor involved in immune tolerance and evasion in the immune microenvironment. Heat shock proteins (HSPs) are involved in the occurrence, progression, and immune regulation of tumors. Therefore, HSPs have been considered potential therapeutic targets. Here, we aimed to elucidate the value of HSP family A (Hsp70) member 4 (HSPA4) in the diagnosis and predicting prognosis of HCC, and its relationship with immune cell infiltration, immune cell biomarkers, and immune checkpoints. Gene mutation, DNA methylation, and the pathway involved in HCC were also analyzed.\\n    \\n\\n\\n\\n\\n\\n          Methods:\\n        \\n\\n      \\n      The gene expression omnibus (GEO) and The Cancer Genome Atlas (TCGA) databases were used to compare HSPA4 expression, and the results were confirmed by immunohistochemical staining of clinical samples. R package was used to analyze the correlation between HSPA4 and cancer stage, and to establish receiver operating characteristic (ROC) curve of diagnosis, time-dependent survival ROC curve, and a nomogram model. cBioPortal and MethSurv were used to identify genetic alterations and DNA methylation, and their effect on prognosis. The Tumor Immune Estimation Resource (TIMER) was used to analyze immune cell infiltration, immune cell biomarkers, and immune checkpoints. The STRING database was used to analyze protein-protein interaction network information. Gene Ontology (GO) analysis and the Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were performed to investigate the functions of HSPA4 and its functional partner genes.\\n    \\n\\n\\n\\n\\n\\n          Results:\\n        \\n\\n      \\n      Overexpression of HSPA4 was identified in 25 cancers. Overexpression of HSPA4 considerably correlated with cancer stage and alpha-fetoprotein (AFP) level in HCC. Patients with higher HSPA4 expression showed poorer prognosis. HSPA4 expression can accurately identify tumor from normal tissue (AUC = 0.957). The area under 1-, 3-, and 5-year survival ROCs were above 0.6. The HSPA4 genetic alteration rate was 1.3%. Among the 14 DNA methylation CpG sites, seven were related to the prognosis of HCC. HSPA4 was positively related to immune cell infiltration and immune checkpoints (PD-1 and CTLA-4) in HCC. The KEGG pathway enrichment analysis revealed HSPA4 enrichment in antigen processing and presentation together with HSPA8 and HSP90AA1. We verified the value of HSPA4 in the diagnosis and predicting prognosis of HCC. HSPA4 may not only participate in the occurrence and progression but also the immune regulation of HCC. Therefore, HSPA4 can be a potential diagnostic and prognostic biomarker and a therapeutic target for HCC.</td>\n",
       "      <td>[significant correlation between hspa4 and prognosis and immune regulation in hepatocellular carcinoma]</td>\n",
       "      <td>[background                    hepatocellular carcinoma hcc is an inflammationassociated tumor involved in immune tolerance and evasion in the immune microenvironment heat shock proteins hsps are involved in the occurrence progression and immune regulation of tumors therefore hsps have been considered potential therapeutic targets here we aimed to elucidate the value of hsp family a hsp70 member 4 hspa4 in the diagnosis and predicting prognosis of hcc and its relationship with immune cell infiltration immune cell biomarkers and immune checkpoints gene mutation dna methylation and the pathway involved in hcc were also analyzed              methods                    the gene expression omnibus geo and the cancer genome atlas tcga databases were used to compare hspa4 expression and the results were confirmed by immunohistochemical staining of clinical samples r package was used to analyze the correlation between hspa4 and cancer stage and to establish receiver operating characteristic roc curve of diagnosis timedependent survival roc curve and a nomogram model cbioportal and methsurv were used to identify genetic alterations and dna methylation and their effect on prognosis the tumor immune estimation resource timer was used to analyze immune cell infiltration immune cell biomarkers and immune checkpoints the string database was used to analyze proteinprotein interaction network information gene ontology go analysis and the kyoto encyclopedia of genes and genomes kegg analyses were performed to investigate the functions of hspa4 and its functional partner genes              results                    overexpression of hspa4 was identified in 25 cancers overexpression of hspa4 considerably correlated with cancer stage and alphafetoprotein afp level in hcc patients with higher hspa4 expression showed poorer prognosis hspa4 expression can accurately identify tumor from normal tissue auc  0957 the area under 1 3 and 5year survival rocs were above 06 the hspa4 genetic alteration rate was 13 among the 14 dna methylation cpg sites seven were related to the prognosis of hcc hspa4 was positively related to immune cell infiltration and immune checkpoints pd1 and ctla4 in hcc the kegg pathway enrichment analysis revealed hspa4 enrichment in antigen processing and presentation together with hspa8 and hsp90aa1 we verified the value of hspa4 in the diagnosis and predicting prognosis of hcc hspa4 may not only participate in the occurrence and progression but also the immune regulation of hcc therefore hspa4 can be a potential diagnostic and prognostic biomarker and a therapeutic target for hcc]</td>\n",
       "      <td>significant correlation between hspa4 and prognosis and immune regulation in hepatocellular carcinoma background                    hepatocellular carcinoma hcc is an inflammationassociated tumor involved in immune tolerance and evasion in the immune microenvironment heat shock proteins hsps are involved in the occurrence progression and immune regulation of tumors therefore hsps have been considered potential therapeutic targets here we aimed to elucidate the value of hsp family a hsp70 member 4 hspa4 in the diagnosis and predicting prognosis of hcc and its relationship with immune cell infiltration immune cell biomarkers and immune checkpoints gene mutation dna methylation and the pathway involved in hcc were also analyzed              methods                    the gene expression omnibus geo and the cancer genome atlas tcga databases were used to compare hspa4 expression and the results were confirmed by immunohistochemical staining of clinical samples r package was used to analyze the correlation between hspa4 and cancer stage and to establish receiver operating characteristic roc curve of diagnosis timedependent survival roc curve and a nomogram model cbioportal and methsurv were used to identify genetic alterations and dna methylation and their effect on prognosis the tumor immune estimation resource timer was used to analyze immune cell infiltration immune cell biomarkers and immune checkpoints the string database was used to analyze proteinprotein interaction network information gene ontology go analysis and the kyoto encyclopedia of genes and genomes kegg analyses were performed to investigate the functions of hspa4 and its functional partner genes              results                    overexpression of hspa4 was identified in 25 cancers overexpression of hspa4 considerably correlated with cancer stage and alphafetoprotein afp level in hcc patients with higher hspa4 expression showed poorer prognosis hspa4 expression can accurately identify tumor from normal tissue auc  0957 the area under 1 3 and 5year survival rocs were above 06 the hspa4 genetic alteration rate was 13 among the 14 dna methylation cpg sites seven were related to the prognosis of hcc hspa4 was positively related to immune cell infiltration and immune checkpoints pd1 and ctla4 in hcc the kegg pathway enrichment analysis revealed hspa4 enrichment in antigen processing and presentation together with hspa8 and hsp90aa1 we verified the value of hspa4 in the diagnosis and predicting prognosis of hcc hspa4 may not only participate in the occurrence and progression but also the immune regulation of hcc therefore hspa4 can be a potential diagnostic and prognostic biomarker and a therapeutic target for hcc</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>HSPA4 regulated glioma progression via activation of AKT signaling pathway</td>\n",
       "      <td>37339521</td>\n",
       "      <td>https://pubmed.ncbi.nlm.nih.gov/37339521</td>\n",
       "      <td>Glioma is still an incurable disease with high invasiveness. Heat shock 70 kDa protein 4 (HSPA4) is a member of the HSP110 family, and is associated with the development and progression of various cancers. In the current study, we assessed the expression of HSPA4 in clinical samples, and found that HSPA4 was up-regulated in glioma tissues and correlated with tumor recurrence and grade. Survival analyses demonstrated that glioma patients with high HSPA4 expression had lower overall survival and disease-free survival times. In vitro knockdown of HSPA4 inhibited glioma cell proliferation, mediated cell cycle arrest at G2 phase and apoptosis, and reduced the migration ability. In vivo, the growth of HSPA4-knockdown xenografts was markedly suppressed compared to the tumors formed by HSPA4-positive control cells. Additionally, Gene set enrichment analyses disclosed that HSPA4 was associated with the PI3K/Akt signaling pathway. The regulatory effect of the AKT activator SC79 on cell proliferation and apoptosis was suppressed by HSPA4 knockdown, indicating that HSPA4 is capable of promoting glioma development. In summary, these data showed that HSPA4 is likely to play a pivotal role in the progression of glioma, and consequently may be a promising therapeutic target for glioma therapy.</td>\n",
       "      <td>[hspa4 regulated glioma progression via activation of akt signaling pathway]</td>\n",
       "      <td>[glioma is still an incurable disease with high invasiveness heat shock 70 kda protein 4 hspa4 is a member of the hsp110 family and is associated with the development and progression of various cancers in the current study we assessed the expression of hspa4 in clinical samples and found that hspa4 was upregulated in glioma tissues and correlated with tumor recurrence and grade survival analyses demonstrated that glioma patients with high hspa4 expression had lower overall survival and diseasefree survival times in vitro knockdown of hspa4 inhibited glioma cell proliferation mediated cell cycle arrest at g2 phase and apoptosis and reduced the migration ability in vivo the growth of hspa4knockdown xenografts was markedly suppressed compared to the tumors formed by hspa4positive control cells additionally gene set enrichment analyses disclosed that hspa4 was associated with the pi3kakt signaling pathway the regulatory effect of the akt activator sc79 on cell proliferation and apoptosis was suppressed by hspa4 knockdown indicating that hspa4 is capable of promoting glioma development in summary these data showed that hspa4 is likely to play a pivotal role in the progression of glioma and consequently may be a promising therapeutic target for glioma therapy]</td>\n",
       "      <td>hspa4 regulated glioma progression via activation of akt signaling pathway glioma is still an incurable disease with high invasiveness heat shock 70 kda protein 4 hspa4 is a member of the hsp110 family and is associated with the development and progression of various cancers in the current study we assessed the expression of hspa4 in clinical samples and found that hspa4 was upregulated in glioma tissues and correlated with tumor recurrence and grade survival analyses demonstrated that glioma patients with high hspa4 expression had lower overall survival and diseasefree survival times in vitro knockdown of hspa4 inhibited glioma cell proliferation mediated cell cycle arrest at g2 phase and apoptosis and reduced the migration ability in vivo the growth of hspa4knockdown xenografts was markedly suppressed compared to the tumors formed by hspa4positive control cells additionally gene set enrichment analyses disclosed that hspa4 was associated with the pi3kakt signaling pathway the regulatory effect of the akt activator sc79 on cell proliferation and apoptosis was suppressed by hspa4 knockdown indicating that hspa4 is capable of promoting glioma development in summary these data showed that hspa4 is likely to play a pivotal role in the progression of glioma and consequently may be a promising therapeutic target for glioma therapy</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                                                                   title  \\\n",
       "0  Tumor-educated B cells selectively promote breast cancer lymph node metastasis by HSPA4-targeting IgG   \n",
       "1                       HSPA4 upregulation induces immune evasion via ALKBH5/CD58 axis in gastric cancer   \n",
       "2                              HSPA4 Knockdown Retarded Progression and Development of Colorectal Cancer   \n",
       "4  Significant correlation between HSPA4 and prognosis and immune regulation in hepatocellular carcinoma   \n",
       "5                             HSPA4 regulated glioma progression via activation of AKT signaling pathway   \n",
       "\n",
       "       pmid                                       url  \\\n",
       "0  30643287  https://pubmed.ncbi.nlm.nih.gov/30643287   \n",
       "1  38589927  https://pubmed.ncbi.nlm.nih.gov/38589927   \n",
       "2  34163243  https://pubmed.ncbi.nlm.nih.gov/34163243   \n",
       "4  34754620  https://pubmed.ncbi.nlm.nih.gov/34754620   \n",
       "5  37339521  https://pubmed.ncbi.nlm.nih.gov/37339521   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   abstract  \\\n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Primary tumors may create the premetastatic niche in secondary organs for subsequent metastasis. Humoral immunity contributes to the progression of certain cancers, but the roles of B cells and their derived antibodies in premetastatic niche formation are poorly defined. Using a mouse model of spontaneous lymph node metastasis of breast cancer, we show that primary tumors induced B cell accumulation in draining lymph nodes. These B cells selectively promoted lymph node metastasis by producing pathogenic IgG that targeted glycosylated membrane protein HSPA4, and activated the HSPA4-binding protein ITGB5 and the downstream Src/NF-κB pathway in tumor cells for CXCR4/SDF1α-axis-mediated metastasis. High serum anti-HSPA4 IgG was correlated with high tumor HSPA4 expression and poor prognosis of breast cancer subjects. Our findings identify a key role for tumor-educated B cells and their derived antibodies in lymph node premetastatic niche formation, providing potential targets for cancer intervention.   \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Introduction:\\n        \\n\\n      \\n      Gastric cancer (GC) is one of the leading causes of cancer-related death worldwide. Recently, targeted therapies including PD1 (programmed cell death 1) antibodies have been used in advanced GC patients. However, identifying new biomarker for immunotherapy is still urgently needed. The objective of this study is to unveil the immune evasion mechanism of GC cells and identify new biomarkers for immune checkpoint blockade therapy in patients with GC.\\n    \\n\\n\\n\\n\\n\\n          Methods:\\n        \\n\\n      \\n      Coimmunoprecipitation and meRIP were performed to investigate the mechanism of immune evasion of GC cells. Cocuture system was established to evaluate the cytotoxicity of cocultured CD8\\n+\\n T cells. The clinical significance of HSPA4 upregulation was analyzed by multiplex fluorescent immunohistochemistry staining in GC tumor tissues.\\n    \\n\\n\\n\\n\\n\\n          Results:\\n        \\n\\n      \\n      Histone acetylation causes HSPA4 upregulation in GC tumor tissues. HSPA4 upregulation increases the protein stability of m\\n6\\nA demethylase ALKBH5. ALKBH5 decreases CD58 in GC cells through m\\n6\\nA methylation regulation. The cytotoxicity of CD8\\n+\\n T cells are impaired and PD1/PDL1 axis is activated when CD8\\n+\\n T cells are cocultured with HSPA4 overexpressed GC cells. HSPA4 upregulation is associated with worse 5-year overall survival of GC patients receiving only surgery. It is an independent prognosis factor for worse survival of GC patients. In GC patients receiving the combined chemotherapy with anti-PD1 immunotherapy, HSPA4 upregulation is observed in responders compared with non-responders.\\n    \\n\\n\\n\\n\\n\\n          Conclusion:\\n        \\n\\n      \\n      HSPA4 upregulation causes the decrease of CD58 in GC cells via HSPA4/ALKBH5/CD58 axis, followed by PD1/PDL1 activation and impairment of CD8\\n+\\n T cell's cytotoxicity, finally induces immune evasion of GC cells. HSPA4 upregulation is associated with worse overall survival of GC patients with only surgery. Meanwhile, HSPA4 upregulation predicts for better response in GC patients receiving the combined immunotherapy.   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Purpose:\\n        \\n\\n      \\n      Colorectal cancer (CRC) is a common malignancy associated with high morbidity and mortality. Heat shock 70 kDa protein 4 (HSPA4) has been shown to exert regulatory roles during tumor progression in different cancer types. Here, we investigated the expression and cellular functions of HSPA4 in CRC.\\n    \\n\\n\\n\\n\\n\\n          Materials and methods:\\n        \\n\\n      \\n      Expression of HSPA4 in CRC tissues and paracancerous tissues was analyzed by RT-qPCR and immunohistochemistry IHC staining. The functional roles of HSPA4 were explored using shRNA-mediated knockdown in HCT116 and RKO CRC cell lines, both in vitro and in tumor xenograft studies.\\n    \\n\\n\\n\\n\\n\\n          Results:\\n        \\n\\n      \\n      HSPA4 expression was significantly increased at the RNA and protein levels in CRC tissues compared with noncancerous tissues. Moreover, HSPA4 expression was positively associated with tumor stage and its high expression of HSPA4 indicated poor patient prognosis. In vitro studies established that HSPA4 knockdown inhibited proliferation and migration, causing arrest in the G2-phase of the cell cycle along with increased levels of apoptosis. This phenotype was recapitulated in vivo where HSPA4 knockdown suppressed xenograft growth. Mechanistic investigations showed silencing of HSPA4 reduced activation of the PI3K, Akt signaling axis while also downregulating the cell cycle progression markers, CCND1 and CDK6. Similarly, there was altered expression of apoptosis-related proteins consistent with the increase in apoptosis.\\n    \\n\\n\\n\\n\\n\\n          Conclusion:\\n        \\n\\n      \\n      Our findings demonstrate clinical significance for HSPA4 in CRC, further showing that HSPA4 contributes to CRC tumorigenesis through effects on proliferation, migration and survival. Thus, HSPA4 represents a novel prognostic indicator as well as a promising therapeutic target in CRC.   \n",
       "4  Background:\\n        \\n\\n      \\n      Hepatocellular carcinoma (HCC) is an inflammation-associated tumor involved in immune tolerance and evasion in the immune microenvironment. Heat shock proteins (HSPs) are involved in the occurrence, progression, and immune regulation of tumors. Therefore, HSPs have been considered potential therapeutic targets. Here, we aimed to elucidate the value of HSP family A (Hsp70) member 4 (HSPA4) in the diagnosis and predicting prognosis of HCC, and its relationship with immune cell infiltration, immune cell biomarkers, and immune checkpoints. Gene mutation, DNA methylation, and the pathway involved in HCC were also analyzed.\\n    \\n\\n\\n\\n\\n\\n          Methods:\\n        \\n\\n      \\n      The gene expression omnibus (GEO) and The Cancer Genome Atlas (TCGA) databases were used to compare HSPA4 expression, and the results were confirmed by immunohistochemical staining of clinical samples. R package was used to analyze the correlation between HSPA4 and cancer stage, and to establish receiver operating characteristic (ROC) curve of diagnosis, time-dependent survival ROC curve, and a nomogram model. cBioPortal and MethSurv were used to identify genetic alterations and DNA methylation, and their effect on prognosis. The Tumor Immune Estimation Resource (TIMER) was used to analyze immune cell infiltration, immune cell biomarkers, and immune checkpoints. The STRING database was used to analyze protein-protein interaction network information. Gene Ontology (GO) analysis and the Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were performed to investigate the functions of HSPA4 and its functional partner genes.\\n    \\n\\n\\n\\n\\n\\n          Results:\\n        \\n\\n      \\n      Overexpression of HSPA4 was identified in 25 cancers. Overexpression of HSPA4 considerably correlated with cancer stage and alpha-fetoprotein (AFP) level in HCC. Patients with higher HSPA4 expression showed poorer prognosis. HSPA4 expression can accurately identify tumor from normal tissue (AUC = 0.957). The area under 1-, 3-, and 5-year survival ROCs were above 0.6. The HSPA4 genetic alteration rate was 1.3%. Among the 14 DNA methylation CpG sites, seven were related to the prognosis of HCC. HSPA4 was positively related to immune cell infiltration and immune checkpoints (PD-1 and CTLA-4) in HCC. The KEGG pathway enrichment analysis revealed HSPA4 enrichment in antigen processing and presentation together with HSPA8 and HSP90AA1. We verified the value of HSPA4 in the diagnosis and predicting prognosis of HCC. HSPA4 may not only participate in the occurrence and progression but also the immune regulation of HCC. Therefore, HSPA4 can be a potential diagnostic and prognostic biomarker and a therapeutic target for HCC.   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Glioma is still an incurable disease with high invasiveness. Heat shock 70 kDa protein 4 (HSPA4) is a member of the HSP110 family, and is associated with the development and progression of various cancers. In the current study, we assessed the expression of HSPA4 in clinical samples, and found that HSPA4 was up-regulated in glioma tissues and correlated with tumor recurrence and grade. Survival analyses demonstrated that glioma patients with high HSPA4 expression had lower overall survival and disease-free survival times. In vitro knockdown of HSPA4 inhibited glioma cell proliferation, mediated cell cycle arrest at G2 phase and apoptosis, and reduced the migration ability. In vivo, the growth of HSPA4-knockdown xenografts was markedly suppressed compared to the tumors formed by HSPA4-positive control cells. Additionally, Gene set enrichment analyses disclosed that HSPA4 was associated with the PI3K/Akt signaling pathway. The regulatory effect of the AKT activator SC79 on cell proliferation and apoptosis was suppressed by HSPA4 knockdown, indicating that HSPA4 is capable of promoting glioma development. In summary, these data showed that HSPA4 is likely to play a pivotal role in the progression of glioma, and consequently may be a promising therapeutic target for glioma therapy.   \n",
       "\n",
       "                                                                                           Title_Sentences  \\\n",
       "0    [tumoreducated b cells selectively promote breast cancer lymph node metastasis by hspa4targeting igg]   \n",
       "1                        [hspa4 upregulation induces immune evasion via alkbh5cd58 axis in gastric cancer]   \n",
       "2                              [hspa4 knockdown retarded progression and development of colorectal cancer]   \n",
       "4  [significant correlation between hspa4 and prognosis and immune regulation in hepatocellular carcinoma]   \n",
       "5                             [hspa4 regulated glioma progression via activation of akt signaling pathway]   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Abstract_Sentences  \\\n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  [primary tumors may create the premetastatic niche in secondary organs for subsequent metastasis humoral immunity contributes to the progression of certain cancers but the roles of b cells and their derived antibodies in premetastatic niche formation are poorly defined using a mouse model of spontaneous lymph node metastasis of breast cancer we show that primary tumors induced b cell accumulation in draining lymph nodes these b cells selectively promoted lymph node metastasis by producing pathogenic igg that targeted glycosylated membrane protein hspa4 and activated the hspa4binding protein itgb5 and the downstream srcnfb pathway in tumor cells for cxcr4sdf1axismediated metastasis high serum antihspa4 igg was correlated with high tumor hspa4 expression and poor prognosis of breast cancer subjects our findings identify a key role for tumoreducated b cells and their derived antibodies in lymph node premetastatic niche formation providing potential targets for cancer intervention]   \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     [introduction                    gastric cancer gc is one of the leading causes of cancerrelated death worldwide recently targeted therapies including pd1 programmed cell death 1 antibodies have been used in advanced gc patients however identifying new biomarker for immunotherapy is still urgently needed the objective of this study is to unveil the immune evasion mechanism of gc cells and identify new biomarkers for immune checkpoint blockade therapy in patients with gc              methods                    coimmunoprecipitation and merip were performed to investigate the mechanism of immune evasion of gc cells cocuture system was established to evaluate the cytotoxicity of cocultured cd8 t cells the clinical significance of hspa4 upregulation was analyzed by multiplex fluorescent immunohistochemistry staining in gc tumor tissues              results                    histone acetylation causes hspa4 upregulation in gc tumor tissues hspa4 upregulation increases the protein stability of m6a demethylase alkbh5 alkbh5 decreases cd58 in gc cells through m6a methylation regulation the cytotoxicity of cd8 t cells are impaired and pd1pdl1 axis is activated when cd8 t cells are cocultured with hspa4 overexpressed gc cells hspa4 upregulation is associated with worse 5year overall survival of gc patients receiving only surgery it is an independent prognosis factor for worse survival of gc patients in gc patients receiving the combined chemotherapy with antipd1 immunotherapy hspa4 upregulation is observed in responders compared with nonresponders              conclusion                    hspa4 upregulation causes the decrease of cd58 in gc cells via hspa4alkbh5cd58 axis followed by pd1pdl1 activation and impairment of cd8 t cells cytotoxicity finally induces immune evasion of gc cells hspa4 upregulation is associated with worse overall survival of gc patients with only surgery meanwhile hspa4 upregulation predicts for better response in gc patients receiving the combined immunotherapy]   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               [purpose                    colorectal cancer crc is a common malignancy associated with high morbidity and mortality heat shock 70 kda protein 4 hspa4 has been shown to exert regulatory roles during tumor progression in different cancer types here we investigated the expression and cellular functions of hspa4 in crc              materials and methods                    expression of hspa4 in crc tissues and paracancerous tissues was analyzed by rtqpcr and immunohistochemistry ihc staining the functional roles of hspa4 were explored using shrnamediated knockdown in hct116 and rko crc cell lines both in vitro and in tumor xenograft studies              results                    hspa4 expression was significantly increased at the rna and protein levels in crc tissues compared with noncancerous tissues moreover hspa4 expression was positively associated with tumor stage and its high expression of hspa4 indicated poor patient prognosis in vitro studies established that hspa4 knockdown inhibited proliferation and migration causing arrest in the g2phase of the cell cycle along with increased levels of apoptosis this phenotype was recapitulated in vivo where hspa4 knockdown suppressed xenograft growth mechanistic investigations showed silencing of hspa4 reduced activation of the pi3k akt signaling axis while also downregulating the cell cycle progression markers ccnd1 and cdk6 similarly there was altered expression of apoptosisrelated proteins consistent with the increase in apoptosis              conclusion                    our findings demonstrate clinical significance for hspa4 in crc further showing that hspa4 contributes to crc tumorigenesis through effects on proliferation migration and survival thus hspa4 represents a novel prognostic indicator as well as a promising therapeutic target in crc]   \n",
       "4  [background                    hepatocellular carcinoma hcc is an inflammationassociated tumor involved in immune tolerance and evasion in the immune microenvironment heat shock proteins hsps are involved in the occurrence progression and immune regulation of tumors therefore hsps have been considered potential therapeutic targets here we aimed to elucidate the value of hsp family a hsp70 member 4 hspa4 in the diagnosis and predicting prognosis of hcc and its relationship with immune cell infiltration immune cell biomarkers and immune checkpoints gene mutation dna methylation and the pathway involved in hcc were also analyzed              methods                    the gene expression omnibus geo and the cancer genome atlas tcga databases were used to compare hspa4 expression and the results were confirmed by immunohistochemical staining of clinical samples r package was used to analyze the correlation between hspa4 and cancer stage and to establish receiver operating characteristic roc curve of diagnosis timedependent survival roc curve and a nomogram model cbioportal and methsurv were used to identify genetic alterations and dna methylation and their effect on prognosis the tumor immune estimation resource timer was used to analyze immune cell infiltration immune cell biomarkers and immune checkpoints the string database was used to analyze proteinprotein interaction network information gene ontology go analysis and the kyoto encyclopedia of genes and genomes kegg analyses were performed to investigate the functions of hspa4 and its functional partner genes              results                    overexpression of hspa4 was identified in 25 cancers overexpression of hspa4 considerably correlated with cancer stage and alphafetoprotein afp level in hcc patients with higher hspa4 expression showed poorer prognosis hspa4 expression can accurately identify tumor from normal tissue auc  0957 the area under 1 3 and 5year survival rocs were above 06 the hspa4 genetic alteration rate was 13 among the 14 dna methylation cpg sites seven were related to the prognosis of hcc hspa4 was positively related to immune cell infiltration and immune checkpoints pd1 and ctla4 in hcc the kegg pathway enrichment analysis revealed hspa4 enrichment in antigen processing and presentation together with hspa8 and hsp90aa1 we verified the value of hspa4 in the diagnosis and predicting prognosis of hcc hspa4 may not only participate in the occurrence and progression but also the immune regulation of hcc therefore hspa4 can be a potential diagnostic and prognostic biomarker and a therapeutic target for hcc]   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        [glioma is still an incurable disease with high invasiveness heat shock 70 kda protein 4 hspa4 is a member of the hsp110 family and is associated with the development and progression of various cancers in the current study we assessed the expression of hspa4 in clinical samples and found that hspa4 was upregulated in glioma tissues and correlated with tumor recurrence and grade survival analyses demonstrated that glioma patients with high hspa4 expression had lower overall survival and diseasefree survival times in vitro knockdown of hspa4 inhibited glioma cell proliferation mediated cell cycle arrest at g2 phase and apoptosis and reduced the migration ability in vivo the growth of hspa4knockdown xenografts was markedly suppressed compared to the tumors formed by hspa4positive control cells additionally gene set enrichment analyses disclosed that hspa4 was associated with the pi3kakt signaling pathway the regulatory effect of the akt activator sc79 on cell proliferation and apoptosis was suppressed by hspa4 knockdown indicating that hspa4 is capable of promoting glioma development in summary these data showed that hspa4 is likely to play a pivotal role in the progression of glioma and consequently may be a promising therapeutic target for glioma therapy]   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Combined_Sentences  \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    tumoreducated b cells selectively promote breast cancer lymph node metastasis by hspa4targeting igg primary tumors may create the premetastatic niche in secondary organs for subsequent metastasis humoral immunity contributes to the progression of certain cancers but the roles of b cells and their derived antibodies in premetastatic niche formation are poorly defined using a mouse model of spontaneous lymph node metastasis of breast cancer we show that primary tumors induced b cell accumulation in draining lymph nodes these b cells selectively promoted lymph node metastasis by producing pathogenic igg that targeted glycosylated membrane protein hspa4 and activated the hspa4binding protein itgb5 and the downstream srcnfb pathway in tumor cells for cxcr4sdf1axismediated metastasis high serum antihspa4 igg was correlated with high tumor hspa4 expression and poor prognosis of breast cancer subjects our findings identify a key role for tumoreducated b cells and their derived antibodies in lymph node premetastatic niche formation providing potential targets for cancer intervention  \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           hspa4 upregulation induces immune evasion via alkbh5cd58 axis in gastric cancer introduction                    gastric cancer gc is one of the leading causes of cancerrelated death worldwide recently targeted therapies including pd1 programmed cell death 1 antibodies have been used in advanced gc patients however identifying new biomarker for immunotherapy is still urgently needed the objective of this study is to unveil the immune evasion mechanism of gc cells and identify new biomarkers for immune checkpoint blockade therapy in patients with gc              methods                    coimmunoprecipitation and merip were performed to investigate the mechanism of immune evasion of gc cells cocuture system was established to evaluate the cytotoxicity of cocultured cd8 t cells the clinical significance of hspa4 upregulation was analyzed by multiplex fluorescent immunohistochemistry staining in gc tumor tissues              results                    histone acetylation causes hspa4 upregulation in gc tumor tissues hspa4 upregulation increases the protein stability of m6a demethylase alkbh5 alkbh5 decreases cd58 in gc cells through m6a methylation regulation the cytotoxicity of cd8 t cells are impaired and pd1pdl1 axis is activated when cd8 t cells are cocultured with hspa4 overexpressed gc cells hspa4 upregulation is associated with worse 5year overall survival of gc patients receiving only surgery it is an independent prognosis factor for worse survival of gc patients in gc patients receiving the combined chemotherapy with antipd1 immunotherapy hspa4 upregulation is observed in responders compared with nonresponders              conclusion                    hspa4 upregulation causes the decrease of cd58 in gc cells via hspa4alkbh5cd58 axis followed by pd1pdl1 activation and impairment of cd8 t cells cytotoxicity finally induces immune evasion of gc cells hspa4 upregulation is associated with worse overall survival of gc patients with only surgery meanwhile hspa4 upregulation predicts for better response in gc patients receiving the combined immunotherapy  \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           hspa4 knockdown retarded progression and development of colorectal cancer purpose                    colorectal cancer crc is a common malignancy associated with high morbidity and mortality heat shock 70 kda protein 4 hspa4 has been shown to exert regulatory roles during tumor progression in different cancer types here we investigated the expression and cellular functions of hspa4 in crc              materials and methods                    expression of hspa4 in crc tissues and paracancerous tissues was analyzed by rtqpcr and immunohistochemistry ihc staining the functional roles of hspa4 were explored using shrnamediated knockdown in hct116 and rko crc cell lines both in vitro and in tumor xenograft studies              results                    hspa4 expression was significantly increased at the rna and protein levels in crc tissues compared with noncancerous tissues moreover hspa4 expression was positively associated with tumor stage and its high expression of hspa4 indicated poor patient prognosis in vitro studies established that hspa4 knockdown inhibited proliferation and migration causing arrest in the g2phase of the cell cycle along with increased levels of apoptosis this phenotype was recapitulated in vivo where hspa4 knockdown suppressed xenograft growth mechanistic investigations showed silencing of hspa4 reduced activation of the pi3k akt signaling axis while also downregulating the cell cycle progression markers ccnd1 and cdk6 similarly there was altered expression of apoptosisrelated proteins consistent with the increase in apoptosis              conclusion                    our findings demonstrate clinical significance for hspa4 in crc further showing that hspa4 contributes to crc tumorigenesis through effects on proliferation migration and survival thus hspa4 represents a novel prognostic indicator as well as a promising therapeutic target in crc  \n",
       "4  significant correlation between hspa4 and prognosis and immune regulation in hepatocellular carcinoma background                    hepatocellular carcinoma hcc is an inflammationassociated tumor involved in immune tolerance and evasion in the immune microenvironment heat shock proteins hsps are involved in the occurrence progression and immune regulation of tumors therefore hsps have been considered potential therapeutic targets here we aimed to elucidate the value of hsp family a hsp70 member 4 hspa4 in the diagnosis and predicting prognosis of hcc and its relationship with immune cell infiltration immune cell biomarkers and immune checkpoints gene mutation dna methylation and the pathway involved in hcc were also analyzed              methods                    the gene expression omnibus geo and the cancer genome atlas tcga databases were used to compare hspa4 expression and the results were confirmed by immunohistochemical staining of clinical samples r package was used to analyze the correlation between hspa4 and cancer stage and to establish receiver operating characteristic roc curve of diagnosis timedependent survival roc curve and a nomogram model cbioportal and methsurv were used to identify genetic alterations and dna methylation and their effect on prognosis the tumor immune estimation resource timer was used to analyze immune cell infiltration immune cell biomarkers and immune checkpoints the string database was used to analyze proteinprotein interaction network information gene ontology go analysis and the kyoto encyclopedia of genes and genomes kegg analyses were performed to investigate the functions of hspa4 and its functional partner genes              results                    overexpression of hspa4 was identified in 25 cancers overexpression of hspa4 considerably correlated with cancer stage and alphafetoprotein afp level in hcc patients with higher hspa4 expression showed poorer prognosis hspa4 expression can accurately identify tumor from normal tissue auc  0957 the area under 1 3 and 5year survival rocs were above 06 the hspa4 genetic alteration rate was 13 among the 14 dna methylation cpg sites seven were related to the prognosis of hcc hspa4 was positively related to immune cell infiltration and immune checkpoints pd1 and ctla4 in hcc the kegg pathway enrichment analysis revealed hspa4 enrichment in antigen processing and presentation together with hspa8 and hsp90aa1 we verified the value of hspa4 in the diagnosis and predicting prognosis of hcc hspa4 may not only participate in the occurrence and progression but also the immune regulation of hcc therefore hspa4 can be a potential diagnostic and prognostic biomarker and a therapeutic target for hcc  \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   hspa4 regulated glioma progression via activation of akt signaling pathway glioma is still an incurable disease with high invasiveness heat shock 70 kda protein 4 hspa4 is a member of the hsp110 family and is associated with the development and progression of various cancers in the current study we assessed the expression of hspa4 in clinical samples and found that hspa4 was upregulated in glioma tissues and correlated with tumor recurrence and grade survival analyses demonstrated that glioma patients with high hspa4 expression had lower overall survival and diseasefree survival times in vitro knockdown of hspa4 inhibited glioma cell proliferation mediated cell cycle arrest at g2 phase and apoptosis and reduced the migration ability in vivo the growth of hspa4knockdown xenografts was markedly suppressed compared to the tumors formed by hspa4positive control cells additionally gene set enrichment analyses disclosed that hspa4 was associated with the pi3kakt signaling pathway the regulatory effect of the akt activator sc79 on cell proliferation and apoptosis was suppressed by hspa4 knockdown indicating that hspa4 is capable of promoting glioma development in summary these data showed that hspa4 is likely to play a pivotal role in the progression of glioma and consequently may be a promising therapeutic target for glioma therapy  "
      ]
     },
     "execution_count": 474,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Apply preprocessing\n",
    "df['Title_Sentences'] = df['title'].apply(custom_preprocessor)\n",
    "df['Abstract_Sentences'] = df['abstract'].apply(custom_preprocessor)\n",
    "\n",
    "# Combine sentences into a single list\n",
    "df['Combined_Sentences'] = df.apply(lambda row: row['Title_Sentences'] + row['Abstract_Sentences'], axis=1)\n",
    "# convert the list of sentences into a single string\n",
    "df['Combined_Sentences'] = df['Combined_Sentences'].apply(lambda x: ' '.join(x))\n",
    "\n",
    "df.head()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Step 3: Zero-Shot Classification"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Setup the transformer and define labels"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 475,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Hardware accelerator e.g. GPU is available in the environment, but no `device` argument is passed to the `Pipeline` object. Model will be on CPU.\n"
     ]
    }
   ],
   "source": [
    "# Load the zero-shot classification pipeline\n",
    "classifier = pipeline('zero-shot-classification', model='facebook/bart-large-mnli')\n",
    "\n",
    "# Define candidate labels to classify the text\n",
    "candidate_labels = [\"ubiquitination\", \"HSC70\", \"proteasome\", \"cardiac hypertrophy\", \"cancer\", \"apoptosis\", \"autophagy\", \"nucleotide exchange factor\", \"P62/SQSTM1\", \"LC3\"]"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Classify each sentence for labels related to chaperones and cellular health"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 476,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Sentence: tumoreducated b cells selectively promote breast cancer lymph node metastasis by hspa4targeting igg primary tumors may create the premetastatic niche \n",
      "Classification Result: ['cancer', 'LC3', 'HSC70', 'P62/SQSTM1', 'proteasome', 'ubiquitination', 'nucleotide exchange factor', 'autophagy', 'apoptosis', 'cardiac hypertrophy']\n",
      "Scores: [0.6762353181838989, 0.10858528316020966, 0.050915852189064026, 0.033793073147535324, 0.03292522951960564, 0.02974163554608822, 0.023961974307894707, 0.02216721512377262, 0.013303634710609913, 0.008370772935450077]\n",
      "\n",
      "Sentence: hspa4 upregulation induces immune evasion via alkbh5cd58 axis in gastric cancer introduction                    gastric cancer gc is one of the leadin\n",
      "Classification Result: ['cancer', 'LC3', 'proteasome', 'P62/SQSTM1', 'nucleotide exchange factor', 'ubiquitination', 'autophagy', 'HSC70', 'apoptosis', 'cardiac hypertrophy']\n",
      "Scores: [0.8288431763648987, 0.028598923236131668, 0.026072241365909576, 0.022245757281780243, 0.020209170877933502, 0.01953403279185295, 0.01899723708629608, 0.016946135088801384, 0.014060711488127708, 0.004492597654461861]\n",
      "\n",
      "Sentence: hspa4 knockdown retarded progression and development of colorectal cancer purpose                    colorectal cancer crc is a common malignancy asso\n",
      "Classification Result: ['cancer', 'apoptosis', 'HSC70', 'LC3', 'ubiquitination', 'nucleotide exchange factor', 'proteasome', 'autophagy', 'P62/SQSTM1', 'cardiac hypertrophy']\n",
      "Scores: [0.6838890910148621, 0.18289880454540253, 0.0476415641605854, 0.017762573435902596, 0.013554077595472336, 0.01349665131419897, 0.013225321657955647, 0.012429192662239075, 0.009191642515361309, 0.005911041516810656]\n",
      "\n",
      "Sentence: significant correlation between hspa4 and prognosis and immune regulation in hepatocellular carcinoma background                    hepatocellular car\n",
      "Classification Result: ['HSC70', 'cancer', 'proteasome', 'ubiquitination', 'nucleotide exchange factor', 'LC3', 'apoptosis', 'autophagy', 'P62/SQSTM1', 'cardiac hypertrophy']\n",
      "Scores: [0.4874506890773773, 0.35568249225616455, 0.038450539112091064, 0.031093154102563858, 0.028420859947800636, 0.024431895464658737, 0.011402040719985962, 0.009845827706158161, 0.009130297228693962, 0.004092233721166849]\n",
      "\n",
      "Sentence: hspa4 regulated glioma progression via activation of akt signaling pathway glioma is still an incurable disease with high invasiveness heat shock 70 k\n",
      "Classification Result: ['cancer', 'apoptosis', 'HSC70', 'LC3', 'ubiquitination', 'P62/SQSTM1', 'proteasome', 'autophagy', 'nucleotide exchange factor', 'cardiac hypertrophy']\n",
      "Scores: [0.4648561179637909, 0.23765619099140167, 0.09346775710582733, 0.05643676221370697, 0.03615890070796013, 0.032402154058218, 0.030986363068223, 0.02160457707941532, 0.01776445470750332, 0.008666709996759892]\n",
      "\n",
      "Sentence: hspa4 is a biomarker of placenta accreta and enhances the angiogenesis ability of vessel endothelial cells placenta accreta spectrum pas accounts for \n",
      "Classification Result: ['HSC70', 'LC3', 'P62/SQSTM1', 'proteasome', 'ubiquitination', 'autophagy', 'apoptosis', 'nucleotide exchange factor', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.4966731369495392, 0.1006326824426651, 0.09644834697246552, 0.09344158321619034, 0.07684452086687088, 0.04421541467308998, 0.028219686821103096, 0.0276396032422781, 0.02462054416537285, 0.011264543980360031]\n",
      "\n",
      "Sentence: sirt1 attenuates neuroinflammation by deacetylating hspa4 in a mouse model of parkinsons disease as a deacetylase sirt1 plays essential roles in vario\n",
      "Classification Result: ['LC3', 'HSC70', 'nucleotide exchange factor', 'proteasome', 'ubiquitination', 'P62/SQSTM1', 'autophagy', 'apoptosis', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.2330816388130188, 0.20804788172245026, 0.11927977949380875, 0.10994639992713928, 0.08826261013746262, 0.08770354837179184, 0.06373874098062515, 0.04760589450597763, 0.02791428007185459, 0.014419217593967915]\n",
      "\n",
      "Sentence: respiratory distress and early neonatal lethality in hspa4lhspa4 doublemutant mice heat shock proteins hspa4l and hspa4 are closely related members of\n",
      "Classification Result: ['ubiquitination', 'apoptosis', 'LC3', 'proteasome', 'HSC70', 'nucleotide exchange factor', 'P62/SQSTM1', 'autophagy', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.4246019423007965, 0.21762579679489136, 0.10841723531484604, 0.056180939078330994, 0.05290480703115463, 0.0410538911819458, 0.0408858023583889, 0.02992233820259571, 0.015358109027147293, 0.013049167580902576]\n",
      "\n",
      "Sentence: heatshock protein hspa4 is required for progression of spermatogenesis heatshock protein 110 hsp110 family members act as nucleotide exchange factors \n",
      "Classification Result: ['ubiquitination', 'nucleotide exchange factor', 'apoptosis', 'LC3', 'HSC70', 'autophagy', 'proteasome', 'P62/SQSTM1', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.3297133445739746, 0.29956603050231934, 0.281399130821228, 0.02513297274708748, 0.015224108472466469, 0.014687546528875828, 0.014494226314127445, 0.010050131008028984, 0.006288782227784395, 0.003443694906309247]\n",
      "\n",
      "Sentence: targeted disruption of hspa4 gene leads to cardiac hypertrophy and fibrosis failure of molecular chaperones to direct the correct folding of newly syn\n",
      "Classification Result: ['cardiac hypertrophy', 'nucleotide exchange factor', 'ubiquitination', 'HSC70', 'LC3', 'proteasome', 'P62/SQSTM1', 'autophagy', 'apoptosis', 'cancer']\n",
      "Scores: [0.8372184634208679, 0.06903614848852158, 0.029573654755949974, 0.027263110503554344, 0.014713093638420105, 0.007774637546390295, 0.006700717378407717, 0.0033421479165554047, 0.003269474720582366, 0.0011085461592301726]\n",
      "\n",
      "Sentence: hspa4 hsp70 is involved in the radioadaptive response results from mouse splenocytes in a continuation of our earlier study on the involvement of hsp2\n",
      "Classification Result: ['HSC70', 'apoptosis', 'LC3', 'ubiquitination', 'P62/SQSTM1', 'autophagy', 'proteasome', 'nucleotide exchange factor', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.5988345146179199, 0.30074137449264526, 0.033009082078933716, 0.017333270981907845, 0.014308900572359562, 0.011125129647552967, 0.010509158484637737, 0.007582932244986296, 0.004334898665547371, 0.0022207850124686956]\n",
      "\n",
      "Sentence: frameshift mutations of hspa4 and med13 in gastric and colorectal cancers frameshift mutation of genes containing mononucleotide repeats is a feature \n",
      "Classification Result: ['cancer', 'HSC70', 'LC3', 'P62/SQSTM1', 'proteasome', 'nucleotide exchange factor', 'autophagy', 'ubiquitination', 'apoptosis', 'cardiac hypertrophy']\n",
      "Scores: [0.6432225704193115, 0.1453183889389038, 0.05034518241882324, 0.030098071321845055, 0.02602965198457241, 0.025406083092093468, 0.023706695064902306, 0.023656247183680534, 0.018160678446292877, 0.014056447893381119]\n",
      "\n",
      "Sentence: retracted inhibition of dnajc12 inhibited tumorigenesis of rectal cancer via downregulating hspa4 expression this retracts the article doi 10115520221\n",
      "Classification Result: ['cancer', 'LC3', 'HSC70', 'nucleotide exchange factor', 'proteasome', 'P62/SQSTM1', 'ubiquitination', 'autophagy', 'apoptosis', 'cardiac hypertrophy']\n",
      "Scores: [0.6370541453361511, 0.08907180279493332, 0.05057113245129585, 0.045451611280441284, 0.04511318728327751, 0.04405881091952324, 0.03164035826921463, 0.027510959655046463, 0.025960778817534447, 0.0035671379882842302]\n",
      "\n",
      "Sentence: inhibition of dnajc12 inhibited tumorigenesis of rectal cancer via downregulating hspa4 expression background                    dysregulation of dnaj\n",
      "Classification Result: ['cancer', 'apoptosis', 'LC3', 'ubiquitination', 'autophagy', 'proteasome', 'P62/SQSTM1', 'nucleotide exchange factor', 'HSC70', 'cardiac hypertrophy']\n",
      "Scores: [0.5907357335090637, 0.264640212059021, 0.027166495099663734, 0.022523388266563416, 0.018470600247383118, 0.018300067633390427, 0.017822779715061188, 0.017755402252078056, 0.01619390957057476, 0.006391445174813271]\n",
      "\n",
      "Sentence: unveiling the potential of hspa4 a comprehensive pancancer analysis of hspa4 in diagnosis prognosis and immunotherapy with the global rise in cancer i\n",
      "Classification Result: ['cancer', 'HSC70', 'LC3', 'P62/SQSTM1', 'ubiquitination', 'proteasome', 'autophagy', 'apoptosis', 'nucleotide exchange factor', 'cardiac hypertrophy']\n",
      "Scores: [0.5279096364974976, 0.31183382868766785, 0.045621804893016815, 0.03398207202553749, 0.02643195167183876, 0.01581285521388054, 0.013731658458709717, 0.011169352568686008, 0.008499864488840103, 0.0050068930722773075]\n",
      "\n",
      "Sentence: panoptosis signaling enables broad immune response in psoriasis from pathogenesis to new therapeutic strategies background                    accumula\n",
      "Classification Result: ['apoptosis', 'P62/SQSTM1', 'LC3', 'HSC70', 'proteasome', 'nucleotide exchange factor', 'autophagy', 'ubiquitination', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.6641538143157959, 0.06482314318418503, 0.06311546266078949, 0.049287620931863785, 0.048304978758096695, 0.033879805356264114, 0.0294849444180727, 0.027378685772418976, 0.011909901164472103, 0.0076616788282990456]\n",
      "\n",
      "Sentence: induction of hspa4 and hspa14 by nbs1 overexpression contributes to nbs1induced in vitro metastatic and transformation activity background            \n",
      "Classification Result: ['LC3', 'ubiquitination', 'nucleotide exchange factor', 'proteasome', 'cancer', 'P62/SQSTM1', 'HSC70', 'autophagy', 'apoptosis', 'cardiac hypertrophy']\n",
      "Scores: [0.25288575887680054, 0.1234440952539444, 0.11243037134408951, 0.10668135434389114, 0.10293423384428024, 0.10271197557449341, 0.06724876910448074, 0.059310588985681534, 0.04668101668357849, 0.025671856477856636]\n",
      "\n",
      "Sentence: involvement of heat shock protein a4apg2 in refractory inflammatory bowel disease background                    expression of heat shock protein a4 hs\n",
      "Classification Result: ['apoptosis', 'cancer', 'LC3', 'ubiquitination', 'proteasome', 'P62/SQSTM1', 'autophagy', 'HSC70', 'nucleotide exchange factor', 'cardiac hypertrophy']\n",
      "Scores: [0.5739322900772095, 0.11487095057964325, 0.0832766443490982, 0.04989133030176163, 0.04155595973134041, 0.04046689346432686, 0.03515058383345604, 0.03287486359477043, 0.019742997363209724, 0.008237608708441257]\n",
      "\n",
      "Sentence: upregulation of heat shock proteins hspa12a hsp90b1 hspa4 hspa5 and hspa6 in tumour tissues is associated with poor outcomes from hbvrelated earlystag\n",
      "Classification Result: ['cancer', 'LC3', 'ubiquitination', 'HSC70', 'proteasome', 'P62/SQSTM1', 'autophagy', 'nucleotide exchange factor', 'apoptosis', 'cardiac hypertrophy']\n",
      "Scores: [0.4939296841621399, 0.07859646528959274, 0.06900397688150406, 0.06751395761966705, 0.06565982103347778, 0.06253086775541306, 0.05111895501613617, 0.05052195116877556, 0.03434833884239197, 0.026775943115353584]\n",
      "\n",
      "Sentence: prognostic and immunological roles of heat shock protein a4 in lung adenocarcinoma background                    heat shock protein a4 hspa4 belongs t\n",
      "Classification Result: ['cancer', 'LC3', 'P62/SQSTM1', 'ubiquitination', 'proteasome', 'HSC70', 'apoptosis', 'autophagy', 'nucleotide exchange factor', 'cardiac hypertrophy']\n",
      "Scores: [0.5465537309646606, 0.09679972380399704, 0.05349654704332352, 0.05144747346639633, 0.050890397280454636, 0.04898878186941147, 0.04847288876771927, 0.047027066349983215, 0.031873688101768494, 0.02444973587989807]\n",
      "\n",
      "Sentence: analysis of damageassociated molecular patterns in amyotrophic lateral sclerosis based on scrnaseq and bulk rnaseq data background                    \n",
      "Classification Result: ['LC3', 'P62/SQSTM1', 'HSC70', 'nucleotide exchange factor', 'proteasome', 'ubiquitination', 'autophagy', 'apoptosis', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.20579901337623596, 0.17841197550296783, 0.1409396082162857, 0.12257152795791626, 0.10093910992145538, 0.09059058874845505, 0.07103487849235535, 0.04402172565460205, 0.03245916962623596, 0.013232306577265263]\n",
      "\n",
      "Sentence: heat shock protein a4 controls cell migration and gastric ulcer healing aims and methods                    heat shock protein a4 hspa4 also called ap\n",
      "Classification Result: ['ubiquitination', 'LC3', 'cancer', 'HSC70', 'proteasome', 'autophagy', 'P62/SQSTM1', 'apoptosis', 'nucleotide exchange factor', 'cardiac hypertrophy']\n",
      "Scores: [0.19576118886470795, 0.191048264503479, 0.12745964527130127, 0.10010135173797607, 0.09441658854484558, 0.08446420729160309, 0.0837879329919815, 0.06843727082014084, 0.03785333037376404, 0.016670171171426773]\n",
      "\n",
      "Sentence: pyroptosisrelated gene signature elicits immune response in rosacea rosacea is a complex chronic inflammatory skin disorder with high morbidity pyropt\n",
      "Classification Result: ['LC3', 'HSC70', 'proteasome', 'nucleotide exchange factor', 'P62/SQSTM1', 'ubiquitination', 'autophagy', 'apoptosis', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.19240662455558777, 0.15029065310955048, 0.14177311956882477, 0.12323413044214249, 0.10825397819280624, 0.10657994449138641, 0.08174264430999756, 0.06068076938390732, 0.024016983807086945, 0.011021149344742298]\n",
      "\n",
      "Sentence: hsp70 binds to specific noncoding rna and regulates human rna polymerase iii molecular chaperones are critical for protein homeostasis and are implica\n",
      "Classification Result: ['HSC70', 'LC3', 'proteasome', 'cancer', 'autophagy', 'ubiquitination', 'nucleotide exchange factor', 'P62/SQSTM1', 'apoptosis', 'cardiac hypertrophy']\n",
      "Scores: [0.46195539832115173, 0.11290419846773148, 0.08512595295906067, 0.07717068493366241, 0.06900456547737122, 0.0651739165186882, 0.04735808074474335, 0.03858424723148346, 0.02281089313328266, 0.0199119932949543]\n",
      "\n",
      "Sentence: the expression profiles and prognostic values of hsp70s in hepatocellular carcinoma background                    the hsp70 family of heat shock prote\n",
      "Classification Result: ['cancer', 'HSC70', 'LC3', 'P62/SQSTM1', 'proteasome', 'autophagy', 'nucleotide exchange factor', 'ubiquitination', 'apoptosis', 'cardiac hypertrophy']\n",
      "Scores: [0.7078880071640015, 0.09475371241569519, 0.051869284361600876, 0.030356870964169502, 0.027009187266230583, 0.021068139001727104, 0.01962924376130104, 0.018800443038344383, 0.01618260145187378, 0.012442408129572868]\n",
      "\n",
      "Sentence: heat shock protein a4 ablation leads to skeletal muscle myopathy associated with dysregulated autophagy and induced apoptosis background              \n",
      "Classification Result: ['autophagy', 'apoptosis', 'LC3', 'proteasome', 'P62/SQSTM1', 'HSC70', 'ubiquitination', 'nucleotide exchange factor', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.4210154712200165, 0.3445170521736145, 0.050990305840969086, 0.05040876939892769, 0.03547067195177078, 0.035319529473781586, 0.028489161282777786, 0.020289331674575806, 0.008987520821392536, 0.004512111656367779]\n",
      "\n",
      "Sentence: lncrna rmrp prevents mitochondrial dysfunction and cardiomyocyte apoptosis via the mir15phsp70 axis in lpsinduced sepsis mice both long noncoding rna \n",
      "Classification Result: ['apoptosis', 'HSC70', 'LC3', 'ubiquitination', 'nucleotide exchange factor', 'proteasome', 'autophagy', 'P62/SQSTM1', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.6944118142127991, 0.11561210453510284, 0.03909246623516083, 0.03127467632293701, 0.028828119859099388, 0.027441736310720444, 0.021579021587967873, 0.021104197949171066, 0.018338963389396667, 0.0023168171755969524]\n",
      "\n",
      "Sentence: distinct gene expression profiles underlie morphological and etiological differences in pediatric cataracts purpose                    pediatric catar\n",
      "Classification Result: ['HSC70', 'LC3', 'P62/SQSTM1', 'proteasome', 'nucleotide exchange factor', 'autophagy', 'ubiquitination', 'apoptosis', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.4028168320655823, 0.2022763192653656, 0.11118368059396744, 0.08534248173236847, 0.0662551075220108, 0.04804328829050064, 0.03843917325139046, 0.021027252078056335, 0.01651357300579548, 0.00810230802744627]\n",
      "\n",
      "Sentence: basigin is necessary for normal decidualization of human uterine stromal cells study question                    does basigin bsg regulate human endom\n",
      "Classification Result: ['ubiquitination', 'LC3', 'proteasome', 'nucleotide exchange factor', 'P62/SQSTM1', 'HSC70', 'autophagy', 'apoptosis', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.14201202988624573, 0.14180301129817963, 0.1377532184123993, 0.13012215495109558, 0.10056103765964508, 0.08240477740764618, 0.0751735270023346, 0.06904479116201401, 0.0649217963218689, 0.056203603744506836]\n",
      "\n",
      "Sentence: chemoproteomic approach for the quantitative identification of arsenicbinding proteins arsenic is a widespread environmental contaminant and longterm \n",
      "Classification Result: ['HSC70', 'LC3', 'proteasome', 'ubiquitination', 'P62/SQSTM1', 'autophagy', 'nucleotide exchange factor', 'apoptosis', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.6090287566184998, 0.13370932638645172, 0.06378675252199173, 0.05560239776968956, 0.04943690448999405, 0.027354825288057327, 0.026751933619379997, 0.01470903493463993, 0.010687509551644325, 0.008932597935199738]\n",
      "\n",
      "Sentence: evidence for a common biological pathway linking three parkinsons diseasecausing genes parkin pink1 and dj1 parkinsons disease pd is characterised by \n",
      "Classification Result: ['LC3', 'nucleotide exchange factor', 'HSC70', 'P62/SQSTM1', 'autophagy', 'proteasome', 'ubiquitination', 'apoptosis', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.20981965959072113, 0.18751364946365356, 0.12459763139486313, 0.11059455573558807, 0.1061900183558464, 0.09884166717529297, 0.07349752634763718, 0.0485762357711792, 0.02707657963037491, 0.01329241506755352]\n",
      "\n",
      "Sentence: network analysis reveals important genes in human placenta aim                    to determine which genes are important in placenta by network analys\n",
      "Classification Result: ['nucleotide exchange factor', 'proteasome', 'LC3', 'P62/SQSTM1', 'HSC70', 'ubiquitination', 'autophagy', 'apoptosis', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.18058659136295319, 0.17367996275424957, 0.16895657777786255, 0.12476321309804916, 0.12388627231121063, 0.08576375991106033, 0.052875202149152756, 0.040446508675813675, 0.028239071369171143, 0.020802872255444527]\n",
      "\n",
      "Sentence: identification and analysis of immunerelated gene signature in hepatocellular carcinoma background                    hepatocellular carcinoma hcc ori\n",
      "Classification Result: ['cancer', 'proteasome', 'ubiquitination', 'LC3', 'P62/SQSTM1', 'nucleotide exchange factor', 'HSC70', 'autophagy', 'apoptosis', 'cardiac hypertrophy']\n",
      "Scores: [0.4850424826145172, 0.13699817657470703, 0.12357082217931747, 0.07197832316160202, 0.049352504312992096, 0.03976759687066078, 0.03804057464003563, 0.02136012353003025, 0.019283225759863853, 0.014606177806854248]\n",
      "\n",
      "Sentence: phossnpsregulated gene network and pathway significant for rheumatoid arthritis objectives                    peripheral blood mononuclear cells pbmcs\n",
      "Classification Result: ['LC3', 'P62/SQSTM1', 'HSC70', 'nucleotide exchange factor', 'proteasome', 'ubiquitination', 'autophagy', 'apoptosis', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.17660972476005554, 0.1507110297679901, 0.146304190158844, 0.13662773370742798, 0.1249762773513794, 0.11452573537826538, 0.06007208675146103, 0.04314188286662102, 0.033484384417533875, 0.013546943664550781]\n",
      "\n",
      "Sentence: prognostic model of immunerelated genes for patients with hepatocellular carcinoma background                    immunerelated genes irgs are closely \n",
      "Classification Result: ['cancer', 'LC3', 'nucleotide exchange factor', 'proteasome', 'P62/SQSTM1', 'HSC70', 'ubiquitination', 'autophagy', 'apoptosis', 'cardiac hypertrophy']\n",
      "Scores: [0.4918593168258667, 0.13926151394844055, 0.07891695201396942, 0.06545411050319672, 0.06340229511260986, 0.05095098912715912, 0.044153980910778046, 0.0324726440012455, 0.019985254853963852, 0.013542968779802322]\n",
      "\n",
      "Sentence: finetuning of the hsc70based human protein disaggregase machinery by the distinctive cterminal extension of apg2 apg2 one of the three cytosolic hsp11\n",
      "Classification Result: ['nucleotide exchange factor', 'HSC70', 'LC3', 'proteasome', 'autophagy', 'P62/SQSTM1', 'ubiquitination', 'apoptosis', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.7367839813232422, 0.2023712545633316, 0.019972512498497963, 0.010377070866525173, 0.009023579768836498, 0.008001484908163548, 0.00650414451956749, 0.003272618865594268, 0.0022204581182450056, 0.0014729382237419486]\n",
      "\n",
      "Sentence: increased ehsp70toihsp70 ratio in prediabetic and diabetic postmenopausal women a biomarker of cardiometabolic risk decreased estrogen levels in menop\n",
      "Classification Result: ['HSC70', 'LC3', 'ubiquitination', 'proteasome', 'P62/SQSTM1', 'autophagy', 'nucleotide exchange factor', 'apoptosis', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.4944668114185333, 0.1276496797800064, 0.08270733058452606, 0.08002372086048126, 0.06866656243801117, 0.04630749300122261, 0.039862945675849915, 0.031135940924286842, 0.019198406487703323, 0.009981086477637291]\n",
      "\n",
      "Sentence: identification of abnormal protein expressions associated with mouse spermatogenesis induced by cyclophosphamide cyclophosphamide cp is a clinical ant\n",
      "Classification Result: ['apoptosis', 'LC3', 'HSC70', 'proteasome', 'P62/SQSTM1', 'autophagy', 'ubiquitination', 'nucleotide exchange factor', 'cancer', 'cardiac hypertrophy']\n",
      "Scores: [0.40404167771339417, 0.20232455432415009, 0.08766907453536987, 0.08277533203363419, 0.07972622662782669, 0.04667294770479202, 0.043665267527103424, 0.02766423672437668, 0.014469830319285393, 0.010990829207003117]\n",
      "\n",
      "Sentence: genetic diversity and selective signature in dabieshan cattle revealed by wholegenome resequencing dabieshan cattle are a typical breed of southern ch\n",
      "Classification Result: ['proteasome', 'nucleotide exchange factor', 'ubiquitination', 'LC3', 'HSC70', 'P62/SQSTM1', 'autophagy', 'apoptosis', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.19736294448375702, 0.16934338212013245, 0.13893800973892212, 0.11350049078464508, 0.11331464350223541, 0.0893108993768692, 0.0880327820777893, 0.04415726661682129, 0.036794740706682205, 0.009244889952242374]\n",
      "\n",
      "Sentence: in silico analysis of hsp70 gene family in bovine genome heat shock proteins hsps members of molecular chaperones families fulfill essential roles und\n",
      "Classification Result: ['HSC70', 'LC3', 'P62/SQSTM1', 'ubiquitination', 'proteasome', 'autophagy', 'nucleotide exchange factor', 'cardiac hypertrophy', 'apoptosis', 'cancer']\n",
      "Scores: [0.34301096200942993, 0.17710822820663452, 0.12254372239112854, 0.10155997425317764, 0.07514403015375137, 0.050411637872457504, 0.04138454049825668, 0.03773907199501991, 0.03625918924808502, 0.014838680624961853]\n",
      "\n",
      "Sentence: stress response protein rbm3 promotes the development of colitisassociated cancer background                    colitisassociated cancer cac is caused\n",
      "Classification Result: ['cancer', 'apoptosis', 'LC3', 'ubiquitination', 'HSC70', 'P62/SQSTM1', 'proteasome', 'nucleotide exchange factor', 'autophagy', 'cardiac hypertrophy']\n",
      "Scores: [0.6000838875770569, 0.10404537618160248, 0.08434296399354935, 0.04253014549612999, 0.0410415381193161, 0.03546326234936714, 0.033172834664583206, 0.03196020796895027, 0.019526051357388496, 0.007833784446120262]\n",
      "\n",
      "Sentence: immunogenomic landscape analysis of prognostic immunerelated genes in hepatocellular carcinoma hepatocellular carcinoma hcc is one of the leading caus\n",
      "Classification Result: ['cancer', 'LC3', 'P62/SQSTM1', 'HSC70', 'nucleotide exchange factor', 'ubiquitination', 'proteasome', 'autophagy', 'cardiac hypertrophy', 'apoptosis']\n",
      "Scores: [0.6871975064277649, 0.0696650967001915, 0.045868612825870514, 0.04140869528055191, 0.03579767048358917, 0.03519665449857712, 0.02923043631017208, 0.024226492270827293, 0.017212076112627983, 0.014196805655956268]\n",
      "\n",
      "Sentence: hsp70 expression signature in renal cell carcinoma a clinical and bioinformatic analysis approach heat shock proteins hsps are cytoprotective against \n",
      "Classification Result: ['cancer', 'HSC70', 'LC3', 'ubiquitination', 'P62/SQSTM1', 'proteasome', 'apoptosis', 'autophagy', 'nucleotide exchange factor', 'cardiac hypertrophy']\n",
      "Scores: [0.49462759494781494, 0.2935177981853485, 0.047891128808259964, 0.03436434641480446, 0.033262159675359726, 0.028723182156682014, 0.019498368725180626, 0.019412638619542122, 0.01672890968620777, 0.011973869055509567]\n",
      "\n",
      "Sentence: comparative proteomics analysis of gastric cancer stem cells cancer stem cells cscs are responsible for cancer progression metastasis and recurrence t\n",
      "Classification Result: ['cancer', 'proteasome', 'LC3', 'P62/SQSTM1', 'HSC70', 'ubiquitination', 'nucleotide exchange factor', 'autophagy', 'apoptosis', 'cardiac hypertrophy']\n",
      "Scores: [0.741066575050354, 0.08473309129476547, 0.0484272725880146, 0.02505371905863285, 0.022679690271615982, 0.022593310102820396, 0.018910424783825874, 0.01605200208723545, 0.010995397344231606, 0.009488435462117195]\n",
      "\n",
      "Sentence: identification and characterization of hadscderived exosome proteins from different isolation methods exosomes are secreted into the extracellular spa\n",
      "Classification Result: ['proteasome', 'LC3', 'nucleotide exchange factor', 'HSC70', 'P62/SQSTM1', 'ubiquitination', 'autophagy', 'apoptosis', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.28933796286582947, 0.20562082529067993, 0.1112465038895607, 0.10078415274620056, 0.09955322742462158, 0.06760898977518082, 0.0416678749024868, 0.03592124581336975, 0.02452791854739189, 0.023731302469968796]\n",
      "\n",
      "Sentence: development of an immunerelated prognostic index associated with hepatocellular carcinoma liver hepatocellular carcinoma lihc an inflammationassociate\n",
      "Classification Result: ['cancer', 'LC3', 'HSC70', 'nucleotide exchange factor', 'P62/SQSTM1', 'ubiquitination', 'proteasome', 'autophagy', 'apoptosis', 'cardiac hypertrophy']\n",
      "Scores: [0.7597023248672485, 0.05110084265470505, 0.038591474294662476, 0.033063486218452454, 0.031816307455301285, 0.02836671844124794, 0.022469395771622658, 0.01645921729505062, 0.010853087529540062, 0.00757717015221715]\n",
      "\n",
      "Sentence: hsp70 gene family in sebastiscus marmoratus the genomewide identification and transcriptome analysis under thermal stress heat shock protein 70 kda hs\n",
      "Classification Result: ['HSC70', 'ubiquitination', 'LC3', 'proteasome', 'P62/SQSTM1', 'autophagy', 'nucleotide exchange factor', 'cardiac hypertrophy', 'apoptosis', 'cancer']\n",
      "Scores: [0.4115295708179474, 0.1439158022403717, 0.13238096237182617, 0.08335259556770325, 0.07834981381893158, 0.04582740738987923, 0.037572890520095825, 0.02941928803920746, 0.02889883704483509, 0.008752813562750816]\n",
      "\n",
      "Sentence: network pharmacological evaluation of withania somnifera bioactive phytochemicals for identifying novel potential inhibitors against neurodegenerative\n",
      "Classification Result: ['LC3', 'ubiquitination', 'HSC70', 'P62/SQSTM1', 'autophagy', 'nucleotide exchange factor', 'apoptosis', 'proteasome', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.20503130555152893, 0.14734239876270294, 0.12108933180570602, 0.10277959704399109, 0.10087762027978897, 0.09838046878576279, 0.08973512798547745, 0.07295653223991394, 0.04215920716524124, 0.019648410379886627]\n",
      "\n",
      "Sentence: the multitarget mechanism of cyclosporin a in the treatment of vitiligo based on network pharmacology network pharmacology is an emerging discipline t\n",
      "Classification Result: ['LC3', 'HSC70', 'P62/SQSTM1', 'proteasome', 'nucleotide exchange factor', 'ubiquitination', 'autophagy', 'apoptosis', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.2982150912284851, 0.2442132532596588, 0.09791159629821777, 0.08386904001235962, 0.07604655623435974, 0.06966160982847214, 0.06384160369634628, 0.03131775185465813, 0.02334911935031414, 0.01157440897077322]\n",
      "\n",
      "Sentence: relationship between the plasma proteome and changes in inflammatory markers after bariatric surgery severe obesity is a disease associated with multi\n",
      "Classification Result: ['proteasome', 'LC3', 'nucleotide exchange factor', 'ubiquitination', 'P62/SQSTM1', 'HSC70', 'autophagy', 'apoptosis', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.7965855598449707, 0.04297134652733803, 0.031632762402296066, 0.03060411475598812, 0.03009592555463314, 0.026623757556080818, 0.014385964721441269, 0.01377642247825861, 0.008636308833956718, 0.004687911365181208]\n",
      "\n",
      "Sentence: a novel prognostic index of hepatocellular carcinoma based on immunogenomic landscape analysis changes in immune responses to hepatocellular carcinoma\n",
      "Classification Result: ['cancer', 'LC3', 'P62/SQSTM1', 'HSC70', 'nucleotide exchange factor', 'proteasome', 'ubiquitination', 'autophagy', 'apoptosis', 'cardiac hypertrophy']\n",
      "Scores: [0.7687985301017761, 0.06798004359006882, 0.033268317580223083, 0.030326154083013535, 0.025600403547286987, 0.023213298991322517, 0.01985546573996544, 0.011643124744296074, 0.011100232601165771, 0.008214494213461876]\n",
      "\n",
      "Sentence: wholegenome analyses reveal genomic characteristics and selection signatures of lincang humped cattle at the chinamyanmar border the location on the y\n",
      "Classification Result: ['proteasome', 'nucleotide exchange factor', 'ubiquitination', 'LC3', 'HSC70', 'P62/SQSTM1', 'autophagy', 'apoptosis', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.1918058693408966, 0.16197915375232697, 0.13272680342197418, 0.12883169949054718, 0.10389898717403412, 0.09811967611312866, 0.07519444823265076, 0.049626562744379044, 0.04133664071559906, 0.01648009940981865]\n",
      "\n",
      "Sentence: low birth weight intensifies changes in markers of hepatocarcinogenesis induced by fructose consumption in rats intrauterine growth restriction iugr d\n",
      "Classification Result: ['HSC70', 'cancer', 'LC3', 'nucleotide exchange factor', 'P62/SQSTM1', 'proteasome', 'ubiquitination', 'autophagy', 'apoptosis', 'cardiac hypertrophy']\n",
      "Scores: [0.5608823895454407, 0.1718495488166809, 0.07236230373382568, 0.04111086577177048, 0.03975136578083038, 0.03475400060415268, 0.03275229409337044, 0.023638257756829262, 0.014480918645858765, 0.00841799657791853]\n",
      "\n",
      "Sentence: systematic analysis of sexlinked molecular alterations and therapies in cancer though patient sex influences response to cancer treatments little is k\n",
      "Classification Result: ['cancer', 'LC3', 'HSC70', 'P62/SQSTM1', 'proteasome', 'nucleotide exchange factor', 'ubiquitination', 'autophagy', 'apoptosis', 'cardiac hypertrophy']\n",
      "Scores: [0.5462839007377625, 0.10918035358190536, 0.0676594078540802, 0.05705081671476364, 0.052160948514938354, 0.04396427795290947, 0.04361654818058014, 0.03769734129309654, 0.02555234357714653, 0.016834057867527008]\n",
      "\n",
      "Sentence: integrated analysis of differentially expressed genes implicated in ovarian cancer progression objective                    ovarian cancer oc is a com\n",
      "Classification Result: ['cancer', 'LC3', 'nucleotide exchange factor', 'ubiquitination', 'HSC70', 'P62/SQSTM1', 'proteasome', 'autophagy', 'apoptosis', 'cardiac hypertrophy']\n",
      "Scores: [0.7357251048088074, 0.05813981592655182, 0.047186002135276794, 0.0332149937748909, 0.032757196575403214, 0.030655287206172943, 0.02761077508330345, 0.015070467256009579, 0.013141697272658348, 0.006498734466731548]\n",
      "\n",
      "Sentence: molecular studies of phenotype variation in canine rpgrxlpra1 purpose                    canine xlinked progressive retinal atrophy 1 xlpra1 caused by\n",
      "Classification Result: ['proteasome', 'nucleotide exchange factor', 'P62/SQSTM1', 'LC3', 'ubiquitination', 'autophagy', 'HSC70', 'apoptosis', 'cancer', 'cardiac hypertrophy']\n",
      "Scores: [0.27113470435142517, 0.15913273394107819, 0.13904769718647003, 0.1344354748725891, 0.10749615728855133, 0.054028186947107315, 0.051392488181591034, 0.051153529435396194, 0.018230153247714043, 0.013948862440884113]\n",
      "\n",
      "Sentence: apoptosis genes as a key to identification of inverse comorbidity of huntingtons disease and cancer cancer and neurodegenerative disorders present ove\n",
      "Classification Result: ['apoptosis', 'cancer', 'P62/SQSTM1', 'LC3', 'ubiquitination', 'nucleotide exchange factor', 'HSC70', 'proteasome', 'autophagy', 'cardiac hypertrophy']\n",
      "Scores: [0.7578390836715698, 0.10235011577606201, 0.060835711658000946, 0.019745133817195892, 0.013329299166798592, 0.011784333735704422, 0.010988748632371426, 0.009937931783497334, 0.008980817161500454, 0.004208920057862997]\n",
      "\n",
      "Sentence: expression of heat shock proteins in periapical granulomas introduction                    cells from virtually all organisms respond to a variety of \n",
      "Classification Result: ['LC3', 'ubiquitination', 'proteasome', 'HSC70', 'P62/SQSTM1', 'autophagy', 'nucleotide exchange factor', 'apoptosis', 'cancer', 'cardiac hypertrophy']\n",
      "Scores: [0.23160122334957123, 0.15507324039936066, 0.13545413315296173, 0.10850955545902252, 0.10521938651800156, 0.10255776345729828, 0.05942441523075104, 0.049623508006334305, 0.029228122904896736, 0.023308705538511276]\n",
      "\n",
      "Sentence: ischemiaresponsive protein irp94 gene expression in neurons an increased expression of the ischemiaresponsive protein gene irp94 was detected in a mon\n",
      "Classification Result: ['LC3', 'HSC70', 'P62/SQSTM1', 'proteasome', 'ubiquitination', 'autophagy', 'apoptosis', 'cancer', 'nucleotide exchange factor', 'cardiac hypertrophy']\n",
      "Scores: [0.4128152132034302, 0.16134677827358246, 0.10422411561012268, 0.0912543311715126, 0.09013168513774872, 0.04651706665754318, 0.034754376858472824, 0.024607021361589432, 0.0236329585313797, 0.010716473683714867]\n",
      "\n",
      "Sentence: effect of tannic acid on doxorubicininduced cellular stress expression levels of heat shock genes in rat spleen doxorubicin dox an anthracycline group\n",
      "Classification Result: ['LC3', 'ubiquitination', 'proteasome', 'P62/SQSTM1', 'HSC70', 'autophagy', 'nucleotide exchange factor', 'apoptosis', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.20272134244441986, 0.15035735070705414, 0.11627595126628876, 0.115510493516922, 0.11520001292228699, 0.10010509192943573, 0.08008262515068054, 0.058030933141708374, 0.03350866958498955, 0.028207572177052498]\n",
      "\n",
      "Sentence: role of cct4erbb signaling in nephroblastoma implications for a biomarker of wilms tumor wilms tumor is a common abdominal malignant tumor in children\n",
      "Classification Result: ['cancer', 'LC3', 'HSC70', 'P62/SQSTM1', 'nucleotide exchange factor', 'proteasome', 'ubiquitination', 'apoptosis', 'autophagy', 'cardiac hypertrophy']\n",
      "Scores: [0.578360378742218, 0.09874456375837326, 0.06527768075466156, 0.05426126718521118, 0.04707477241754532, 0.0441431999206543, 0.037834491580724716, 0.026981724426150322, 0.02693168818950653, 0.020390193909406662]\n",
      "\n",
      "Sentence: proteinprotein interactions underlying the behavioral and psychological symptoms of dementia bpsd and alzheimers disease alzheimers disease ad is a de\n",
      "Classification Result: ['LC3', 'HSC70', 'ubiquitination', 'proteasome', 'P62/SQSTM1', 'nucleotide exchange factor', 'autophagy', 'cardiac hypertrophy', 'apoptosis', 'cancer']\n",
      "Scores: [0.22230905294418335, 0.1656779795885086, 0.15061795711517334, 0.12998050451278687, 0.09647613018751144, 0.08628952503204346, 0.07609491050243378, 0.030601490288972855, 0.02872760407626629, 0.013224874623119831]\n",
      "\n",
      "Sentence: prion protein is associated with a worse prognosis of head and neck squamous cell carcinoma background                    head and neck squamous cell \n",
      "Classification Result: ['cancer', 'LC3', 'proteasome', 'P62/SQSTM1', 'nucleotide exchange factor', 'ubiquitination', 'HSC70', 'autophagy', 'apoptosis', 'cardiac hypertrophy']\n",
      "Scores: [0.5599150061607361, 0.1077977642416954, 0.058880358934402466, 0.05466243997216225, 0.04976871237158775, 0.04481813311576843, 0.03860090672969818, 0.03718511015176773, 0.03215940296649933, 0.01621214486658573]\n",
      "\n",
      "Sentence: ngs study of glucocorticoid response genes in inflammatory bowel disease patients introduction                    despite intensive research and a lon\n",
      "Classification Result: ['LC3', 'HSC70', 'P62/SQSTM1', 'nucleotide exchange factor', 'ubiquitination', 'proteasome', 'autophagy', 'apoptosis', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.42826104164123535, 0.12041694670915604, 0.09385073930025101, 0.08784400671720505, 0.07200955599546432, 0.07125399261713028, 0.06243623420596123, 0.03689092770218849, 0.01918601058423519, 0.007850523106753826]\n",
      "\n",
      "Sentence: regulation of human hsc70 atpase and chaperone activities by apg2 role of the acidic subdomain protein aggregate reactivation in metazoans is accompli\n",
      "Classification Result: ['HSC70', 'nucleotide exchange factor', 'LC3', 'proteasome', 'P62/SQSTM1', 'autophagy', 'ubiquitination', 'apoptosis', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.5205379724502563, 0.3758060336112976, 0.04140188544988632, 0.020244142040610313, 0.011259795166552067, 0.010336479172110558, 0.00981845147907734, 0.004776418209075928, 0.003508185036480427, 0.002310642972588539]\n",
      "\n",
      "Sentence: gene expression characteristics of tumor and adjacent nontumor tissues of pancreatic ductal adenocarcinoma pdac insilico background                   \n",
      "Classification Result: ['cancer', 'LC3', 'nucleotide exchange factor', 'HSC70', 'P62/SQSTM1', 'ubiquitination', 'proteasome', 'autophagy', 'apoptosis', 'cardiac hypertrophy']\n",
      "Scores: [0.7239177823066711, 0.06829502433538437, 0.045022834092378616, 0.0400790311396122, 0.03502880409359932, 0.029870957136154175, 0.026242919266223907, 0.012545115314424038, 0.010640336200594902, 0.008357193320989609]\n",
      "\n",
      "Sentence: cep55 implications for immunotherapy and survival in hepatocellular carcinoma background                    hepatocellular carcinoma hcc is a highly a\n",
      "Classification Result: ['cancer', 'LC3', 'apoptosis', 'nucleotide exchange factor', 'P62/SQSTM1', 'ubiquitination', 'HSC70', 'proteasome', 'autophagy', 'cardiac hypertrophy']\n",
      "Scores: [0.8304930329322815, 0.028126835823059082, 0.027692055329680443, 0.022519314661622047, 0.021088464185595512, 0.017789021134376526, 0.016545455902814865, 0.016326067969202995, 0.013334454968571663, 0.0060853250324726105]\n",
      "\n",
      "Sentence: functional diversity between hsp70 paralogs caused by variable interactions with specific cochaperones heat shock protein 70 hsp70 chaperones play a c\n",
      "Classification Result: ['HSC70', 'nucleotide exchange factor', 'LC3', 'proteasome', 'P62/SQSTM1', 'ubiquitination', 'autophagy', 'apoptosis', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.4240340292453766, 0.41410526633262634, 0.050231002271175385, 0.03370357304811478, 0.020530153065919876, 0.01939345709979534, 0.017247656360268593, 0.008489278145134449, 0.008207703940570354, 0.004057983867824078]\n",
      "\n",
      "Sentence: sequence and expression analysis of hsp70 family genes in artemia franciscana thus far only one gene from the heat shock protein 70 hsp70 family has b\n",
      "Classification Result: ['HSC70', 'proteasome', 'LC3', 'ubiquitination', 'apoptosis', 'autophagy', 'nucleotide exchange factor', 'P62/SQSTM1', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.7804140448570251, 0.04370702803134918, 0.03740157559514046, 0.03355865925550461, 0.02826726622879505, 0.022246254608035088, 0.02185550332069397, 0.016136305406689644, 0.008726178668439388, 0.007687207777053118]\n",
      "\n",
      "Sentence: upregulation of hspa1ahspa1bhspa7 and downregulation of hspa9 were related to poor survival in colon cancer the human hsp70 family is a type of heat s\n",
      "Classification Result: ['cancer', 'HSC70', 'LC3', 'proteasome', 'ubiquitination', 'P62/SQSTM1', 'autophagy', 'nucleotide exchange factor', 'apoptosis', 'cardiac hypertrophy']\n",
      "Scores: [0.5576558113098145, 0.2900741398334503, 0.035718515515327454, 0.02364925667643547, 0.0219389870762825, 0.02089095115661621, 0.016016105189919472, 0.013792657293379307, 0.01235191524028778, 0.007911674678325653]\n",
      "\n",
      "Sentence: machine learning for building immune genetic model in hepatocellular carcinoma patients background                    hepatocellular carcinoma hcc is \n",
      "Classification Result: ['cancer', 'LC3', 'HSC70', 'ubiquitination', 'proteasome', 'P62/SQSTM1', 'nucleotide exchange factor', 'autophagy', 'apoptosis', 'cardiac hypertrophy']\n",
      "Scores: [0.5046643018722534, 0.1291389763355255, 0.0724223330616951, 0.06671015918254852, 0.06222693994641304, 0.05386482924222946, 0.04533861204981804, 0.03270917758345604, 0.022240694612264633, 0.010683959349989891]\n",
      "\n",
      "Sentence: noncoding rnas orchestrate cell growth death and drug resistance in renal cell carcinoma aim we aimed to explore the roles of noncoding rnas ncrnas in\n",
      "Classification Result: ['cancer', 'LC3', 'apoptosis', 'HSC70', 'proteasome', 'ubiquitination', 'autophagy', 'P62/SQSTM1', 'nucleotide exchange factor', 'cardiac hypertrophy']\n",
      "Scores: [0.35408398509025574, 0.1523168385028839, 0.07644697278738022, 0.0749099999666214, 0.07238100469112396, 0.07210711389780045, 0.06376833468675613, 0.058696579188108444, 0.052200913429260254, 0.023088207468390465]\n",
      "\n",
      "Sentence: molecular association of pathogenetic contributors to preeclampsia preeclampsia associome background                    preeclampsia is the most commo\n",
      "Classification Result: ['proteasome', 'LC3', 'ubiquitination', 'nucleotide exchange factor', 'cancer', 'HSC70', 'P62/SQSTM1', 'cardiac hypertrophy', 'autophagy', 'apoptosis']\n",
      "Scores: [0.32840022444725037, 0.2005952149629593, 0.12514738738536835, 0.08235321938991547, 0.0705491304397583, 0.05536270514130592, 0.04915611445903778, 0.03745817020535469, 0.030503129586577415, 0.020474722608923912]\n",
      "\n",
      "Sentence: identification of a fiveimmune gene model as an independent prognostic factor in hepatocellular carcinoma background                    hepatocellular\n",
      "Classification Result: ['cancer', 'LC3', 'proteasome', 'ubiquitination', 'HSC70', 'P62/SQSTM1', 'nucleotide exchange factor', 'autophagy', 'apoptosis', 'cardiac hypertrophy']\n",
      "Scores: [0.7121207118034363, 0.07198405265808105, 0.03853277117013931, 0.0368933267891407, 0.03515385463833809, 0.030442172661423683, 0.027639450505375862, 0.02271096594631672, 0.015053200535476208, 0.009469499811530113]\n",
      "\n",
      "Sentence: bioinformatics analysis of common genetic and molecular traits and association of portal hypertension with pulmonary hypertension portal hypertension \n",
      "Classification Result: ['nucleotide exchange factor', 'LC3', 'proteasome', 'HSC70', 'P62/SQSTM1', 'ubiquitination', 'autophagy', 'cardiac hypertrophy', 'apoptosis', 'cancer']\n",
      "Scores: [0.1910933256149292, 0.16551674902439117, 0.14661505818367004, 0.1165863573551178, 0.11498188972473145, 0.07935638725757599, 0.07363715767860413, 0.05387323722243309, 0.03741098567843437, 0.020928865298628807]\n",
      "\n",
      "Sentence: epigenetic rewiring of pathways related to odour perception in immune cells exposed to sarscov2 in vivo and in vitro a majority of sarscov2 recoverees\n",
      "Classification Result: ['LC3', 'ubiquitination', 'proteasome', 'nucleotide exchange factor', 'HSC70', 'P62/SQSTM1', 'autophagy', 'apoptosis', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.22408653795719147, 0.13976432383060455, 0.13463181257247925, 0.13322581350803375, 0.12377702444791794, 0.09859094768762589, 0.058884795755147934, 0.036809250712394714, 0.030958017334342003, 0.019271383062005043]\n",
      "\n",
      "Sentence: differentially expressed cell cycle genes and stat13driven multiple cancer entanglement in psoriasis coupled with other comorbidities psoriasis is a p\n",
      "Classification Result: ['cancer', 'LC3', 'ubiquitination', 'proteasome', 'HSC70', 'nucleotide exchange factor', 'P62/SQSTM1', 'autophagy', 'apoptosis', 'cardiac hypertrophy']\n",
      "Scores: [0.22339515388011932, 0.1632625162601471, 0.1305706799030304, 0.11650244891643524, 0.08714228868484497, 0.08134986460208893, 0.07889261841773987, 0.06381086260080338, 0.030588125810027122, 0.02448534406721592]\n",
      "\n",
      "Sentence: epigenetic biomarkers screening of noncoding rna and dna methylation based on peripheral blood monocytes in smokers this study aims to use bioinformat\n",
      "Classification Result: ['autophagy', 'ubiquitination', 'LC3', 'proteasome', 'HSC70', 'P62/SQSTM1', 'nucleotide exchange factor', 'apoptosis', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.28420618176460266, 0.2380678951740265, 0.11759985238313675, 0.09899286180734634, 0.06744298338890076, 0.06737178564071655, 0.06320298463106155, 0.03144555538892746, 0.022301938384771347, 0.00936792604625225]\n",
      "\n",
      "Sentence: identification of candidate genomic regions for egg yolk moisture content based on a genomewide association study background                    eggs r\n",
      "Classification Result: ['proteasome', 'LC3', 'nucleotide exchange factor', 'P62/SQSTM1', 'HSC70', 'ubiquitination', 'autophagy', 'apoptosis', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.2001657634973526, 0.15717661380767822, 0.1327017992734909, 0.12195009738206863, 0.10555603355169296, 0.08533765375614166, 0.07624936103820801, 0.05396343767642975, 0.04237344115972519, 0.024525774642825127]\n",
      "\n",
      "Sentence: evaluation of the genetic diversity population structure and selection signatures of three native chinese pig populations indigenous pig populations i\n",
      "Classification Result: ['proteasome', 'nucleotide exchange factor', 'LC3', 'HSC70', 'ubiquitination', 'autophagy', 'P62/SQSTM1', 'apoptosis', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.181122288107872, 0.17634378373622894, 0.12993331253528595, 0.11034262925386429, 0.09766208380460739, 0.09577718377113342, 0.09227441251277924, 0.05504560470581055, 0.042601700872182846, 0.018897011876106262]\n",
      "\n",
      "Sentence: rnathermsw direct temperature simulations for predicting the location of rna thermometers the mechanism of rna thermometers is a subject of growing in\n",
      "Classification Result: ['ubiquitination', 'LC3', 'P62/SQSTM1', 'HSC70', 'nucleotide exchange factor', 'autophagy', 'proteasome', 'cardiac hypertrophy', 'apoptosis', 'cancer']\n",
      "Scores: [0.24219951033592224, 0.1652587354183197, 0.1397017240524292, 0.12893158197402954, 0.1028335690498352, 0.060530081391334534, 0.05940285697579384, 0.0423700287938118, 0.03930703550577164, 0.019464902579784393]\n",
      "\n",
      "Sentence: huzhangqingmaiyin inhibits proliferation of human retinal capillary endothelial cells exposed to high glucose background                    diabetic r\n",
      "Classification Result: ['apoptosis', 'LC3', 'proteasome', 'nucleotide exchange factor', 'HSC70', 'P62/SQSTM1', 'autophagy', 'ubiquitination', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.8407390713691711, 0.04486582800745964, 0.040445782244205475, 0.019570106640458107, 0.01615721359848976, 0.015635844320058823, 0.011168387718498707, 0.008422533981502056, 0.002191215753555298, 0.0008040551911108196]\n",
      "\n",
      "Sentence: analysis of ppi networks of transcriptomic expression identifies hub genes associated with newcastle disease virus persistent infection in bladder can\n",
      "Classification Result: ['cancer', 'proteasome', 'nucleotide exchange factor', 'LC3', 'HSC70', 'P62/SQSTM1', 'ubiquitination', 'autophagy', 'apoptosis', 'cardiac hypertrophy']\n",
      "Scores: [0.47668060660362244, 0.11300751566886902, 0.10097980499267578, 0.07306694239377975, 0.06028517708182335, 0.04856066405773163, 0.044475432485342026, 0.03935365006327629, 0.029737215489149094, 0.013853121548891068]\n",
      "\n",
      "Sentence: a simplified and effective approach for the isolation of small pluripotent stem cells derived from human peripheral blood pluripotent stem cells are k\n",
      "Classification Result: ['proteasome', 'LC3', 'nucleotide exchange factor', 'ubiquitination', 'autophagy', 'P62/SQSTM1', 'HSC70', 'apoptosis', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.38699793815612793, 0.13059774041175842, 0.12370210140943527, 0.0848795473575592, 0.07385942339897156, 0.07205740362405777, 0.06844552606344223, 0.0285772904753685, 0.021107332780957222, 0.009775599464774132]\n",
      "\n",
      "Sentence: the expression profiles and prognostic values of hsps family members in head and neck cancer background                    head and neck squamous cell\n",
      "Classification Result: ['cancer', 'LC3', 'proteasome', 'P62/SQSTM1', 'HSC70', 'nucleotide exchange factor', 'ubiquitination', 'apoptosis', 'autophagy', 'cardiac hypertrophy']\n",
      "Scores: [0.7137622833251953, 0.060160212218761444, 0.04738366976380348, 0.037924762815237045, 0.03453079238533974, 0.028841610997915268, 0.028481241315603256, 0.01814572699368, 0.017941175028681755, 0.012828483246266842]\n",
      "\n",
      "Sentence: zebrafish heat shock protein a4 genes in the intestinal epithelium are upregulated during inflammation a number of heat shock proteins hsps including \n",
      "Classification Result: ['HSC70', 'LC3', 'ubiquitination', 'proteasome', 'P62/SQSTM1', 'autophagy', 'nucleotide exchange factor', 'apoptosis', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.524435818195343, 0.13935033977031708, 0.0977175161242485, 0.0757344588637352, 0.05933922529220581, 0.04006669670343399, 0.02455456554889679, 0.021461885422468185, 0.010463982820510864, 0.006875541061162949]\n",
      "\n",
      "Sentence: inhibition of endoplasmic reticulum stress alleviates triplenegative breast cancer cell viability migration and invasion by synteninsox4wntcatenin pat\n",
      "Classification Result: ['cancer', 'LC3', 'P62/SQSTM1', 'proteasome', 'nucleotide exchange factor', 'HSC70', 'ubiquitination', 'autophagy', 'apoptosis', 'cardiac hypertrophy']\n",
      "Scores: [0.8117712140083313, 0.04779026657342911, 0.03252151980996132, 0.0226175244897604, 0.0225503072142601, 0.02227092534303665, 0.017290843650698662, 0.011803991161286831, 0.00651667732745409, 0.004866665229201317]\n",
      "\n",
      "Sentence: a bioinformatic approach for the identification of molecular determinants of resistancesensitivity to cancer thermotherapy application of heat above 4\n",
      "Classification Result: ['cancer', 'apoptosis', 'LC3', 'HSC70', 'P62/SQSTM1', 'proteasome', 'ubiquitination', 'autophagy', 'nucleotide exchange factor', 'cardiac hypertrophy']\n",
      "Scores: [0.5800161957740784, 0.13588282465934753, 0.06347498297691345, 0.05476946011185646, 0.04349198192358017, 0.03234103322029114, 0.030230754986405373, 0.027806611731648445, 0.02432532235980034, 0.007660776376724243]\n",
      "\n",
      "Sentence: heat shock protein 70 protects the lungs from hyperoxic injury in a neonatal rat model of bronchopulmonary dysplasia hyperoxia plays a significant rol\n",
      "Classification Result: ['HSC70', 'apoptosis', 'LC3', 'ubiquitination', 'autophagy', 'proteasome', 'P62/SQSTM1', 'nucleotide exchange factor', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.4898083508014679, 0.3424533009529114, 0.045140571892261505, 0.03057023137807846, 0.029702799394726753, 0.02461349405348301, 0.020848620682954788, 0.008229197934269905, 0.005829619709402323, 0.0028038164600729942]\n",
      "\n",
      "Sentence: transcriptome analysis provides the first insight into the molecular basis of temperature plasticity in banggai cardinalfish pterapogon kauderni bangg\n",
      "Classification Result: ['HSC70', 'LC3', 'nucleotide exchange factor', 'proteasome', 'ubiquitination', 'P62/SQSTM1', 'autophagy', 'apoptosis', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.6633723974227905, 0.07078209519386292, 0.06949381530284882, 0.057796377688646317, 0.04655718058347702, 0.04019758477807045, 0.02361418306827545, 0.013266758061945438, 0.010364443063735962, 0.004555197432637215]\n",
      "\n",
      "Sentence: human and yeast hsp110 chaperones exhibit functional differences hsp110 proteins constitute a heterogeneous family of abundant molecular chaperones re\n",
      "Classification Result: ['HSC70', 'LC3', 'proteasome', 'P62/SQSTM1', 'nucleotide exchange factor', 'autophagy', 'ubiquitination', 'apoptosis', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.23467816412448883, 0.23278234899044037, 0.1887243539094925, 0.096551813185215, 0.06612693518400192, 0.06209849193692207, 0.04333413019776344, 0.03212227672338486, 0.028338586911559105, 0.015242907218635082]\n",
      "\n",
      "Sentence: identification of methylated genes and mirna signatures in nasopharyngeal carcinoma by bioinformatics analysis nasopharyngeal carcinoma npc is prevale\n",
      "Classification Result: ['cancer', 'proteasome', 'LC3', 'HSC70', 'nucleotide exchange factor', 'P62/SQSTM1', 'ubiquitination', 'apoptosis', 'autophagy', 'cardiac hypertrophy']\n",
      "Scores: [0.694286048412323, 0.06399350613355637, 0.04413391277194023, 0.042532190680503845, 0.0397711843252182, 0.03904192894697189, 0.0237367432564497, 0.02017330937087536, 0.019977306947112083, 0.01235390268266201]\n",
      "\n",
      "Sentence: the human allicinproteome sthioallylation of proteins by the garlic defence substance allicin and its biological effects a single clove of edible garl\n",
      "Classification Result: ['apoptosis', 'proteasome', 'LC3', 'ubiquitination', 'HSC70', 'nucleotide exchange factor', 'P62/SQSTM1', 'autophagy', 'cancer', 'cardiac hypertrophy']\n",
      "Scores: [0.6324931383132935, 0.1368451565504074, 0.05911313742399216, 0.043880850076675415, 0.03511175885796547, 0.02562638744711876, 0.024374252185225487, 0.019284946843981743, 0.016220513731241226, 0.0070498320274055]\n",
      "\n",
      "Sentence: identification of glutamylprolyltrna synthetase as a new therapeutic target in hepatocellular carcinoma via a novel bioinformatic approach background \n",
      "Classification Result: ['cancer', 'LC3', 'proteasome', 'ubiquitination', 'P62/SQSTM1', 'nucleotide exchange factor', 'HSC70', 'apoptosis', 'autophagy', 'cardiac hypertrophy']\n",
      "Scores: [0.7706862688064575, 0.03844004124403, 0.03634754195809364, 0.031842779368162155, 0.03099052421748638, 0.02990034408867359, 0.021903211250901222, 0.015411818400025368, 0.014060663990676403, 0.010416720062494278]\n",
      "\n",
      "Sentence: changes in the proteome profile of people achieving remission of type 2 diabetes after bariatric surgery bariatric surgery bs results in metabolic pat\n",
      "Classification Result: ['proteasome', 'LC3', 'nucleotide exchange factor', 'P62/SQSTM1', 'HSC70', 'ubiquitination', 'autophagy', 'apoptosis', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.4476080536842346, 0.1264195293188095, 0.09933371096849442, 0.08329370617866516, 0.07994870096445084, 0.0661434680223465, 0.050490763038396835, 0.026055609807372093, 0.012591522186994553, 0.008114852011203766]\n",
      "\n",
      "Sentence: hsp110 protects heatdenatured proteins and confers cellular thermoresistance the 110kda heat shock protein hsp110 has long been recognized as one of t\n",
      "Classification Result: ['LC3', 'HSC70', 'ubiquitination', 'P62/SQSTM1', 'proteasome', 'autophagy', 'cardiac hypertrophy', 'apoptosis', 'nucleotide exchange factor', 'cancer']\n",
      "Scores: [0.1799115538597107, 0.15757721662521362, 0.14758659899234772, 0.12939226627349854, 0.1257828176021576, 0.11340633034706116, 0.042533569037914276, 0.03780176863074303, 0.033614516258239746, 0.03239332512021065]\n",
      "\n",
      "Sentence: the potential role of heat shock proteins in acute spinal cord injury purpose                    this study aims to investigate the differential expre\n",
      "Classification Result: ['LC3', 'HSC70', 'ubiquitination', 'P62/SQSTM1', 'proteasome', 'autophagy', 'nucleotide exchange factor', 'apoptosis', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.2677016854286194, 0.13868974149227142, 0.13266000151634216, 0.12415808439254761, 0.10059687495231628, 0.06741809844970703, 0.06160030514001846, 0.05146317929029465, 0.03312382474541664, 0.02258811518549919]\n",
      "\n",
      "Sentence: whole exome sequencing and system biology analysis support the twohit mechanism in the onset of ameloblastoma background                    ameloblast\n",
      "Classification Result: ['cancer', 'HSC70', 'LC3', 'P62/SQSTM1', 'nucleotide exchange factor', 'proteasome', 'ubiquitination', 'autophagy', 'apoptosis', 'cardiac hypertrophy']\n",
      "Scores: [0.4502679109573364, 0.11821354925632477, 0.08300621062517166, 0.06852375715970993, 0.0683450996875763, 0.06447018682956696, 0.0467536486685276, 0.04055777192115784, 0.03137084096670151, 0.028491035103797913]\n",
      "\n",
      "Sentence: optimized postconditioning algorithm protects liver graft after liver transplantation in rats background                    ischemia reperfusion injur\n",
      "Classification Result: ['LC3', 'proteasome', 'HSC70', 'nucleotide exchange factor', 'P62/SQSTM1', 'ubiquitination', 'apoptosis', 'autophagy', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.2623835504055023, 0.14120621979236603, 0.1323973834514618, 0.11149271577596664, 0.08884097635746002, 0.08187200874090195, 0.07952861487865448, 0.07120204716920853, 0.017236895859241486, 0.01383958663791418]\n",
      "\n",
      "Sentence: an immunogenic cell deathrelated regulators classification patterns and immune microenvironment infiltration characterization in intracranial aneurysm\n",
      "Classification Result: ['LC3', 'proteasome', 'nucleotide exchange factor', 'HSC70', 'P62/SQSTM1', 'ubiquitination', 'apoptosis', 'autophagy', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.3262781500816345, 0.14840838313102722, 0.11929646134376526, 0.10380864888429642, 0.09118679910898209, 0.0797535628080368, 0.05845845863223076, 0.04111865907907486, 0.016085900366306305, 0.015605009160935879]\n",
      "\n",
      "Sentence: dynamically changed hsp70 after reperfusion following cerebral infarction in human and rats correlation with p38 mapk we aimed to clarify the correlat\n",
      "Classification Result: ['HSC70', 'LC3', 'P62/SQSTM1', 'ubiquitination', 'proteasome', 'autophagy', 'nucleotide exchange factor', 'apoptosis', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.29699206352233887, 0.2106407880783081, 0.11394497752189636, 0.08693996071815491, 0.08323434740304947, 0.06987962871789932, 0.05925657972693443, 0.04640373960137367, 0.021275531500577927, 0.011432330124080181]\n",
      "\n",
      "Sentence: analysis and differential expression of primo genes using rnaseq and qrtpcr experiments although the existence of the primo vasculature system has bee\n",
      "Classification Result: ['LC3', 'P62/SQSTM1', 'HSC70', 'proteasome', 'nucleotide exchange factor', 'ubiquitination', 'autophagy', 'apoptosis', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.1941370666027069, 0.1438608318567276, 0.14105646312236786, 0.1393202543258667, 0.11925727874040604, 0.11853796243667603, 0.07309838384389877, 0.03831685706973076, 0.02429693378508091, 0.00811801292002201]\n",
      "\n",
      "Sentence: neuroprotective effects of selegiline on rat neural stem cells treated with hydrogen peroxide oxidative stress and reactive oxygen species generation \n",
      "Classification Result: ['apoptosis', 'LC3', 'HSC70', 'proteasome', 'P62/SQSTM1', 'nucleotide exchange factor', 'ubiquitination', 'autophagy', 'cancer', 'cardiac hypertrophy']\n",
      "Scores: [0.7055193185806274, 0.06947477161884308, 0.04731994867324829, 0.03678610920906067, 0.035965610295534134, 0.034981127828359604, 0.03132662922143936, 0.0285380557179451, 0.005597306415438652, 0.00449120020493865]\n",
      "\n",
      "Sentence: smell detection agent optimisation framework and systems biology approach to detect dysregulated subnetwork in cancer data network biology has become \n",
      "Classification Result: ['cancer', 'LC3', 'nucleotide exchange factor', 'proteasome', 'P62/SQSTM1', 'HSC70', 'ubiquitination', 'apoptosis', 'autophagy', 'cardiac hypertrophy']\n",
      "Scores: [0.7241074442863464, 0.06230386346578598, 0.041479527950286865, 0.03920918330550194, 0.03501219302415848, 0.03396432846784592, 0.031090736389160156, 0.013038797304034233, 0.012181701138615608, 0.00761221069842577]\n",
      "\n",
      "Sentence: study on synergistic antioxidant effect of typical functional components of hydroethanolic leaf extract from ginkgo biloba in vitro the predicted anti\n",
      "Classification Result: ['apoptosis', 'LC3', 'HSC70', 'P62/SQSTM1', 'proteasome', 'ubiquitination', 'autophagy', 'nucleotide exchange factor', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.5942145586013794, 0.12222111970186234, 0.06358379870653152, 0.04770004749298096, 0.046718720346689224, 0.040105629712343216, 0.03523505851626396, 0.030399130657315254, 0.010328060016036034, 0.009493878111243248]\n",
      "\n",
      "Sentence: identification of immune hub genes associated with braak stages in alzheimers disease and their correlation of immune infiltration background         \n",
      "Classification Result: ['LC3', 'ubiquitination', 'P62/SQSTM1', 'proteasome', 'nucleotide exchange factor', 'HSC70', 'autophagy', 'apoptosis', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.17231617867946625, 0.14135247468948364, 0.13895834982395172, 0.13499943912029266, 0.13472086191177368, 0.11084959656000137, 0.06723694503307343, 0.055658672004938126, 0.026881292462348938, 0.017026128247380257]\n",
      "\n",
      "Sentence: establishment of a prognostic model for hepatocellular carcinoma based on bioinformatics and the role of nr6a1 in the progression of hcc background an\n",
      "Classification Result: ['cancer', 'LC3', 'nucleotide exchange factor', 'HSC70', 'proteasome', 'ubiquitination', 'P62/SQSTM1', 'autophagy', 'cardiac hypertrophy', 'apoptosis']\n",
      "Scores: [0.7014483213424683, 0.09213253855705261, 0.03908255323767662, 0.03162919357419014, 0.029724739491939545, 0.02936135046184063, 0.028505418449640274, 0.020014993846416473, 0.014094142243266106, 0.014006732031702995]\n",
      "\n",
      "Sentence: identification of proteomic markers for prediction of the response to 5fluorouracil based neoadjuvant chemoradiotherapy in locally advanced rectal can\n",
      "Classification Result: ['cancer', 'LC3', 'nucleotide exchange factor', 'proteasome', 'P62/SQSTM1', 'HSC70', 'apoptosis', 'ubiquitination', 'autophagy', 'cardiac hypertrophy']\n",
      "Scores: [0.35371339321136475, 0.13780426979064941, 0.09383684396743774, 0.0931025892496109, 0.08104321360588074, 0.06830274313688278, 0.052437640726566315, 0.049911219626665115, 0.04472484812140465, 0.025123216211795807]\n",
      "\n",
      "Sentence: proliferation of dental folliclederived cell populations in heatstress conditions objectives                    isolation and purification of adult st\n",
      "Classification Result: ['HSC70', 'LC3', 'nucleotide exchange factor', 'P62/SQSTM1', 'ubiquitination', 'proteasome', 'autophagy', 'apoptosis', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.3068912625312805, 0.16731178760528564, 0.11267969757318497, 0.09231607615947723, 0.0867757648229599, 0.08656077086925507, 0.07006900757551193, 0.034899089485406876, 0.03032459132373333, 0.012171954847872257]\n",
      "\n",
      "Sentence: genomewide scan reveals divergent selection among taurine and zebu cattle populations from different regions in this study to identify genomic signatu\n",
      "Classification Result: ['LC3', 'proteasome', 'nucleotide exchange factor', 'HSC70', 'P62/SQSTM1', 'ubiquitination', 'autophagy', 'apoptosis', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.18581321835517883, 0.16232480108737946, 0.16117063164710999, 0.12328504025936127, 0.1180078536272049, 0.0984686091542244, 0.07400218397378922, 0.03686053678393364, 0.025724638253450394, 0.014342465437948704]\n",
      "\n",
      "Sentence: identification of thioredoxin1 as a biomarker of lung cancer and evaluation of its prognostic value based on bioinformatics analysis background       \n",
      "Classification Result: ['cancer', 'LC3', 'HSC70', 'P62/SQSTM1', 'ubiquitination', 'autophagy', 'proteasome', 'nucleotide exchange factor', 'apoptosis', 'cardiac hypertrophy']\n",
      "Scores: [0.6482029557228088, 0.11340633779764175, 0.04376097768545151, 0.04143356531858444, 0.035119667649269104, 0.03222540020942688, 0.031130677089095116, 0.023499278351664543, 0.016268685460090637, 0.014952437952160835]\n",
      "\n",
      "Sentence: gene expression profile analysis of eno1 knockdown in gastric cancer cell line mgc803 gastric cancer gc is the third leading cause of cancerassociated\n",
      "Classification Result: ['cancer', 'LC3', 'nucleotide exchange factor', 'HSC70', 'proteasome', 'P62/SQSTM1', 'ubiquitination', 'autophagy', 'apoptosis', 'cardiac hypertrophy']\n",
      "Scores: [0.40355467796325684, 0.13037815690040588, 0.08745193481445312, 0.08416450023651123, 0.07220710813999176, 0.06936191022396088, 0.05515513941645622, 0.05208852142095566, 0.029347259551286697, 0.016290783882141113]\n",
      "\n",
      "Sentence: identification and validation of stageassociated pbmc biomarkers in breast cancer using msbased proteomics background it is welldescribed that the tra\n",
      "Classification Result: ['cancer', 'proteasome', 'LC3', 'HSC70', 'P62/SQSTM1', 'ubiquitination', 'nucleotide exchange factor', 'autophagy', 'apoptosis', 'cardiac hypertrophy']\n",
      "Scores: [0.42628681659698486, 0.19476129114627838, 0.08021924644708633, 0.061566613614559174, 0.061038125306367874, 0.04743988439440727, 0.045698314905166626, 0.03805473446846008, 0.02685050293803215, 0.018084488809108734]\n",
      "\n",
      "Sentence: immune profiles of male giant panda ailuropoda melanoleuca during the breeding season background                    the giant panda ailuropoda melanol\n",
      "Classification Result: ['proteasome', 'autophagy', 'LC3', 'HSC70', 'nucleotide exchange factor', 'ubiquitination', 'P62/SQSTM1', 'apoptosis', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.3231261670589447, 0.3014688193798065, 0.07115714251995087, 0.0659666433930397, 0.060270044952631, 0.058212198317050934, 0.05233718827366829, 0.0380195714533329, 0.023676589131355286, 0.005765663459897041]\n",
      "\n",
      "Sentence: a comprehensive stemness gene expression analysis signifies the role of abc transporters and molecular chaperons in determining the fate of human neur\n",
      "Classification Result: ['HSC70', 'LC3', 'nucleotide exchange factor', 'proteasome', 'P62/SQSTM1', 'ubiquitination', 'autophagy', 'cardiac hypertrophy', 'apoptosis', 'cancer']\n",
      "Scores: [0.28987374901771545, 0.1563241183757782, 0.12443607300519943, 0.10230410844087601, 0.09323200583457947, 0.09262638539075851, 0.06228791922330856, 0.0357719250023365, 0.03232518583536148, 0.01081848330795765]\n",
      "\n",
      "Sentence: the functional mechanisms of synchronizing royal jelly consumption and physical activity on rat with multiple sclerosislike behaviors hallmarks based \n",
      "Classification Result: ['P62/SQSTM1', 'LC3', 'HSC70', 'nucleotide exchange factor', 'ubiquitination', 'proteasome', 'autophagy', 'apoptosis', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.16042496263980865, 0.15892402827739716, 0.14005742967128754, 0.13447405397891998, 0.12004899978637695, 0.10974909365177155, 0.08629269897937775, 0.040479954332113266, 0.038057755678892136, 0.011490986682474613]\n",
      "\n",
      "Sentence: gene cloning of immunogenic antigens overexpressed in pancreatic cancer the serological analysis of recombinant cdna expression libraries serex by uti\n",
      "Classification Result: ['cancer', 'LC3', 'ubiquitination', 'HSC70', 'P62/SQSTM1', 'proteasome', 'nucleotide exchange factor', 'autophagy', 'apoptosis', 'cardiac hypertrophy']\n",
      "Scores: [0.6314001083374023, 0.08503429591655731, 0.051451947540044785, 0.04780878871679306, 0.04273610562086105, 0.03811797499656677, 0.03312017023563385, 0.03243351727724075, 0.02550719492137432, 0.012389914132654667]\n",
      "\n",
      "Sentence: acute ozoneinduced transcriptional changes in markers of oxidative stress and glucocorticoid signaling in the rat hippocampus and hypothalamus are sex\n",
      "Classification Result: ['LC3', 'HSC70', 'proteasome', 'nucleotide exchange factor', 'P62/SQSTM1', 'autophagy', 'ubiquitination', 'apoptosis', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.2059250921010971, 0.15573371946811676, 0.14592799544334412, 0.13248856365680695, 0.10853955149650574, 0.07193409651517868, 0.07179754972457886, 0.04229653999209404, 0.0356258861720562, 0.02973097935318947]\n",
      "\n",
      "Sentence: influence of mild chronic stress and social isolation on acute ozoneinduced alterations in stress biomarkers and brainregionspecific gene expression i\n",
      "Classification Result: ['LC3', 'proteasome', 'nucleotide exchange factor', 'ubiquitination', 'P62/SQSTM1', 'HSC70', 'autophagy', 'apoptosis', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.21229217946529388, 0.20460186898708344, 0.1677131950855255, 0.09593869745731354, 0.09450505673885345, 0.08309635519981384, 0.05608714371919632, 0.045283012092113495, 0.02665586583316326, 0.013826701790094376]\n",
      "\n",
      "Sentence: apg2 has a chaperonelike activity similar to hsp110 and is overexpressed in hepatocellular carcinomas hepatocellular carcinoma hcc is the fifth most c\n",
      "Classification Result: ['cancer', 'apoptosis', 'LC3', 'ubiquitination', 'P62/SQSTM1', 'HSC70', 'autophagy', 'proteasome', 'nucleotide exchange factor', 'cardiac hypertrophy']\n",
      "Scores: [0.7133538126945496, 0.13916179537773132, 0.03985793888568878, 0.022330405190587044, 0.0214413870126009, 0.019788352772593498, 0.014319381676614285, 0.0140326377004385, 0.010491438210010529, 0.005222812294960022]\n",
      "\n",
      "Sentence: let7c mirna inhibits the proliferation and migration of heatdenatured dermal fibroblasts through downregulating hsp70 wound healing is a complex physi\n",
      "Classification Result: ['HSC70', 'LC3', 'P62/SQSTM1', 'proteasome', 'ubiquitination', 'autophagy', 'nucleotide exchange factor', 'apoptosis', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.5207950472831726, 0.1794475018978119, 0.09066759049892426, 0.05836663395166397, 0.05354709178209305, 0.039926279336214066, 0.02743828110396862, 0.01669679395854473, 0.006796844303607941, 0.0063178641721606255]\n",
      "\n",
      "Sentence: bioinformatics enrichment analysis of genes and pathways related to maternal type 1 diabetes associated with adverse fetal outcomes maternal type 1 di\n",
      "Classification Result: ['LC3', 'HSC70', 'proteasome', 'nucleotide exchange factor', 'P62/SQSTM1', 'ubiquitination', 'apoptosis', 'autophagy', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.20908114314079285, 0.15131500363349915, 0.13582472503185272, 0.131088525056839, 0.13073399662971497, 0.07767375558614731, 0.06504876166582108, 0.053559836000204086, 0.03268205374479294, 0.012992201372981071]\n",
      "\n",
      "Sentence: transient hypoxia leads to increased serum levels of heat shock protein27 70 and caspasecleaved cytokeratin 18 background                    chronic o\n",
      "Classification Result: ['HSC70', 'LC3', 'ubiquitination', 'P62/SQSTM1', 'proteasome', 'nucleotide exchange factor', 'autophagy', 'apoptosis', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.4672119617462158, 0.15750063955783844, 0.08704131841659546, 0.07718100398778915, 0.06584358215332031, 0.04207565262913704, 0.03969859704375267, 0.025484204292297363, 0.02465125359594822, 0.013311784714460373]\n",
      "\n",
      "Sentence: insights into adaption and growth evolution a comparative genomics study on two distinct cattle breeds from northern and southern china mongolian catt\n",
      "Classification Result: ['LC3', 'nucleotide exchange factor', 'proteasome', 'HSC70', 'P62/SQSTM1', 'ubiquitination', 'autophagy', 'apoptosis', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.1759127527475357, 0.17100730538368225, 0.13479439914226532, 0.11591845005750656, 0.11489588022232056, 0.10299104452133179, 0.07556351274251938, 0.05714301019906998, 0.03674894943833351, 0.015024717897176743]\n",
      "\n",
      "Sentence: cellular responses of novel human pancreatic cell line 11b4 to hyperglycemia the novel humanderived pancreatic cell line 11b4 exhibits insulin secreti\n",
      "Classification Result: ['apoptosis', 'nucleotide exchange factor', 'proteasome', 'ubiquitination', 'LC3', 'autophagy', 'HSC70', 'P62/SQSTM1', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.7472105622291565, 0.05826914682984352, 0.04651790112257004, 0.04045230522751808, 0.03297620639204979, 0.0290702972561121, 0.01977797970175743, 0.01360021810978651, 0.007270451635122299, 0.004854945465922356]\n",
      "\n",
      "Sentence: toxicity induced by cytokines glucose and lipids increase apoptosis and hamper insulin secretion in the 11e7 beta cellline basic research on types 1 a\n",
      "Classification Result: ['apoptosis', 'proteasome', 'LC3', 'HSC70', 'P62/SQSTM1', 'autophagy', 'ubiquitination', 'nucleotide exchange factor', 'cancer', 'cardiac hypertrophy']\n",
      "Scores: [0.8069339990615845, 0.0520094558596611, 0.03945614770054817, 0.02083754353225231, 0.01958327181637287, 0.018802320584654808, 0.01863952726125717, 0.015923326835036278, 0.00391780398786068, 0.0038965982384979725]\n",
      "\n",
      "Sentence: heat shock 70 protein genes and genetic susceptibility to apical periodontitis introduction                    heat shock proteins hsps protect cells \n",
      "Classification Result: ['HSC70', 'LC3', 'proteasome', 'P62/SQSTM1', 'autophagy', 'ubiquitination', 'nucleotide exchange factor', 'apoptosis', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.636443555355072, 0.09404943138360977, 0.05492619052529335, 0.04855832830071449, 0.041507538408041, 0.03935818374156952, 0.030183373019099236, 0.027204224839806557, 0.0185463335365057, 0.009222830645740032]\n",
      "\n",
      "Sentence: stip1 correlates with tumor immune infiltration and prognosis as a potential immunotherapy target a pancancer bioinformatics analysis objective       \n",
      "Classification Result: ['cancer', 'LC3', 'HSC70', 'P62/SQSTM1', 'proteasome', 'nucleotide exchange factor', 'autophagy', 'ubiquitination', 'apoptosis', 'cardiac hypertrophy']\n",
      "Scores: [0.7341511845588684, 0.05624724179506302, 0.0370912030339241, 0.03243367373943329, 0.02767065353691578, 0.026706045493483543, 0.026700299233198166, 0.02664194442331791, 0.02412881702184677, 0.008228963240981102]\n",
      "\n",
      "Sentence: evaluation of seminal plasma proteomics and relevance of fsh in identification of nonobstructive azoospermia a preliminary study nonobstructive azoosp\n",
      "Classification Result: ['LC3', 'proteasome', 'nucleotide exchange factor', 'HSC70', 'ubiquitination', 'autophagy', 'P62/SQSTM1', 'apoptosis', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.24095073342323303, 0.18462319672107697, 0.12382402271032333, 0.10506840795278549, 0.0974334329366684, 0.08338368684053421, 0.07072125375270844, 0.04288744181394577, 0.03399200737476349, 0.017115822061896324]\n",
      "\n",
      "Sentence: insertional mutagenesis by replicationdeficient retroviral vectors encoding the large t oncogene insertion sites of replicationdeficient retroviral ve\n",
      "Classification Result: ['apoptosis', 'cancer', 'LC3', 'HSC70', 'proteasome', 'P62/SQSTM1', 'ubiquitination', 'nucleotide exchange factor', 'autophagy', 'cardiac hypertrophy']\n",
      "Scores: [0.5817974209785461, 0.25671878457069397, 0.0450807586312294, 0.028338858857750893, 0.023372206836938858, 0.018474867567420006, 0.015758614987134933, 0.01299815159291029, 0.011641399003565311, 0.005818893201649189]\n",
      "\n",
      "Sentence: metaanalyses of microarray datasets identifies ano1 and fadd as prognostic markers of head and neck cancer the head and neck squamous cell carcinoma h\n",
      "Classification Result: ['cancer', 'LC3', 'ubiquitination', 'proteasome', 'nucleotide exchange factor', 'P62/SQSTM1', 'HSC70', 'autophagy', 'apoptosis', 'cardiac hypertrophy']\n",
      "Scores: [0.7431555986404419, 0.04981303587555885, 0.04353414475917816, 0.03630300611257553, 0.033792268484830856, 0.032445911318063736, 0.029745837673544884, 0.01549330074340105, 0.01011415384709835, 0.005602733697742224]\n",
      "\n",
      "Sentence: identification of mrna and noncoding rna hubs using network analysis in organ tropism regulated triple negative breast cancer metastasis triple negati\n",
      "Classification Result: ['cancer', 'LC3', 'ubiquitination', 'nucleotide exchange factor', 'HSC70', 'proteasome', 'P62/SQSTM1', 'apoptosis', 'autophagy', 'cardiac hypertrophy']\n",
      "Scores: [0.5293551087379456, 0.09591338783502579, 0.08240969479084015, 0.07138912379741669, 0.06211347505450249, 0.050747014582157135, 0.041316479444503784, 0.02657282166182995, 0.025871671736240387, 0.014311226084828377]\n",
      "\n",
      "Sentence: proteomicbased identification of apg2 as a therapeutic target for chronic myeloid leukemia the oncogenic bcrabl tyrosine kinase induces constitutive e\n",
      "Classification Result: ['apoptosis', 'cancer', 'proteasome', 'LC3', 'HSC70', 'P62/SQSTM1', 'ubiquitination', 'autophagy', 'nucleotide exchange factor', 'cardiac hypertrophy']\n",
      "Scores: [0.5325375199317932, 0.2538036108016968, 0.0836162269115448, 0.03825835883617401, 0.03305923566222191, 0.01946575939655304, 0.013091559521853924, 0.01072981208562851, 0.010354088619351387, 0.0050838058814406395]\n",
      "\n",
      "Sentence: analysis of the transcriptome data in litopenaeus vannamei reveals the immune basis and predicts the hub regulationgenes in response to highph stress \n",
      "Classification Result: ['HSC70', 'proteasome', 'LC3', 'nucleotide exchange factor', 'ubiquitination', 'P62/SQSTM1', 'autophagy', 'apoptosis', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.23058490455150604, 0.21274057030677795, 0.13351869583129883, 0.12105585634708405, 0.10231167823076248, 0.06421226263046265, 0.06149614229798317, 0.029643060639500618, 0.02602544054389, 0.018411356955766678]\n",
      "\n",
      "Sentence: identification of grasp1 as a novel 97 kda autoantigen localized to endosomes we have identified an autoantigen that is recognized by antibodies from \n",
      "Classification Result: ['LC3', 'ubiquitination', 'HSC70', 'P62/SQSTM1', 'proteasome', 'apoptosis', 'autophagy', 'cardiac hypertrophy', 'nucleotide exchange factor', 'cancer']\n",
      "Scores: [0.2748863101005554, 0.1830066740512848, 0.14044103026390076, 0.09798726439476013, 0.08000235259532928, 0.07631436735391617, 0.07182859629392624, 0.03816147893667221, 0.022612806409597397, 0.014759098179638386]\n",
      "\n",
      "Sentence: highcontent functional screen to identify proteins that correct f508delcftr function cystic fibrosis is caused by mutations in cftr with a deletion of\n",
      "Classification Result: ['LC3', 'proteasome', 'nucleotide exchange factor', 'HSC70', 'P62/SQSTM1', 'autophagy', 'ubiquitination', 'apoptosis', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.2774454951286316, 0.14298059046268463, 0.12126390635967255, 0.11764830350875854, 0.1001768484711647, 0.08819811046123505, 0.0799407809972763, 0.03671365976333618, 0.023440681397914886, 0.012191646732389927]\n",
      "\n",
      "Sentence: hsp70 inhibition reverses cell adhesion mediated and acquired drug resistance in multiple myeloma heat shock proteins hsps are a super family of highl\n",
      "Classification Result: ['apoptosis', 'HSC70', 'LC3', 'cancer', 'P62/SQSTM1', 'proteasome', 'ubiquitination', 'autophagy', 'nucleotide exchange factor', 'cardiac hypertrophy']\n",
      "Scores: [0.6464576721191406, 0.21735575795173645, 0.03593757748603821, 0.025952382013201714, 0.02139395847916603, 0.017031025141477585, 0.015023473650217056, 0.013129468075931072, 0.004130571149289608, 0.003588123945519328]\n",
      "\n",
      "Sentence: novel underlying genetic markers for asthenozoospermia due to abnormal spermatogenesis and reproductive organ inflammation asthenozoospermia a male fe\n",
      "Classification Result: ['LC3', 'nucleotide exchange factor', 'P62/SQSTM1', 'HSC70', 'proteasome', 'ubiquitination', 'autophagy', 'cardiac hypertrophy', 'apoptosis', 'cancer']\n",
      "Scores: [0.20861893892288208, 0.1496046483516693, 0.13700495660305023, 0.12830109894275665, 0.12218521535396576, 0.08783870190382004, 0.0678911805152893, 0.039059415459632874, 0.038861233741045, 0.020634571090340614]\n",
      "\n",
      "Sentence: the association between heatshock protein polymorphisms and prognosis in lung cancer patients treated with platinumbased chemotherapy objective       \n",
      "Classification Result: ['cancer', 'LC3', 'P62/SQSTM1', 'HSC70', 'ubiquitination', 'proteasome', 'autophagy', 'nucleotide exchange factor', 'apoptosis', 'cardiac hypertrophy']\n",
      "Scores: [0.5974072217941284, 0.0859169289469719, 0.07879403978586197, 0.057581543922424316, 0.04175257310271263, 0.03759068250656128, 0.03172553330659866, 0.0256978627294302, 0.02319045551121235, 0.020343143492937088]\n",
      "\n",
      "Sentence: rhamnolipids functionalized agnpsinduced oxidative stress and modulation of toxicity pathway genes in cultured mcf7 cells rhamnolipids extracted from \n",
      "Classification Result: ['cancer', 'apoptosis', 'LC3', 'proteasome', 'HSC70', 'ubiquitination', 'P62/SQSTM1', 'autophagy', 'nucleotide exchange factor', 'cardiac hypertrophy']\n",
      "Scores: [0.5044047832489014, 0.34556844830513, 0.05180506035685539, 0.019163358956575394, 0.01877378299832344, 0.01756993681192398, 0.014792948961257935, 0.012167137116193771, 0.011299057863652706, 0.0044554453343153]\n",
      "\n",
      "Sentence: hsp110 expression changes in rat primary myocardial cells exposed to heat stress in vitro we investigated and described the kinetics of heat shock pro\n",
      "Classification Result: ['LC3', 'ubiquitination', 'HSC70', 'P62/SQSTM1', 'proteasome', 'autophagy', 'nucleotide exchange factor', 'apoptosis', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.2382126897573471, 0.19299045205116272, 0.1176045686006546, 0.10676027834415436, 0.08653157949447632, 0.07730884104967117, 0.06600689142942429, 0.04822801053524017, 0.045588500797748566, 0.020768161863088608]\n",
      "\n",
      "Sentence: integrated analysis of immunity and ferroptosisrelated biomarker signatures to improve the prognosis prediction of hepatocellular carcinoma background\n",
      "Classification Result: ['cancer', 'LC3', 'ubiquitination', 'proteasome', 'P62/SQSTM1', 'nucleotide exchange factor', 'HSC70', 'autophagy', 'apoptosis', 'cardiac hypertrophy']\n",
      "Scores: [0.5774557590484619, 0.10450339317321777, 0.05588826164603233, 0.050123509019613266, 0.04724430292844772, 0.046268921345472336, 0.04425159469246864, 0.028946327045559883, 0.02822531759738922, 0.017092648893594742]\n",
      "\n",
      "Sentence: the antimicrobial protein s100a12 identified as a potential autoantigen in a subgroup of atopic dermatitis patients background                    atop\n",
      "Classification Result: ['HSC70', 'LC3', 'ubiquitination', 'P62/SQSTM1', 'autophagy', 'proteasome', 'apoptosis', 'nucleotide exchange factor', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.4231843054294586, 0.16891849040985107, 0.08655626326799393, 0.08324624598026276, 0.07497957348823547, 0.05518137291073799, 0.037751391530036926, 0.03273329138755798, 0.02605099231004715, 0.011398051865398884]\n",
      "\n",
      "Sentence: network pharmacology and bioinformatics approach reveals the therapeutic mechanism of action of baicalein in hepatocellular carcinoma liver cancer is \n",
      "Classification Result: ['cancer', 'apoptosis', 'LC3', 'proteasome', 'HSC70', 'P62/SQSTM1', 'autophagy', 'nucleotide exchange factor', 'ubiquitination', 'cardiac hypertrophy']\n",
      "Scores: [0.6670790314674377, 0.10744953900575638, 0.04862301051616669, 0.03332166373729706, 0.032721422612667084, 0.030397433787584305, 0.027290111407637596, 0.023013753816485405, 0.022614071145653725, 0.00749001232907176]\n",
      "\n",
      "Sentence: profile of the spleen transcriptome in beef steers with variation in gain and feed intake we have previously identified components of the immune syste\n",
      "Classification Result: ['ubiquitination', 'proteasome', 'LC3', 'nucleotide exchange factor', 'HSC70', 'P62/SQSTM1', 'autophagy', 'apoptosis', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.4753217399120331, 0.16221356391906738, 0.07899761945009232, 0.07793441414833069, 0.06526000052690506, 0.06319644302129745, 0.03938734158873558, 0.016175659373402596, 0.015039150603115559, 0.0064739929512143135]\n",
      "\n",
      "Sentence: mining the key regulatory genes of chicken inosine 5monophosphate metabolism based on time series microarray data imp inosine 5monophosphate is a comp\n",
      "Classification Result: ['LC3', 'proteasome', 'HSC70', 'P62/SQSTM1', 'ubiquitination', 'nucleotide exchange factor', 'autophagy', 'cardiac hypertrophy', 'apoptosis', 'cancer']\n",
      "Scores: [0.1883770078420639, 0.15827929973602295, 0.12984685599803925, 0.12415913492441177, 0.11563442647457123, 0.11182236671447754, 0.08614952862262726, 0.03746504336595535, 0.037379808723926544, 0.010886507108807564]\n",
      "\n",
      "Sentence: strong expression of heat shock proteins in growth plate cartilage an immunohistochemical study of hsp28 hsp70 and hsp110 heat shock proteins hsps are\n",
      "Classification Result: ['apoptosis', 'HSC70', 'LC3', 'proteasome', 'ubiquitination', 'P62/SQSTM1', 'autophagy', 'nucleotide exchange factor', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.5555042028427124, 0.18109771609306335, 0.08006566762924194, 0.045834384858608246, 0.040104348212480545, 0.03029792010784149, 0.028788451105356216, 0.015480445697903633, 0.012587019242346287, 0.010239866562187672]\n",
      "\n",
      "Sentence: heat shock protein and heat shock factor expression in sperm relation to oligozoospermia and varicocele purpose                    varicocele may be a\n",
      "Classification Result: ['proteasome', 'LC3', 'nucleotide exchange factor', 'P62/SQSTM1', 'ubiquitination', 'HSC70', 'autophagy', 'apoptosis', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.1968517154455185, 0.19617576897144318, 0.13157108426094055, 0.12041277438402176, 0.11163870990276337, 0.08990546315908432, 0.07366683334112167, 0.041261911392211914, 0.021799840033054352, 0.016715971753001213]\n",
      "\n",
      "Sentence: screening of autoantibodies as potential biomarkers for hepatocellular carcinoma by using t7 phase display system background                    hepato\n",
      "Classification Result: ['cancer', 'HSC70', 'LC3', 'proteasome', 'ubiquitination', 'autophagy', 'nucleotide exchange factor', 'P62/SQSTM1', 'apoptosis', 'cardiac hypertrophy']\n",
      "Scores: [0.41577622294425964, 0.13223280012607574, 0.12300175428390503, 0.07149998098611832, 0.061443082988262177, 0.053818028420209885, 0.050421420484781265, 0.04639681056141853, 0.02951783500611782, 0.015892039984464645]\n",
      "\n",
      "Sentence: molecular cloning and expression analysis of five heat shock protein 70 hsp70 family members in lateolabrax maculatus with vibrio harveyi infection he\n",
      "Classification Result: ['ubiquitination', 'HSC70', 'LC3', 'P62/SQSTM1', 'proteasome', 'autophagy', 'nucleotide exchange factor', 'apoptosis', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.5415143966674805, 0.1648428589105606, 0.11242013424634933, 0.05008156597614288, 0.044018954038619995, 0.03362395241856575, 0.024591773748397827, 0.014945916831493378, 0.009411257691681385, 0.00454922067001462]\n",
      "\n",
      "Sentence: hspa4ldeficient mice display increased incidence of male infertility and hydronephrosis development the hspa4l gene also known as apg1 or osp94 belong\n",
      "Classification Result: ['ubiquitination', 'apoptosis', 'LC3', 'autophagy', 'proteasome', 'nucleotide exchange factor', 'HSC70', 'P62/SQSTM1', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.6177418828010559, 0.22867020964622498, 0.0481935553252697, 0.027460886165499687, 0.023277979344129562, 0.014237248338758945, 0.013686846941709518, 0.011513207107782364, 0.009330926463007927, 0.005887249950319529]\n",
      "\n",
      "Sentence: agerelated differential responses to curcumininduced apoptosis during the initiation of colon cancer in rats curcumin is a widelyused dietary suppleme\n",
      "Classification Result: ['apoptosis', 'cancer', 'HSC70', 'LC3', 'nucleotide exchange factor', 'P62/SQSTM1', 'proteasome', 'ubiquitination', 'autophagy', 'cardiac hypertrophy']\n",
      "Scores: [0.5233442187309265, 0.30747008323669434, 0.08162004500627518, 0.027534494176506996, 0.014114800840616226, 0.013332254253327847, 0.011087223887443542, 0.010704465210437775, 0.007134970743209124, 0.003657484194263816]\n",
      "\n",
      "Sentence: overexpression of heat shock protein hsp90aa1 and translocase of the outer mitochondrial membrane tom34 in hcvinduced hepatocellular carcinoma a pilot\n",
      "Classification Result: ['cancer', 'LC3', 'ubiquitination', 'proteasome', 'P62/SQSTM1', 'HSC70', 'nucleotide exchange factor', 'autophagy', 'apoptosis', 'cardiac hypertrophy']\n",
      "Scores: [0.7127916216850281, 0.08549312502145767, 0.055906131863594055, 0.028884079307317734, 0.028230750933289528, 0.027680380269885063, 0.02117196097970009, 0.02063041180372238, 0.011857598088681698, 0.0073539698496460915]\n",
      "\n",
      "Sentence: induction of the hsp110105 family in the rat hippocampus in cerebral ischemia and ischemic tolerance recently the authors isolated a novel gene of the\n",
      "Classification Result: ['LC3', 'proteasome', 'ubiquitination', 'autophagy', 'HSC70', 'apoptosis', 'nucleotide exchange factor', 'P62/SQSTM1', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.35864096879959106, 0.14235882461071014, 0.13330818712711334, 0.10341181606054306, 0.10116767138242722, 0.05193191021680832, 0.046448513865470886, 0.03634101152420044, 0.015155075117945671, 0.01123602595180273]\n",
      "\n",
      "Sentence: hsp110 is a bona fide chaperone using atp to unfold stable misfolded polypeptides and reciprocally collaborate with hsp70 to solubilize protein aggreg\n",
      "Classification Result: ['nucleotide exchange factor', 'HSC70', 'LC3', 'proteasome', 'ubiquitination', 'P62/SQSTM1', 'autophagy', 'apoptosis', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.6250675916671753, 0.1417255997657776, 0.05358823761343956, 0.04943018779158592, 0.03512803092598915, 0.030528748407959938, 0.02350279502570629, 0.016035031527280807, 0.014078890904784203, 0.010914838872849941]\n",
      "\n",
      "Sentence: identification of cancer stem cellrelated biomarkers in lung adenocarcinoma by stemness index and weighted correlation network analysis background    \n",
      "Classification Result: ['cancer', 'HSC70', 'LC3', 'nucleotide exchange factor', 'P62/SQSTM1', 'proteasome', 'ubiquitination', 'apoptosis', 'autophagy', 'cardiac hypertrophy']\n",
      "Scores: [0.5741683840751648, 0.17233866453170776, 0.05655524879693985, 0.03823119029402733, 0.03769354149699211, 0.03250093013048172, 0.02787066251039505, 0.02648397907614708, 0.020159676671028137, 0.013997717760503292]\n",
      "\n",
      "Sentence: differential molecular and cellular responses of glp1 secreting lcells and pancreatic alpha cells to glucotoxicity and lipotoxicity knowledge of the e\n",
      "Classification Result: ['apoptosis', 'nucleotide exchange factor', 'LC3', 'proteasome', 'HSC70', 'P62/SQSTM1', 'ubiquitination', 'autophagy', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.4919184446334839, 0.10254552215337753, 0.10047414153814316, 0.09064008295536041, 0.05885540693998337, 0.05305510014295578, 0.042944274842739105, 0.04068783298134804, 0.01034197025001049, 0.008537203073501587]\n",
      "\n",
      "Sentence: enteral glutamine infusion modulates ubiquitination of heat shock proteins grp75 and apg2 in the human duodenal mucosa glutamine the most abundant ami\n",
      "Classification Result: ['ubiquitination', 'proteasome', 'LC3', 'P62/SQSTM1', 'HSC70', 'autophagy', 'nucleotide exchange factor', 'apoptosis', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.7854508757591248, 0.09692580252885818, 0.05043037235736847, 0.024154843762516975, 0.018290521577000618, 0.010026526637375355, 0.0053312028758227825, 0.00430882116779685, 0.0026832229923456907, 0.002397847129032016]\n",
      "\n",
      "Sentence: novel candidate genes of the park7 interactome as mediators of apoptosis and acetylation in multiple sclerosis an in silico analysis background       \n",
      "Classification Result: ['apoptosis', 'LC3', 'P62/SQSTM1', 'nucleotide exchange factor', 'HSC70', 'autophagy', 'ubiquitination', 'proteasome', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.7670505046844482, 0.04786420986056328, 0.037973009049892426, 0.03292012959718704, 0.026487454771995544, 0.02595045417547226, 0.025320013985037804, 0.02493106946349144, 0.007277684286236763, 0.004225331358611584]\n",
      "\n",
      "Sentence: elucidation of the inhibitory mechanisms of nipponoparmelia laevior lichen extract against influenza a h1n1 virus through proteomic analyses lichens c\n",
      "Classification Result: ['proteasome', 'apoptosis', 'LC3', 'nucleotide exchange factor', 'P62/SQSTM1', 'HSC70', 'autophagy', 'ubiquitination', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.5423052906990051, 0.14473339915275574, 0.06591074913740158, 0.04969017207622528, 0.04711885377764702, 0.046549372375011444, 0.041086554527282715, 0.035652220249176025, 0.019776854664087296, 0.007176468148827553]\n",
      "\n",
      "Sentence: identification and characterization of genes related to the development of breast muscles in pekin duck pekin duck is worldfamous for its fast growth \n",
      "Classification Result: ['proteasome', 'ubiquitination', 'LC3', 'nucleotide exchange factor', 'HSC70', 'autophagy', 'P62/SQSTM1', 'cardiac hypertrophy', 'apoptosis', 'cancer']\n",
      "Scores: [0.1549151986837387, 0.14595377445220947, 0.13430443406105042, 0.13033930957317352, 0.11216099560260773, 0.10637161880731583, 0.0912356898188591, 0.07207970321178436, 0.043955981731414795, 0.008683230727910995]\n",
      "\n",
      "Sentence: decrease in level of apg2 a member of the heat shock protein 110 family in murine brain following systemic administration of kainic acid apg2 belongs \n",
      "Classification Result: ['HSC70', 'LC3', 'P62/SQSTM1', 'proteasome', 'ubiquitination', 'autophagy', 'nucleotide exchange factor', 'apoptosis', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.6540520787239075, 0.1221124678850174, 0.0539463572204113, 0.050401996821165085, 0.03579529747366905, 0.027437753975391388, 0.02402905561029911, 0.013622377067804337, 0.01132314745336771, 0.007279504556208849]\n",
      "\n",
      "Sentence: molecular mechanisms of toxicity and cell damage by chemicals in a human pancreatic beta cell line 11b4 objectives                    mechanisms of to\n",
      "Classification Result: ['apoptosis', 'nucleotide exchange factor', 'proteasome', 'LC3', 'P62/SQSTM1', 'HSC70', 'ubiquitination', 'autophagy', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.5635307431221008, 0.10043156147003174, 0.08823257684707642, 0.05910516902804375, 0.04948713630437851, 0.04107637330889702, 0.038865216076374054, 0.02978837490081787, 0.016198216006159782, 0.013284626416862011]\n",
      "\n",
      "Sentence: expression of an hsp110 family ischemiaresponsive protein irp94 in the rat brain after transient forebrain ischemia the transcriptional expression of \n",
      "Classification Result: ['LC3', 'P62/SQSTM1', 'ubiquitination', 'proteasome', 'HSC70', 'autophagy', 'nucleotide exchange factor', 'apoptosis', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.3951652944087982, 0.13040806353092194, 0.12231390178203583, 0.08677297830581665, 0.07162376493215561, 0.06344018131494522, 0.05107375234365463, 0.03729597106575966, 0.025866495445370674, 0.016039546579122543]\n",
      "\n",
      "Sentence: integrating bioinformatics and drug sensitivity analyses to identify molecular characteristics associated with targeting necroptosis in breast cancer \n",
      "Classification Result: ['apoptosis', 'cancer', 'ubiquitination', 'proteasome', 'nucleotide exchange factor', 'autophagy', 'LC3', 'P62/SQSTM1', 'HSC70', 'cardiac hypertrophy']\n",
      "Scores: [0.3625379204750061, 0.2866804301738739, 0.1155921071767807, 0.08329301327466965, 0.035698238760232925, 0.030424190685153008, 0.028353605419397354, 0.027851630002260208, 0.02232501283288002, 0.00724388612434268]\n",
      "\n",
      "Sentence: expression of material mrna in the hypothalamus and frontal cortex in a rat model of fatal hypothermia diagnosis of fatal hypothermia is considered to\n",
      "Classification Result: ['HSC70', 'LC3', 'ubiquitination', 'autophagy', 'proteasome', 'P62/SQSTM1', 'nucleotide exchange factor', 'apoptosis', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.22557291388511658, 0.2255486398935318, 0.1315871924161911, 0.10148761421442032, 0.08541320264339447, 0.08225655555725098, 0.055360276252031326, 0.04989989101886749, 0.028439322486519814, 0.014434369280934334]\n",
      "\n",
      "Sentence: transcriptomic and functional pathway features were associated with survival after pathological complete response to neoadjuvant chemotherapy in breas\n",
      "Classification Result: ['cancer', 'LC3', 'HSC70', 'proteasome', 'nucleotide exchange factor', 'P62/SQSTM1', 'ubiquitination', 'apoptosis', 'autophagy', 'cardiac hypertrophy']\n",
      "Scores: [0.4044126272201538, 0.12724356353282928, 0.07944580912590027, 0.06970895826816559, 0.06820385903120041, 0.06402884423732758, 0.06160685047507286, 0.05201038718223572, 0.045303601771593094, 0.02803545445203781]\n",
      "\n",
      "Sentence: gene expression metaanalysis identifies vdac1 as a predictor of poor outcome in early stage nonsmall cell lung cancer background                    th\n",
      "Classification Result: ['cancer', 'nucleotide exchange factor', 'proteasome', 'LC3', 'ubiquitination', 'P62/SQSTM1', 'HSC70', 'autophagy', 'apoptosis', 'cardiac hypertrophy']\n",
      "Scores: [0.7551096081733704, 0.060652412474155426, 0.0464848168194294, 0.0461624413728714, 0.029501916840672493, 0.017789287492632866, 0.016718989238142967, 0.012270654551684856, 0.009044610895216465, 0.0062652998603880405]\n",
      "\n",
      "Sentence: integrated analysis of genomewide mirnas and targeted gene expression in esophageal squamous cell carcinoma escc and relation to prognosis background \n",
      "Classification Result: ['cancer', 'LC3', 'nucleotide exchange factor', 'P62/SQSTM1', 'HSC70', 'ubiquitination', 'proteasome', 'autophagy', 'apoptosis', 'cardiac hypertrophy']\n",
      "Scores: [0.7127757668495178, 0.06381060183048248, 0.03811076655983925, 0.034818071871995926, 0.03471379727125168, 0.03238646686077118, 0.031191419810056686, 0.022096483036875725, 0.01739921234548092, 0.012697420082986355]\n",
      "\n",
      "Sentence: assessment of the risk of blastomere biopsy during preimplantation genetic diagnosis in a mouse model reducing female ovary function with an increase \n",
      "Classification Result: ['proteasome', 'LC3', 'P62/SQSTM1', 'HSC70', 'ubiquitination', 'nucleotide exchange factor', 'autophagy', 'apoptosis', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.462804913520813, 0.17740298807621002, 0.08718999475240707, 0.07611795514822006, 0.05639709159731865, 0.05424550920724869, 0.037628814578056335, 0.021070588380098343, 0.01854202151298523, 0.00860003475099802]\n",
      "\n",
      "Sentence: expression of apg2 protein a member of the heat shock protein 110 family in developing rat brain apg2 protein is a member of the heat shock protein 11\n",
      "Classification Result: ['LC3', 'proteasome', 'P62/SQSTM1', 'HSC70', 'ubiquitination', 'autophagy', 'apoptosis', 'nucleotide exchange factor', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.23503530025482178, 0.14073699712753296, 0.12861181795597076, 0.12800979614257812, 0.11923059076070786, 0.10694164037704468, 0.06026576831936836, 0.043622687458992004, 0.021422866731882095, 0.016122549772262573]\n",
      "\n",
      "Sentence: interactome networks between the human respiratory syncytial virus hrsv the human metapneumovirus mpv and their host in silico investigation and compa\n",
      "Classification Result: ['LC3', 'proteasome', 'P62/SQSTM1', 'HSC70', 'ubiquitination', 'nucleotide exchange factor', 'autophagy', 'apoptosis', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.2029181718826294, 0.160647913813591, 0.13746494054794312, 0.13218605518341064, 0.12357903271913528, 0.11829723417758942, 0.051193758845329285, 0.0424695760011673, 0.020570537075400352, 0.010672749020159245]\n",
      "\n",
      "Sentence: human mitochondrial chaperone mthsp70 and cysteine desulfurase nfs1 bind preferentially to the disordered conformation whereas cochaperone hsc20 binds\n",
      "Classification Result: ['HSC70', 'LC3', 'P62/SQSTM1', 'ubiquitination', 'proteasome', 'nucleotide exchange factor', 'autophagy', 'cardiac hypertrophy', 'apoptosis', 'cancer']\n",
      "Scores: [0.6520745158195496, 0.08599285036325455, 0.05265916883945465, 0.051678091287612915, 0.045594919472932816, 0.04154449701309204, 0.027133924886584282, 0.020055240020155907, 0.01637815125286579, 0.006888642907142639]\n",
      "\n",
      "Sentence: gene expression profiling of primary human articular chondrocytes in highdensity micromasses reveals patterns of recovery maintenance re and dediffere\n",
      "Classification Result: ['apoptosis', 'proteasome', 'LC3', 'nucleotide exchange factor', 'HSC70', 'ubiquitination', 'P62/SQSTM1', 'autophagy', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.5279608964920044, 0.10876966267824173, 0.10420527309179306, 0.09397854655981064, 0.045049965381622314, 0.04238136112689972, 0.034874673932790756, 0.02194240875542164, 0.01277854572981596, 0.008058629930019379]\n",
      "\n",
      "Sentence: identification of an overexpressed gene hspa4l the product of which can provoke prevalent humoral immune responses in leukemia patients objective     \n",
      "Classification Result: ['ubiquitination', 'HSC70', 'cancer', 'LC3', 'proteasome', 'P62/SQSTM1', 'autophagy', 'apoptosis', 'nucleotide exchange factor', 'cardiac hypertrophy']\n",
      "Scores: [0.3463473916053772, 0.20929303765296936, 0.20570290088653564, 0.09214066714048386, 0.04556431248784065, 0.03362589702010155, 0.02066982537508011, 0.01910983771085739, 0.014877906069159508, 0.012668195180594921]\n",
      "\n",
      "Sentence: characterization of the constitutive pig ovary heat shock chaperone machinery and its response to acute thermal stress or to seasonal variations reduc\n",
      "Classification Result: ['HSC70', 'LC3', 'proteasome', 'ubiquitination', 'P62/SQSTM1', 'autophagy', 'nucleotide exchange factor', 'apoptosis', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.47535642981529236, 0.15691103041172028, 0.09065999835729599, 0.07260049879550934, 0.06113788112998009, 0.04431980103254318, 0.042136941105127335, 0.025656061246991158, 0.02172902412712574, 0.009492313489317894]\n",
      "\n",
      "Sentence: multistate proteomics analysis reveals novel strategies used by a hibernator to precondition the heart and conserve atp for winter heterothermy the hi\n",
      "Classification Result: ['proteasome', 'LC3', 'apoptosis', 'P62/SQSTM1', 'nucleotide exchange factor', 'HSC70', 'ubiquitination', 'autophagy', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.42399391531944275, 0.11605557054281235, 0.11514074355363846, 0.0878167673945427, 0.07223689556121826, 0.07176884263753891, 0.04777274280786514, 0.03606697544455528, 0.02269643172621727, 0.006451066117733717]\n",
      "\n",
      "Sentence: cloning of human cdnas for apg1 and apg2 members of the hsp110 family and chromosomal assignment of their genes in mice the hsp110sse family is compos\n",
      "Classification Result: ['LC3', 'ubiquitination', 'HSC70', 'P62/SQSTM1', 'autophagy', 'proteasome', 'nucleotide exchange factor', 'apoptosis', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.2317904680967331, 0.18913617730140686, 0.1353793442249298, 0.09801784157752991, 0.09320507943630219, 0.07737462222576141, 0.06926578283309937, 0.05837906152009964, 0.03295189142227173, 0.014499790966510773]\n",
      "\n",
      "Sentence: altered expression of high molecular weight heat shock proteins after oct4b1 suppression in human tumor cell lines objective                    oct4b1\n",
      "Classification Result: ['cancer', 'apoptosis', 'HSC70', 'LC3', 'P62/SQSTM1', 'proteasome', 'autophagy', 'nucleotide exchange factor', 'ubiquitination', 'cardiac hypertrophy']\n",
      "Scores: [0.34090226888656616, 0.30987516045570374, 0.1157570332288742, 0.07873113453388214, 0.03564445301890373, 0.028668146580457687, 0.02775920368731022, 0.02716514654457569, 0.02659538947045803, 0.008902030996978283]\n",
      "\n",
      "Sentence: altered expression of heat shock protein 110 family members in mouse hippocampal neurons following trimethyltin treatment in vivo and in vitro the hea\n",
      "Classification Result: ['LC3', 'proteasome', 'ubiquitination', 'autophagy', 'P62/SQSTM1', 'apoptosis', 'HSC70', 'nucleotide exchange factor', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.2626405954360962, 0.14487390220165253, 0.1202196478843689, 0.11047983169555664, 0.10864952951669693, 0.07964812219142914, 0.06322767585515976, 0.05049891397356987, 0.03675687313079834, 0.023004896938800812]\n",
      "\n",
      "Sentence: the ischemiaresponsive protein 94 irp94 activates dendritic cells through nk cell receptor protein2nk group 2 member d nkrp2nkg2d leading to their mat\n",
      "Classification Result: ['apoptosis', 'cancer', 'autophagy', 'proteasome', 'LC3', 'ubiquitination', 'P62/SQSTM1', 'HSC70', 'nucleotide exchange factor', 'cardiac hypertrophy']\n",
      "Scores: [0.7884702086448669, 0.08915035426616669, 0.021077608689665794, 0.020615283399820328, 0.019761379808187485, 0.0190265029668808, 0.01253249030560255, 0.012177156284451485, 0.011882716789841652, 0.005306316073983908]\n",
      "\n",
      "Sentence: the effects of nonyl phenoxypolyethoxyl ethanol on cell damage pathway gene expression in sknsh cells backgroundaims                    most pesticide\n",
      "Classification Result: ['cancer', 'HSC70', 'LC3', 'apoptosis', 'P62/SQSTM1', 'nucleotide exchange factor', 'proteasome', 'ubiquitination', 'autophagy', 'cardiac hypertrophy']\n",
      "Scores: [0.2560742199420929, 0.1827952116727829, 0.13934311270713806, 0.08667189627885818, 0.08463297039270401, 0.07602374255657196, 0.07086681574583054, 0.04792790859937668, 0.03798859193921089, 0.01767549104988575]\n",
      "\n",
      "Sentence: mechanisms involved in therapeutic effects of scutellaria baicalensis georgi in oral squamous cell carcinoma based on systems biology and structural b\n",
      "Classification Result: ['cancer', 'LC3', 'P62/SQSTM1', 'HSC70', 'nucleotide exchange factor', 'proteasome', 'ubiquitination', 'autophagy', 'apoptosis', 'cardiac hypertrophy']\n",
      "Scores: [0.7035601139068604, 0.06541727483272552, 0.06094937026500702, 0.03403734788298607, 0.030784571543335915, 0.028918065130710602, 0.025047674775123596, 0.02493296191096306, 0.017776383087038994, 0.008576195687055588]\n",
      "\n",
      "Sentence: shrnamediated gene silencing of heat shock protein 70 inhibits human colon cancer growth heat shock protein 70 hsp70 a chaperone involved in tumor pro\n",
      "Classification Result: ['cancer', 'apoptosis', 'HSC70', 'LC3', 'ubiquitination', 'P62/SQSTM1', 'autophagy', 'proteasome', 'nucleotide exchange factor', 'cardiac hypertrophy']\n",
      "Scores: [0.4581046402454376, 0.2187556028366089, 0.18852463364601135, 0.044556744396686554, 0.027551595121622086, 0.02086990885436535, 0.01672893390059471, 0.01285741850733757, 0.006651897449046373, 0.005398707464337349]\n",
      "\n",
      "Sentence: systematic proteomic identification of the heat shock proteins hsp that interact with estrogen receptor alpha er and biochemical characterization of t\n",
      "Classification Result: ['HSC70', 'cancer', 'proteasome', 'LC3', 'ubiquitination', 'P62/SQSTM1', 'nucleotide exchange factor', 'autophagy', 'apoptosis', 'cardiac hypertrophy']\n",
      "Scores: [0.43953990936279297, 0.2425241619348526, 0.134313702583313, 0.05754906311631203, 0.04002681002020836, 0.028986360877752304, 0.023290706798434258, 0.015770189464092255, 0.009988663718104362, 0.008010360412299633]\n",
      "\n",
      "Sentence: overexpression of apg2 increases cell proliferation and protects from oxidative damage in baf3bcrabl cells apg2 a mammalian heatshock protein belongin\n",
      "Classification Result: ['cancer', 'LC3', 'proteasome', 'ubiquitination', 'P62/SQSTM1', 'HSC70', 'autophagy', 'apoptosis', 'nucleotide exchange factor', 'cardiac hypertrophy']\n",
      "Scores: [0.34567689895629883, 0.1571369469165802, 0.12404375523328781, 0.0791144147515297, 0.07073624432086945, 0.058376993983983994, 0.056412555277347565, 0.04916248098015785, 0.031236110255122185, 0.028103595599532127]\n",
      "\n",
      "Sentence: escherichia coliinduced temporal and differential secretion of heatshock protein 70 and interleukin1 by human fetal membranes in a twocompartment cult\n",
      "Classification Result: ['HSC70', 'LC3', 'nucleotide exchange factor', 'proteasome', 'ubiquitination', 'P62/SQSTM1', 'autophagy', 'apoptosis', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.5514023900032043, 0.12610101699829102, 0.06372111290693283, 0.058450955897569656, 0.05807814747095108, 0.05561758950352669, 0.04414060339331627, 0.025345535948872566, 0.01200611051172018, 0.005136603023856878]\n",
      "\n",
      "Sentence: functional analysis of a dietary recombinant fatty acid binding protein 10 fabp10 on the epinephelus coioides in response to acute low temperature cha\n",
      "Classification Result: ['LC3', 'proteasome', 'HSC70', 'ubiquitination', 'P62/SQSTM1', 'nucleotide exchange factor', 'autophagy', 'apoptosis', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.2853371798992157, 0.1596151739358902, 0.1252635270357132, 0.11486704647541046, 0.09192029386758804, 0.0651402696967125, 0.06277809292078018, 0.039516400545835495, 0.036094289273023605, 0.01946769841015339]\n",
      "\n",
      "Sentence: expressions of hsp110 family members in the testes and epididymis of mice at different stages of development and their regulation by hormones objectiv\n",
      "Classification Result: ['LC3', 'HSC70', 'nucleotide exchange factor', 'P62/SQSTM1', 'ubiquitination', 'proteasome', 'autophagy', 'apoptosis', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.2004873901605606, 0.18864580988883972, 0.11666634678840637, 0.11414496600627899, 0.10299372673034668, 0.10170280933380127, 0.06338231265544891, 0.058576252311468124, 0.0358240082859993, 0.01757637970149517]\n",
      "\n",
      "Sentence: cerebral activation and distribution of inducible hsp110 and hsp70 mrnas following focal ischemia in rat a potential function for inducible heat shock\n",
      "Classification Result: ['HSC70', 'LC3', 'ubiquitination', 'proteasome', 'P62/SQSTM1', 'nucleotide exchange factor', 'autophagy', 'apoptosis', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.32826703786849976, 0.1630161553621292, 0.13259302079677582, 0.10671786963939667, 0.07918810844421387, 0.061644259840250015, 0.05225450173020363, 0.043276410549879074, 0.0199460256844759, 0.013096709735691547]\n",
      "\n",
      "Sentence: effects of a dissostichus mawsonicam recombinant proteins feed additive on the juvenile orangespotted grouper epinephelus coioides under the acute low\n",
      "Classification Result: ['LC3', 'proteasome', 'HSC70', 'ubiquitination', 'nucleotide exchange factor', 'P62/SQSTM1', 'autophagy', 'apoptosis', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.23730477690696716, 0.20395797491073608, 0.12123804539442062, 0.11230231076478958, 0.0811772495508194, 0.0802147164940834, 0.07594769448041916, 0.04087749123573303, 0.03348371759057045, 0.013496048748493195]\n",
      "\n",
      "Sentence: human esophageal microvascular endothelial cells respond to acidic ph stress by pi3kakt and p38 mapkregulated induction of hsp70 and hsp27 the heat sh\n",
      "Classification Result: ['HSC70', 'LC3', 'proteasome', 'nucleotide exchange factor', 'P62/SQSTM1', 'ubiquitination', 'autophagy', 'apoptosis', 'cancer', 'cardiac hypertrophy']\n",
      "Scores: [0.38580143451690674, 0.15854865312576294, 0.09529100358486176, 0.09200172126293182, 0.08111587911844254, 0.07360663264989853, 0.04948979616165161, 0.027293357998132706, 0.019947027787566185, 0.01690453290939331]\n",
      "\n",
      "Sentence: immunocytochemical investigations of heat shock proteins expression during thymic apoptosis induced by glucocorticoids the aim of our study was to inv\n",
      "Classification Result: ['apoptosis', 'HSC70', 'ubiquitination', 'LC3', 'autophagy', 'proteasome', 'P62/SQSTM1', 'nucleotide exchange factor', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.5160390138626099, 0.11422491073608398, 0.09139591455459595, 0.0896238312125206, 0.06398981064558029, 0.04243297129869461, 0.040683191269636154, 0.016995493322610855, 0.015682704746723175, 0.008932163938879967]\n",
      "\n",
      "Sentence: association of met439thr substitution in heat shock protein 70 gene with postoperative atrial fibrillation and serum hsp70 protein levels background  \n",
      "Classification Result: ['HSC70', 'LC3', 'P62/SQSTM1', 'proteasome', 'ubiquitination', 'autophagy', 'nucleotide exchange factor', 'apoptosis', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.7652363181114197, 0.09303256124258041, 0.027196239680051804, 0.026993563398718834, 0.02280297316610813, 0.0196524728089571, 0.015927867963910103, 0.0151215810328722, 0.010453546419739723, 0.003582901554182172]\n",
      "\n",
      "Sentence: molecular cloning of a novel member of the hsp110 family of genes ischemiaresponsive protein 94 kda irp94 expressed in rat brain after transient foreb\n",
      "Classification Result: ['LC3', 'ubiquitination', 'HSC70', 'proteasome', 'P62/SQSTM1', 'autophagy', 'apoptosis', 'nucleotide exchange factor', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.30626988410949707, 0.18415409326553345, 0.16868548095226288, 0.08517812192440033, 0.07748878747224808, 0.057124603539705276, 0.05352037772536278, 0.027992157265543938, 0.022397641092538834, 0.01718885451555252]\n",
      "\n",
      "Sentence: an immunohistochemical study of apg2 protein in the rat hippocampus after transient forebrain ischemia the cellular localization and spatiotemporal ex\n",
      "Classification Result: ['LC3', 'HSC70', 'proteasome', 'P62/SQSTM1', 'ubiquitination', 'autophagy', 'apoptosis', 'nucleotide exchange factor', 'cancer', 'cardiac hypertrophy']\n",
      "Scores: [0.4429418742656708, 0.12849117815494537, 0.1112586259841919, 0.08158835023641586, 0.07265190780162811, 0.06337592005729675, 0.050394948571920395, 0.03187425807118416, 0.008878066204488277, 0.008544791489839554]\n",
      "\n",
      "Sentence: erk12 phosphorylation induced by electromagnetic fields diminishes during neoplastic transformation it has been suggested that electromagnetic em fiel\n",
      "Classification Result: ['HSC70', 'LC3', 'cancer', 'ubiquitination', 'P62/SQSTM1', 'nucleotide exchange factor', 'proteasome', 'autophagy', 'apoptosis', 'cardiac hypertrophy']\n",
      "Scores: [0.3402596414089203, 0.216207817196846, 0.09293222427368164, 0.0866568461060524, 0.06511756032705307, 0.05852936580777168, 0.05616474896669388, 0.034799620509147644, 0.031265974044799805, 0.018066199496388435]\n",
      "\n",
      "Sentence: hsp70ry further characterization of a novel member of the hsp70 protein family hsp70ry was identified as a member of the hsp70 protein family on the b\n",
      "Classification Result: ['LC3', 'HSC70', 'ubiquitination', 'autophagy', 'proteasome', 'P62/SQSTM1', 'apoptosis', 'nucleotide exchange factor', 'cardiac hypertrophy', 'cancer']\n",
      "Scores: [0.32947254180908203, 0.2292381078004837, 0.11411513388156891, 0.08880922943353653, 0.06007342413067818, 0.04942760989069939, 0.0397430844604969, 0.03509974852204323, 0.03506317362189293, 0.018957968801259995]\n",
      "\n",
      "Sentence: cleavage at the carboxylterminus of ku80 during apoptosis in human jurkat t cells we have previously reported that the amount of apg2 an hsp110 family\n",
      "Classification Result: ['apoptosis', 'LC3', 'proteasome', 'P62/SQSTM1', 'ubiquitination', 'HSC70', 'autophagy', 'nucleotide exchange factor', 'cancer', 'cardiac hypertrophy']\n",
      "Scores: [0.6834895610809326, 0.08805730938911438, 0.04608280956745148, 0.04154928773641586, 0.04036886245012283, 0.03848240524530411, 0.031074047088623047, 0.014282752759754658, 0.009205181151628494, 0.007407756522297859]\n",
      "\n"
     ]
    }
   ],
   "source": [
    "# Create an empty DataFrame to store the results\n",
    "results_df = pd.DataFrame(columns=['Sentence', 'Labels', 'Scores'])\n",
    "\n",
    "# Loop through each sentence in the DataFrame and classify it\n",
    "for sentence in df['Combined_Sentences'].tolist():\n",
    "    # Perform zero-shot classification\n",
    "    classification_result = classifier(sentence, candidate_labels)\n",
    "    \n",
    "    # Extract classification results\n",
    "    labels = classification_result['labels']\n",
    "    scores = classification_result['scores']\n",
    "    \n",
    "    # Print the classification result\n",
    "    print(f\"Sentence: {sentence[:150]}\")\n",
    "    print(f\"Classification Result: {labels}\")\n",
    "    print(f\"Scores: {scores}\")\n",
    "    print()\n",
    "    \n",
    "    # Create a temporary DataFrame for this sentence\n",
    "    temp_df = pd.DataFrame({'Sentence': [sentence], 'Labels': [labels], 'Scores': [scores]})\n",
    "    \n",
    "    # Append the result to the results_df DataFrame\n",
    "    results_df = pd.concat([results_df, temp_df], ignore_index=True)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Saving the current results"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 477,
   "metadata": {},
   "outputs": [],
   "source": [
    "current_time = datetime.now().strftime(\"%Y-%m-%d_%H-%M-%S\")\n",
    "\n",
    "# save the results to a CSV file with the current time stamp\n",
    "filename = f\"zero_shot_classification_results_{current_time}.csv\"\n",
    "results_df.to_csv(filename, index=False)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Step 4: Data Visualization"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 446,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Sentence</th>\n",
       "      <th>Labels</th>\n",
       "      <th>Scores</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>tumoreducated b cells selectively promote breast cancer lymph node metastasis by hspa4targeting igg primary tumors may create the premetastatic niche in secondary organs for subsequent metastasis humoral immunity contributes to the progression of certain cancers but the roles of b cells and their derived antibodies in premetastatic niche formation are poorly defined using a mouse model of spontaneous lymph node metastasis of breast cancer we show that primary tumors induced b cell accumulation in draining lymph nodes these b cells selectively promoted lymph node metastasis by producing pathogenic igg that targeted glycosylated membrane protein hspa4 and activated the hspa4binding protein itgb5 and the downstream srcnfb pathway in tumor cells for cxcr4sdf1axismediated metastasis high serum antihspa4 igg was correlated with high tumor hspa4 expression and poor prognosis of breast cancer subjects our findings identify a key role for tumoreducated b cells and their derived antibodies in lymph node premetastatic niche formation providing potential targets for cancer intervention</td>\n",
       "      <td>['cancer', 'LC3', 'HSC70', 'P62/SQSTM1', 'proteasome', 'ubiquitination', 'nucleotide exchange factor', 'autophagy', 'apoptosis', 'cardiac hypertrophy']</td>\n",
       "      <td>[0.6762353181838989, 0.10858528316020966, 0.050915852189064026, 0.033793073147535324, 0.03292522951960564, 0.02974163554608822, 0.023961974307894707, 0.02216721512377262, 0.013303634710609913, 0.008370772935450077]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>hspa4 upregulation induces immune evasion via alkbh5cd58 axis in gastric cancer introduction                    gastric cancer gc is one of the leading causes of cancerrelated death worldwide recently targeted therapies including pd1 programmed cell death 1 antibodies have been used in advanced gc patients however identifying new biomarker for immunotherapy is still urgently needed the objective of this study is to unveil the immune evasion mechanism of gc cells and identify new biomarkers for immune checkpoint blockade therapy in patients with gc              methods                    coimmunoprecipitation and merip were performed to investigate the mechanism of immune evasion of gc cells cocuture system was established to evaluate the cytotoxicity of cocultured cd8 t cells the clinical significance of hspa4 upregulation was analyzed by multiplex fluorescent immunohistochemistry staining in gc tumor tissues              results                    histone acetylation causes hspa4 upregulation in gc tumor tissues hspa4 upregulation increases the protein stability of m6a demethylase alkbh5 alkbh5 decreases cd58 in gc cells through m6a methylation regulation the cytotoxicity of cd8 t cells are impaired and pd1pdl1 axis is activated when cd8 t cells are cocultured with hspa4 overexpressed gc cells hspa4 upregulation is associated with worse 5year overall survival of gc patients receiving only surgery it is an independent prognosis factor for worse survival of gc patients in gc patients receiving the combined chemotherapy with antipd1 immunotherapy hspa4 upregulation is observed in responders compared with nonresponders              conclusion                    hspa4 upregulation causes the decrease of cd58 in gc cells via hspa4alkbh5cd58 axis followed by pd1pdl1 activation and impairment of cd8 t cells cytotoxicity finally induces immune evasion of gc cells hspa4 upregulation is associated with worse overall survival of gc patients with only surgery meanwhile hspa4 upregulation predicts for better response in gc patients receiving the combined immunotherapy</td>\n",
       "      <td>['cancer', 'LC3', 'proteasome', 'P62/SQSTM1', 'nucleotide exchange factor', 'ubiquitination', 'autophagy', 'HSC70', 'apoptosis', 'cardiac hypertrophy']</td>\n",
       "      <td>[0.8288431763648987, 0.028598923236131668, 0.026072241365909576, 0.022245757281780243, 0.020209170877933502, 0.01953403279185295, 0.01899723708629608, 0.016946135088801384, 0.014060711488127708, 0.004492597654461861]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>hspa4 knockdown retarded progression and development of colorectal cancer purpose                    colorectal cancer crc is a common malignancy associated with high morbidity and mortality heat shock 70 kda protein 4 hspa4 has been shown to exert regulatory roles during tumor progression in different cancer types here we investigated the expression and cellular functions of hspa4 in crc              materials and methods                    expression of hspa4 in crc tissues and paracancerous tissues was analyzed by rtqpcr and immunohistochemistry ihc staining the functional roles of hspa4 were explored using shrnamediated knockdown in hct116 and rko crc cell lines both in vitro and in tumor xenograft studies              results                    hspa4 expression was significantly increased at the rna and protein levels in crc tissues compared with noncancerous tissues moreover hspa4 expression was positively associated with tumor stage and its high expression of hspa4 indicated poor patient prognosis in vitro studies established that hspa4 knockdown inhibited proliferation and migration causing arrest in the g2phase of the cell cycle along with increased levels of apoptosis this phenotype was recapitulated in vivo where hspa4 knockdown suppressed xenograft growth mechanistic investigations showed silencing of hspa4 reduced activation of the pi3k akt signaling axis while also downregulating the cell cycle progression markers ccnd1 and cdk6 similarly there was altered expression of apoptosisrelated proteins consistent with the increase in apoptosis              conclusion                    our findings demonstrate clinical significance for hspa4 in crc further showing that hspa4 contributes to crc tumorigenesis through effects on proliferation migration and survival thus hspa4 represents a novel prognostic indicator as well as a promising therapeutic target in crc</td>\n",
       "      <td>['cancer', 'apoptosis', 'HSC70', 'LC3', 'ubiquitination', 'nucleotide exchange factor', 'proteasome', 'autophagy', 'P62/SQSTM1', 'cardiac hypertrophy']</td>\n",
       "      <td>[0.6838890910148621, 0.18289880454540253, 0.0476415641605854, 0.017762573435902596, 0.013554077595472336, 0.01349665131419897, 0.013225321657955647, 0.012429192662239075, 0.009191642515361309, 0.005911041516810656]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>significant correlation between hspa4 and prognosis and immune regulation in hepatocellular carcinoma background                    hepatocellular carcinoma hcc is an inflammationassociated tumor involved in immune tolerance and evasion in the immune microenvironment heat shock proteins hsps are involved in the occurrence progression and immune regulation of tumors therefore hsps have been considered potential therapeutic targets here we aimed to elucidate the value of hsp family a hsp70 member 4 hspa4 in the diagnosis and predicting prognosis of hcc and its relationship with immune cell infiltration immune cell biomarkers and immune checkpoints gene mutation dna methylation and the pathway involved in hcc were also analyzed              methods                    the gene expression omnibus geo and the cancer genome atlas tcga databases were used to compare hspa4 expression and the results were confirmed by immunohistochemical staining of clinical samples r package was used to analyze the correlation between hspa4 and cancer stage and to establish receiver operating characteristic roc curve of diagnosis timedependent survival roc curve and a nomogram model cbioportal and methsurv were used to identify genetic alterations and dna methylation and their effect on prognosis the tumor immune estimation resource timer was used to analyze immune cell infiltration immune cell biomarkers and immune checkpoints the string database was used to analyze proteinprotein interaction network information gene ontology go analysis and the kyoto encyclopedia of genes and genomes kegg analyses were performed to investigate the functions of hspa4 and its functional partner genes              results                    overexpression of hspa4 was identified in 25 cancers overexpression of hspa4 considerably correlated with cancer stage and alphafetoprotein afp level in hcc patients with higher hspa4 expression showed poorer prognosis hspa4 expression can accurately identify tumor from normal tissue auc  0957 the area under 1 3 and 5year survival rocs were above 06 the hspa4 genetic alteration rate was 13 among the 14 dna methylation cpg sites seven were related to the prognosis of hcc hspa4 was positively related to immune cell infiltration and immune checkpoints pd1 and ctla4 in hcc the kegg pathway enrichment analysis revealed hspa4 enrichment in antigen processing and presentation together with hspa8 and hsp90aa1 we verified the value of hspa4 in the diagnosis and predicting prognosis of hcc hspa4 may not only participate in the occurrence and progression but also the immune regulation of hcc therefore hspa4 can be a potential diagnostic and prognostic biomarker and a therapeutic target for hcc</td>\n",
       "      <td>['HSC70', 'cancer', 'proteasome', 'ubiquitination', 'nucleotide exchange factor', 'LC3', 'apoptosis', 'autophagy', 'P62/SQSTM1', 'cardiac hypertrophy']</td>\n",
       "      <td>[0.4874506890773773, 0.35568249225616455, 0.038450539112091064, 0.031093154102563858, 0.028420859947800636, 0.024431895464658737, 0.011402040719985962, 0.009845827706158161, 0.009130297228693962, 0.004092233721166849]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>hspa4 regulated glioma progression via activation of akt signaling pathway glioma is still an incurable disease with high invasiveness heat shock 70 kda protein 4 hspa4 is a member of the hsp110 family and is associated with the development and progression of various cancers in the current study we assessed the expression of hspa4 in clinical samples and found that hspa4 was upregulated in glioma tissues and correlated with tumor recurrence and grade survival analyses demonstrated that glioma patients with high hspa4 expression had lower overall survival and diseasefree survival times in vitro knockdown of hspa4 inhibited glioma cell proliferation mediated cell cycle arrest at g2 phase and apoptosis and reduced the migration ability in vivo the growth of hspa4knockdown xenografts was markedly suppressed compared to the tumors formed by hspa4positive control cells additionally gene set enrichment analyses disclosed that hspa4 was associated with the pi3kakt signaling pathway the regulatory effect of the akt activator sc79 on cell proliferation and apoptosis was suppressed by hspa4 knockdown indicating that hspa4 is capable of promoting glioma development in summary these data showed that hspa4 is likely to play a pivotal role in the progression of glioma and consequently may be a promising therapeutic target for glioma therapy</td>\n",
       "      <td>['cancer', 'apoptosis', 'HSC70', 'LC3', 'ubiquitination', 'P62/SQSTM1', 'proteasome', 'autophagy', 'nucleotide exchange factor', 'cardiac hypertrophy']</td>\n",
       "      <td>[0.4648561179637909, 0.23765619099140167, 0.09346775710582733, 0.05643676221370697, 0.03615890070796013, 0.032402154058218, 0.030986363068223, 0.02160457707941532, 0.01776445470750332, 0.008666709996759892]</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Sentence  \\\n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    tumoreducated b cells selectively promote breast cancer lymph node metastasis by hspa4targeting igg primary tumors may create the premetastatic niche in secondary organs for subsequent metastasis humoral immunity contributes to the progression of certain cancers but the roles of b cells and their derived antibodies in premetastatic niche formation are poorly defined using a mouse model of spontaneous lymph node metastasis of breast cancer we show that primary tumors induced b cell accumulation in draining lymph nodes these b cells selectively promoted lymph node metastasis by producing pathogenic igg that targeted glycosylated membrane protein hspa4 and activated the hspa4binding protein itgb5 and the downstream srcnfb pathway in tumor cells for cxcr4sdf1axismediated metastasis high serum antihspa4 igg was correlated with high tumor hspa4 expression and poor prognosis of breast cancer subjects our findings identify a key role for tumoreducated b cells and their derived antibodies in lymph node premetastatic niche formation providing potential targets for cancer intervention   \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           hspa4 upregulation induces immune evasion via alkbh5cd58 axis in gastric cancer introduction                    gastric cancer gc is one of the leading causes of cancerrelated death worldwide recently targeted therapies including pd1 programmed cell death 1 antibodies have been used in advanced gc patients however identifying new biomarker for immunotherapy is still urgently needed the objective of this study is to unveil the immune evasion mechanism of gc cells and identify new biomarkers for immune checkpoint blockade therapy in patients with gc              methods                    coimmunoprecipitation and merip were performed to investigate the mechanism of immune evasion of gc cells cocuture system was established to evaluate the cytotoxicity of cocultured cd8 t cells the clinical significance of hspa4 upregulation was analyzed by multiplex fluorescent immunohistochemistry staining in gc tumor tissues              results                    histone acetylation causes hspa4 upregulation in gc tumor tissues hspa4 upregulation increases the protein stability of m6a demethylase alkbh5 alkbh5 decreases cd58 in gc cells through m6a methylation regulation the cytotoxicity of cd8 t cells are impaired and pd1pdl1 axis is activated when cd8 t cells are cocultured with hspa4 overexpressed gc cells hspa4 upregulation is associated with worse 5year overall survival of gc patients receiving only surgery it is an independent prognosis factor for worse survival of gc patients in gc patients receiving the combined chemotherapy with antipd1 immunotherapy hspa4 upregulation is observed in responders compared with nonresponders              conclusion                    hspa4 upregulation causes the decrease of cd58 in gc cells via hspa4alkbh5cd58 axis followed by pd1pdl1 activation and impairment of cd8 t cells cytotoxicity finally induces immune evasion of gc cells hspa4 upregulation is associated with worse overall survival of gc patients with only surgery meanwhile hspa4 upregulation predicts for better response in gc patients receiving the combined immunotherapy   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           hspa4 knockdown retarded progression and development of colorectal cancer purpose                    colorectal cancer crc is a common malignancy associated with high morbidity and mortality heat shock 70 kda protein 4 hspa4 has been shown to exert regulatory roles during tumor progression in different cancer types here we investigated the expression and cellular functions of hspa4 in crc              materials and methods                    expression of hspa4 in crc tissues and paracancerous tissues was analyzed by rtqpcr and immunohistochemistry ihc staining the functional roles of hspa4 were explored using shrnamediated knockdown in hct116 and rko crc cell lines both in vitro and in tumor xenograft studies              results                    hspa4 expression was significantly increased at the rna and protein levels in crc tissues compared with noncancerous tissues moreover hspa4 expression was positively associated with tumor stage and its high expression of hspa4 indicated poor patient prognosis in vitro studies established that hspa4 knockdown inhibited proliferation and migration causing arrest in the g2phase of the cell cycle along with increased levels of apoptosis this phenotype was recapitulated in vivo where hspa4 knockdown suppressed xenograft growth mechanistic investigations showed silencing of hspa4 reduced activation of the pi3k akt signaling axis while also downregulating the cell cycle progression markers ccnd1 and cdk6 similarly there was altered expression of apoptosisrelated proteins consistent with the increase in apoptosis              conclusion                    our findings demonstrate clinical significance for hspa4 in crc further showing that hspa4 contributes to crc tumorigenesis through effects on proliferation migration and survival thus hspa4 represents a novel prognostic indicator as well as a promising therapeutic target in crc   \n",
       "3  significant correlation between hspa4 and prognosis and immune regulation in hepatocellular carcinoma background                    hepatocellular carcinoma hcc is an inflammationassociated tumor involved in immune tolerance and evasion in the immune microenvironment heat shock proteins hsps are involved in the occurrence progression and immune regulation of tumors therefore hsps have been considered potential therapeutic targets here we aimed to elucidate the value of hsp family a hsp70 member 4 hspa4 in the diagnosis and predicting prognosis of hcc and its relationship with immune cell infiltration immune cell biomarkers and immune checkpoints gene mutation dna methylation and the pathway involved in hcc were also analyzed              methods                    the gene expression omnibus geo and the cancer genome atlas tcga databases were used to compare hspa4 expression and the results were confirmed by immunohistochemical staining of clinical samples r package was used to analyze the correlation between hspa4 and cancer stage and to establish receiver operating characteristic roc curve of diagnosis timedependent survival roc curve and a nomogram model cbioportal and methsurv were used to identify genetic alterations and dna methylation and their effect on prognosis the tumor immune estimation resource timer was used to analyze immune cell infiltration immune cell biomarkers and immune checkpoints the string database was used to analyze proteinprotein interaction network information gene ontology go analysis and the kyoto encyclopedia of genes and genomes kegg analyses were performed to investigate the functions of hspa4 and its functional partner genes              results                    overexpression of hspa4 was identified in 25 cancers overexpression of hspa4 considerably correlated with cancer stage and alphafetoprotein afp level in hcc patients with higher hspa4 expression showed poorer prognosis hspa4 expression can accurately identify tumor from normal tissue auc  0957 the area under 1 3 and 5year survival rocs were above 06 the hspa4 genetic alteration rate was 13 among the 14 dna methylation cpg sites seven were related to the prognosis of hcc hspa4 was positively related to immune cell infiltration and immune checkpoints pd1 and ctla4 in hcc the kegg pathway enrichment analysis revealed hspa4 enrichment in antigen processing and presentation together with hspa8 and hsp90aa1 we verified the value of hspa4 in the diagnosis and predicting prognosis of hcc hspa4 may not only participate in the occurrence and progression but also the immune regulation of hcc therefore hspa4 can be a potential diagnostic and prognostic biomarker and a therapeutic target for hcc   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   hspa4 regulated glioma progression via activation of akt signaling pathway glioma is still an incurable disease with high invasiveness heat shock 70 kda protein 4 hspa4 is a member of the hsp110 family and is associated with the development and progression of various cancers in the current study we assessed the expression of hspa4 in clinical samples and found that hspa4 was upregulated in glioma tissues and correlated with tumor recurrence and grade survival analyses demonstrated that glioma patients with high hspa4 expression had lower overall survival and diseasefree survival times in vitro knockdown of hspa4 inhibited glioma cell proliferation mediated cell cycle arrest at g2 phase and apoptosis and reduced the migration ability in vivo the growth of hspa4knockdown xenografts was markedly suppressed compared to the tumors formed by hspa4positive control cells additionally gene set enrichment analyses disclosed that hspa4 was associated with the pi3kakt signaling pathway the regulatory effect of the akt activator sc79 on cell proliferation and apoptosis was suppressed by hspa4 knockdown indicating that hspa4 is capable of promoting glioma development in summary these data showed that hspa4 is likely to play a pivotal role in the progression of glioma and consequently may be a promising therapeutic target for glioma therapy   \n",
       "\n",
       "                                                                                                                                                    Labels  \\\n",
       "0  ['cancer', 'LC3', 'HSC70', 'P62/SQSTM1', 'proteasome', 'ubiquitination', 'nucleotide exchange factor', 'autophagy', 'apoptosis', 'cardiac hypertrophy']   \n",
       "1  ['cancer', 'LC3', 'proteasome', 'P62/SQSTM1', 'nucleotide exchange factor', 'ubiquitination', 'autophagy', 'HSC70', 'apoptosis', 'cardiac hypertrophy']   \n",
       "2  ['cancer', 'apoptosis', 'HSC70', 'LC3', 'ubiquitination', 'nucleotide exchange factor', 'proteasome', 'autophagy', 'P62/SQSTM1', 'cardiac hypertrophy']   \n",
       "3  ['HSC70', 'cancer', 'proteasome', 'ubiquitination', 'nucleotide exchange factor', 'LC3', 'apoptosis', 'autophagy', 'P62/SQSTM1', 'cardiac hypertrophy']   \n",
       "4  ['cancer', 'apoptosis', 'HSC70', 'LC3', 'ubiquitination', 'P62/SQSTM1', 'proteasome', 'autophagy', 'nucleotide exchange factor', 'cardiac hypertrophy']   \n",
       "\n",
       "                                                                                                                                                                                                                      Scores  \n",
       "0     [0.6762353181838989, 0.10858528316020966, 0.050915852189064026, 0.033793073147535324, 0.03292522951960564, 0.02974163554608822, 0.023961974307894707, 0.02216721512377262, 0.013303634710609913, 0.008370772935450077]  \n",
       "1   [0.8288431763648987, 0.028598923236131668, 0.026072241365909576, 0.022245757281780243, 0.020209170877933502, 0.01953403279185295, 0.01899723708629608, 0.016946135088801384, 0.014060711488127708, 0.004492597654461861]  \n",
       "2     [0.6838890910148621, 0.18289880454540253, 0.0476415641605854, 0.017762573435902596, 0.013554077595472336, 0.01349665131419897, 0.013225321657955647, 0.012429192662239075, 0.009191642515361309, 0.005911041516810656]  \n",
       "3  [0.4874506890773773, 0.35568249225616455, 0.038450539112091064, 0.031093154102563858, 0.028420859947800636, 0.024431895464658737, 0.011402040719985962, 0.009845827706158161, 0.009130297228693962, 0.004092233721166849]  \n",
       "4             [0.4648561179637909, 0.23765619099140167, 0.09346775710582733, 0.05643676221370697, 0.03615890070796013, 0.032402154058218, 0.030986363068223, 0.02160457707941532, 0.01776445470750332, 0.008666709996759892]  "
      ]
     },
     "execution_count": 446,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#load the results\n",
    "#results_df = pd.read_csv('zero_shot_classification_results_2024-07-22_16-20-46.csv')\n",
    "results_df.head()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Plotting the distribution of labels"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 447,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# extract the labels and scores from the DataFrame\n",
    "results_df['Labels'] = results_df['Labels'].apply(lambda x: eval(x))\n",
    "results_df['Scores'] = results_df['Scores'].apply(lambda x: eval(x))\n",
    "\n",
    "# Extract the top label and score for each sentence\n",
    "results_df['Top Label'] = results_df['Labels'].apply(lambda x: x[0])\n",
    "results_df['Top Score'] = results_df['Scores'].apply(lambda x: x[0])\n",
    "\n",
    "# plot the distribution of the top labels\n",
    "import matplotlib.pyplot as plt\n",
    "import seaborn as sns\n",
    "\n",
    "plt.figure(figsize=(10, 6))\n",
    "sns.countplot(y=\"Top Label\", data=results_df, order=results_df['Top Label'].value_counts().index, palette='viridis')\n",
    "plt.title(\"Distribution of Top Labels\")\n",
    "plt.xlabel(\"Count\")\n",
    "plt.ylabel(\"Label\")\n",
    "plt.show()\n",
    "\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Cancer was recognized most often followed by autophagy related LC3 and proteostasis related chaperon HSC70"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 448,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Sentence</th>\n",
       "      <th>Labels</th>\n",
       "      <th>Scores</th>\n",
       "      <th>Top Label</th>\n",
       "      <th>Top Score</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>tumoreducated b cells selectively promote breast cancer lymph node metastasis by hspa4targeting igg primary tumors may create the premetastatic niche in secondary organs for subsequent metastasis humoral immunity contributes to the progression of certain cancers but the roles of b cells and their derived antibodies in premetastatic niche formation are poorly defined using a mouse model of spontaneous lymph node metastasis of breast cancer we show that primary tumors induced b cell accumulation in draining lymph nodes these b cells selectively promoted lymph node metastasis by producing pathogenic igg that targeted glycosylated membrane protein hspa4 and activated the hspa4binding protein itgb5 and the downstream srcnfb pathway in tumor cells for cxcr4sdf1axismediated metastasis high serum antihspa4 igg was correlated with high tumor hspa4 expression and poor prognosis of breast cancer subjects our findings identify a key role for tumoreducated b cells and their derived antibodies in lymph node premetastatic niche formation providing potential targets for cancer intervention</td>\n",
       "      <td>[cancer, LC3, HSC70, P62/SQSTM1, proteasome, ubiquitination, nucleotide exchange factor, autophagy, apoptosis, cardiac hypertrophy]</td>\n",
       "      <td>[0.6762353181838989, 0.10858528316020966, 0.050915852189064026, 0.033793073147535324, 0.03292522951960564, 0.02974163554608822, 0.023961974307894707, 0.02216721512377262, 0.013303634710609913, 0.008370772935450077]</td>\n",
       "      <td>cancer</td>\n",
       "      <td>0.676235</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>hspa4 upregulation induces immune evasion via alkbh5cd58 axis in gastric cancer introduction                    gastric cancer gc is one of the leading causes of cancerrelated death worldwide recently targeted therapies including pd1 programmed cell death 1 antibodies have been used in advanced gc patients however identifying new biomarker for immunotherapy is still urgently needed the objective of this study is to unveil the immune evasion mechanism of gc cells and identify new biomarkers for immune checkpoint blockade therapy in patients with gc              methods                    coimmunoprecipitation and merip were performed to investigate the mechanism of immune evasion of gc cells cocuture system was established to evaluate the cytotoxicity of cocultured cd8 t cells the clinical significance of hspa4 upregulation was analyzed by multiplex fluorescent immunohistochemistry staining in gc tumor tissues              results                    histone acetylation causes hspa4 upregulation in gc tumor tissues hspa4 upregulation increases the protein stability of m6a demethylase alkbh5 alkbh5 decreases cd58 in gc cells through m6a methylation regulation the cytotoxicity of cd8 t cells are impaired and pd1pdl1 axis is activated when cd8 t cells are cocultured with hspa4 overexpressed gc cells hspa4 upregulation is associated with worse 5year overall survival of gc patients receiving only surgery it is an independent prognosis factor for worse survival of gc patients in gc patients receiving the combined chemotherapy with antipd1 immunotherapy hspa4 upregulation is observed in responders compared with nonresponders              conclusion                    hspa4 upregulation causes the decrease of cd58 in gc cells via hspa4alkbh5cd58 axis followed by pd1pdl1 activation and impairment of cd8 t cells cytotoxicity finally induces immune evasion of gc cells hspa4 upregulation is associated with worse overall survival of gc patients with only surgery meanwhile hspa4 upregulation predicts for better response in gc patients receiving the combined immunotherapy</td>\n",
       "      <td>[cancer, LC3, proteasome, P62/SQSTM1, nucleotide exchange factor, ubiquitination, autophagy, HSC70, apoptosis, cardiac hypertrophy]</td>\n",
       "      <td>[0.8288431763648987, 0.028598923236131668, 0.026072241365909576, 0.022245757281780243, 0.020209170877933502, 0.01953403279185295, 0.01899723708629608, 0.016946135088801384, 0.014060711488127708, 0.004492597654461861]</td>\n",
       "      <td>cancer</td>\n",
       "      <td>0.828843</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>hspa4 knockdown retarded progression and development of colorectal cancer purpose                    colorectal cancer crc is a common malignancy associated with high morbidity and mortality heat shock 70 kda protein 4 hspa4 has been shown to exert regulatory roles during tumor progression in different cancer types here we investigated the expression and cellular functions of hspa4 in crc              materials and methods                    expression of hspa4 in crc tissues and paracancerous tissues was analyzed by rtqpcr and immunohistochemistry ihc staining the functional roles of hspa4 were explored using shrnamediated knockdown in hct116 and rko crc cell lines both in vitro and in tumor xenograft studies              results                    hspa4 expression was significantly increased at the rna and protein levels in crc tissues compared with noncancerous tissues moreover hspa4 expression was positively associated with tumor stage and its high expression of hspa4 indicated poor patient prognosis in vitro studies established that hspa4 knockdown inhibited proliferation and migration causing arrest in the g2phase of the cell cycle along with increased levels of apoptosis this phenotype was recapitulated in vivo where hspa4 knockdown suppressed xenograft growth mechanistic investigations showed silencing of hspa4 reduced activation of the pi3k akt signaling axis while also downregulating the cell cycle progression markers ccnd1 and cdk6 similarly there was altered expression of apoptosisrelated proteins consistent with the increase in apoptosis              conclusion                    our findings demonstrate clinical significance for hspa4 in crc further showing that hspa4 contributes to crc tumorigenesis through effects on proliferation migration and survival thus hspa4 represents a novel prognostic indicator as well as a promising therapeutic target in crc</td>\n",
       "      <td>[cancer, apoptosis, HSC70, LC3, ubiquitination, nucleotide exchange factor, proteasome, autophagy, P62/SQSTM1, cardiac hypertrophy]</td>\n",
       "      <td>[0.6838890910148621, 0.18289880454540253, 0.0476415641605854, 0.017762573435902596, 0.013554077595472336, 0.01349665131419897, 0.013225321657955647, 0.012429192662239075, 0.009191642515361309, 0.005911041516810656]</td>\n",
       "      <td>cancer</td>\n",
       "      <td>0.683889</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>significant correlation between hspa4 and prognosis and immune regulation in hepatocellular carcinoma background                    hepatocellular carcinoma hcc is an inflammationassociated tumor involved in immune tolerance and evasion in the immune microenvironment heat shock proteins hsps are involved in the occurrence progression and immune regulation of tumors therefore hsps have been considered potential therapeutic targets here we aimed to elucidate the value of hsp family a hsp70 member 4 hspa4 in the diagnosis and predicting prognosis of hcc and its relationship with immune cell infiltration immune cell biomarkers and immune checkpoints gene mutation dna methylation and the pathway involved in hcc were also analyzed              methods                    the gene expression omnibus geo and the cancer genome atlas tcga databases were used to compare hspa4 expression and the results were confirmed by immunohistochemical staining of clinical samples r package was used to analyze the correlation between hspa4 and cancer stage and to establish receiver operating characteristic roc curve of diagnosis timedependent survival roc curve and a nomogram model cbioportal and methsurv were used to identify genetic alterations and dna methylation and their effect on prognosis the tumor immune estimation resource timer was used to analyze immune cell infiltration immune cell biomarkers and immune checkpoints the string database was used to analyze proteinprotein interaction network information gene ontology go analysis and the kyoto encyclopedia of genes and genomes kegg analyses were performed to investigate the functions of hspa4 and its functional partner genes              results                    overexpression of hspa4 was identified in 25 cancers overexpression of hspa4 considerably correlated with cancer stage and alphafetoprotein afp level in hcc patients with higher hspa4 expression showed poorer prognosis hspa4 expression can accurately identify tumor from normal tissue auc  0957 the area under 1 3 and 5year survival rocs were above 06 the hspa4 genetic alteration rate was 13 among the 14 dna methylation cpg sites seven were related to the prognosis of hcc hspa4 was positively related to immune cell infiltration and immune checkpoints pd1 and ctla4 in hcc the kegg pathway enrichment analysis revealed hspa4 enrichment in antigen processing and presentation together with hspa8 and hsp90aa1 we verified the value of hspa4 in the diagnosis and predicting prognosis of hcc hspa4 may not only participate in the occurrence and progression but also the immune regulation of hcc therefore hspa4 can be a potential diagnostic and prognostic biomarker and a therapeutic target for hcc</td>\n",
       "      <td>[HSC70, cancer, proteasome, ubiquitination, nucleotide exchange factor, LC3, apoptosis, autophagy, P62/SQSTM1, cardiac hypertrophy]</td>\n",
       "      <td>[0.4874506890773773, 0.35568249225616455, 0.038450539112091064, 0.031093154102563858, 0.028420859947800636, 0.024431895464658737, 0.011402040719985962, 0.009845827706158161, 0.009130297228693962, 0.004092233721166849]</td>\n",
       "      <td>HSC70</td>\n",
       "      <td>0.487451</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>hspa4 regulated glioma progression via activation of akt signaling pathway glioma is still an incurable disease with high invasiveness heat shock 70 kda protein 4 hspa4 is a member of the hsp110 family and is associated with the development and progression of various cancers in the current study we assessed the expression of hspa4 in clinical samples and found that hspa4 was upregulated in glioma tissues and correlated with tumor recurrence and grade survival analyses demonstrated that glioma patients with high hspa4 expression had lower overall survival and diseasefree survival times in vitro knockdown of hspa4 inhibited glioma cell proliferation mediated cell cycle arrest at g2 phase and apoptosis and reduced the migration ability in vivo the growth of hspa4knockdown xenografts was markedly suppressed compared to the tumors formed by hspa4positive control cells additionally gene set enrichment analyses disclosed that hspa4 was associated with the pi3kakt signaling pathway the regulatory effect of the akt activator sc79 on cell proliferation and apoptosis was suppressed by hspa4 knockdown indicating that hspa4 is capable of promoting glioma development in summary these data showed that hspa4 is likely to play a pivotal role in the progression of glioma and consequently may be a promising therapeutic target for glioma therapy</td>\n",
       "      <td>[cancer, apoptosis, HSC70, LC3, ubiquitination, P62/SQSTM1, proteasome, autophagy, nucleotide exchange factor, cardiac hypertrophy]</td>\n",
       "      <td>[0.4648561179637909, 0.23765619099140167, 0.09346775710582733, 0.05643676221370697, 0.03615890070796013, 0.032402154058218, 0.030986363068223, 0.02160457707941532, 0.01776445470750332, 0.008666709996759892]</td>\n",
       "      <td>cancer</td>\n",
       "      <td>0.464856</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Sentence  \\\n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    tumoreducated b cells selectively promote breast cancer lymph node metastasis by hspa4targeting igg primary tumors may create the premetastatic niche in secondary organs for subsequent metastasis humoral immunity contributes to the progression of certain cancers but the roles of b cells and their derived antibodies in premetastatic niche formation are poorly defined using a mouse model of spontaneous lymph node metastasis of breast cancer we show that primary tumors induced b cell accumulation in draining lymph nodes these b cells selectively promoted lymph node metastasis by producing pathogenic igg that targeted glycosylated membrane protein hspa4 and activated the hspa4binding protein itgb5 and the downstream srcnfb pathway in tumor cells for cxcr4sdf1axismediated metastasis high serum antihspa4 igg was correlated with high tumor hspa4 expression and poor prognosis of breast cancer subjects our findings identify a key role for tumoreducated b cells and their derived antibodies in lymph node premetastatic niche formation providing potential targets for cancer intervention   \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           hspa4 upregulation induces immune evasion via alkbh5cd58 axis in gastric cancer introduction                    gastric cancer gc is one of the leading causes of cancerrelated death worldwide recently targeted therapies including pd1 programmed cell death 1 antibodies have been used in advanced gc patients however identifying new biomarker for immunotherapy is still urgently needed the objective of this study is to unveil the immune evasion mechanism of gc cells and identify new biomarkers for immune checkpoint blockade therapy in patients with gc              methods                    coimmunoprecipitation and merip were performed to investigate the mechanism of immune evasion of gc cells cocuture system was established to evaluate the cytotoxicity of cocultured cd8 t cells the clinical significance of hspa4 upregulation was analyzed by multiplex fluorescent immunohistochemistry staining in gc tumor tissues              results                    histone acetylation causes hspa4 upregulation in gc tumor tissues hspa4 upregulation increases the protein stability of m6a demethylase alkbh5 alkbh5 decreases cd58 in gc cells through m6a methylation regulation the cytotoxicity of cd8 t cells are impaired and pd1pdl1 axis is activated when cd8 t cells are cocultured with hspa4 overexpressed gc cells hspa4 upregulation is associated with worse 5year overall survival of gc patients receiving only surgery it is an independent prognosis factor for worse survival of gc patients in gc patients receiving the combined chemotherapy with antipd1 immunotherapy hspa4 upregulation is observed in responders compared with nonresponders              conclusion                    hspa4 upregulation causes the decrease of cd58 in gc cells via hspa4alkbh5cd58 axis followed by pd1pdl1 activation and impairment of cd8 t cells cytotoxicity finally induces immune evasion of gc cells hspa4 upregulation is associated with worse overall survival of gc patients with only surgery meanwhile hspa4 upregulation predicts for better response in gc patients receiving the combined immunotherapy   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           hspa4 knockdown retarded progression and development of colorectal cancer purpose                    colorectal cancer crc is a common malignancy associated with high morbidity and mortality heat shock 70 kda protein 4 hspa4 has been shown to exert regulatory roles during tumor progression in different cancer types here we investigated the expression and cellular functions of hspa4 in crc              materials and methods                    expression of hspa4 in crc tissues and paracancerous tissues was analyzed by rtqpcr and immunohistochemistry ihc staining the functional roles of hspa4 were explored using shrnamediated knockdown in hct116 and rko crc cell lines both in vitro and in tumor xenograft studies              results                    hspa4 expression was significantly increased at the rna and protein levels in crc tissues compared with noncancerous tissues moreover hspa4 expression was positively associated with tumor stage and its high expression of hspa4 indicated poor patient prognosis in vitro studies established that hspa4 knockdown inhibited proliferation and migration causing arrest in the g2phase of the cell cycle along with increased levels of apoptosis this phenotype was recapitulated in vivo where hspa4 knockdown suppressed xenograft growth mechanistic investigations showed silencing of hspa4 reduced activation of the pi3k akt signaling axis while also downregulating the cell cycle progression markers ccnd1 and cdk6 similarly there was altered expression of apoptosisrelated proteins consistent with the increase in apoptosis              conclusion                    our findings demonstrate clinical significance for hspa4 in crc further showing that hspa4 contributes to crc tumorigenesis through effects on proliferation migration and survival thus hspa4 represents a novel prognostic indicator as well as a promising therapeutic target in crc   \n",
       "3  significant correlation between hspa4 and prognosis and immune regulation in hepatocellular carcinoma background                    hepatocellular carcinoma hcc is an inflammationassociated tumor involved in immune tolerance and evasion in the immune microenvironment heat shock proteins hsps are involved in the occurrence progression and immune regulation of tumors therefore hsps have been considered potential therapeutic targets here we aimed to elucidate the value of hsp family a hsp70 member 4 hspa4 in the diagnosis and predicting prognosis of hcc and its relationship with immune cell infiltration immune cell biomarkers and immune checkpoints gene mutation dna methylation and the pathway involved in hcc were also analyzed              methods                    the gene expression omnibus geo and the cancer genome atlas tcga databases were used to compare hspa4 expression and the results were confirmed by immunohistochemical staining of clinical samples r package was used to analyze the correlation between hspa4 and cancer stage and to establish receiver operating characteristic roc curve of diagnosis timedependent survival roc curve and a nomogram model cbioportal and methsurv were used to identify genetic alterations and dna methylation and their effect on prognosis the tumor immune estimation resource timer was used to analyze immune cell infiltration immune cell biomarkers and immune checkpoints the string database was used to analyze proteinprotein interaction network information gene ontology go analysis and the kyoto encyclopedia of genes and genomes kegg analyses were performed to investigate the functions of hspa4 and its functional partner genes              results                    overexpression of hspa4 was identified in 25 cancers overexpression of hspa4 considerably correlated with cancer stage and alphafetoprotein afp level in hcc patients with higher hspa4 expression showed poorer prognosis hspa4 expression can accurately identify tumor from normal tissue auc  0957 the area under 1 3 and 5year survival rocs were above 06 the hspa4 genetic alteration rate was 13 among the 14 dna methylation cpg sites seven were related to the prognosis of hcc hspa4 was positively related to immune cell infiltration and immune checkpoints pd1 and ctla4 in hcc the kegg pathway enrichment analysis revealed hspa4 enrichment in antigen processing and presentation together with hspa8 and hsp90aa1 we verified the value of hspa4 in the diagnosis and predicting prognosis of hcc hspa4 may not only participate in the occurrence and progression but also the immune regulation of hcc therefore hspa4 can be a potential diagnostic and prognostic biomarker and a therapeutic target for hcc   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   hspa4 regulated glioma progression via activation of akt signaling pathway glioma is still an incurable disease with high invasiveness heat shock 70 kda protein 4 hspa4 is a member of the hsp110 family and is associated with the development and progression of various cancers in the current study we assessed the expression of hspa4 in clinical samples and found that hspa4 was upregulated in glioma tissues and correlated with tumor recurrence and grade survival analyses demonstrated that glioma patients with high hspa4 expression had lower overall survival and diseasefree survival times in vitro knockdown of hspa4 inhibited glioma cell proliferation mediated cell cycle arrest at g2 phase and apoptosis and reduced the migration ability in vivo the growth of hspa4knockdown xenografts was markedly suppressed compared to the tumors formed by hspa4positive control cells additionally gene set enrichment analyses disclosed that hspa4 was associated with the pi3kakt signaling pathway the regulatory effect of the akt activator sc79 on cell proliferation and apoptosis was suppressed by hspa4 knockdown indicating that hspa4 is capable of promoting glioma development in summary these data showed that hspa4 is likely to play a pivotal role in the progression of glioma and consequently may be a promising therapeutic target for glioma therapy   \n",
       "\n",
       "                                                                                                                                Labels  \\\n",
       "0  [cancer, LC3, HSC70, P62/SQSTM1, proteasome, ubiquitination, nucleotide exchange factor, autophagy, apoptosis, cardiac hypertrophy]   \n",
       "1  [cancer, LC3, proteasome, P62/SQSTM1, nucleotide exchange factor, ubiquitination, autophagy, HSC70, apoptosis, cardiac hypertrophy]   \n",
       "2  [cancer, apoptosis, HSC70, LC3, ubiquitination, nucleotide exchange factor, proteasome, autophagy, P62/SQSTM1, cardiac hypertrophy]   \n",
       "3  [HSC70, cancer, proteasome, ubiquitination, nucleotide exchange factor, LC3, apoptosis, autophagy, P62/SQSTM1, cardiac hypertrophy]   \n",
       "4  [cancer, apoptosis, HSC70, LC3, ubiquitination, P62/SQSTM1, proteasome, autophagy, nucleotide exchange factor, cardiac hypertrophy]   \n",
       "\n",
       "                                                                                                                                                                                                                      Scores  \\\n",
       "0     [0.6762353181838989, 0.10858528316020966, 0.050915852189064026, 0.033793073147535324, 0.03292522951960564, 0.02974163554608822, 0.023961974307894707, 0.02216721512377262, 0.013303634710609913, 0.008370772935450077]   \n",
       "1   [0.8288431763648987, 0.028598923236131668, 0.026072241365909576, 0.022245757281780243, 0.020209170877933502, 0.01953403279185295, 0.01899723708629608, 0.016946135088801384, 0.014060711488127708, 0.004492597654461861]   \n",
       "2     [0.6838890910148621, 0.18289880454540253, 0.0476415641605854, 0.017762573435902596, 0.013554077595472336, 0.01349665131419897, 0.013225321657955647, 0.012429192662239075, 0.009191642515361309, 0.005911041516810656]   \n",
       "3  [0.4874506890773773, 0.35568249225616455, 0.038450539112091064, 0.031093154102563858, 0.028420859947800636, 0.024431895464658737, 0.011402040719985962, 0.009845827706158161, 0.009130297228693962, 0.004092233721166849]   \n",
       "4             [0.4648561179637909, 0.23765619099140167, 0.09346775710582733, 0.05643676221370697, 0.03615890070796013, 0.032402154058218, 0.030986363068223, 0.02160457707941532, 0.01776445470750332, 0.008666709996759892]   \n",
       "\n",
       "  Top Label  Top Score  \n",
       "0    cancer   0.676235  \n",
       "1    cancer   0.828843  \n",
       "2    cancer   0.683889  \n",
       "3     HSC70   0.487451  \n",
       "4    cancer   0.464856  "
      ]
     },
     "execution_count": 448,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "results_df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 449,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAA/MAAAImCAYAAAAfeNqLAAAAOXRFWHRTb2Z0d2FyZQBNYXRwbG90bGliIHZlcnNpb24zLjguMCwgaHR0cHM6Ly9tYXRwbG90bGliLm9yZy81sbWrAAAACXBIWXMAAA9hAAAPYQGoP6dpAACLyElEQVR4nOzdd3QU5dvG8WvTSEgohi6dYAKBUEOTJgFFihCKikBoiiJFaVIEQ5FepAT40XuRDiJFEQRFEQhdWmhSpUoLWUib9w9eVlZCCWTZbPh+zsk57Owzz9xzb0hy7ZQ1GYZhCAAAAAAAOAwnexcAAAAAAAAShzAPAAAAAICDIcwDAAAAAOBgCPMAAAAAADgYwjwAAAAAAA6GMA8AAAAAgIMhzAMAAAAA4GAI8wAAAAAAOBjCPAAAAAAADoYwDwDAS6Jbt27y8/PT5MmT7V3KCxcbG6uZM2eqXr16KlasmIoXL6569epp6tSpio6Otnd5T7RmzRpVqVJFAQEBCg0NTbJ5z549Kz8/vyd+LVu2LMm2+V8hISEKCQl57nmWLVsmPz8/nT179rnnCgoKUo8ePZ57HgCwJRd7FwAAAGwvMjJSP/74o3x9fbVo0SK1bt1aJpPJ3mW9MF999ZV++OEHtW7dWgEBATIMQ+Hh4Ro7dqx27dqlCRMm2LvEx+rXr5/y5MmjIUOGKEuWLEk2b+bMmbVw4ULL48uXL6t9+/b69NNP9cYbb1iW58qVK8m2CQBIGoR5AABeAqtXr1ZcXJx69+6tZs2aacuWLapYsaK9y3ohzp8/r+XLl6tfv356//33LcsrVqwob29vDRo0SPv27VORIkXsWOXjXb9+XeXLl1eZMmWSdF43NzcVK1bM8vj+Ue1cuXJZLQcAJD+cZg8AwEtg6dKlKlOmjMqUKaO8efPq22+/tTzXqlUrBQcHP7ROx44dVatWLcvj8PBwNW3aVEWLFlXp0qXVvXt3/fPPP5bnly1bJn9/fy1evFgVKlRQpUqVdPToUcXFxWny5MmqXbu2ihQpomLFiqlRo0baunWr1fY2bdqk+vXrq0iRIqpevbq+//57vfnmmwoLC7OMuX79ukJDQ/X6668rICBA77333kPz/NeVK1dkGIYMw3jouXfeeUedO3dW2rRpLcuuXr2qL7/8Uq+//rqKFy+uJk2aaOfOnZbn7969q/Hjx+vtt99WQECA3nrrLU2ePFnx8fGWMSEhIeratas+++wzlShRQh9//LFl3WHDhqly5coqXLiw3nnnHa1Zs+aRtW/btk1+fn6SpPHjx1udRv7bb7+pcePGKlmypMqUKaMuXbro77//fuLr8Syedp979OihSZMmqXz58ipRooQ+/fRTnTlz5pm2+V+LFy9W/fr1VaxYMRUpUkR169ZNsHe7du1ScHCwAgICEuxvYl8D6d5lDnXq1FGRIkVUtmxZde3aVZcuXUqS/QKAZ0WYBwAghTt+/Lj27t2revXqSZLq16+vn3/+WRcvXpQk1a1bV4cOHdKJEycs69y+fVs///yz6tatK0nasWOHWrRoIXd3d40ePVpffvmltm/frmbNmunOnTuW9eLi4jRx4kQNGDBAHTt2VP78+TVixAiNHz9e77//vqZOnar+/fvr2rVr+vzzzxUVFSVJ+uOPP9S2bVtly5ZNYWFhatKkifr06WMVTu/evavmzZtrw4YN6tSpk8aNG6esWbPqo48+emygL1CggLJly6bBgwerX79++uWXXxQZGSlJ8vb21ieffKI8efJIkqKiotSoUSP9/vvv6tKli8aNGydPT0999NFHOn78uAzDUJs2bTR16lQ1bNhQEydO1Ntvv63Ro0erT58+Vttdu3atXF1dNX78eDVr1kyGYahdu3b69ttv1bJlS/3vf/9T8eLF1alTJ61YsSLB2gsVKmQ5Db5hw4ZauHChMmfOrJUrV6pVq1bKkiWLvvnmG/Xs2VO7d+/W+++/r6tXrz729UisxOzzhg0btHTpUvXq1Uv9+/fX4cOH1axZM8vr/KzmzZun0NBQVa1aVZMmTdLw4cPl6uqqL774QufPn7ca+9VXX+ntt9/W+PHjlT9/fnXq1Elbtmyx7EtiX4OdO3eqa9eueuuttzRlyhT17NlTf/zxh7p06fJc+wQAz80AAAAp2pAhQ4zAwEDjzp07hmEYxsWLF42CBQsaYWFhhmEYxu3bt41ixYpZHhuGYSxfvtzw8/Mzzp8/bxiGYbz//vtG7dq1jdjYWMuYEydOGAULFjTmzp1rGIZhLF261PD19TUWLVpktf3OnTsbM2bMsFr2ww8/GL6+vsauXbsMwzCMxo0bG++8844RHx9vGfP9998bvr6+xtixYw3DMIyFCxcavr6+xp49eyxj4uPjjSZNmhj169d/bA+OHDli1K1b1/D19TV8fX2NAgUKGA0aNDCmTJlimM1my7i5c+cafn5+xqFDhyzL7ty5Y7z99tvGggULjE2bNhm+vr7GypUrreYfP3684evraxw9etQwDMNo2rSpUbhwYeP27duWMVu2bDF8fX2N1atXW63btWtXo3z58kZMTMwj63+wD3FxcUb58uWNFi1aWI05deqUUahQIWPYsGGGYTz69XicM2fOGL6+vsbSpUstyxKzz/7+/sapU6csYw4cOGD4+vpavkcS0rRpU6Np06aPrWvw4MGW/brvzz//NHx9fY1Vq1YZhvHv/k6aNMlqXHBwsPH+++8bhvH0r0GVKlWM7t27G4ZhGJMmTTKKFStm+f9zvydhYWFW368A8KJxZB4AgBQsNjZW3333napVq6a7d+/q5s2bcnd3V5kyZbR48WLFxcUpderUevPNN61ONV69erVKly6tbNmyyWw2a+/evapcubIMw1BsbKxiY2OVM2dO+fj46LfffrPapq+vr9XjkSNHqkWLFvrnn3+0e/duLVu2TN99950kKSYmRtHR0dq9e7eqV69udVO+6tWry8Xl39v7bN26VZkyZVKhQoUsNcTFxalKlSr6888/dePGjUf2wdfXVytWrNCSJUvUsWNHlSlTRkePHtXw4cMVHBxsuVwgPDxcOXLkUIECBSzrpkqVSmvXrlWjRo20fft2OTs7q2bNmlbz16lTR9K90+Lvy5Ejh1KnTm1Vv8lkUuXKlS31x8bGKigoSJcvX37qU+BPnjypy5cv65133rFanitXLhUvXtyqhvv7/jwSs8/Fixe3ulmev7+/cubMqfDw8OeqoUePHvriiy9069Yt7d+/X6tWrdK8efMk3fseelCNGjWsHlerVk179uzR7du3n+k1KFWqlO7cuaN33nlHo0aN0s6dO1WhQgW1b9/+pbqJJIDkhxvgAQCQgm3atElXrlzRsmXLEvx4sZ9//lnVqlVTcHCwVq5cqcOHDytz5sz6/fff1b9/f0nSzZs3FR8frylTpmjKlCkPzZEqVSqrxxkyZLB6vH//fvXr10/79++Xu7u78ufPr+zZs0u6d9rz9evXFRcX99B6Li4ueuWVVyyPr1+/rsuXL6tQoUIJ7uvly5eVLl26x/YjICBAAQEB+vTTT2U2mzVjxgyNGTNGU6ZMUffu3XX9+vWH6njQjRs39Morr1i9ySBJmTJlkiTdunXLsixjxoxWY65fvy7DMFSiRIkE57506ZIKFiz42Prvz5PQ/PeXHTx40GrZ4/bnaSRmnzNnzvzQ+hkyZNDNmzefq4bTp08rNDRUf/zxh1xcXJQvXz7LvQSM/9wL4X5dD27fMAxFRkY+02tQvHhxTZ48WTNnztS0adM0ceJEZcqUSa1bt1bz5s2fa78A4HkQ5gEASMGWLFmi7Nmza/DgwQ8999lnn+nbb79VtWrVVLZsWWXJkkVr165VlixZ5OLiourVq0uSPD09ZTKZ1KJFC6sb4t3n4eHxyO1HRkbqo48+kp+fn77//nv5+PjIyclJmzdv1g8//CDpXthydXW1utZbkuLj43Xt2jXL4zRp0ihPnjwaMWJEgtvKkSNHgsuHDh2qn3/+WevWrXuo7rZt2+qHH37QsWPHLNtI6HPKd+/eLS8vL6VLl07Xrl1TbGysVbi9fzO0B998+K80adIoderUmj17doLP586d+5HrPih9+vSS7t3Y778uX7782BqeRWL2+f4bDQ+6cuXKc320XXx8vD7++GO5urpq0aJF8vf3l4uLi44dO2Y5w+NBN27ckLu7u9X2nZ2dlS5dumd+DSpWrKiKFSvKbDbrjz/+0OzZszVo0CAVK1ZMRYsWfeZ9A4DnwWn2AACkUFeuXNGvv/6qWrVqWe5k/+BXzZo19dtvv+nMmTNycnJS7dq1tWHDBq1bt05Vq1aVl5eXJMnLy0v+/v46ceKE5ch2QECAXnvtNY0bN+6h07ofdOLECV2/fl3NmjXTa6+9Jiene396/PLLL5LuBTVnZ2eVKFFCP/30k9W6GzduVGxsrOVx6dKl9ffffytDhgxWdWzdulVTp06Vs7NzgjXkzZtXJ0+eTPCO5bdv39alS5csp6IHBgbqzJkzOnLkiGVMdHS0OnTooEWLFql06dKKi4t7aK77obJkyZKP7EXp0qUVFRUlwzCs6j969KjGjx9vta+PkzdvXmXKlEmrVq2yWn7mzBnt2bPnkUedn1Vi9nn37t1Wn3Bw4MABnT17VuXKlXvm7V+7dk0nT55Uw4YNVaRIEcsbCg9+Dz3o119/tfw7Pj5e69atU9GiReXu7v5Mr8HQoUPVsGFDGYYhDw8PValSRd27d5ckqxs0AsCLxpF5AABSqOXLlys2NjbBo+mSVK9ePc2fP1+LFi1Sly5dFBwcrGnTpsnZ2Vn/+9//rMZ27txZH3/8sbp06aI6deooLi5O06dP1969e/Xpp58+soa8efPKy8tLEydOlIuLi1xcXPTDDz9oyZIlkiSz2Szp3lkCISEh+uyzz9SwYUOdP39eY8aMkSTLdcn169fX3Llz1bJlS7Vp00bZsmXT77//rilTpqhp06ZydXVNsIbg4GCtWrVK3bp107Zt21S5cmWlTZtWf/31l2bPni13d3e1atXKso05c+bo008/1eeffy5vb2/NmzdPd+7cUUhIiHLmzKkyZcqoT58+unTpkvz9/bV9+3ZNmTJF9erVe+zd4itXrqxSpUqpbdu2atu2rXx8fLRv3z6FhYWpQoUK8vb2fuS6D3JyclLnzp3Vs2dPderUScHBwbp27ZrGjRundOnSqWXLlk81z9OqVKnSU++z2WxW69at9emnn+r27dsaNWqUfH19Vbt27cdu48KFC5o5c+ZDy/Pnz68KFSooe/bsmjdvnrJmzaq0adNqy5YtmjVrlmWbDxo9erTi4uKULVs2LViwQCdPntSMGTMkPdtrUK5cOc2YMUM9evRQnTp1FBMTo6lTpyp9+vQqW7ZsYtsJAEmGMA8AQAq1fPlyvfbaa1Y3c3tQkSJFlC9fPi1dulQdOnSQr6+vChYsqIsXL6p8+fJWYytUqKBp06Zp3Lhx+uyzz+Tq6qpChQppxowZKlas2CNrSJMmjSZMmKBhw4bp888/l6enpwoWLKi5c+eqdevWCg8PV1BQkAIDAxUWFqYxY8aobdu2yp49u7766it16tRJnp6ekqTUqVNr3rx5GjlypIYPH65bt24pe/bs6tKliyWMJ8TNzU3Tpk3T7NmztW7dOq1evVp37txR5syZFRQUpE8//dRyXbmXl5fmzp2rYcOGaeDAgYqNjVXRokU1Z84cy6nikyZN0tixYzV79mz9888/ypEjhzp16vTEEO3k5KTJkydrzJgxmjRpkq5evaosWbKoRYsWateu3WPX/a/69evL09NTkyZNUrt27eTl5aWKFSuqc+fOD10z/rxMJtNT73NgYKDKli2rXr16SZKCgoLUrVs3ubm5PXYbp0+fTvBSkHr16qlChQqaMGGCBg4cqB49esjNzU358+fX//73Pw0aNEjh4eEKCQmxrDNw4EANGzZMp06dkq+vr6ZMmaLSpUtLerbXoFKlShoxYoSmT59uueldyZIlNXv2bMslDwBgDybjv3cNAQAAeME2bNigrFmzWt3c7ujRo6pdu7YmTJigqlWr2rE6PI37gXrOnDl2rgQAXg4cmQcAAHa3ZcsWrVmzRl27dlXevHl14cIF/e9//1O+fPlUoUIFe5cHAECyQ5gHAAB21717d7m7u+t///ufLl26pPTp06tixYrq0qXLQx99BwAAOM0eAAAAAACHw0fTAQAAAADgYAjzAAAAAAA4GMI8AAAAAAAOhhvgAcnA7t27ZRiGXF1d7V0KAAAAADuKiYmRyWRS8eLFHzuOI/NAMmAYhuULSc8wDEVHR9NfG6G/tkV/bYv+2hb9tS36a3v02Lbob8KeNhdwZB5IBlxdXRUdHa38+fMrderU9i4nxYmKitKhQ4for43QX9uiv7ZFf22L/toW/bU9emxb9Ddh+/fvf6pxHJkHAAAAAMDBEOYBAAAAAHAwhHkgGTGZTPYuIUUymUzy8PCgvzZCf22L/toW/bUt+gsAtsM180Ay4ebmJg8PD3uXkSJ5eHjI39/f3mWkWPTXtuivbdFf26K/SSM+Ll5OzhyDA2CNMA8kI8N6TNeZExfsXQYAAEgmcubLqm5DWtm7DADJEGEeSEbOnLig44fO2LsMAAAAAMkc5+sAAAAAAOBgCPMAAAAAADgYwjwAAAAAAA6GMA8AAAAAgIMhzAMAAAAA4GAI8wAAAAAAOBjCPAAAAAAADoYwDwAAAACAgyHMAwAAAADgYAjzAAAAAAA4GMI8AAAAAAAOhjAPAAAAAICDIcwDAAAAAOBgXOxdAPAkUVFR+uabb7Ru3Trdvn1b/v7+6t69u4oUKaKlS5dqzpw5OnHihJycnBQQEKAePXqoUKFCkqSgoCA1atRI+/fv15YtW+Tm5qa6deuqW7ducnG59+3/559/auTIkdqzZ488PDxUrVo19ejRQ6lTp5ZhGJo6daq+/fZbXblyRXny5NGHH36oOnXqSJK2bdumZs2aqWvXrpo6dapeffVVLVmyRM7OznbrFwAASFqG4iWTYZdtx8XHKDIyMsHnoqKiZDabFRkZqfj4eJts38XFRe7u7jaZG8DzIcwj2evUqZOOHTumQYMGKXfu3JoyZYo+/PBD9e/fX3369NGAAQNUqlQpXblyRQMGDFCvXr20YsUKy/phYWH64osv1KVLF23ZskUDBgyQv7+/goODdfbsWYWEhCgoKEgLFy5UZGSkevbsqdDQUI0YMUKjRo3SqlWrFBoaKh8fH+3YsUN9+/bVrVu31KRJE8s2Nm3apIULF8psNhPkAQBIQWK9LinO47pkss/2j1w7rrp1f7HPxiU5OTkpODhY7dq1s1sNABJGmEeydvLkSW3atElTp05VxYoVJUmhoaHy9PRUhgwZNGDAAAUHB0uSsmfPrnfffVd9+vSxmqNixYpq1qyZJClPnjxasmSJdu3apeDgYC1atEjp0qXTkCFD5OrqKkkaMGCAtm/frqioKM2cOVPDhg1TlSpVJEm5cuXSuXPnNG3aNKsw36pVK+XJk8fG3QAAAC+aPYN8chAfH68VK1YQ5oFkiDCPZO3IkSOSpGLFilmWubm5qWfPnpKk48ePa8KECTp16pROnjypQ4cOPXSamY+Pj9XjNGnSKCYmxjJ/oUKFLEFekkqVKqVSpUpp3759unv3rrp3727ZniTFxsYqOjpad+7csSwjyAMAkDI5m9O/1IH+/pF5AMkPYR7J2v3r2k2mh3+Drl69Wt26dVPt2rVVpEgRNWzYUBEREerfv7/VODc3t4fWNQzDMn9Ccz84ZvTo0cqXL99Dzz84b6pUqZ5yjwAAgCNxicws58iMdrtmPq9vdg2b2SXB56KiohQRESFfX1+lTp3aJtvnmnkg+SLMI1m7f1R9//79KleunKR7R8arVaumVKlSqWHDhurXr59l/IYNGyTdC+KPCukPyp8/v1atWqW4uDjLte7r16/X119/rdWrV8vFxUXnz5+3nGYvSbNnz9axY8ceetMAAACkTCY5SfbJ8nJ2cpWXl1eCzzk5OcnDw0NeXl42C/MAki8+mg7JWt68efXWW2+pX79+2rp1q06ePKnQ0FBFR0crd+7c2rVrlw4cOKDTp09r5syZmjt3riQpOjr6qeZv3Lixrl27pj59+uj48eMKDw/XiBEjVL58eaVJk0aNGjXS6NGjtWLFCp05c0bLly/X8OHDlTFjRlvuNgAAAAA8FkfmkewNHjxYw4YNU6dOnXT37l0VLVpU06dPl6enp0JDQ9W0aVO5ubmpQIEClnF79+5V6dKlnzh3lixZNH36dI0YMUL16tVT2rRpVbNmTXXu3FmS1LNnT3l7e2vs2LG6dOmSsmbNqvbt2+vjjz+29W4DAAAAwCOZjPsXBgOwm/3790uSJn+9SscPnbFzNQAAILnwKZhTYYu+TPC5qKgoHTp0SAULFuQ0exuhx7ZFfxN2PxsEBAQ8dhyn2QMAAAAA4GAI8wAAAAAAOBjCPAAAAAAADoYwDwAAAACAgyHMAwAAAADgYAjzAAAAAAA4GMI8AAAAAAAOhjAPAAAAAICDIcwDAAAAAOBgCPMAAAAAADgYwjwAAAAAAA7Gxd4FAPhXznxZ7V0CAABIRvjbAMCjEOaBZKTbkFb2LgEAACQz8XHxcnLmhFoA1vipACQT0dHRMpvN9i4jRTKbzTp48CD9tRH6a1v017bor23R36RBkAeQEH4yAMmIYRj2LiFFMgxDZrOZ/toI/bUt+mtb9Ne26C8A2A5hHgAAAAAAB0OYBwAAAADAwRDmAQAAAABwMIR5AAAAAAAcDGEeAAAAAAAHQ5gHkhGTyWTvElIkk8kkDw8P+msj9BcAAODFc7F3AQDucXNzk4eHh73LSJE8PDzk7+9v7zJSLEftb3xcPJ/dDAAAHBZhHkhGhg9drDNnLtu7DCDFy5kzk77o/q69ywAAAHhmhHkgGTlz5rKOH/vb3mUAAAAASOY4vxAAAAAAAAdDmAcAAAAAwMEQ5gEAAAAAcDCEeQAAAAAAHAxhHgAAAAAAB0OYBwAAAADAwRDmAQAAAABwMIR5AAAAAAAcDGEeAAAAAAAHQ5gHAAAAAMDBEObx0ggKClJYWNhjx4SHh6t9+/YqX768ihYtqlq1amnKlCmKjo62Gjdnzhy99dZbCggIUK1atbRkyRJblg4AAAAAVgjzwP+bO3euWrRooZw5c2ry5Mn6/vvv9fHHH2vGjBn69NNPFRcXJ0lasGCBRo4cqY4dO2rNmjVq3ry5QkNDtX79ejvvAQAAAICXhYu9CwCSgyNHjmjw4MHq0aOHQkJCLMtz5syp7Nmzq0mTJlq9erXq1KmjW7duqXPnzqpZs6ZlzPz58/X777/rzTfftNcuAAAAAHiJEOYBSYsXL1batGn1wQcfPPRcYGCgZs2aJX9/f0nSxx9/bHkuJiZG69at07Fjx9S+ffsXVi8AAACAlxthHpC0f/9+BQQEyMUl4f8SZcuWfWhZeHi4QkJCFB8frwYNGqhq1aq2LhOAJMOIk2Q81xxxcdGKjIxMmoL+n4uLi9zd3ZN0TgAAgEchzAOSrl+/rpw5cyZqnbx582r58uX6888/NWjQIL3yyiv64osvbFQhAEmKiTupuPi/n3uewxFS3bqrkqCifzk5OSk4OFjt2rVL0nkBAAASwg3wAEne3t66fv16otbJkCGDChQooIYNG6pNmzaaPXv2Q3e9B5C0kiLI20p8fLxWrFhh7zIAAMBLgjAPSCpevLj2799vuWP9f3Xv3l1z586VJG3evFnHjx+3et7X11fR0dGJfkMAQOI4O2WzdwmPdP/IPAAAwIvAafaApAYNGmjWrFmaP3++1d3spXvXxq9YsUJlypSRJH3zzTfy8/PTsGHDLGP27t2r9OnTK2PGjC+0buBl4+qcVy5OufS818znzZdFQ4d/lDRF/T+umQcAAC8SYR4vlVOnTumXX36xWpYqVSqVKVNGn3/+uQYPHqy///5bderUUapUqfTHH39o9OjRqlKliurUqSPp3t3su3btqqJFi6pChQr6448/NG3aNHXr1k1OTpzsAtiayeT83HM4O7vJy8srCaoBAACwD8I8XiqrVq3SqlXWN73KkiWLfvnlF3388cfKly+f5syZo2XLlunOnTvKmTOn2rRpoyZNmljudF+rVi3FxsZqypQpGjJkiF599VV99dVXevfdd+2xSwAAAABeQoR5vDQ2btz4xDHVqlVTtWrVnjiubt26qlu3blKUBQAAAACJxjnBAAAAAAA4GMI8AAAAAAAOhjAPAAAAAICDIcwDAAAAAOBgCPMAAAAAADgYwjwAAAAAAA6GMA8AAAAAgIMhzAMAAAAA4GAI8wAAAAAAOBjCPAAAAAAADoYwDwAAAACAg3GxdwEA/pUzZyZ7lwC8FPi/BgAAHB1hHkhGvuj+rr1LAF4a8XHxcnLmBDUAAOCY+CsGSCaio6NlNpvtXUaKZDabdfDgQfprI47aX4I8AABwZPwlAyQjhmHYu4QUyTAMmc1m+msj9BcAAODFI8wDAAAAAOBgCPMAAAAAADgYwjwAAAAAAA6GMA8AAAAAgIMhzAMAAAAA4GAI80AyYjKZ7F1CimQymeTh4UF/bYT+2hb9tS36CwBwVC72LgDAPW5ubvLw8LB3GSmSh4eH/P397V1GikV/bYv+2tbL3t+4+Hg5O3FsBwAcEWEeSEYGjV+u0+ev2LsMAMBLINerGfVlu3r2LgMA8IwI80Aycvr8FR3764K9ywAAAACQzHFeFQAAAAAADoYwDwAAAACAgyHMAwAAAADgYAjzAAAAAAA4GMI8AAAAAAAOhjAPAAAAAICDIcwDAAAAAOBgCPMAAAAAADgYwjwAAAAAAA6GMA8AAAAAgINxsXcBwH+FhIQoe/bsGjJkyEPP9ejRQ+fOndOcOXMkSatWrdLcuXMVEREhScqXL5/effddNWrU6KF1ly9frsWLF+vo0aMyDEP58+dX8+bNVaNGDUnS2bNnVbVq1QRrMplMOnz4sGXc119/rR07dsjd3V316tVT586d5ezsnCT7DwAAAABPQpiHw1qyZIkGDBigL7/8UqVKlZJhGNq6dasGDhyoK1euqH379pIkwzDUqVMnbd26VR06dFDZsmVlMpn0448/qkuXLjp58qTatm2rbNmyacuWLVbbuHz5spo2baqQkBBJUkxMjD788EPlzZtX3377rU6fPq1evXopVapU+uyzz154DwAAAAC8nAjzcFjz589Xw4YN9d5771mW5cuXTxcuXNDs2bMtYf7bb7/Vjz/+qCVLlsjf398y9tNPP5VhGBo/frzq1q2r7NmzK1OmTFbb6NGjh3x9ffX5559Lkn744QedP39eixcvVtq0aeXr66urV69q2LBhatOmjdzc3F7AngMAAAB42RHm4bCcnJy0a9cu3bhxQ+nSpbMsb926terXr295PH/+fAUFBVkF+fuaNWumUqVKPRTiJemnn37S1q1btWzZMjk53bu9RHh4uAoVKqS0adNaxpUtW1aRkZE6fPiwihQpkpS7CAAAAAAJIszDYbVu3VodO3ZUpUqVVKZMGQUGBqps2bIKCAiwhO3o6GhFRESobt26Cc7h5eWlUqVKJfjcmDFj9M4776hAgQKWZRcuXFDWrFmtxmXOnFmSdP78ecI8AMDCMOIkI97eZTxSXGy0IiMjbbqNqKgomc1mRUZGKj7++Xvh4uIid3f3JKgMABwfYR7J0qpVq/TDDz88tDw6OlolSpSQJFWvXl0LFy7UnDlztGXLFm3evFmSlCdPHg0aNEglS5bU9evXJcnqyP3T+O2333T06FGNHj3aavmdO3esjspLUqpUqSRJd+/eTdQ2AAApl3HzqBR1zt5lPNaJS1LdusvsXUaiODk5KTg4WO3atbN3KQBgd4R5JEtBQUHq2rXrQ8tHjBhhCeiSVKRIEQ0fPlyGYSgiIkKbN2/W7Nmz1bp1a61fv17p06eXyWTStWvXErX9FStWKDAwUD4+PlbL3d3dFR0dbbXsfohPnTp1orYBAEjBknmQd1Tx8fFasWIFYR4AxOfMI5ny9PRU7ty5H/ry9PSUdO9096+//loXL16UdO+j4/z8/PTxxx9r1qxZun37tnbs2CE3NzcVLlxYe/bsSXA7kZGRat68uf744w/LstjYWG3atEk1a9Z8aHzWrFl16dIlq2X3H2fJkiUpdh0AkBKkzm7vClKk+0fmAQAcmYeDcnNz08KFC5U1a1a1bt3a6jkvLy9JUsaMGSVJ7733nvr27auDBw8+dBO8OXPmaPv27RowYIBl2bFjx3Tz5k2VLVv2oe2WKlVKK1asUGRkpGU7W7dulaenp9W19QCAl5sp7Wsy0uRL1tfM58uVRaO+am7TbURFRSkiIkK+vr5JcgYb18wDwL8I83BI3t7e+uijjzR69GhFRkbq7bfflpeXl44dO6YJEyZYbognSQ0bNtSGDRvUsmVLffbZZypfvrzu3Lmj77//XtOmTVPnzp2VM2dOy9yHDx+Wm5ub8ubN+9B2q1WrptGjR6tjx47q2rWrzp49q1GjRqlVq1Z8LB0AwIrJ5CyZnO1dxiM5u7hZ3pi2FScnJ3l4eMjLy4vL0QAgiRHm4bA6duyoPHnyaNGiRZo3b57u3LmjbNmyqWbNmvrkk08s45ycnDR+/HjNnTtXixcv1siRI+Xi4qL8+fMrLCxM1apVs5r38uXLSpcunUwm00PbTJUqlaZOnap+/frpvffeU7p06dS4cWO1bdvW5vsLAAAAAPeZDMMw7F0E8LLbv3+/JGn8t3/o2F8X7FwNAOBlkD9PVk0c2PrJA59DVFSUDh06pIIFC3Jk3gbor+3RY9uivwm7nw0CAgIeO44b4AEAAAAA4GAI8wAAAAAAOBjCPAAAAAAADoYwDwAAAACAgyHMAwAAAADgYAjzAAAAAAA4GMI8AAAAAAAOhjAPAAAAAICDIcwDAAAAAOBgCPMAAAAAADgYwjwAAAAAAA7Gxd4FAPhXrlcz2rsEAMBLgt85AODYCPNAMvJlu3r2LgEA8BKJi4+XsxMnagKAI+KnN5BMREdHy2w227uMFMlsNuvgwYP010bor23RX9t62ftLkAcAx8VPcCAZMQzD3iWkSIZhyGw2018bob+2RX9ti/4CABwVYR4AAAAAAAdDmAcAAAAAwMEQ5gEAAAAAcDCEeQAAAAAAHAxhHgAAAAAAB0OYB5IRk8lk7xJSJJPJJA8PD/prI/TXtuivbdFf26K/tkV/gZebi70LAHCPm5ubPDw87F1GiuTh4SF/f397l5Fi0V/bor+2RX9ti/7alq36GxcfL2cnjvkByR1hHkhG+s5crr8uXLF3GQAA4CWVJ2tG9W1Rz95lAHgKhHkgGfnrwhVFnL1g7zIAAAAAJHOcPwMAAAAAgIMhzAMAAAAA4GAI8wAAAAAAOBjCPAAAAAAADoYwDwAAAACAgyHMAwAAAADgYAjzAAAAAAA4GMI8AAAAAAAOhjAPAAAAAICDIcwDAAAAAOBgCPMAAAAAADgYwjxSpPPnz2v16tVJNl+PHj0UEhKSZPMBAAAAwPNwsXcBgC10795d2bNnV61atZJkvl69eikuLi5J5gIAAACA50WYB55CmjRp7F0CAAAAAFgQ5pHkjh49qlGjRmnnzp26ffu2smXLpqZNm6p58+YKCwvT77//rjfeeEMzZsxQXFycqlWrpl69esnLy0uSdP36dY0ZM0YbN27UtWvXVKhQIXXp0kWBgYGS9MQ5QkJCtH37dknS9u3btXHjRt25c0cTJ07UqlWrdOnSJfn4+Kh9+/aqVq2aJCkuLk7ffPONvv/+e129elU5cuRQ8+bN9cEHH0i6d5r9uXPnNGfOHEnStGnTtGDBAl24cEGZM2dWgwYN1LZtW5lMphfdbgAA4Cji4yQj3t5VPFZ8TLQiIyPtXUaiubi4yN3d3d5lAC8UYR5Jymw2q2XLlipbtqzmz58vFxcXLV26VIMGDVLp0qUlSfv375d0LxBHRkaqV69e6tixo6ZOnaq4uDi1atVKMTExGjp0qDJlyqS5c+eqRYsWWrBggQICAp44R1hYmNq0aaOsWbMqNDRUktS5c2cdPHhQoaGhyps3r1avXq327dtr/Pjxqlq1qubPn69169Zp1KhRypIli37++Wf17dtXr732muVNhPs2btyoiRMnavTo0cqbN6/27Nmjbt26KUeOHKpbt+6LajUAAHAgrheOyvnaOSX3t/3PRUh1Ny2zdxmJ5uTkpODgYLVr187epQAvDGEeScpsNqtZs2Zq3Lix5Uh7+/btNWnSJB05ckSSZDKZNHr0aGXJkkWSFBoaqtatW+vEiRM6c+aMDhw4oFWrVsnX19fy/N69ezVt2jSNHj36iXPky5dPrq6ucnd3l7e3t44fP64NGzZo4sSJqlKliqWmI0eOaOLEiapatapOnz6t1KlTK2fOnMqUKZOaNm2qfPnyKW/evA/t4+nTp5UqVSrlyJFDr776ql599VVlzpxZr776qk17CwAAHJcjBHlHFh8frxUrVhDm8VLhbvZIUt7e3mrcuLHWrFmj/v3768MPP9Qbb7wh6d4PWUnKkyePJYRLUvHixSVJERERioiIUJo0aSxBXroX3AMDAy1vBjxpjv+6v17JkiWtlj84Z5MmTRQZGalKlSrp3Xff1ejRo5UhQwZlyJDhofnq1KmjV155RW+99Zbq1KmjoUOHysnJiTAPAAAeKe6V7DLsXUQKdv/IPPAy4cg8ktSVK1f03nvv6ZVXXlHVqlVVrlw5BQQEqHLlypYxrq6uVuvcD/nOzs4yDCPB687j4+Pl4vLvt+vj5nhaD86ZJ08e/fjjj9q+fbt+++03y5H8wYMHq169elbreXt7a+XKldq9e7d+++03bdmyRdOnT1eHDh3Uvn37p94+AAB4ecRkfU0xmfMl+2vm87+aRRM6Nbd3GYnGNfN4GRHmkaRWrVql69ev64cffrAE7vtHvw3j3vvRJ0+e1K1btyx3iN+9e7ckqWDBgnJzc9PNmzcVERFhdXR+586dyp8/v+Xx4+b4r/vz7Ny503KavSSFh4db5pw9e7YyZMigWrVqqXz58urWrZtatmypNWvWPBTmV65cqcjISDVp0kQlS5bUZ599pt69e2vNmjWEeQAA8GhOzpKe/sCDPTi5ulkulQSQvBHmkaSyZs0qs9mstWvXKjAwUCdOnNDgwYMlSdHR0ZKkqKgodevWTZ06ddLVq1fVv39/1axZUzly5FDWrFnl5+enLl26qHfv3sqYMaPmzp2riIgI9enTx7Kdx80hSZ6enjp37pwuXLig/Pnzq3LlyurXr5+ke0fhV69erQ0bNliuwb969arGjx8vd3d3FShQQMePH9fBgwfVvPnD70zfvXtXQ4cOlaenpwIDA3XhwgVt375dpUqVsmVrAQAAAMCCMI8k9fbbb+vAgQMaOnSoIiMjlT17dr377rvasGGD9u3bp1dffVXZsmWTr6+vGjduLBcXF73zzjvq2rWrpHunSM2YMUNDhw5Vhw4dFB0drUKFCmnmzJkqVqyYZTuPm0OSGjVqpO7du6tOnTraunWrRo0apW+++Ua9e/fWzZs39dprryksLExvvvmmpHs3xIuNjdXXX3+tK1euKFOmTGrcuLE++eSTh/bxvffe040bNzRhwgT9/fffSpcunapXr261fQAAAACwJZNx/9xn4AUICwvT8uXLtXHjRrvOkdzc/6i9kav/UMTZC3auBgAAvKx8c2TVzB6t7V1GshEVFaVDhw6pYMGCSp06tb3LSXHob8LuZ4P7H8v9KNzNHgAAAAAAB0OYBwAAAADAwRDm8UJ16NDhuU+PT4o5AAAAAMCREeYBAAAAAHAwhHkAAAAAABwMYR4AAAAAAAdDmAcAAAAAwMEQ5gEAAAAAcDCEeQAAAAAAHAxhHgAAAAAAB+Ni7wIA/CtP1oz2LgEAALzE+FsEcByEeSAZ6duinr1LAAAAL7m4+Hg5O3ECL5Dc8b8USCaio6NlNpvtXUaKZDabdfDgQfprI/TXtuivbdFf26K/tmWr/hLkAcfA/1QgGTEMw94lpEiGYchsNtNfG6G/tkV/bYv+2hb9tS36C7zcCPMAAAAAADgYwjwAAAAAAA6GMA8AAAAAgIMhzAMAAAAA4GAI8wAAAAAAOBjCPAAAAAAADoYwDyQjJpPJ3iWkSCaTSR4eHvTXRuivbdFfAACQEBd7FwDgHjc3N3l4eNi7jBTJw8ND/v7+9i4jxaK/tpVc+hsXHy9nJ44BAACQXBDmgWSk96JlOnn5ir3LAAAreTNl1ID36tu7DAAA8ADCPJCMnLx8RYfPX7B3GQAAAACSOc6XAwAAAADAwRDmAQAAAABwMIR5AAAAAAAcDGEeAAAAAAAHQ5gHAAAAAMDBEOYBAAAAAHAwhHkAAAAAABwMYR4AAAAAAAdDmAcAAAAAwMEQ5gEAAAAAcDCEebxQ165d0+LFi+1dBgAAAAA4NMI8Xqhhw4bpu+++s3cZAAAAAODQCPN4oQzDsHcJAAAAAODwXOxdAJInPz8/9e3bV999950OHDig3Llzq2PHjqpataokKSwsTL/99pteffVVbdq0SXXr1lWfPn20e/dujRo1SgcOHJCLi4uqVq2q7t27K126dOrRo4eWL19umf/IkSMyDENTp07Vt99+qytXrihPnjz68MMPVadOHUstGzdu1OTJk3XkyBHFxsbKz89PnTt31uuvvy5J+uuvv/T1119rz549io+PV4kSJdStWzf5+flJkq5fv64xY8Zo48aNunbtmgoVKqQuXbooMDDQsi87d+5UUFCQJk+erMjISAUFBalnz54aPny41q9fr7Rp06pjx46qV6+eJD1V3QBSkLg4mV7iNyPjo6MVGRlp7zJsIioqSmazWZGRkYqPj3+uuVxcXOTu7p5ElQEA8HiEeTzSsGHD1LVrVw0cOFDLli1T+/btNW/ePJUoUUKStHv3bgUEBGjlypWKi4vTvn37FBISovfee0+hoaG6evWqvv76a7Vq1UqLFy9Wr169dOfOHV24cEFhYWGSpFGjRmnVqlUKDQ2Vj4+PduzYob59++rWrVtq0qSJ/vzzT7Vr105ffPGFhg8frtu3b2vUqFHq2rWrNm3aJDc3N3Xu3Fl+fn5aunSpYmNjNXToULVv317r169XXFycWrVqpZiYGA0dOlSZMmXS3Llz1aJFCy1YsEABAQGSpPDwcKVNm1azZs3SmTNn1K5dO/32229q06aN2rRpoxkzZig0NFRvvPGGXnnllSfWDSDl8PjrmNwunJPJ3oXY0SVJdb9fbu8ykj0nJycFBwerXbt29i4FAPASIMzjkRo0aGAJpl27dtWOHTs0d+5cS5iXpM8++0xp0qSRJHXs2FF+fn4KDQ2VJOXPn18jR45UnTp19Ouvv6py5cpyd3eXq6urMmXKpKioKM2cOVPDhg1TlSpVJEm5cuXSuXPnNG3aNDVp0kTOzs7q3bu3VUBu1qyZWrVqpatXrypbtmw6ffq0ypcvrxw5csjFxUWDBg3SiRMnFB8fry1btujAgQNatWqVfH19JUmhoaHau3evpk2bptGjR0uS4uPjNWDAAKVNm1Y+Pj4qWLCgXF1d1bJlS0lSixYttGjRIp06dUqpUqV6Yt0AUo6XPcjj6cXHx2vFihWEeQDAC0GYxyOVLl3a6nHRokX1+++/Wx5nyJDBEuQlKSIiQuXLl7dax8/PT2nTptWRI0dUuXJlq+eOHTumu3fvqnv37urZs6dleWxsrKKjo3Xnzh0VLFhQ6dKl05QpU3Ty5En99ddfOnTokCQpLi5OktSpUycNGjRICxYsUNmyZVWxYkXVqFFDTk5OioiIUJo0aSxBXpJMJpMCAwP166+/Wu1L2rRpLY89PDyULVs2y+NUqVJJku7evftUdXOaJZByRGfNTqDHU7l/ZB4AgBeBMI9HcnGx/vaIj4+Xk9O/90z8b2A1DEMm08N/7sbHx8vV1fWh5fdvhjd69Gjly5fvoefd3Ny0Y8cOtWrVSpUrV1ZgYKBq1aols9lsddSjSZMmevvtt7V582Zt3bpV33zzjcLCwrRixYrH1vTg/iVU34P7mti6AaQc5jz5Zc6Z96W+Zv61rJk1pXULe5dhE1FRUYqIiJCvr69Sp079XHNxzTwA4EUizOOR9u/fr6CgIMvjPXv2qFChQo8c7+vrq/DwcKtlhw8fVmRkpHx8fCTJKljny5dPLi4uOn/+vOV0dUmaPXu2jh07pv79+2vatGkqU6aMxo0bZ3l+zpw5ku6F6itXrmjChAn6+OOPVb9+fdWvX18XL15UpUqVtH37dvn5+enmzZuWP9Tu27lzp/Lnz/9MfXmaugGkMM7OenmjvOTk5iYvLy97l2ETTk5O8vDwkJeX13OHeQAAXiQ+mg6PNGvWLK1atUonT57U0KFDdfjwYTVv3vyR41u0aKHDhw+rf//+On78uLZv366uXbvK399f5cqVkySlTp1aly5d0pkzZ5QmTRo1atRIo0eP1ooVK3TmzBktX75cw4cPV8aMGSVJ2bJl05EjRxQeHq6zZ89q6dKlGjNmjCQpOjpa6dOn16ZNm9S7d28dOnRIZ86c0fz58+Xq6qrChQurfPny8vPzU5cuXbRt2zYdP35c/fr1U0RExGP35XGepm4AAAAAsCWOzOOR3n//fc2YMUNHjx5VgQIFNG3aNBUoUOCR44sXL64pU6ZozJgxCg4OlpeXl6pVq6YuXbpYTmMPDg7W+vXrVbt2ba1fv149e/aUt7e3xo4dq0uXLilr1qxq3769Pv74Y0n3brB35coVtWnTRtK9m+oNGjRIX3zxhfbt2ycfHx9NmTJFQ4cOVYsWLWQ2m1WwYEFNnjxZuXLlkiTNmDFDQ4cOVYcOHRQdHa1ChQpp5syZKlas2DP35kl1AwAAAIAtmQzjJb4IEI/k5+enwYMHq379+vYu5aWwf/9+SdKQX7bq8PkLdq4GAKwVeDWr5rVLmW9WRkVF6dChQypYsCCn2dsA/bUt+mt79Ni26G/C7meD+x+j/ShPfWT+wbt2P4nJZNKgQYOeejwAAAAAAHh6Tx3mt23b9tSTJnT3cAAAAAAAkDSeOsxv3LjRlnUgmTly5Ii9SwAAAAAAPMJz3c0+Pj5ehw8f1i+//KLIyEhdv349icoCAAAAAACP8sx3s1+5cqVGjhypS5cuyWQyacmSJQoLC5Orq6tGjhwpNze3pKwTAAAAAAD8v2c6Mr9mzRp1795dZcuW1ahRo3T/hvhvvfWWfvnlF02YMCFJiwQAAAAAAP96piPzEydOVKNGjdS3b1/FxcVZltevX19Xr17VokWL1LFjx6SqEQAAAAAAPOCZjsyfPHlSb775ZoLPFS1aVBcvXnyuogAAAAAAwKM9U5jPkCGDjh8/nuBzx48fV4YMGZ6rKAAAAAAA8GjPFOZr1qypsWPHat26dYqOjpZ077Pl//zzT02YMEFvv/12khYJAAAAAAD+9UzXzHfs2FERERHq2LGjnJzuvR8QEhKiqKgoBQYG6vPPP0/SIgEAAAAAwL+eKcy7ublp6tSp+u2337R161bduHFDadKkUenSpVW5cmWZTKakrhN4KeTNlNHeJQDAQ/jZBABA8vPMnzMvSeXLl1eJEiV069YtpU+fns+WB57TgPfq27sEAEhQXHy8nJ2e6eo8AABgA8/8W/n333/XBx98oJIlS6py5coqUaKEmjZtqvDw8KSsD3hpREdHy2w227uMFMlsNuvgwYP010bor20ll/4S5AEASF6e6TfzmjVr1KpVK929e1ft27dX37591aZNG12/fl0tWrTQH3/8kdR1Ai8FwzDsXUKKZBiGzGYz/bUR+mtb9BcAACTkmU6z/9///qdatWpp5MiRVsvbtWuntm3bavjw4Vq6dGmSFAgAAAAAAKw905H5U6dOqV69eg8tN5lMaty4sY4ePfrchQEAAAAAgIQ9U5j38fHRwYMHE3zu77//Vq5cuZ6rKAAAAAAA8GhPfZr9+fPnLf9u1aqVQkND5eTkpBo1aihTpky6ceOGfv31V4WFhWngwIE2KRYAAAAAACQizAcFBVl9frxhGBoxYsRD180bhqFPPvlEhw4dSroqAQAAAACAxVOH+UGDBlmFeQBJj/9jtmEymeTh4UF/bYT+2hb9tS36CwBwVE8d5uvXr2/LOoCXnpubmzw8POxdRork4eEhf39/e5eRYtFf26K/tvW0/Y2Lj5ez0zPdaggAAJt4po+mk6QLFy5o165dio6OtiyLj4+X2WxWeHi4Ro0alSQFAi+TnquX6MTVK/YuAwDwgHwZMmpwrYb2LgMAACvPFObXrl2rL774QrGxsZbT0gzDsPw7X758SVch8BI5cfWKDl/6295lAAAAAEjmnul8sUmTJsnf31/Lli1T/fr1VadOHa1evVpffPGFXFxc9OWXXyZ1nQAAAAAA4P8905H5kydPasSIEfL391e5cuU0depU+fj4yMfHR1evXtXEiRNVvnz5pK4VAAAAAADoGY/MOzk5KX369JKkPHny6MSJE4qPj5ckVaxYUceOHUuyAgEAAAAAgLVnCvP58uXTzp07Jd0L8zExMZbPlb9586bVTfEAAAAAAEDSeqbT7Bs1aqQ+ffooKipKnTt3VpkyZfTll1+qYcOGmjt3rgoVKpTUdQIAAAAAgP/3TEfm3333XfXq1UsxMTGSpK+//lp3797VwIEDFRcXp169eiVpkQAAAAAA4F/P/DnzTZo0sfw7Z86cWrt2ra5du6ZDhw5p5syZGjx4cJIUCAAAAAAArD3TkfmEmEwmeXt769ixY1qxYkVSTQsAAAAAAP4jycI8AAAAAAB4MQjzAAAAAAA4GMI8rCxbtkx+fn6PHRMUFKSwsDCbbfP8+fNavXq1zbZnGIaWL1+uq1evJrh9AAAAAEjunvkGeHh5LVmyRKlSpUqy+WrWrKmKFStaHnfv3l3Zs2dXrVq1bLK9HTt2qEePHtqwYUOC2wcAAACA5O6pw3yzZs2eatyFCxeeuRg4Bm9v7ySdz93dXe7u7i9se4ZhJGr7AAAAAJDcPHWY/28AepQsWbIoS5Ysz1wQbMvPz0+DBw9W/fr1LcuCgoJUr149dejQwbJs8eLFCgsL082bN1WpUiX17dvXEqr/O37x4sWaMmWKLl68qNKlS6ts2bKaN2+eNm7c+FTbXLZsmXr27KkjR44oJCRE27dvlyRt375dGzdutBobFham7du3q1KlSpozZ46uXbum4sWLq2/fvsqXL58k6ejRoxo1apR27typ27dvK1u2bGratKmaN2+ubdu2Wd6Yqlq1quUjFO9vX5KuX7+uMWPGaOPGjbp27ZoKFSqkLl26KDAwUJKeqgYAsJm4OJnin+53MpJGfHS0IiMj7V2GQ4qKipLZbFZkZKTi4+Ntui0XFxfenAfwUnnqMD9nzhxb1oFkZvbs2Ro9erTc3Nz09ddfq1WrVlq+fLlMJpPVuFWrVqlPnz7q2bOnKlSooLVr12rMmDHKmDHjM203LCxMbdq0UdasWRUaGprgmN27d8vDw0OTJ0/W7du31b17d/Xr10+zZs2S2WxWy5YtVbZsWc2fP18uLi5aunSpBg0apNKlS6t48eIKCwtThw4dtHjxYvn6+mrNmjWWuePi4tSqVSvFxMRo6NChypQpk+bOnasWLVpowYIFCggIeGINAGArngdPyP3UeZmePBRJ6B9JdRestHcZeAInJycFBwerXbt29i4FAF4IboCHBA0fPlwlSpRQ4cKFNXToUB06dEhbt259aNysWbNUs2ZNhYSEKG/evGrbtq0qVKjwzNtNnz69XF1d5e7u/sjT62NjYzVs2DAVKFBAJUuWVEhIiHbu3ClJMpvNatasmfr27SsfHx/lzp1b7du3lyQdOXJEbm5uSpcunaR7p+//9x38LVu26MCBAxo5cqTKli0rHx8fhYaGytfXV9OmTXuqGgDAVtxPE+SBR4mPj9eKFSvsXQYAvDDcAA8P8fT0VIECBSyP8+TJo3Tp0ikiIkKvv/661dhjx46pTp06VstKly6tw4cP26y+jBkzKn369JbHadKkUUxMjKR7Ab1x48Zas2aNDh8+rFOnTunQoUOS9FSn90VERChNmjTy9fW1LDOZTAoMDNSvv/76VDUAgK3cyfUqR+aBR7h/ZB4AXhaE+ZfQf+9/8N8Q6uzs/NA68fHxcnNze6r5Ehr3pG0mxqPqkKQrV67ovffe0yuvvKKqVauqXLlyCggIUOXKlZ9qbsMwHrqUQLq3/y4u//53eVwNAGArt/3z6bZfbq6Zf8Fey5RFMxq1sncZDikqKkoRERHy9fVV6tSpbbotrpkH8LIhzL9kXF1ddevWLcvjyMhI/fPPP1Zjbt68qdOnTytXrlyS7p2efuvWLauj1ff5+/tr586dat68uWXZ/v37E73NpLJq1Spdv35dP/zwg1xdXS31S/++oZBQWL/Pz89PN2/etPzhcd/OnTuVP39+m9QMAIni7Czj4fdcYUNObm7y8vKydxkOycnJSR4eHvLy8rJ5mAeAlw3XzL9kihcvroULF+rAgQOKiIhQt27drI44S/d+8Xbs2FF79uzRnj171K1bN5UuXdpyN/cHffLJJ1q/fr2mTJmiv/76S/PmzdN3332X6G0+yNPTU+fOnXumjznMmjWrzGaz1q5dq/Pnz2vLli3q3LmzJCk6OlqSLH9MHD58WLdv37Zav3z58vLz81OXLl20bds2HT9+XP369VNERITVGxYAAAAAYE+E+ZdM3759lSlTJjVq1EitW7e23OH9Qd7e3qpbt67atm2rli1bysfHR2PGjElwvsqVK2v06NFatmyZateurZ9++kkNGjRI9DYf1KhRI0VERKhOnTqKi4tL1P69/fbb+vDDDzV06FDVqFFDgwYNUsOGDVWqVCnt27dPkuTr66vKlSurY8eOWrhwodX6Li4umjFjhgoWLKgOHTqoQYMGioiI0MyZM1WsWLFE1QIAAAAAtmIynvYD5IGnFBYWpuXLl1s+Zx5Pdv/ShAG7f9PhS3/buRoAwIMKZM6mhc3a2LsMhxQVFaVDhw6pYMGCnGZvA/TX9uixbdHfhN3PBvc/FvtRODIPAAAAAICDIcwDAAAAAOBgCPNIch06dOAUewAAAACwIcI8AAAAAAAOhjAPAAAAAICDIcwDAAAAAOBgCPMAAAAAADgYwjwAAAAAAA6GMA8AAAAAgIMhzAMAAAAA4GAI8wAAAAAAOBgXexcA4F/5MmS0dwkAgP/gZzMAIDkizAPJyOBaDe1dAgAgAXHx8XJ24oRGAEDywW8lIJmIjo6W2Wy2dxkpktls1sGDB+mvjdBf26K/tvW0/SXIAwCSG34zAcmIYRj2LiFFMgxDZrOZ/toI/bUt+mtb9BcA4KgI8wAAAAAAOBjCPAAAAAAADoYwDwAAAACAgyHMAwAAAADgYAjzAAAAAAA4GMI8kIyYTCZ7l5AimUwmeXh40F8bob+2RX9ti/4CAByVi70LAHCPm5ubPDw87F1GiuTh4SF/f397l5Fi0V/bor+2Zc/+xsXH8/n1AIBnRpgHkpF+vyzSqeuX7V0GAMDGcqfPpD6V3rN3GQAAB0aYB5KRU9cvK+Kf8/YuAwAAAEAyx7ldAAAAAAA4GMI8AAAAAAAOhjAPAAAAAICDIcwDAAAAAOBgCPMAAAAAADgYwjwAAAAAAA6GMA8AAAAAgIMhzAMAAAAA4GAI8wAAAAAAOBjCPAAAAAAADibFh/lt27bJz89PZ8+eTbI5o6KiNG/ePMvjHj16KCQk5IXWkJSSe31PMnDgQJUsWVLFixfXn3/++dzznT9/XqtXr06CygAAAADANlzsXYAjmj59upYtW6YmTZpIknr16qW4uDg7V/VyOnz4sGbPnq3Q0FC98cYbypw583PP2b17d2XPnl21atVKggoBAAAAIOkR5p+BYRhWj9OkSWOnSnDz5k1JUqVKlZQ9e3Y7VwMAAAAAL4bdT7P38/PTokWL1LJlSxUpUkQVK1bUpEmTLM+HhYUpKCjIap1ly5bJz8/P8jg2NtYyrmjRoqpfv75++eWXBLdnGIamTJmiqlWrqmjRoqpbt66+++47qzHHjx9XmzZtVKZMGZUsWVKfffaZzp8/b6ln3LhxOnfunOXU9P+eZh8eHq53331XRYoUUXBwsI4cOZLoGv7r1q1b+uqrr1S2bFmVLFlSzZo10/79+yVJMTExqlevnurVq6fY2FhJ0tGjR1WkSBHNmDHjqXu0efNmvfPOOypcuLBq1aqlTZs2WZ67efOm+vTpo8qVK6tQoUIqX768+vTpozt37kj691T9zZs3q3bt2pY5fv75Z8sccXFxGjVqlCpUqKCiRYuqQ4cOGjhwoFXvjh8/rtatW6t48eKqUKGCunTposuXLyfYk2XLllnWrVatmuXfO3fuVMuWLVWyZEkVLlxYtWvX1vfff2+17vfff6+6deuqSJEiqlq1qqVPISEh2r59u5YvX275vrtz545Gjx6tqlWrKiAgQMHBwfrpp5+s6ggKCtLAgQMVGBioNm3aPPa1BAAAAIDnlSyOzA8bNkxfffWVQkNDtXLlSn3zzTcqWbKkAgMDn2r9QYMGac2aNQoNDVXhwoW1fPlytW3bVitWrHho7KhRo7Rq1SqFhobKx8dHO3bsUN++fXXr1i01adJE586d0/vvv6/XX39ds2bNUnR0tIYOHaqmTZvqu+++U6tWrRQVFaU1a9ZoyZIl8vb2tpr/zJkzatWqlYKDgzVkyBAdO3ZMoaGhiarhvwzDUOvWreXq6qpJkybJy8tLK1eu1AcffKBFixbJ399fw4cPV/369TVt2jS1bNlSXbp0UenSpdWiRYun7tHs2bPVv39/Zc6cWSNGjFDHjh3122+/ydPTU927d9eFCxc0duxYZciQQXv27FHPnj2VL18+NW/e3DLH8OHD1atXL2XIkEHffPONunbtql9++UWenp4aMWKEli9frv79+8vHx0fz58/XnDlzVKpUKUnSxYsX1bhxY9WqVUs9evSQ2WxWWFiYGjVqpFWrVil16tRWfalZs6a8vLzUoUMHLV68WLly5dLFixfVqlUrNW7cWH379lVsbKymTp2qnj17qmzZssqYMaPWrVunL774Qp06ddJbb72lgwcPqmfPnvLy8lJYWJjatGmjrFmzWl63zp076+DBgwoNDVXevHm1evVqtW/fXuPHj1fVqlUlSefOndPFixe1fPlyyxscgMOKjZPijSePA/DM4u9GKzIy0t5l2FxUVJTMZrMiIyMVHx9v73JSHPr7ZC4uLnJ3d7d3GYBNJIswX69ePdWtW1eS1LFjR82fP187d+58qjAfGRmpRYsWqXfv3qpZs6Yk6fPPP1d8fLxu375tNTYqKkozZ87UsGHDVKVKFUlSrly5dO7cOU2bNk1NmjTR/PnzlTp1ao0YMUJubm6SpLFjxyooKEjfffedGjdurNSpU8vZ2VmZMmV6qJ5FixYpY8aM6tOnj5ydneXj46O///5bgwcPfuoa/uuPP/7Q7t27tXXrVsubB507d9auXbs0e/ZsDRkyRPnz51fnzp31zTffKCIiQlevXtWMGTNkMpmeukdffvmlypQpI0lq166dfvrpJx0/flxFihRR+fLlFRgYqAIFCkiScuTIoblz5z501kHHjh1Vrlw5y7/r1q2riIgIFShQQPPnz1fPnj311ltvSZK++uor7d6927LuggULlDlzZqs3P0aPHq2yZctq3bp1ql+/vtW23N3dlS5dOkmSt7e30qdPrzNnzqh9+/b68MMP5eR078STTz75RMuWLdNff/2ljBkzaubMmapRo4Y+/vhjSVKePHl0+/ZteXh4KH369HJ1dZW7u7u8vb11/PhxbdiwQRMnTrS8Xu3bt9eRI0c0ceJES5iXpLZt2ypnzpwPvX6AI3He8Zecj1yQiSwP2NQZSXUnfv/EcQCej5OTk4KDg9WuXTt7lwIkuWQR5n18fKwee3l5KSYm5qnWPXnypGJiYlSsWDGr5Z06dZJ07/Tv+44dO6a7d++qe/fu6tmzp2V5bGysoqOjdefOHUVERKhw4cKWIC9JGTJkUN68eR8KrgmJiIiQv7+/nJ2dLctKlCiRqBr+++7hgQMHJMkqOEpSdHS07t69a3ncvHlzbdiwQd9//73Gjx+vDBkyJKpHefPmtTyXNm1aSbIcZW7cuLE2btyolStX6vTp04qIiNCZM2eUJ08eqznz5ctn+beXl5eke5cBHD9+XHfu3HmohpIlS+rw4cOSpIMHD+r48eMqXry41Zi7d+/q+PHjeho5c+ZUgwYNNHfuXB07dkx//fWXDh06JEmWmxQeOXJENWrUsFrv3XffTXC++695yZIlrZYHBgZq5MiRVsv+2wvAERHkAQApSXx8vFasWEGYR4qULML8g8H5vgdvMvffG87dvy5cklxdXZ96O/fnGT16tFXofLAOwzBkMpkeei4uLu6pt/Xfel1cXB567nE1/Fd8fLy8vLy0bNmyx46/deuWTp8+LRcXF23ZskXVqlWT9PQ9un8k+7/7YhiG2rRpoyNHjuidd95R9erV1blzZ3311VdPVb9hGJYe/Lc3D4qPj1fZsmXVp0+fh5572psMHj9+XB988IH8/f1Vvnx5Va1aVa+88opVWHdxcUnwNU6M+Ph4q9dVEqdwIUWI88tKoAcApBj3j8wDKVGyCPOP4+rqqsjISKuQferUKcvzuXPnlqurq/bv3285BVySGjZsqLffflsBAQGWZfny5ZOLi4vOnz9vOWVaunet+LFjx9S/f3/5+vpq1apVio6OtgTTK1eu6NSpU2rcuLEkPTYIFixYUMuWLbNa//6N6p62hv/y9fVVZGSkoqOj9dprr1mW9+7dWwUKFFDTpk0lSX379pW7u7vGjRunTz/9VFWqVFHlypUT1aOEHDx4UJs3b9aiRYtUtGhRSfeOtp8+ffqpTyvPnTu33N3dtWfPHhUsWNCyfN++fZY+vfbaa1qzZo2yZctmWXb9+nV1795dLVu2VNmyZZ+4nQULFihDhgyaOXOmZdnGjRsl/ftGgo+Pj9VrIt27p8DZs2c1YcIEq+W+vr6S7t1U78HXKzw8XPnz53+qfQccSVypPIornpNr5gEby/9KVo2r0dreZdhcVFSUIiIi5Ovr+9C9b/D86O+Tcc08UrJkH+ZLlCihUaNGafLkyapVq5Z2795tdYTaw8NDTZs21ZgxY+Tt7a3XXntNS5cu1bFjx1SlShVduXLFMjZNmjRq1KiRRo8eLU9PT5UsWVLh4eEaPny4Wre+9wv1gw8+0IIFC9S1a1e1bdvWcgO8V155xfK546lTp9aNGzd08uRJ5ciRw6reDz74QPPmzdOXX36pTz/9VKdPn9a4ceMSVcN/VaxYUQULFlTHjh3Vu3dvvfrqq/r222+1dOlSTZ8+XZK0evVqrV27VnPmzFFgYKAaNmyoXr166bvvvpO3t/dT9yghGTNmlIuLi9auXStvb29dv35dEydO1OXLlxUdHf1Ur6OHh4dCQkI0duxYZcqUST4+Plq6dKn27Nmj0qVLS7p3Kv/ChQvVuXNntWvXTiaTScOHD9fBgwet3sR4nKxZs+rChQvavHmz8ufPrwMHDmjAgAGSZKn1448/VocOHRQQEKA33nhD+/fv17fffqt+/fpJkjw9PXXu3DlduHBB+fPnV+XKlS3P5cmTR6tXr9aGDRs0evTop6oJcDguzk8eA+C5OKVys1yOlpI5OTnJw8NDXl5ehE0boL/Ayy3Zh/nSpUurU6dOmjt3rsaPH69SpUqpe/fu6t69u2VM586d5eLior59++rmzZvy8/PT5MmT5ePj81BQ7dmzp7y9vTV27FhdunRJWbNmVfv27S03Q8uZM6fmzJmjESNG6P3335ebm5vKly+v4cOHW64jf+utt7Ro0SLVqVNHc+fOtZo/S5YsmjVrlgYNGqR69eopW7Zs+vTTTy1h8Glq+C9nZ2dNnz5dw4cPV6dOnWQ2m+Xj46OwsDCVK1dOFy9eVL9+/dS0aVPLTQO7d++uX375RaGhoRo3blyievRfWbJk0ZAhQxQWFqZ58+YpU6ZMeuONN9SiRQtt2LDhsafOP+jzzz9XTEyMevfuLbPZrCpVqqhq1aqW6/5z5sypuXPnauTIkWrcuLGcnZ1VrFgxzZo1y3L9/5M0a9ZMJ06cULdu3RQdHa08efKoc+fOGjt2rPbt26dKlSopKChIX3/9taZMmaJhw4Ype/bs+vLLL1WvXj1JUqNGjdS9e3fVqVNHW7du1ahRo/TNN9+od+/eunnzpl577TWFhYXpzTfffKqaAAAAACCpmYynTWLAc1q/fr1Klixp9XF+rVq1UtasWTVo0CA7VmZ/90/7H3XyF0X8c97O1QAAbM3X+1VNr5Pyb8gVFRWlQ4cOqWDBghw5tgH6a3v02Lbob8LuZ4MnXQ798B3PABuZNm2aunTpokOHDunMmTOaOXOm/vjjD9WpU8fepQEAAACAQyHM44UZMWKEPD091aJFC9WuXVurVq3SmDFjnurGdgAAAACAfyX7a+aRcuTIkcPqZoAAAAAAgGfDkXkAAAAAABwMYR4AAAAAAAdDmAcAAAAAwMEQ5gEAAAAAcDCEeQAAAAAAHAxhHgAAAAAAB0OYBwAAAADAwRDmAQAAAABwMC72LgDAv3Knz2TvEgAALwA/7wEAz4swDyQjfSq9Z+8SAAAvSFx8vJydOEkSAPBs+A0CJBPR0dEym832LiNFMpvNOnjwIP21EfprW/TXtuzZX4I8AOB58FsESEYMw7B3CSmSYRgym83010bor23RX9uivwAAR0WYBwAAAADAwRDmAQAAAABwMIR5AAAAAAAcDGEeAAAAAAAHQ5gHAAAAAMDBEOaBZMRkMtm7hBTJZDLJw8OD/toI/bUt+gsAABLiYu8CANzj5uYmDw8Pe5eRInl4eMjf39/eZaRY9Ne2HLm/8Ua8nEwcNwAAwBYI80AyMmnvXP0dedHeZQDAc8vmlUWfFG1q7zIAAEixCPNAMvJ35EWdunnO3mUAAAAASOY49w0AAAAAAAdDmAcAAAAAwMEQ5gEAAAAAcDCEeQAAAAAAHAxhHgAAAAAAB0OYBwAAAADAwRDmAQAAAABwMIR5AAAAAAAcDGEeAAAAAAAHQ5gHAAAAAMDBEOZhN9euXdPixYuTdM6QkBD16NEjSecEAAAAgOSGMA+7GTZsmL777jt7lwEAAAAADocwD7sxDMPeJQAAAACAQyLM45kdPXpUbdu2VZkyZVS4cGG9+eabmjVrliQpLCxMQUFBVuOXLVsmPz8/SVKPHj20fPlybd++3bIsLi5OM2fOVPXq1RUQEKDq1atr0aJFlvW3bdsmPz8/bdiwQW+99ZaKFSumFi1a6Pjx41bbuX37tr788ksFBgaqZMmS6tGjh6KioizPb9y4UY0aNVLx4sUVEBCghg0b6vfff7c8HxcXp1GjRqlChQoqWrSoOnTooIEDByokJESSFBwcrJ49e1pt85dfflHhwoX1zz//PG9bAQAAAOCJXOxdAByT2WxWy5YtVbZsWc2fP18uLi5aunSpBg0apNKlSz9x/V69eunOnTu6cOGCwsLCJElDhgzRypUr9dVXXykgIEC//fab+vfvr7t371qCtCQNHDhQffr0UdasWTV8+HA1a9ZM69atU5o0aSRJP/74oz755BMtW7ZMR48eVadOnZQtWzZ9/vnn+vPPP9WuXTt98cUXGj58uG7fvq1Ro0apa9eu2rRpk9zc3DRixAgtX75c/fv3l4+Pj+bPn685c+aoVKlSkqT69etr9OjR6tOnj9zd3SVJK1euVJUqVeTt7Z3UrQaQgsTHxEtxL8dZSbGuMYqMjLR3GU8UFRUls9msyMhIxcfHP/d8Li4ult8NAADYEmEez8RsNqtZs2Zq3LixvLy8JEnt27fXpEmTdOTIkSeunyZNGrm7u8vV1VWZMmVSZGSkFixYoB49euidd96RJOXJk0dnzpzRxIkT1bRpU8u6PXr0UOXKlSVJI0aM0BtvvKHVq1erUaNGkqSAgAB17txZkpQrVy6VL19ef/75pyTJ2dlZvXv3VpMmTSzzNWvWTK1atdLVq1eVPn16zZ8/Xz179tRbb70lSfrqq6+0e/duy/g6depo+PDh+umnn1S7dm1FRkbqp59+0ujRo5+1nQBeAtc2ntOt3VeklyPL66z+VF2tt3cZL5yTk5OCg4PVrl07e5cCAEjhCPN4Jt7e3mrcuLHWrFmjw4cP69SpUzp06JAkPdORjRMnTigmJkYlS5a0Wh4YGKgZM2bo6tWrlmUPHvlPnz698uTJo4iICMuyvHnzWs2RLl06nTt3TpJUsGBBpUuXTlOmTNHJkyf1119/WeqOi4vT8ePHdefOHRUrVsxqjpIlS+rw4cOWbQYFBWnFihWqXbu21q5dqzRp0qhixYqJ3m8AL4+XKci/zOLj47VixQrCPADA5rhmHs/kypUrqlOnjhYuXKiMGTOqUaNGWrZsmdWY/97gLjY29pHz3R9rMpmslt9/Y8DF5d/3nR789/0xTk7/fis7Ozs/cjs7duxQ9erVtXfvXvn6+qpdu3YaPnz4Q3M/6eZ8DRo00O+//64rV67ou+++U506dR6qCwAelKZ4Rsn05HFwbPePzAMAYGukDzyTVatW6fr16/rhhx/k6uoqSZbT6w3DkKurqyIjI2UYhiWgnzp1ymqOB4N7vnz55OLiovDwcBUoUMCyPDw8XJkyZVK6dOksy/bv369y5cpJkv755x+dOnVKLVu2fKq6p02bpjJlymjcuHGWZXPmzLHUnTt3brm7u2vPnj0qWLCgZcy+ffvk5uZmeVyhQgVlypRJixcv1s6dO9WnT5+n2j6Al9crQdmVrmK2l+aa+ZxpsqlH2fb2LuOJoqKiFBERIV9fX6VOnfq55+OaeQDAi0KYxzPJmjWrzGaz1q5dq8DAQJ04cUKDBw+WJEVHR6tEiRIaNWqUJk+erFq1amn37t0PHblPnTq1Ll26pDNnzihnzpx67733NHbsWKVLl05FihTRli1bNH/+fHXu3Nkq+Pfr109ff/210qRJo2HDhilTpkx6++23n6rubNmy6aefflJ4eLiyZs2qbdu2acyYMZa6PTw8FBISorFjxypTpkzy8fHR0qVLtWfPHqvT++8feZk4caIKFy6s/PnzP29LAbwEnFydJFd7V/FiuHi4Wu6pkpw5OTnJw8NDXl5eSRLmAQB4UQjzeCZvv/22Dhw4oKFDhyoyMlLZs2fXu+++qw0bNmjfvn364IMP1KlTJ82dO1fjx49XqVKl1L17d3Xv3t0yR3BwsNavX6/atWtr/fr16tWrl1555RWNHDlSV65cUe7cuRUaGqr33nvPatvvvvuuunbtqps3b6ps2bKaPXu2PDw8nqruzz77TFeuXFGbNm0kSfnz59egQYP0xRdfaN++ffLx8dHnn3+umJgY9e7dW2azWVWqVFHVqlV19+5dq7nq16+viRMnqn79+s/ZTQAAAABIHJPxpIuDgWRi27ZtatasmTZs2KAcOXLYbDvr169XyZIlrT5mrlWrVsqaNasGDRpkWbZjxw61bt1av/76q+Vj8Z7V/v37JUlLb/6oUzfPPddcAJAc5E6bXX3Ld7F3GU8UFRWlQ4cOqWDBghyZtwH6a1v01/bosW3R34TdzwYBAQGPHceReeA/pk2bpvnz56tbt27y8vLShg0b9Mcff2j69OmSpOPHjysiIkITJ05UvXr1njvIAwAAAEBicTd74D9GjBghT09PtWjRQrVr19aqVas0ZswYlS1bVpL0119/qWfPnkqXLp06depk52oBAAAAvIw4Mg+HUaZMGcsd820pR44cVne7/6+qVatqz549Nq8DAAAAAB6FI/MAAAAAADgYwjwAAAAAAA6GMA8AAAAAgIMhzAMAAAAA4GAI8wAAAAAAOBjCPAAAAAAADoYwDwAAAACAgyHMAwAAAADgYFzsXQCAf2XzymLvEgAgSfDzDAAA2yLMA8nIJ0Wb2rsEAEgy8Ua8nEycBAgAgC3wGxZIJqKjo2U2m+1dRopkNpt18OBB+msj9Ne2HLm/BHkAAGyH37JAMmIYhr1LSJEMw5DZbKa/NkJ/bYv+AgCAhBDmAQAAAABwMIR5AAAAAAAcDGEeAAAAAAAHQ5gHAAAAAMDBEOYBAAAAAHAwhHkgGTGZTPYuIUUymUzy8PCgvzZCf22L/toW/bUt+mtb9Nf26LFt0d/nYzL4rBvA7vbv3y9JCggIsHMlAAAAwMsl3oiXkyn5HOd+2mzg8iKKAfB0Vh2ZoKtR5+1dBgAAAPBSyJD6Vb3j19beZTwTwjyQjFyNOq+Lt/+ydxkAAAAAkrnkcy4BAAAAAAB4KoR5AAAAAAAcDGEeAAAAAAAHQ5gHAAAAAMDBEOYBAAAAAHAwhHkAAAAAABwMYR4AAAAAAAdDmAcAAAAAwMEQ5gEAAAAAcDCEeQAAAAAAHAxhHgAAAAAAB0OYdxAhISHq0aOHJGnbtm3y8/PT2bNnbbKtsLAwBQUF2WTu57Vz506Fh4fbfDt+fn5atmyZzbcDAAAAAM+CMO+Aihcvri1btihbtmz2LuWFa9y4sU6fPm3vMgAAAADArlzsXQASz83NTZkyZbJ3GQAAAAAAO+HI/HOKiorSgAEDVKFCBRUvXlxNmjTRvn37LM8vXbpUwcHBKlKkiIoVK6aQkBAdOHDA8nxQUJAGDRqkmjVrqkyZMvrjjz8UHR2tQYMGqVy5cgoMDNTIkSMVHx9vWee/p9lfuHBBXbt21euvv65ChQqpcuXKGjVqlNU6f/75p1q2bKnixYvr9ddfV2hoqKKioh67b1OmTFHlypVVpEgRhYSE6K+//pIkDRw4UNWqVbMae+vWLRUpUkQbNmzQsmXLVKlSJS1dulSVK1dW8eLF1a5dO128eNEyPjo6WsOHD1fFihVVvHhxvffee9qyZYvl+WXLlikoKEgDBw5UYGCg2rRpIz8/P0lSz5491aNHD509e1Z+fn6aMGGCypcvr6CgIN28eVPXr19Xv379LLV/8MEHVqfmh4WF6YMPPtCkSZNUtmxZlSpVSj179lRkZKTVPp08eVItW7ZUkSJFVKFCBU2aNEmS9M8//6hw4cJasWKF1fgRI0aoXr16j+0pAAAAACQFwvxz6tSpk37++WcNGjRIK1asUN68efXhhx/qn3/+0fr169WnTx+1aNFCa9eu1axZs3Tnzh316tXLao4FCxaod+/emjp1qkqUKKEBAwZozZo1GjJkiBYsWKDz588/9jrxTz75RP/884+mTZumdevW6aOPPtLEiRO1ceNGSdLZs2cVEhIib29vLVy4UOPGjdO2bdsUGhr6yDnPnTunnTt3atKkSZo7d64uX75sqbthw4Y6c+aMVU1r1qyRl5eXKleuLOle4J0+fbpGjhypWbNm6e+//9ZHH32k2NhYSfcC+a+//qrhw4dr+fLlqlGjhtq0aaNNmzZZ1XDx4kUtX75cXbp0sYT9L7/80qqH3333nWbNmqUxY8bI09NTrVq1Unh4uIYOHarly5erQIECatGihfbv329ZZ//+/dq0aZOmTZumcePGaceOHerYsaNVD+bOnau6detq9erVaty4sb755htt3bpV3t7eeuONN6zCfHx8vFatWqX69es/sqcAAAAAkFQ4zf45nDx5Ups2bdLUqVNVsWJFSVJoaKg8PT11/fp1pU+fXgMGDFBwcLAkKXv27Hr33XfVp08fq3kqV66s119/XZIUGRmpZcuWqU+fPpZgPGjQIG3bti3BGu7cuaO6deuqevXqyp49u6R7N8ubPHmyjhw5omrVqmnRokVKly6dhgwZIldXV0nSgAEDtH379kfum4uLi4YPH640adJIkho1aqRRo0ZJundzuEKFCum7775TYGCgJGn58uWqW7euXFzufUvFxMRo2LBhKlSokCRp+PDhqlmzprZu3apcuXLp+++/15IlSxQQECBJatmypQ4fPqxp06bpjTfesNTRtm1b5cyZ06q2NGnSKE2aNLpx44ake9fR58+fX5K0efNmHThwQKtWrZKvr6/lNdm7d6+mTZum0aNHS5JMJpNGjx6tLFmyWMa0bt1aJ06cUL58+SRJH3zwgeW1a9u2raZPn64///xT5cqVU4MGDdS2bVtdvHhRWbJk0datW3X16lXVrl37kT0FAAAAgKRCmH8OR44ckSQVK1bMsszNzU09e/aUJOXLl0/e3t6aMGGCTp06pZMnT+rQoUNWp79LUu7cuS3/PnnypGJiYiwhV5JSpUqlggULJliDu7u7mjZtqnXr1mnWrFk6deqUDh8+rEuXLlm2c+TIERUqVMgS5CWpVKlSKlWq1CP3LWPGjJYgL0lp06bVnTt3LI8bNGig0aNHq3fv3vr777+1e/du9e/f3/K8p6enJchLko+Pj9KmTauIiAjL6ezNmjWz2mZMTIzSpk1rtSxPnjyPrPG+B/sXERGhNGnSWIK8dC+4BwYG6tdff7Wa936Ql+7dVPD++vfDfN68ea22kzZtWt29e1eSVKlSJWXIkEErV67Uxx9/rOXLlysoKEivvPLKE+sFAAAAgOdFmH8O949Cm0ymBJ9fvXq1unXrptq1a6tIkSJq2LChIiIirEKvdC+QP+22/stsNqtJkyYym82qUaOG6tatq6+++kpNmjSxWvdRNT6Ks7PzY59/5513NHToUP3888+KiIhQQECAVYB+8I2D+wzDkLOzswzDkCTNmzdPnp6eVmOcnKyv/Hia3jw4xjCMBPc1Pj7eqof/re/+Gx8P7ndCPbhfu7Ozs4KDg7Vq1So1bdpUP/30k8aMGfPEWgEAAAAgKXDN/HPw8fGRJKtrsWNjY/XGG29o9erVmjhxoho2bKihQ4eqSZMmKlWqlM6cOSPp31CY0JypUqXSzp07reY8fPhwguN//fVXHThwQHPmzNFnn32mmjVrysvLS1evXrVsI3/+/Dp48KDi4uIs661fv16VKlWS2Wx+pn1Pmzat3nzzTf3444/68ccfH7pW/Pr161YfIXf06FHdunVL/v7+eu211yRJly5dUu7cuS1fy5Yt09KlS5+pnvv8/Px08+ZNRUREWC3fuXOn5VR86d4ZELdu3bI83r17tyQ98gyIhDRo0EARERGaO3euvLy8VKFCheeqHQAAAACeFmH+OeTNm1dvvfWW+vXrp61bt+rkyZMKDQ1VdHS0ypUrp2zZsmnXrl06cOCATp8+rZkzZ2ru3LmS7t3NPSGpU6dW06ZNNXbsWP344486fvy4+vTpY3Un+AdlzZpV0r2bwJ07d07h4eFq27atYmJiLNto3Lixrl27pj59+uj48eMKDw/XiBEjVL58eXl4eDzz/jdo0EA//fSTTp06leC14t26ddP+/fu1d+9edevWTcWLF1epUqX02muvqUqVKurTp482bNigM2fOaNq0aZo0adJD18cn1J/jx4/r2rVrCT5fvnx5+fn5qUuXLtq2bZuOHz+ufv36KSIiQs2bN7eMi4qKUrdu3RQREaGtW7eqf//+qlmzpnLkyPHU+583b16VKFFC48ePV3Bw8BPPZgAAAACApMJp9s9p8ODBGjZsmDp16qS7d++qaNGimj59ury9vfXVV18pNDRUTZs2lZubmwoUKGAZu3fvXpUuXTrBObt06aJUqVKpf//+un37tmrUqKGgoKAExxYpUkQ9e/bUzJkzLTd0q1mzprJly6a9e/dKkrJkyaLp06dbPjotbdq0qlmzpjp37vxc+16uXDm98sorKlGixEPXuktS7dq19fHHHysmJkZBQUHq1auX5RT4UaNGadSoUerTp49u3LihnDlz6uuvv1aDBg0eu81WrVpp6tSpOnHixEOfCiDdu6RgxowZGjp0qDp06KDo6GgVKlRIM2fOtLq3QbZs2eTr66vGjRvLxcVF77zzjrp27ZroHtSvX1+7du3iI+kAAAAAvFAm41HnewNPEBUVpQoVKmjcuHGWu/FL9z4jvmfPnpYbBCY3YWFhWr58ueWj+57HuHHj9Ntvv2nBggXPNc/9SzV2xi7Uxdt/PXddAAAAAJ4si2cetSg+wN5lWLmfDR68KXpCODKPRLtx44b++OMPrV27Vq+++qrKlStn75JeuPDwcP3111+aNWvWQzc0BAAAAABbI8wj0WJjY9WrVy95e3tr9OjRib5Tfkrw888/a968eWrQoIFq1Khh73IAAAAAvGQ4zR5IBjjNHgAAAHjxHPk0e+5mDwAAAACAgyHMAwAAAADgYAjzAAAAAAA4GMI8AAAAAAAOhjAPAAAAAICDIcwDAAAAAOBgCPMAAAAAADgYF3sXAOBfGVK/au8SAAAAgJeGI//9TZgHkpF3/NrauwQAAADgpRJvxMvJ5HgnrTtexUAKFR0dLbPZbO8yUiSz2ayDBw/SXxuhv7ZFf22L/toW/bUt+mt79Ni2kkt/HTHIS4R5IFkxDMPeJaRIhmHIbDbTXxuhv7ZFf22L/toW/bUt+mt79Ni26O/zIcwDAAAAAOBgCPMAAAAAADgYwjwAAAAAAA6GMA8AAAAAgIMhzAMAAAAA4GAI8wAAAAAAOBjCPJCMmEwme5eQIplMJnl4eNBfAAAApBgu9i4AwD1ubm7y8PCwdxkpkoeHh/z9/e1dRpIzjDiZTM72LgMAAAB2QJgHkpFdx/op0nzK3mXAAXh55FaJ/H3sXQYAAADshDAPJCOR5lO6ERVh7zIAAAAAJHNcMw8AAAAAgIMhzAMAAAAA4GAI8wAAAAAAOBjCPAAAAAAADoYwDwAAAACAgyHMAwAAAADgYAjzAAAAAAA4GMI8AAAAAAAOhjAPAAAAAICDIcwDAAAAAOBgCPMvgaCgIPn5+Vm+ChYsqMDAQIWEhCg8PNwybvPmzapfv74CAgJUrVo1zZs3z2qeXbt2KSQkRCVLllTFihXVq1cvXb9+/aHtVa9eXbt27ZIknTx5Up07d1a5cuVUuHBhBQUFqV+/frpy5cpD6x08eFBdunRRpUqVVKRIEb311lsaMmSILl++/NDYJ8179uxZq31O6CssLMxq3IEDBxLsX40aNeTn56dt27YlWEexYsV09uzZR78AAAAAAJDECPMviVatWmnLli3asmWLNm/erPnz58vT01MfffSRLly4oO3bt+vTTz9VhQoVtHr1arVu3VoDBw7UmjVrJN0LrR9++KEKFCigxYsXa9SoUdq3b58+++wzq+2cOXNG169fV9GiRXXlyhV98MEHcnFx0ZQpU/TDDz+of//+ljcFoqOjLet99913eu+99+Tp6alx48ZpzZo1+vLLL7Vnzx7Vq1dPR44csYx9mnmzZctm2d8tW7aoVatWypo160PL7nN1ddW6dese6tvhw4d18uTJBHt65MgRtWzZUmaz+bleGwAAAABILBd7F4AXI3Xq1MqUKZPlcebMmdWvXz9VqlRJP/74o9avX69q1aqpc+fOkqRcuXJp7969Cg8PV82aNbVixQplzpxZX375pUwmk/Lly6c+ffqoSZMmOnPmjHLmzClJ2rRpk8qXLy9nZ2etW7dOsbGxGjp0qEwmkyQpe/bsevXVV1WjRg39+uuvqlq1qs6cOaOvvvpK7du3V5s2bSw15siRQ6+//rpatmypLl26aOXKlYma98H9TZ06tZydna2WSdK1a9ckSeXKldO6devUpUsXq+fXrFmjwMBA7dixw2r5//73P02cOFE+Pj76+++/n+u1AQAAAIDE4sj8S8zF5d57OYZhKDw8XO+8847V84MGDVJoaKgkqU6dOlbh+UEPnmq/efNmVapUSZJkMpl0+/bth05Pz5cvn1avXq2yZctKkhYuXCgPDw+rI+X3ubm5qUuXLjp69Kh+//33RM2bGDVq1NDp06cfOtV+7dq1qlmz5kPjf/31Vw0fPlzdu3dP9LYAAAAA4HkR5l9SFy9eVP/+/ZU6dWr5+/srPj5ezs7O+uyzz1SuXDnVrVtXixcvtoz38fFRsWLFrOaYMmWKMmXKpAIFCkiS7ty5o507d1rCfK1atfTqq6+qefPmqlu3rgYPHqyffvpJkZGRyp8/vzw9PSVJ4eHhKlKkiNzc3BKstXjx4kqVKpV27tyZqHkTI3v27CpSpIjVqfb79u3TzZs3Vb58+YfGz58/X2+99VaitwMAAAAASYEw/5KYNGmSihcvruLFiysgIECVKlXS0aNHNXr0aMvR9tDQUAUGBmr69OmqV6+e+vXrpyVLliQ435AhQ7R582aFhobK1dVVkrRt2zblz59f3t7ekqT06dNr2bJlat++veLj4zVz5ky1a9dO5cuX1/jx4y1zXbt2TWnTpn1k7SaTSenSpdM///yTqHkTq0aNGlZhfu3atapevbqcnZ2feU4AAAAAsAWumX9JNGrUSCEhIZIkJycnpU+fXmnSpJF07wi0JNWtW1fNmjWTJBUsWFCnTp3SjBkz1LBhQ8s8MTExCg0N1fLly9WnTx+ro9MPnmJ/X7p06dShQwd16NBBV69e1R9//KGFCxdq7NixeuWVV9S4cWN5e3vrxo0bj6zdMAzdunXLUu/TzptYNWrU0LBhw3TgwAH5+/tr7dq1Gjp0aKLnAQAAAABb48j8SyJdunTKnTu3cufOrZw5c1oF4yxZskiSfH19rdbJnz+/1UeuRUZGqnXr1lq1apVGjhypDz74wGr8L7/8osqVK1seT5kyRWvXrrU8zpAhg2rVqqVZs2apaNGi2rx5sySpZMmS2rt3r9Xd7R+0b98+mc1mFS1aNFHzJla2bNlUrFgxrVu3Trt371ZsbKxKlSr1THMBAAAAgC0R5qEsWbJY7l7/oIiICOXKlUuSFB0drU8++UT79+/X1KlTVatWLauxx48f1+3bt1W4cGHLsr1792rChAmKjY21GmsymeTp6akMGTJIkt5//31FR0dr4sSJljELFixQo0aNtHXrVo0cOVLZs2fXG2+8kah5n8Xbb7+tH3/8UWvXrlWNGjXk5MR/EQAAAADJD0kFkqT27dtr4cKFmjdvns6cOaOFCxdq6dKl+vDDDyXdu+Z+586d6t+/v3x8fHT58mXLV3R0tH755RdVrFjRKvy2a9dOZ8+e1YcffqgtW7bo3Llz2r17t4YMGaI9e/aoZcuWkqScOXNq0KBBmjJlinr16qV9+/apVKlS8vb2VosWLbRt2zYNGDDAcoO8p533WdSoUUOnTp3SsmXLHnrDAgAAAACSC66Zh6R718tL90L74MGDlT17dvXp00fBwcGSpO+//16GYVg+h/5Bs2fP1i+//GJ1bb1077r7xYsXa8KECerZs6euXbsmT09PlSpVSt9++61ee+01y9iaNWsqb968mjp1qtq1a6fr168rU6ZMev/993X58mV98cUX6ty5sxo0aJCoeRMrS5YsKlGihC5cuPDQ3fsBAAAAILkwGYZh2LsI4Em2bt2qmzdvqnr16vYuxSb2798vSbqmUboRFWHnauAI0qX2VaWA6fYuQ5IUFRWlQ4cOqWDBgkqdOrW9y0lx6K9t0V/bor+2RX9tjx7bFv1N2P1sEBAQ8NhxHJmHQyhXrpy9SwAAAACAZINr5gEAAAAAcDCEeQAAAAAAHAxhHgAAAAAAB0OYBwAAAADAwRDmAQAAAABwMIR5AAAAAAAcDGEeAAAAAAAHQ5gHAAAAAMDBEOYBAAAAAHAwhHkAAAAAAByMi70LAPAvL4/c9i4BDoLvFQAAgJcbYR5IRkrk72PvEuBADCNOJpOzvcsAAACAHXCaPZBMREdHy2w227uMFMlsNuvgwYMprr8EeQAAgJcXYR5IRgzDsHcJKZJhGDKbzfQXAAAAKYbJ4K9bwO527dolwzDk6uoqk8lk73JSHMMwFBMTQ39thP7aFv21LfprW/TXtuiv7dFj26K/CYuOjpbJZFKJEiUeO45r5oFk4P4PL36I2YbJZJKbm5u9y0ix6K9t0V/bor+2RX9ti/7aHj22LfqbMJPJ9FS5gCPzAAAAAAA4GK6ZBwAAAADAwRDmAQAAAABwMIR5AAAAAAAcDGEeAAAAAAAHQ5gHAAAAAMDBEOYBAAAAAHAwhHkAAAAAABwMYR4AAAAAAAdDmAcAAAAAwMEQ5gEAAAAAcDCEeQAAAAAAHAxhHgAAAAAAB0OYB2wsPj5eY8eOVcWKFVW0aFG1atVKp06deuT4a9euqUuXLipVqpRKlSqlr776SlFRUS+wYseT2B4/uN6HH36osLCwF1Cl40psf48ePaqPP/5YZcqUUbly5fTZZ5/p/PnzL7Bix5LY/v75559q3ry5ihcvrrJlyyo0NFQ3b958gRU7lmf9+SBJq1atkp+fn86ePWvjKh1XYvu7fPly+fn5PfT1tK/Jyyax/Y2JidHIkSNVsWJFFStWTE2bNtWhQ4deYMWOJzE9DgsLS/D718/PTz179nzBlTuGxH4PX758WZ07d1aZMmVUpkwZff7557pw4cILrNixEOYBG5swYYK+/fZbDRgwQAsXLpTJZFLr1q0VHR2d4PjPPvtMZ86c0cyZMzV27Fj99ttv6tev3wuu2rEktseSdOfOHX3xxRfasmXLC6zUMSWmv9euXVPLli3l6empuXPnasqUKbp27Zo++ugj3b171w7VJ3+J6e+lS5fUsmVL5cqVS8uXL9eECRO0a9cude/e3Q6VO4Zn+fkgSefOneNn71NIbH+PHDmi0qVLa8uWLVZfOXLkeMGVO4bE9rdv375asmSJvv76ay1dulTp06dX69atdevWrRdcueNITI9btWr10Pdux44d5e7urubNm9uh+uQvsd/DnTp10t9//60ZM2ZoxowZunDhgtq2bfuCq3YgBgCbuXv3rlG8eHFj/vz5lmU3btwwihQpYnz//fcPjd+1a5fh6+trHDt2zLLs119/Nfz8/IwLFy68kJodTWJ7bBiGsXPnTuPtt982qlatagQGBhpjx459UeU6nMT2d9GiRUaJEiWMO3fuWJb9/fffhq+vr/H777+/kJodybP8jOjUqZMRExNjWTZz5kyjaNGiL6Jch/MsPx8MwzDi4uKMDz74wGjWrJnh6+trnDlz5kWU63Cepb8tW7Y0BgwY8KJKdGiJ7e/p06cNX19f4+eff7YaX6VKFX7+PsKz/oy479SpU0bRokWt1se/EtvfGzduGL6+vsaGDRssy3766SfD19fX+Oeff15IzY6GI/OADR0+fFi3b99W2bJlLcvSpk0rf39/7dix46Hx4eHhypQpk3x8fCzLSpcuLZPJpJ07d76Qmh1NYnssSb/++qvefPNNrVixQmnSpHlRpTqkxPa3XLlyGj9+vFKlSvXQczdu3LBprY4osf0tXry4vvnmG7m4uEiSjh07puXLl6t8+fIvrGZH8iw/HyRp4sSJiomJ0SeffPIiynRYz9LfI0eOKH/+/C+qRIeW2P5u2bJFadOmVaVKlazGb9y4UeXKlXshNTuaZ/0Zcd+QIUP02muv6f3337dlmQ4rsf1NlSqVUqdOrRUrVigyMlKRkZFauXKl8uTJo3Tp0r3I0h2Gi70LAFKy+9f4ZMuWzWp55syZ9ffffz80/uLFiw+NdXNzU/r06RMcj8T3WJI+//xzm9eVUiS2vzly5HjodNlJkyYpVapUKlWqlO0KdVDP8v17X/Xq1fXXX38pe/bsmjBhgs1qdGTP0t99+/Zp+vTpWrJkiS5evGjzGh1ZYvv7zz//6MqVK9qxY4fmzJmj69evq2jRouratavy5s37Qmp2JInt719//aWcOXPqxx9/1OTJk3Xx4kX5+/urR48eVgcJ8K/n+Rm8f/9+bdiwQbNmzZKTE8dHE5LY/qZKlUoDBw5U//79FRgYKJPJpEyZMmnu3Ln0+BHoCmBDZrNZ0r1A/qBUqVIleP2w2Wx+aOzjxiPxPUbiPG9/Z8+erfnz56tz5876v/buNCiKq90D+B8BRcQNo0DAUqIOKLIKg2UwFC5xQ1lCRcqFABEXDIqAGK2URMvEqBhBRCnBaBSNUcEloBAloKio0RiXcgmKxgUVQUFZBpzh3A9W5mYCmHfwRex7/78qPvSZ091PP0xNzTN9+pxu3bq1SIxS9jr5jY2NRWpqKrp3746AgABUVVW1WJxSpW1+q6urERUVhaioKPTu3ftNhChp2ub3jz/+AADo6upixYoVWLNmDaqrqzFp0iSUlpa2fMASo21+KysrcefOHaxfvx4RERHYsGED9PT0MGnSJJSVlb2RmKXmdT6Dt2zZAnt7e427zqRJ2/wKIXD9+nU4Ojpi+/bt+P7772Fubo7Zs2ejsrLyjcQsNSzmiVqQgYEBADSY5KO2thbt27dvtH9jE4LU1tbC0NCwZYKUOG1zTNppbn6FEIiLi8NXX32FGTNmIDAwsCXDlKzXef/a2trCxcUFCQkJuH//Pg4fPtxicUqVtvldtmwZevfuDX9//zcSn9Rpm9/BgwfjzJkzWLFiBWxsbODi4oLExETU19cjPT39jcQsJdrmV19fH8+fP8eaNWvg5uYGOzs7rFmzBsDLVQSooeZ+BldXV+Pw4cMcXv8vtM1vZmYmduzYgVWrVmHQoEGQy+VISkrC/fv3kZaW9kZilhoW80Qt6K9hRSUlJRrtJSUlMDU1bdDf1NS0Qd+6ujqUl5fDxMSk5QKVMG1zTNppTn5fvHiB+fPnIykpCdHR0YiIiGjxOKVK2/zevHkTR48e1Wjr0aMHOnfuzCHhjdA2v2lpaSgoKICjoyMcHR0REhICAPD09MTixYtbPmCJac7nwz+fezU0NISFhQXfv41ozncIPT09jSH1BgYG6NmzJ5dXbEJzv0Pk5+ejvr4eI0eObNH4pE7b/J47dw6WlpYwMjJSt3Xu3BmWlpa4fft2i8YqVSzmiVqQtbU1jIyMcPr0aXXbs2fPcOXKFTg7Ozfo7+LigocPH2qsv/nXvk5OTi0fsARpm2PSTnPyGx0djaysLKxevRqffvrpmwpVkrTNb35+PubOnasx3PDOnTt4+vQpn4lthLb5/fnnn5GRkYF9+/Zh3759WLZsGQBg48aNnGujEdrmd8eOHXB1dYVCoVC3VVZW4vbt25wUrxHa5tfZ2RlKpRKXLl1StykUCty9exe9evV6IzFLTXO/Q5w7dw42Njbo1KnTmwhTsrTNr5mZGf7880+NIfg1NTW4d+8e38NN4AR4RC2obdu2mDJlCmJjY2FsbAxzc3OsWrUKpqamGDlyJFQqFZ48eYKOHTvCwMAA9vb2cHJywrx58/Dll1+iuroaMTEx8Pb25p35JmibY9KOtvlNT0/HwYMHER0dDblcjsePH6uPxf9BQ9rm18vLC5s2bcL8+fMRERGBiooKLFu2DHZ2dvDw8Gjty3nraJvff35Z/GvypnfffZdzPjRC2/x6eHggLi4O0dHRCAsLg0KhwLfffgtjY2P4+Pi09uW8dbTNr7OzM4YMGYIFCxZg6dKl6NKlC9auXQtdXV14eXm19uW8lZr7HeLatWuQyWStGLk0aJtfb29vbNq0CeHh4eofUOPi4tC2bVv4+vq28tW8pVp7bTyi/+uUSqVYuXKlGDx4sHBwcBAhISHqNYvv3r0rZDKZSEtLU/cvLS0VYWFhwsHBQbi6uoqYmBiNNbupIW1z/HceHh5cZ/5faJPfoKAgIZPJGv1r6n/w/52279+ioiIxffp0MWjQICGXy8XChQtFRUVFa4X/1nudz4dTp05xnfl/oW1+r1y5IoKDg8WgQYOEk5OTCAsLE8XFxa0V/ltP2/w+f/5cxMTECFdXV2Fvby+CgoJEYWFha4UvCc35jBgzZoyIjY1tjXAlR9v83rhxQ8yYMUPI5XIxePBg8dlnn/Ez+BV0hBCitX9QICIiIiIiIqL/HJ+ZJyIiIiIiIpIYFvNEREREREREEsNinoiIiIiIiEhiWMwTERERERERSQyLeSIiIiIiIiKJYTFPREREREREJDEs5omIiIiIiIgkhsU8ERERSV50dDSsrKywcePG1g7ljVMqldiyZQt8fHzg4OAAR0dH+Pj4ICUlBXV1da0dHhERtRAdIYRo7SCIiIiImquyshJubm7o2bMnampqcPjwYejo6LR2WG/MwoULkZ2djZCQENja2kIIgbNnz2Lz5s1wc3PD+vXrWztEIiJqAXqtHQARERHR68jMzIRKpcIXX3yBgIAAHD9+HEOHDm3tsN6I4uJi7N27F0uWLMHEiRPV7UOHDoWxsTG+/vprXLx4EXZ2dq0YJRERtQQOsyciIiJJS0tLg6urK1xdXWFpaYmdO3eqXwsODoa3t3eDfcLDwzFu3Dj19tmzZzFlyhTY29tDLpdjwYIFePLkifr19PR0DBgwALt374abmxs++OADFBYWQqVSYePGjfD09ISdnR0cHBzg7++PgoICjfPl5eXB19cXdnZ2GDVqFDIyMjBy5EgkJCSo+5SXl2Px4sUYMmQIbG1t8fHHHzc4zj+VlpZCCIHGBlqOHz8eERER6NSpk7qtrKwMixYtwpAhQ+Do6IjJkyfj3Llz6tdra2uRmJiI0aNHw9bWFh9++CE2btyI+vp6dZ+pU6ciKioKc+bMgZOTE6ZPn67ed+XKlXB3d8fAgQMxfvx4HDx48JXxExFR87GYJyIiIsm6efMmLly4AB8fHwCAr68vcnNz8ejRIwCAl5cXrl69iqKiIvU+VVVVyM3NhZeXFwDg119/RWBgIAwMDBAXF4dFixbhzJkzCAgIgEKhUO+nUqmQlJSEZcuWITw8HH379kVsbCwSExMxceJEpKSkYOnSpXj69Cnmzp2L6upqAMCpU6cQGhoKMzMzJCQkYPLkyYiJicGDBw/Ux66trcUnn3yCnJwczJs3D+vWrYOpqSmmTZv2yoLe2toaZmZmWL58OZYsWYJjx46hsrISAGBsbIwZM2agd+/eAIDq6mr4+/vj5MmTiIyMxLp169ChQwdMmzYNN2/ehBACM2fOREpKCvz8/JCUlITRo0cjLi4OMTExGuc9dOgQ9PX1kZiYiICAAAghMHv2bOzcuRNBQUHYsGEDHB0dMW/ePOzbt6+Z/10iInolQURERCRR33zzjXB2dhYKhUIIIcSjR49E//79RUJCghBCiKqqKuHg4KDeFkKIvXv3CisrK1FcXCyEEGLixInC09NTKJVKdZ+ioiLRv39/kZqaKoQQIi0tTchkMrFr1y6N80dERIjNmzdrtGVnZwuZTCZ+++03IYQQkyZNEuPHjxf19fXqPhkZGUImk4m1a9cKIYT48ccfhUwmE7///ru6T319vZg8ebLw9fV9ZQ6uX78uvLy8hEwmEzKZTFhbW4uPPvpIJCcni5qaGnW/1NRUYWVlJa5evapuUygUYvTo0eKHH34QeXl5QiaTif3792scPzExUchkMlFYWCiEEGLKlCli4MCBoqqqSt3n+PHjQiaTiczMTI19o6KixPvvvy9evHjxymsgIiLt8c48ERERSZJSqcSBAwcwYsQI1NbW4tmzZzAwMICrqyt2794NlUoFQ0NDjBw5UmO4d2ZmJuRyOczMzFBTU4MLFy7A3d0dQggolUoolUr07NkTffr0wYkTJzTOKZPJNLZXr16NwMBAPHnyBOfPn0d6ejoOHDgAAHjx4gXq6upw/vx5jBo1SmNSvlGjRkFP73+nLiooKED37t1hY2OjjkGlUsHDwwOXL19GRUVFk3mQyWTYt28f9uzZg/DwcLi6uqKwsBCrVq2Ct7e3+nGBs2fPwsLCAtbW1up927Vrh0OHDsHf3x9nzpyBrq4uxo4dq3H8CRMmAABOnz6tbrOwsIChoaFG/Do6OnB3d1fHr1QqMWzYMDx+/BiFhYVNxk9ERM3DCfCIiIhIkvLy8lBaWor09HSkp6c3eD03NxcjRoyAt7c39u/fj2vXrqFHjx44efIkli5dCgB49uwZ6uvrkZycjOTk5AbHaNeuncZ2t27dNLYvXbqEJUuW4NKlSzAwMEDfvn1hbm4OABBCoLy8HCqVqsF+enp66Nq1q3q7vLwcjx8/ho2NTaPX+vjxY3Tu3PmV+bC1tYWtrS1mzZqFmpoabN68GfHx8UhOTsaCBQtQXl7eII6/q6ioQNeuXTV+ZACA7t27AwCeP3+ubnvnnXc0+pSXl0MIAScnp0aPXVJSgv79+78yfiIi0g6LeSIiIpKkPXv2wNzcHMuXL2/w2pw5c7Bz506MGDECgwcPhomJCQ4dOgQTExPo6elh1KhRAIAOHTpAR0cHgYGBGhPi/aV9+/ZNnr+yshLTpk2DlZUVMjIy0KdPH7Rp0wZHjx5FdnY2gJfFv76+PsrKyjT2ra+vx9OnT9XbHTt2RO/evREbG9vouSwsLBptX7FiBXJzc5GVldUg7tDQUGRnZ+PGjRvqc9y7d6/BMc6fPw8jIyN07twZT58+hVKp1CjoS0pKAEDjx4d/6tixIwwNDbF169ZGX+/Vq1eT+xIRUfNwmD0RERFJTmlpKfLz8zFu3Dj1TPZ//xs7dixOnDiBu3fvok2bNvD09EROTg6ysrIwfPhwGBkZAQCMjIwwYMAAFBUVqe9s29raol+/fli3bp3G0PJ/KioqQnl5OQICAtCvXz+0afPya9WxY8cAvCzYdXV14eTkhCNHjmjs+8svv0CpVKq35XI5Hjx4gG7dumnEUVBQgJSUFOjq6jYag6WlJW7dutXorPFVVVUoKSlRPxrg7OyMu3fv4vr16+o+dXV1CAsLw65duyCXy6FSqRoc66/HBgYNGtRkLuRyOaqrqyGE0Ii/sLAQiYmJGtdKRET/HbwzT0RERJKzd+9eKJXKRu+mA4CPjw927NiBXbt2ITIyEt7e3ti0aRN0dXWxYcMGjb4RERGYPn06IiMjMWHCBKhUKnz33Xe4cOECZs2a1WQMlpaWMDIyQlJSEvT09KCnp4fs7Gzs2bMHAFBTUwPg5SiBqVOnYs6cOfDz80NxcTHi4+MBQP0cva+vL1JTUxEUFISZM2fCzMwMJ0+eRHJyMqZMmQJ9ff1GY/D29sZPP/2E6OhonD59Gu7u7ujUqRNu376NrVu3wsDAAMHBwepzbNu2DbNmzcLcuXNhbGyM7du3Q6FQYOrUqejZsydcXV0RExODkpISDBgwAGfOnEFycjJ8fHzQt2/fJnPh7u4OFxcXhIaGIjQ0FH369MHFixeRkJAANzc3GBsbN7kvERE1j44QjSxMSkRERPQWGzt2LNq0aYOMjIwm+4wZMwYVFRXIy8tD27Zt4e3tjUePHiE/P7/Bc+EFBQVYt24dLl++DH19fdjY2CAsLAzOzs4AXq4zv3DhQuTk5GgMeT99+jRWrlyJGzduoEOHDujfvz9CQ0MREhICf39/REdHAwCOHDmC+Ph43Lp1C+bm5pg7dy7mzZuHzz//HEFBQQBergG/evVq5OXl4fnz5zA3N4efnx+Cg4PVd/0bU1dXh61btyIrKwu3b9+GQqFAjx49MGzYMMyaNUvjOflHjx5h5cqVyM/Ph1KphL29PaKjo9XPs9fU1GDt2rXIzMzEkydPYGFhAT8/PwQFBalHB0ydOhUAsG3bNo04qqurER8fj6ysLJSVlcHExATjxo3D7NmzG8w9QEREr4/FPBEREVELysnJgampqcbkdoWFhfD09MT69esxfPjwVoyOiIikisPsiYiIiFrQ8ePHcfDgQURFRcHS0hIPHz7Ehg0b8N5778HNza21wyMiIoninXkiIiKiFqRQKBAfH4/s7GyUlJSgS5cuGDp0KCIjIxss8UZERPSfYjFPREREREREJDFcmo6IiIiIiIhIYljMExEREREREUkMi3kiIiIiIiIiiWExT0RERERERCQxLOaJiIiIiIiIJIbFPBEREREREZHEsJgnIiIiIiIikhgW80REREREREQSw2KeiIiIiIiISGL+B427kht/KDiKAAAAAElFTkSuQmCC",
      "text/plain": [
       "<Figure size 1000x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# plot the average score for each label\n",
    "plt.figure(figsize=(10, 6))\n",
    "sns.barplot(x=\"Top Score\", y=\"Top Label\", data=results_df, order=results_df['Top Label'].value_counts().index, palette='viridis')\n",
    "plt.title(\"Average Score for Top Labels\")\n",
    "plt.xlabel(\"Average Score\")\n",
    "plt.ylabel(\"Label\")\n",
    "plt.show()\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Cardiac Hypertrophy shows high recognition even though the frequency was low"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 450,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Top Label\n",
      "apoptosis                     0.840739\n",
      "cardiac hypertrophy           0.837218\n",
      "cancer                        0.830493\n",
      "proteasome                    0.796586\n",
      "ubiquitination                0.785451\n",
      "HSC70                         0.780414\n",
      "nucleotide exchange factor    0.736784\n",
      "LC3                           0.442942\n",
      "autophagy                     0.421015\n",
      "P62/SQSTM1                    0.160425\n",
      "Name: Top Score, dtype: float64\n"
     ]
    }
   ],
   "source": [
    "# Print the maximum score for each label\n",
    "top_scores = results_df.groupby('Top Label')['Top Score'].max().sort_values(ascending=False)\n",
    "print(top_scores)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### If less relevant sequences are filtered out the sequences with high propability can be further analyzed"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 451,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Label</th>\n",
       "      <th>Top Score</th>\n",
       "      <th>Sequence</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>ubiquitination</td>\n",
       "      <td>0.785451</td>\n",
       "      <td>enteral glutamine infusion modulates ubiquitination of heat shock proteins grp75 and apg2 in the human duodenal mucosa glutamine the most abundant amino acid in the human body plays several important roles in the intestine previous studies showed that glutamine may affect protein expression by regulating ubiquitinproteasome system we thus aimed to evaluate the effects of glutamine on ubiquitinated proteins in human duodenal mucosa five healthy male volunteers were included and received during 5 h on two occasions and in a random order either an enteral infusion of maltodextrins alone 025 g kg1 h1 control mimicking carbohydratefed state or maltodextrins with glutamine 0117 g kg1 h1 glutamine endoscopic duodenal biopsies were then taken total cellular protein extracts were separated by 2d gel electrophoresis and analyzed by an immunodetection using antiubiquitin antibody differentially ubiquitinated proteins were then identified by liquid chromatographyelectrospray ionization msms five proteins were differentially ubiquitinated between control and glutamine conditions among these proteins we identified two chaperone proteins grp75 and hsp74 grp75 was less ubiquitinated after glutamine infusion compared with control in contrast hsp74 also called apg2 was more ubiquitinated after glutamine in conclusion we provide evidence that glutamine may regulate ubiquitination processes of specific proteins ie grp75 and apg2 grp75 has protective and antiinflammatory properties while apg2 indirectly regulates stressinduced cell survival and proliferation through interaction with zo1 further studies should confirm these results in stress conditions</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>HSC70</td>\n",
       "      <td>0.780414</td>\n",
       "      <td>sequence and expression analysis of hsp70 family genes in artemia franciscana thus far only one gene from the heat shock protein 70 hsp70 family has been identified in artemia franciscana here we used the draft artemia transcriptome database to search for other genes in the hsp70 family four novel hsp70 genes were identified and designated heat shock cognate 70 hsc70 heat shock 70 kda cognate 5 hsc705 immunoglobulin heavychain binding protein bip and hypoxia upregulated protein 1 hyou1 for each of these genes we obtained nucleotide and deduced amino acid sequences and reconstructed a phylogenetic tree expression analysis revealed that in the juvenile state the transcription of hsp70 and hsc70 was significantly p  005 induction gene expression analysis demonstrated that not all members of the hsp70 family are involved in the response to heat stress and selection and that especially altered expression of hsc70 plays a role in a population selected for increased thermotolerance</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>HSC70</td>\n",
       "      <td>0.765236</td>\n",
       "      <td>association of met439thr substitution in heat shock protein 70 gene with postoperative atrial fibrillation and serum hsp70 protein levels background                    atrial fibrillation af is a common arrhythmia encountered following cardiac surgery previously we have shown that higher expression of heat shock protein hsp 70 was associated with decreased incidence of postoperative af poaf suggestive of an antiarrhythmic role              objective                    we have hypothesised that met493thr substitution of one of the important hsp70 genes may cause loss of these protective antiarrhythmic effects we therefore set out to examine the influence of hsp70 genotype on the incidence of poaf              methods and results                    we prospectively recruited 244 caucasian patients undergoing elective coronary artery bypass surgery the median age was 65 years 4080 years poaf was defined as the characteristic arrhythmia lasting for at least 15 min occurring within first week following surgery and requiring treatment this occurred in 48 patients 197 validated met493thr substitution in hsp70hom was determined using established techniques of 244 patients genotype was determined for 242 cases the three genotypes mm mt and tt were present at frequencies of 066 031 and 003 respectively and were in hardyweinberg equilibrium in unifactorial analysis patients carrier or homozygous for 493thr mutation had significantly higher incidence of poaf pearson chi2  43 p  0037 multivariate analysis confirmed the positive association of hsp70hom with poaf or 243 p  0016 independent of age sex previous myocardial infarction number of distal anastomoses and duration of ventilation respectively serum hsp70 was ranging from 074 to 3191 ngml median 289 and was not correlated with poaf presence of 493thr mutation was also significantly correlated with higher levels of serum hsp70 p  0009              conclusions                    our data show that a mutation in hsp70hom gene is associated with higher incidence of poaf these findings are consistent with our previous results and may suggest that patients harbouring this substitution will have less endogenous myocardial protection against af in stressful situations</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>proteasome</td>\n",
       "      <td>0.796586</td>\n",
       "      <td>relationship between the plasma proteome and changes in inflammatory markers after bariatric surgery severe obesity is a disease associated with multiple adverse effects on health metabolic bariatric surgery mbs can have significant effects on multiple body systems and was shown to improve inflammatory markers in previous shortterm followup studies we evaluated associations between changes in inflammatory markers crp il6 and tnf and circulating proteins after mbs              methods                    sequential window acquisition of all theoretical mass spectra swathms proteomics was performed on plasma samples taken at baseline presurgery and 6 and 12 months after mbs and concurrent analyses of inflammatorymetabolic parameters were carried out the change in absolute abundances of those proteins showing significant change at both 6 and 12 months was tested for correlation with the absolute and percentage  change in inflammatory markers              results                    we found the following results at 6 months there was a correlation between change in il6 and fold change in hspa4 rho  0659 p  0038 and in serpinf1 rho  0714 p  0020 at 12 months there was a positive correlation between change in il6 and fold change in the following proteinslgals3bp rho  0700 p  0036 hsp90b1 rho  0667 p  005 and ace rho  0667 p  005 we found significant inverse correlations at 12 months between change in tnf and the following proteins ephx2 and ace for both rho  0783 p  0013 we also found significant inverse correlations between change in crp at 12 months and shbg rho  0759 p  0029 l1cam rho  0904 p  0002 and ambp rho  0684 p  0042              conclusion                    using swathms we identified several proteins that are involved in the inflammatory response whose levels change in patients who achieve remission of t2dm after bariatric surgery in tandem with changes in il6 tnf andor crp future studies are needed to clarify the underlying mechanisms in how mbs decreases lowgrade inflammation</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>cardiac hypertrophy</td>\n",
       "      <td>0.837218</td>\n",
       "      <td>targeted disruption of hspa4 gene leads to cardiac hypertrophy and fibrosis failure of molecular chaperones to direct the correct folding of newly synthesized proteins leads to the accumulation of misfolded proteins in cells hspa4 is a member of the heat shock protein 110 family hsp110 that acts as a nucleotide exchange factor of hsp70 chaperones we found that the expression of hspa4 is upregulated in murine hearts subjected to pressure overload and in failing human hearts to investigate the cardiac function of hspa4 hspa4 knockout ko mice were generated and exhibited cardiac hypertrophy and fibrosis hspa4 ko hearts were characterized by a significant increase in heart weightbody weight ratio elevated expression of hypertrophic and fibrotic gene markers and concentric hypertrophy with preserved contractile function in response to pressure overload cardiac hypertrophy and remodeling were further aggravated in the hspa4 ko compared to wild type wt mice cardiac hypertrophy in hspa4 ko hearts was associated with enhanced activation of gp130stat3 camkii and calcineurinnfat signaling protein blot and immunofluorescent analyses showed a significant accumulation of polyubiquitinated proteins in cardiac cells of hspa4 ko mice these results suggest that the myocardial remodeling of hspa4 ko mice is due to accumulation of misfolded proteins resulting from impaired chaperone activity further analyses revealed a significant increase in cross sectional area of cardiomyocytes and in expression levels of hypertrophic markers in cultured neonatal hspa4 ko cardiomyocytes suggesting that the hypertrophy of mutant mice was a result of primary defects in cardiomyocytes gene expression profile in hearts of 35weekold mice revealed a differentially expressed gene sets related to ion channels musclespecific contractile proteins and stress response taken together our in vivo data demonstrate that hspa4 gene ablation results in cardiac hypertrophy and fibrosis possibly through its role in protein quality control mechanism</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                 Label  Top Score  \\\n",
       "0       ubiquitination   0.785451   \n",
       "1                HSC70   0.780414   \n",
       "2                HSC70   0.765236   \n",
       "3           proteasome   0.796586   \n",
       "4  cardiac hypertrophy   0.837218   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Sequence  \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        enteral glutamine infusion modulates ubiquitination of heat shock proteins grp75 and apg2 in the human duodenal mucosa glutamine the most abundant amino acid in the human body plays several important roles in the intestine previous studies showed that glutamine may affect protein expression by regulating ubiquitinproteasome system we thus aimed to evaluate the effects of glutamine on ubiquitinated proteins in human duodenal mucosa five healthy male volunteers were included and received during 5 h on two occasions and in a random order either an enteral infusion of maltodextrins alone 025 g kg1 h1 control mimicking carbohydratefed state or maltodextrins with glutamine 0117 g kg1 h1 glutamine endoscopic duodenal biopsies were then taken total cellular protein extracts were separated by 2d gel electrophoresis and analyzed by an immunodetection using antiubiquitin antibody differentially ubiquitinated proteins were then identified by liquid chromatographyelectrospray ionization msms five proteins were differentially ubiquitinated between control and glutamine conditions among these proteins we identified two chaperone proteins grp75 and hsp74 grp75 was less ubiquitinated after glutamine infusion compared with control in contrast hsp74 also called apg2 was more ubiquitinated after glutamine in conclusion we provide evidence that glutamine may regulate ubiquitination processes of specific proteins ie grp75 and apg2 grp75 has protective and antiinflammatory properties while apg2 indirectly regulates stressinduced cell survival and proliferation through interaction with zo1 further studies should confirm these results in stress conditions  \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     sequence and expression analysis of hsp70 family genes in artemia franciscana thus far only one gene from the heat shock protein 70 hsp70 family has been identified in artemia franciscana here we used the draft artemia transcriptome database to search for other genes in the hsp70 family four novel hsp70 genes were identified and designated heat shock cognate 70 hsc70 heat shock 70 kda cognate 5 hsc705 immunoglobulin heavychain binding protein bip and hypoxia upregulated protein 1 hyou1 for each of these genes we obtained nucleotide and deduced amino acid sequences and reconstructed a phylogenetic tree expression analysis revealed that in the juvenile state the transcription of hsp70 and hsc70 was significantly p  005 induction gene expression analysis demonstrated that not all members of the hsp70 family are involved in the response to heat stress and selection and that especially altered expression of hsc70 plays a role in a population selected for increased thermotolerance  \n",
       "2  association of met439thr substitution in heat shock protein 70 gene with postoperative atrial fibrillation and serum hsp70 protein levels background                    atrial fibrillation af is a common arrhythmia encountered following cardiac surgery previously we have shown that higher expression of heat shock protein hsp 70 was associated with decreased incidence of postoperative af poaf suggestive of an antiarrhythmic role              objective                    we have hypothesised that met493thr substitution of one of the important hsp70 genes may cause loss of these protective antiarrhythmic effects we therefore set out to examine the influence of hsp70 genotype on the incidence of poaf              methods and results                    we prospectively recruited 244 caucasian patients undergoing elective coronary artery bypass surgery the median age was 65 years 4080 years poaf was defined as the characteristic arrhythmia lasting for at least 15 min occurring within first week following surgery and requiring treatment this occurred in 48 patients 197 validated met493thr substitution in hsp70hom was determined using established techniques of 244 patients genotype was determined for 242 cases the three genotypes mm mt and tt were present at frequencies of 066 031 and 003 respectively and were in hardyweinberg equilibrium in unifactorial analysis patients carrier or homozygous for 493thr mutation had significantly higher incidence of poaf pearson chi2  43 p  0037 multivariate analysis confirmed the positive association of hsp70hom with poaf or 243 p  0016 independent of age sex previous myocardial infarction number of distal anastomoses and duration of ventilation respectively serum hsp70 was ranging from 074 to 3191 ngml median 289 and was not correlated with poaf presence of 493thr mutation was also significantly correlated with higher levels of serum hsp70 p  0009              conclusions                    our data show that a mutation in hsp70hom gene is associated with higher incidence of poaf these findings are consistent with our previous results and may suggest that patients harbouring this substitution will have less endogenous myocardial protection against af in stressful situations  \n",
       "3                                                                                                                                                                                                                               relationship between the plasma proteome and changes in inflammatory markers after bariatric surgery severe obesity is a disease associated with multiple adverse effects on health metabolic bariatric surgery mbs can have significant effects on multiple body systems and was shown to improve inflammatory markers in previous shortterm followup studies we evaluated associations between changes in inflammatory markers crp il6 and tnf and circulating proteins after mbs              methods                    sequential window acquisition of all theoretical mass spectra swathms proteomics was performed on plasma samples taken at baseline presurgery and 6 and 12 months after mbs and concurrent analyses of inflammatorymetabolic parameters were carried out the change in absolute abundances of those proteins showing significant change at both 6 and 12 months was tested for correlation with the absolute and percentage  change in inflammatory markers              results                    we found the following results at 6 months there was a correlation between change in il6 and fold change in hspa4 rho  0659 p  0038 and in serpinf1 rho  0714 p  0020 at 12 months there was a positive correlation between change in il6 and fold change in the following proteinslgals3bp rho  0700 p  0036 hsp90b1 rho  0667 p  005 and ace rho  0667 p  005 we found significant inverse correlations at 12 months between change in tnf and the following proteins ephx2 and ace for both rho  0783 p  0013 we also found significant inverse correlations between change in crp at 12 months and shbg rho  0759 p  0029 l1cam rho  0904 p  0002 and ambp rho  0684 p  0042              conclusion                    using swathms we identified several proteins that are involved in the inflammatory response whose levels change in patients who achieve remission of t2dm after bariatric surgery in tandem with changes in il6 tnf andor crp future studies are needed to clarify the underlying mechanisms in how mbs decreases lowgrade inflammation  \n",
       "4                                                                                                                                                                                                                    targeted disruption of hspa4 gene leads to cardiac hypertrophy and fibrosis failure of molecular chaperones to direct the correct folding of newly synthesized proteins leads to the accumulation of misfolded proteins in cells hspa4 is a member of the heat shock protein 110 family hsp110 that acts as a nucleotide exchange factor of hsp70 chaperones we found that the expression of hspa4 is upregulated in murine hearts subjected to pressure overload and in failing human hearts to investigate the cardiac function of hspa4 hspa4 knockout ko mice were generated and exhibited cardiac hypertrophy and fibrosis hspa4 ko hearts were characterized by a significant increase in heart weightbody weight ratio elevated expression of hypertrophic and fibrotic gene markers and concentric hypertrophy with preserved contractile function in response to pressure overload cardiac hypertrophy and remodeling were further aggravated in the hspa4 ko compared to wild type wt mice cardiac hypertrophy in hspa4 ko hearts was associated with enhanced activation of gp130stat3 camkii and calcineurinnfat signaling protein blot and immunofluorescent analyses showed a significant accumulation of polyubiquitinated proteins in cardiac cells of hspa4 ko mice these results suggest that the myocardial remodeling of hspa4 ko mice is due to accumulation of misfolded proteins resulting from impaired chaperone activity further analyses revealed a significant increase in cross sectional area of cardiomyocytes and in expression levels of hypertrophic markers in cultured neonatal hspa4 ko cardiomyocytes suggesting that the hypertrophy of mutant mice was a result of primary defects in cardiomyocytes gene expression profile in hearts of 35weekold mice revealed a differentially expressed gene sets related to ion channels musclespecific contractile proteins and stress response taken together our in vivo data demonstrate that hspa4 gene ablation results in cardiac hypertrophy and fibrosis possibly through its role in protein quality control mechanism  "
      ]
     },
     "execution_count": 451,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Define a threshold for considering a sequence as important\n",
    "threshold = 0.7\n",
    "\n",
    "# make a new dataframe with the important sequences for each label\n",
    "important_sequences_df = pd.DataFrame(columns=['Label','Top Score', 'Sequence'])\n",
    "\n",
    "for label in candidate_labels:\n",
    "    # Filter sequences with the current label\n",
    "    label_sequences = results_df[results_df['Top Label'] == label]\n",
    "    \n",
    "    # Filter important sequences\n",
    "    important_sequences = label_sequences[label_sequences['Top Score'] > threshold]\n",
    "    \n",
    "    # Create a temporary DataFrame for this label\n",
    "    temp_df = pd.DataFrame({\n",
    "        'Label': [label]*len(important_sequences),\n",
    "        'Top Score': important_sequences['Top Score'].tolist(),\n",
    "        'Sequence': important_sequences['Sentence'].tolist()\n",
    "    })\n",
    "    \n",
    "    # Append the result to the important_sequences_df DataFrame\n",
    "    important_sequences_df = pd.concat([important_sequences_df, temp_df], ignore_index=True)\n",
    "\n",
    "important_sequences_df.head()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Entity recognition with medspacy to indetify key players"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 452,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Label</th>\n",
       "      <th>Top Score</th>\n",
       "      <th>Sequence</th>\n",
       "      <th>Entities</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>ubiquitination</td>\n",
       "      <td>0.785451</td>\n",
       "      <td>enteral glutamine infusion modulates ubiquitination of heat shock proteins grp75 and apg2 in the human duodenal mucosa glutamine the most abundant amino acid in the human body plays several important roles in the intestine previous studies showed that glutamine may affect protein expression by regulating ubiquitinproteasome system we thus aimed to evaluate the effects of glutamine on ubiquitinated proteins in human duodenal mucosa five healthy male volunteers were included and received during 5 h on two occasions and in a random order either an enteral infusion of maltodextrins alone 025 g kg1 h1 control mimicking carbohydratefed state or maltodextrins with glutamine 0117 g kg1 h1 glutamine endoscopic duodenal biopsies were then taken total cellular protein extracts were separated by 2d gel electrophoresis and analyzed by an immunodetection using antiubiquitin antibody differentially ubiquitinated proteins were then identified by liquid chromatographyelectrospray ionization msms five proteins were differentially ubiquitinated between control and glutamine conditions among these proteins we identified two chaperone proteins grp75 and hsp74 grp75 was less ubiquitinated after glutamine infusion compared with control in contrast hsp74 also called apg2 was more ubiquitinated after glutamine in conclusion we provide evidence that glutamine may regulate ubiquitination processes of specific proteins ie grp75 and apg2 grp75 has protective and antiinflammatory properties while apg2 indirectly regulates stressinduced cell survival and proliferation through interaction with zo1 further studies should confirm these results in stress conditions</td>\n",
       "      <td>[(apg2, ORG), (five, CARDINAL), (5, CARDINAL), (two, CARDINAL), (025, CARDINAL), (2d, CARDINAL), (five, CARDINAL), (two, CARDINAL), (hsp74 grp75, PERSON), (apg2, ORG), (ie grp75, PERSON), (apg2, ORG), (apg2, ORG), (zo1, PERSON)]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>HSC70</td>\n",
       "      <td>0.780414</td>\n",
       "      <td>sequence and expression analysis of hsp70 family genes in artemia franciscana thus far only one gene from the heat shock protein 70 hsp70 family has been identified in artemia franciscana here we used the draft artemia transcriptome database to search for other genes in the hsp70 family four novel hsp70 genes were identified and designated heat shock cognate 70 hsc70 heat shock 70 kda cognate 5 hsc705 immunoglobulin heavychain binding protein bip and hypoxia upregulated protein 1 hyou1 for each of these genes we obtained nucleotide and deduced amino acid sequences and reconstructed a phylogenetic tree expression analysis revealed that in the juvenile state the transcription of hsp70 and hsc70 was significantly p  005 induction gene expression analysis demonstrated that not all members of the hsp70 family are involved in the response to heat stress and selection and that especially altered expression of hsc70 plays a role in a population selected for increased thermotolerance</td>\n",
       "      <td>[(70, CARDINAL), (four, CARDINAL), (70, CARDINAL), (70 kda, QUANTITY), (5, CARDINAL), (1, CARDINAL), (transcription, CARDINAL)]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>HSC70</td>\n",
       "      <td>0.765236</td>\n",
       "      <td>association of met439thr substitution in heat shock protein 70 gene with postoperative atrial fibrillation and serum hsp70 protein levels background                    atrial fibrillation af is a common arrhythmia encountered following cardiac surgery previously we have shown that higher expression of heat shock protein hsp 70 was associated with decreased incidence of postoperative af poaf suggestive of an antiarrhythmic role              objective                    we have hypothesised that met493thr substitution of one of the important hsp70 genes may cause loss of these protective antiarrhythmic effects we therefore set out to examine the influence of hsp70 genotype on the incidence of poaf              methods and results                    we prospectively recruited 244 caucasian patients undergoing elective coronary artery bypass surgery the median age was 65 years 4080 years poaf was defined as the characteristic arrhythmia lasting for at least 15 min occurring within first week following surgery and requiring treatment this occurred in 48 patients 197 validated met493thr substitution in hsp70hom was determined using established techniques of 244 patients genotype was determined for 242 cases the three genotypes mm mt and tt were present at frequencies of 066 031 and 003 respectively and were in hardyweinberg equilibrium in unifactorial analysis patients carrier or homozygous for 493thr mutation had significantly higher incidence of poaf pearson chi2  43 p  0037 multivariate analysis confirmed the positive association of hsp70hom with poaf or 243 p  0016 independent of age sex previous myocardial infarction number of distal anastomoses and duration of ventilation respectively serum hsp70 was ranging from 074 to 3191 ngml median 289 and was not correlated with poaf presence of 493thr mutation was also significantly correlated with higher levels of serum hsp70 p  0009              conclusions                    our data show that a mutation in hsp70hom gene is associated with higher incidence of poaf these findings are consistent with our previous results and may suggest that patients harbouring this substitution will have less endogenous myocardial protection against af in stressful situations</td>\n",
       "      <td>[(70, CARDINAL), (70, CARDINAL), (met493thr, PRODUCT), (one, CARDINAL), (244, CARDINAL), (65 years 4080 years, DATE), (at least 15, CARDINAL), (first week, DATE), (48, CARDINAL), (197, CARDINAL), (met493thr, PRODUCT), (244, CARDINAL), (242, CARDINAL), (066, CARDINAL), (003, CARDINAL), (hardyweinberg, GPE), (493thr, MONEY), (43, CARDINAL), (243 p  0016, QUANTITY), (074, CARDINAL), (3191, CARDINAL), (289, CARDINAL), (493thr, CARDINAL), (0009, DATE)]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>proteasome</td>\n",
       "      <td>0.796586</td>\n",
       "      <td>relationship between the plasma proteome and changes in inflammatory markers after bariatric surgery severe obesity is a disease associated with multiple adverse effects on health metabolic bariatric surgery mbs can have significant effects on multiple body systems and was shown to improve inflammatory markers in previous shortterm followup studies we evaluated associations between changes in inflammatory markers crp il6 and tnf and circulating proteins after mbs              methods                    sequential window acquisition of all theoretical mass spectra swathms proteomics was performed on plasma samples taken at baseline presurgery and 6 and 12 months after mbs and concurrent analyses of inflammatorymetabolic parameters were carried out the change in absolute abundances of those proteins showing significant change at both 6 and 12 months was tested for correlation with the absolute and percentage  change in inflammatory markers              results                    we found the following results at 6 months there was a correlation between change in il6 and fold change in hspa4 rho  0659 p  0038 and in serpinf1 rho  0714 p  0020 at 12 months there was a positive correlation between change in il6 and fold change in the following proteinslgals3bp rho  0700 p  0036 hsp90b1 rho  0667 p  005 and ace rho  0667 p  005 we found significant inverse correlations at 12 months between change in tnf and the following proteins ephx2 and ace for both rho  0783 p  0013 we also found significant inverse correlations between change in crp at 12 months and shbg rho  0759 p  0029 l1cam rho  0904 p  0002 and ambp rho  0684 p  0042              conclusion                    using swathms we identified several proteins that are involved in the inflammatory response whose levels change in patients who achieve remission of t2dm after bariatric surgery in tandem with changes in il6 tnf andor crp future studies are needed to clarify the underlying mechanisms in how mbs decreases lowgrade inflammation</td>\n",
       "      <td>[(6 and 12 months, DATE), (6 and 12 months, DATE), (6 months, DATE), (hspa4, GPE), (0659, DATE), (serpinf1, GPE), (0714 p  0020, ORG), (12 months, DATE), (0700 p  0036, LAW), (0667, DATE), (005, CARDINAL), (0667, DATE), (005, CARDINAL), (12 months, DATE), (ephx2, PERSON), (0783 p  0013, QUANTITY), (12 months, DATE), (0759, DATE), (0029, DATE), (0904 p  0002, DATE), (0684, DATE), (0042, DATE)]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>cardiac hypertrophy</td>\n",
       "      <td>0.837218</td>\n",
       "      <td>targeted disruption of hspa4 gene leads to cardiac hypertrophy and fibrosis failure of molecular chaperones to direct the correct folding of newly synthesized proteins leads to the accumulation of misfolded proteins in cells hspa4 is a member of the heat shock protein 110 family hsp110 that acts as a nucleotide exchange factor of hsp70 chaperones we found that the expression of hspa4 is upregulated in murine hearts subjected to pressure overload and in failing human hearts to investigate the cardiac function of hspa4 hspa4 knockout ko mice were generated and exhibited cardiac hypertrophy and fibrosis hspa4 ko hearts were characterized by a significant increase in heart weightbody weight ratio elevated expression of hypertrophic and fibrotic gene markers and concentric hypertrophy with preserved contractile function in response to pressure overload cardiac hypertrophy and remodeling were further aggravated in the hspa4 ko compared to wild type wt mice cardiac hypertrophy in hspa4 ko hearts was associated with enhanced activation of gp130stat3 camkii and calcineurinnfat signaling protein blot and immunofluorescent analyses showed a significant accumulation of polyubiquitinated proteins in cardiac cells of hspa4 ko mice these results suggest that the myocardial remodeling of hspa4 ko mice is due to accumulation of misfolded proteins resulting from impaired chaperone activity further analyses revealed a significant increase in cross sectional area of cardiomyocytes and in expression levels of hypertrophic markers in cultured neonatal hspa4 ko cardiomyocytes suggesting that the hypertrophy of mutant mice was a result of primary defects in cardiomyocytes gene expression profile in hearts of 35weekold mice revealed a differentially expressed gene sets related to ion channels musclespecific contractile proteins and stress response taken together our in vivo data demonstrate that hspa4 gene ablation results in cardiac hypertrophy and fibrosis possibly through its role in protein quality control mechanism</td>\n",
       "      <td>[(hspa4, GPE), (hspa4, ORG), (110, CARDINAL), (hspa4, GPE), (hspa4 hspa4, FAC), (ko mice, PERSON), (hspa4, PRODUCT), (hspa4, ORG), (hspa4, GPE), (hspa4, FAC), (hspa4, GPE), (hspa4, ORG), (35weekold, CARDINAL), (hspa4, GPE)]</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                 Label  Top Score  \\\n",
       "0       ubiquitination   0.785451   \n",
       "1                HSC70   0.780414   \n",
       "2                HSC70   0.765236   \n",
       "3           proteasome   0.796586   \n",
       "4  cardiac hypertrophy   0.837218   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Sequence  \\\n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        enteral glutamine infusion modulates ubiquitination of heat shock proteins grp75 and apg2 in the human duodenal mucosa glutamine the most abundant amino acid in the human body plays several important roles in the intestine previous studies showed that glutamine may affect protein expression by regulating ubiquitinproteasome system we thus aimed to evaluate the effects of glutamine on ubiquitinated proteins in human duodenal mucosa five healthy male volunteers were included and received during 5 h on two occasions and in a random order either an enteral infusion of maltodextrins alone 025 g kg1 h1 control mimicking carbohydratefed state or maltodextrins with glutamine 0117 g kg1 h1 glutamine endoscopic duodenal biopsies were then taken total cellular protein extracts were separated by 2d gel electrophoresis and analyzed by an immunodetection using antiubiquitin antibody differentially ubiquitinated proteins were then identified by liquid chromatographyelectrospray ionization msms five proteins were differentially ubiquitinated between control and glutamine conditions among these proteins we identified two chaperone proteins grp75 and hsp74 grp75 was less ubiquitinated after glutamine infusion compared with control in contrast hsp74 also called apg2 was more ubiquitinated after glutamine in conclusion we provide evidence that glutamine may regulate ubiquitination processes of specific proteins ie grp75 and apg2 grp75 has protective and antiinflammatory properties while apg2 indirectly regulates stressinduced cell survival and proliferation through interaction with zo1 further studies should confirm these results in stress conditions   \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     sequence and expression analysis of hsp70 family genes in artemia franciscana thus far only one gene from the heat shock protein 70 hsp70 family has been identified in artemia franciscana here we used the draft artemia transcriptome database to search for other genes in the hsp70 family four novel hsp70 genes were identified and designated heat shock cognate 70 hsc70 heat shock 70 kda cognate 5 hsc705 immunoglobulin heavychain binding protein bip and hypoxia upregulated protein 1 hyou1 for each of these genes we obtained nucleotide and deduced amino acid sequences and reconstructed a phylogenetic tree expression analysis revealed that in the juvenile state the transcription of hsp70 and hsc70 was significantly p  005 induction gene expression analysis demonstrated that not all members of the hsp70 family are involved in the response to heat stress and selection and that especially altered expression of hsc70 plays a role in a population selected for increased thermotolerance   \n",
       "2  association of met439thr substitution in heat shock protein 70 gene with postoperative atrial fibrillation and serum hsp70 protein levels background                    atrial fibrillation af is a common arrhythmia encountered following cardiac surgery previously we have shown that higher expression of heat shock protein hsp 70 was associated with decreased incidence of postoperative af poaf suggestive of an antiarrhythmic role              objective                    we have hypothesised that met493thr substitution of one of the important hsp70 genes may cause loss of these protective antiarrhythmic effects we therefore set out to examine the influence of hsp70 genotype on the incidence of poaf              methods and results                    we prospectively recruited 244 caucasian patients undergoing elective coronary artery bypass surgery the median age was 65 years 4080 years poaf was defined as the characteristic arrhythmia lasting for at least 15 min occurring within first week following surgery and requiring treatment this occurred in 48 patients 197 validated met493thr substitution in hsp70hom was determined using established techniques of 244 patients genotype was determined for 242 cases the three genotypes mm mt and tt were present at frequencies of 066 031 and 003 respectively and were in hardyweinberg equilibrium in unifactorial analysis patients carrier or homozygous for 493thr mutation had significantly higher incidence of poaf pearson chi2  43 p  0037 multivariate analysis confirmed the positive association of hsp70hom with poaf or 243 p  0016 independent of age sex previous myocardial infarction number of distal anastomoses and duration of ventilation respectively serum hsp70 was ranging from 074 to 3191 ngml median 289 and was not correlated with poaf presence of 493thr mutation was also significantly correlated with higher levels of serum hsp70 p  0009              conclusions                    our data show that a mutation in hsp70hom gene is associated with higher incidence of poaf these findings are consistent with our previous results and may suggest that patients harbouring this substitution will have less endogenous myocardial protection against af in stressful situations   \n",
       "3                                                                                                                                                                                                                               relationship between the plasma proteome and changes in inflammatory markers after bariatric surgery severe obesity is a disease associated with multiple adverse effects on health metabolic bariatric surgery mbs can have significant effects on multiple body systems and was shown to improve inflammatory markers in previous shortterm followup studies we evaluated associations between changes in inflammatory markers crp il6 and tnf and circulating proteins after mbs              methods                    sequential window acquisition of all theoretical mass spectra swathms proteomics was performed on plasma samples taken at baseline presurgery and 6 and 12 months after mbs and concurrent analyses of inflammatorymetabolic parameters were carried out the change in absolute abundances of those proteins showing significant change at both 6 and 12 months was tested for correlation with the absolute and percentage  change in inflammatory markers              results                    we found the following results at 6 months there was a correlation between change in il6 and fold change in hspa4 rho  0659 p  0038 and in serpinf1 rho  0714 p  0020 at 12 months there was a positive correlation between change in il6 and fold change in the following proteinslgals3bp rho  0700 p  0036 hsp90b1 rho  0667 p  005 and ace rho  0667 p  005 we found significant inverse correlations at 12 months between change in tnf and the following proteins ephx2 and ace for both rho  0783 p  0013 we also found significant inverse correlations between change in crp at 12 months and shbg rho  0759 p  0029 l1cam rho  0904 p  0002 and ambp rho  0684 p  0042              conclusion                    using swathms we identified several proteins that are involved in the inflammatory response whose levels change in patients who achieve remission of t2dm after bariatric surgery in tandem with changes in il6 tnf andor crp future studies are needed to clarify the underlying mechanisms in how mbs decreases lowgrade inflammation   \n",
       "4                                                                                                                                                                                                                    targeted disruption of hspa4 gene leads to cardiac hypertrophy and fibrosis failure of molecular chaperones to direct the correct folding of newly synthesized proteins leads to the accumulation of misfolded proteins in cells hspa4 is a member of the heat shock protein 110 family hsp110 that acts as a nucleotide exchange factor of hsp70 chaperones we found that the expression of hspa4 is upregulated in murine hearts subjected to pressure overload and in failing human hearts to investigate the cardiac function of hspa4 hspa4 knockout ko mice were generated and exhibited cardiac hypertrophy and fibrosis hspa4 ko hearts were characterized by a significant increase in heart weightbody weight ratio elevated expression of hypertrophic and fibrotic gene markers and concentric hypertrophy with preserved contractile function in response to pressure overload cardiac hypertrophy and remodeling were further aggravated in the hspa4 ko compared to wild type wt mice cardiac hypertrophy in hspa4 ko hearts was associated with enhanced activation of gp130stat3 camkii and calcineurinnfat signaling protein blot and immunofluorescent analyses showed a significant accumulation of polyubiquitinated proteins in cardiac cells of hspa4 ko mice these results suggest that the myocardial remodeling of hspa4 ko mice is due to accumulation of misfolded proteins resulting from impaired chaperone activity further analyses revealed a significant increase in cross sectional area of cardiomyocytes and in expression levels of hypertrophic markers in cultured neonatal hspa4 ko cardiomyocytes suggesting that the hypertrophy of mutant mice was a result of primary defects in cardiomyocytes gene expression profile in hearts of 35weekold mice revealed a differentially expressed gene sets related to ion channels musclespecific contractile proteins and stress response taken together our in vivo data demonstrate that hspa4 gene ablation results in cardiac hypertrophy and fibrosis possibly through its role in protein quality control mechanism   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                              Entities  \n",
       "0                                                                                                                                                                                                                                 [(apg2, ORG), (five, CARDINAL), (5, CARDINAL), (two, CARDINAL), (025, CARDINAL), (2d, CARDINAL), (five, CARDINAL), (two, CARDINAL), (hsp74 grp75, PERSON), (apg2, ORG), (ie grp75, PERSON), (apg2, ORG), (apg2, ORG), (zo1, PERSON)]  \n",
       "1                                                                                                                                                                                                                                                                                                                                      [(70, CARDINAL), (four, CARDINAL), (70, CARDINAL), (70 kda, QUANTITY), (5, CARDINAL), (1, CARDINAL), (transcription, CARDINAL)]  \n",
       "2  [(70, CARDINAL), (70, CARDINAL), (met493thr, PRODUCT), (one, CARDINAL), (244, CARDINAL), (65 years 4080 years, DATE), (at least 15, CARDINAL), (first week, DATE), (48, CARDINAL), (197, CARDINAL), (met493thr, PRODUCT), (244, CARDINAL), (242, CARDINAL), (066, CARDINAL), (003, CARDINAL), (hardyweinberg, GPE), (493thr, MONEY), (43, CARDINAL), (243 p  0016, QUANTITY), (074, CARDINAL), (3191, CARDINAL), (289, CARDINAL), (493thr, CARDINAL), (0009, DATE)]  \n",
       "3                                                          [(6 and 12 months, DATE), (6 and 12 months, DATE), (6 months, DATE), (hspa4, GPE), (0659, DATE), (serpinf1, GPE), (0714 p  0020, ORG), (12 months, DATE), (0700 p  0036, LAW), (0667, DATE), (005, CARDINAL), (0667, DATE), (005, CARDINAL), (12 months, DATE), (ephx2, PERSON), (0783 p  0013, QUANTITY), (12 months, DATE), (0759, DATE), (0029, DATE), (0904 p  0002, DATE), (0684, DATE), (0042, DATE)]  \n",
       "4                                                                                                                                                                                                                                      [(hspa4, GPE), (hspa4, ORG), (110, CARDINAL), (hspa4, GPE), (hspa4 hspa4, FAC), (ko mice, PERSON), (hspa4, PRODUCT), (hspa4, ORG), (hspa4, GPE), (hspa4, FAC), (hspa4, GPE), (hspa4, ORG), (35weekold, CARDINAL), (hspa4, GPE)]  "
      ]
     },
     "execution_count": 452,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Load the English language model for spaCy\n",
    "nlp = medspacy.load('en_core_web_sm', disable=['parser'])\n",
    "\n",
    "# Define a function to extract the entities from important sequences\n",
    "def extract_entities(sequence):\n",
    "    # Process the sequence with spaCy\n",
    "    doc = nlp(sequence)\n",
    "    \n",
    "    # Extract entities\n",
    "    entities = [(ent.text, ent.label_) for ent in doc.ents]\n",
    "\n",
    "    return entities\n",
    "\n",
    "# Apply the function to each sequence\n",
    "important_sequences_df['Entities'] = important_sequences_df['Sequence'].apply(extract_entities)\n",
    "\n",
    "important_sequences_df.head()\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### cleaning the entity list to identify names of genes"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 456,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Label</th>\n",
       "      <th>Top Score</th>\n",
       "      <th>Sequence</th>\n",
       "      <th>Entities</th>\n",
       "      <th>Cleaned Entities</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>ubiquitination</td>\n",
       "      <td>0.785451</td>\n",
       "      <td>enteral glutamine infusion modulates ubiquitination of heat shock proteins grp75 and apg2 in the human duodenal mucosa glutamine the most abundant amino acid in the human body plays several important roles in the intestine previous studies showed that glutamine may affect protein expression by regulating ubiquitinproteasome system we thus aimed to evaluate the effects of glutamine on ubiquitinated proteins in human duodenal mucosa five healthy male volunteers were included and received during 5 h on two occasions and in a random order either an enteral infusion of maltodextrins alone 025 g kg1 h1 control mimicking carbohydratefed state or maltodextrins with glutamine 0117 g kg1 h1 glutamine endoscopic duodenal biopsies were then taken total cellular protein extracts were separated by 2d gel electrophoresis and analyzed by an immunodetection using antiubiquitin antibody differentially ubiquitinated proteins were then identified by liquid chromatographyelectrospray ionization msms five proteins were differentially ubiquitinated between control and glutamine conditions among these proteins we identified two chaperone proteins grp75 and hsp74 grp75 was less ubiquitinated after glutamine infusion compared with control in contrast hsp74 also called apg2 was more ubiquitinated after glutamine in conclusion we provide evidence that glutamine may regulate ubiquitination processes of specific proteins ie grp75 and apg2 grp75 has protective and antiinflammatory properties while apg2 indirectly regulates stressinduced cell survival and proliferation through interaction with zo1 further studies should confirm these results in stress conditions</td>\n",
       "      <td>[(apg2, ORG), (five, CARDINAL), (5, CARDINAL), (two, CARDINAL), (025, CARDINAL), (2d, CARDINAL), (five, CARDINAL), (two, CARDINAL), (hsp74 grp75, PERSON), (apg2, ORG), (ie grp75, PERSON), (apg2, ORG), (apg2, ORG), (zo1, PERSON)]</td>\n",
       "      <td>[(apg2, ORG), (hsp74 grp75, PERSON), (apg2, ORG), (ie grp75, PERSON), (apg2, ORG), (apg2, ORG), (zo1, PERSON)]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>HSC70</td>\n",
       "      <td>0.780414</td>\n",
       "      <td>sequence and expression analysis of hsp70 family genes in artemia franciscana thus far only one gene from the heat shock protein 70 hsp70 family has been identified in artemia franciscana here we used the draft artemia transcriptome database to search for other genes in the hsp70 family four novel hsp70 genes were identified and designated heat shock cognate 70 hsc70 heat shock 70 kda cognate 5 hsc705 immunoglobulin heavychain binding protein bip and hypoxia upregulated protein 1 hyou1 for each of these genes we obtained nucleotide and deduced amino acid sequences and reconstructed a phylogenetic tree expression analysis revealed that in the juvenile state the transcription of hsp70 and hsc70 was significantly p  005 induction gene expression analysis demonstrated that not all members of the hsp70 family are involved in the response to heat stress and selection and that especially altered expression of hsc70 plays a role in a population selected for increased thermotolerance</td>\n",
       "      <td>[(70, CARDINAL), (four, CARDINAL), (70, CARDINAL), (70 kda, QUANTITY), (5, CARDINAL), (1, CARDINAL), (transcription, CARDINAL)]</td>\n",
       "      <td>[]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>HSC70</td>\n",
       "      <td>0.765236</td>\n",
       "      <td>association of met439thr substitution in heat shock protein 70 gene with postoperative atrial fibrillation and serum hsp70 protein levels background                    atrial fibrillation af is a common arrhythmia encountered following cardiac surgery previously we have shown that higher expression of heat shock protein hsp 70 was associated with decreased incidence of postoperative af poaf suggestive of an antiarrhythmic role              objective                    we have hypothesised that met493thr substitution of one of the important hsp70 genes may cause loss of these protective antiarrhythmic effects we therefore set out to examine the influence of hsp70 genotype on the incidence of poaf              methods and results                    we prospectively recruited 244 caucasian patients undergoing elective coronary artery bypass surgery the median age was 65 years 4080 years poaf was defined as the characteristic arrhythmia lasting for at least 15 min occurring within first week following surgery and requiring treatment this occurred in 48 patients 197 validated met493thr substitution in hsp70hom was determined using established techniques of 244 patients genotype was determined for 242 cases the three genotypes mm mt and tt were present at frequencies of 066 031 and 003 respectively and were in hardyweinberg equilibrium in unifactorial analysis patients carrier or homozygous for 493thr mutation had significantly higher incidence of poaf pearson chi2  43 p  0037 multivariate analysis confirmed the positive association of hsp70hom with poaf or 243 p  0016 independent of age sex previous myocardial infarction number of distal anastomoses and duration of ventilation respectively serum hsp70 was ranging from 074 to 3191 ngml median 289 and was not correlated with poaf presence of 493thr mutation was also significantly correlated with higher levels of serum hsp70 p  0009              conclusions                    our data show that a mutation in hsp70hom gene is associated with higher incidence of poaf these findings are consistent with our previous results and may suggest that patients harbouring this substitution will have less endogenous myocardial protection against af in stressful situations</td>\n",
       "      <td>[(70, CARDINAL), (70, CARDINAL), (met493thr, PRODUCT), (one, CARDINAL), (244, CARDINAL), (65 years 4080 years, DATE), (at least 15, CARDINAL), (first week, DATE), (48, CARDINAL), (197, CARDINAL), (met493thr, PRODUCT), (244, CARDINAL), (242, CARDINAL), (066, CARDINAL), (003, CARDINAL), (hardyweinberg, GPE), (493thr, MONEY), (43, CARDINAL), (243 p  0016, QUANTITY), (074, CARDINAL), (3191, CARDINAL), (289, CARDINAL), (493thr, CARDINAL), (0009, DATE)]</td>\n",
       "      <td>[(met493thr, PRODUCT), (met493thr, PRODUCT), (hardyweinberg, GPE)]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>proteasome</td>\n",
       "      <td>0.796586</td>\n",
       "      <td>relationship between the plasma proteome and changes in inflammatory markers after bariatric surgery severe obesity is a disease associated with multiple adverse effects on health metabolic bariatric surgery mbs can have significant effects on multiple body systems and was shown to improve inflammatory markers in previous shortterm followup studies we evaluated associations between changes in inflammatory markers crp il6 and tnf and circulating proteins after mbs              methods                    sequential window acquisition of all theoretical mass spectra swathms proteomics was performed on plasma samples taken at baseline presurgery and 6 and 12 months after mbs and concurrent analyses of inflammatorymetabolic parameters were carried out the change in absolute abundances of those proteins showing significant change at both 6 and 12 months was tested for correlation with the absolute and percentage  change in inflammatory markers              results                    we found the following results at 6 months there was a correlation between change in il6 and fold change in hspa4 rho  0659 p  0038 and in serpinf1 rho  0714 p  0020 at 12 months there was a positive correlation between change in il6 and fold change in the following proteinslgals3bp rho  0700 p  0036 hsp90b1 rho  0667 p  005 and ace rho  0667 p  005 we found significant inverse correlations at 12 months between change in tnf and the following proteins ephx2 and ace for both rho  0783 p  0013 we also found significant inverse correlations between change in crp at 12 months and shbg rho  0759 p  0029 l1cam rho  0904 p  0002 and ambp rho  0684 p  0042              conclusion                    using swathms we identified several proteins that are involved in the inflammatory response whose levels change in patients who achieve remission of t2dm after bariatric surgery in tandem with changes in il6 tnf andor crp future studies are needed to clarify the underlying mechanisms in how mbs decreases lowgrade inflammation</td>\n",
       "      <td>[(6 and 12 months, DATE), (6 and 12 months, DATE), (6 months, DATE), (hspa4, GPE), (0659, DATE), (serpinf1, GPE), (0714 p  0020, ORG), (12 months, DATE), (0700 p  0036, LAW), (0667, DATE), (005, CARDINAL), (0667, DATE), (005, CARDINAL), (12 months, DATE), (ephx2, PERSON), (0783 p  0013, QUANTITY), (12 months, DATE), (0759, DATE), (0029, DATE), (0904 p  0002, DATE), (0684, DATE), (0042, DATE)]</td>\n",
       "      <td>[(hspa4, GPE), (serpinf1, GPE), (0714 p  0020, ORG), (0700 p  0036, LAW), (ephx2, PERSON)]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>cardiac hypertrophy</td>\n",
       "      <td>0.837218</td>\n",
       "      <td>targeted disruption of hspa4 gene leads to cardiac hypertrophy and fibrosis failure of molecular chaperones to direct the correct folding of newly synthesized proteins leads to the accumulation of misfolded proteins in cells hspa4 is a member of the heat shock protein 110 family hsp110 that acts as a nucleotide exchange factor of hsp70 chaperones we found that the expression of hspa4 is upregulated in murine hearts subjected to pressure overload and in failing human hearts to investigate the cardiac function of hspa4 hspa4 knockout ko mice were generated and exhibited cardiac hypertrophy and fibrosis hspa4 ko hearts were characterized by a significant increase in heart weightbody weight ratio elevated expression of hypertrophic and fibrotic gene markers and concentric hypertrophy with preserved contractile function in response to pressure overload cardiac hypertrophy and remodeling were further aggravated in the hspa4 ko compared to wild type wt mice cardiac hypertrophy in hspa4 ko hearts was associated with enhanced activation of gp130stat3 camkii and calcineurinnfat signaling protein blot and immunofluorescent analyses showed a significant accumulation of polyubiquitinated proteins in cardiac cells of hspa4 ko mice these results suggest that the myocardial remodeling of hspa4 ko mice is due to accumulation of misfolded proteins resulting from impaired chaperone activity further analyses revealed a significant increase in cross sectional area of cardiomyocytes and in expression levels of hypertrophic markers in cultured neonatal hspa4 ko cardiomyocytes suggesting that the hypertrophy of mutant mice was a result of primary defects in cardiomyocytes gene expression profile in hearts of 35weekold mice revealed a differentially expressed gene sets related to ion channels musclespecific contractile proteins and stress response taken together our in vivo data demonstrate that hspa4 gene ablation results in cardiac hypertrophy and fibrosis possibly through its role in protein quality control mechanism</td>\n",
       "      <td>[(hspa4, GPE), (hspa4, ORG), (110, CARDINAL), (hspa4, GPE), (hspa4 hspa4, FAC), (ko mice, PERSON), (hspa4, PRODUCT), (hspa4, ORG), (hspa4, GPE), (hspa4, FAC), (hspa4, GPE), (hspa4, ORG), (35weekold, CARDINAL), (hspa4, GPE)]</td>\n",
       "      <td>[(hspa4, GPE), (hspa4, ORG), (hspa4, GPE), (hspa4 hspa4, FAC), (ko mice, PERSON), (hspa4, PRODUCT), (hspa4, ORG), (hspa4, GPE), (hspa4, FAC), (hspa4, GPE), (hspa4, ORG), (hspa4, GPE)]</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                 Label  Top Score  \\\n",
       "0       ubiquitination   0.785451   \n",
       "1                HSC70   0.780414   \n",
       "2                HSC70   0.765236   \n",
       "3           proteasome   0.796586   \n",
       "4  cardiac hypertrophy   0.837218   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Sequence  \\\n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        enteral glutamine infusion modulates ubiquitination of heat shock proteins grp75 and apg2 in the human duodenal mucosa glutamine the most abundant amino acid in the human body plays several important roles in the intestine previous studies showed that glutamine may affect protein expression by regulating ubiquitinproteasome system we thus aimed to evaluate the effects of glutamine on ubiquitinated proteins in human duodenal mucosa five healthy male volunteers were included and received during 5 h on two occasions and in a random order either an enteral infusion of maltodextrins alone 025 g kg1 h1 control mimicking carbohydratefed state or maltodextrins with glutamine 0117 g kg1 h1 glutamine endoscopic duodenal biopsies were then taken total cellular protein extracts were separated by 2d gel electrophoresis and analyzed by an immunodetection using antiubiquitin antibody differentially ubiquitinated proteins were then identified by liquid chromatographyelectrospray ionization msms five proteins were differentially ubiquitinated between control and glutamine conditions among these proteins we identified two chaperone proteins grp75 and hsp74 grp75 was less ubiquitinated after glutamine infusion compared with control in contrast hsp74 also called apg2 was more ubiquitinated after glutamine in conclusion we provide evidence that glutamine may regulate ubiquitination processes of specific proteins ie grp75 and apg2 grp75 has protective and antiinflammatory properties while apg2 indirectly regulates stressinduced cell survival and proliferation through interaction with zo1 further studies should confirm these results in stress conditions   \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     sequence and expression analysis of hsp70 family genes in artemia franciscana thus far only one gene from the heat shock protein 70 hsp70 family has been identified in artemia franciscana here we used the draft artemia transcriptome database to search for other genes in the hsp70 family four novel hsp70 genes were identified and designated heat shock cognate 70 hsc70 heat shock 70 kda cognate 5 hsc705 immunoglobulin heavychain binding protein bip and hypoxia upregulated protein 1 hyou1 for each of these genes we obtained nucleotide and deduced amino acid sequences and reconstructed a phylogenetic tree expression analysis revealed that in the juvenile state the transcription of hsp70 and hsc70 was significantly p  005 induction gene expression analysis demonstrated that not all members of the hsp70 family are involved in the response to heat stress and selection and that especially altered expression of hsc70 plays a role in a population selected for increased thermotolerance   \n",
       "2  association of met439thr substitution in heat shock protein 70 gene with postoperative atrial fibrillation and serum hsp70 protein levels background                    atrial fibrillation af is a common arrhythmia encountered following cardiac surgery previously we have shown that higher expression of heat shock protein hsp 70 was associated with decreased incidence of postoperative af poaf suggestive of an antiarrhythmic role              objective                    we have hypothesised that met493thr substitution of one of the important hsp70 genes may cause loss of these protective antiarrhythmic effects we therefore set out to examine the influence of hsp70 genotype on the incidence of poaf              methods and results                    we prospectively recruited 244 caucasian patients undergoing elective coronary artery bypass surgery the median age was 65 years 4080 years poaf was defined as the characteristic arrhythmia lasting for at least 15 min occurring within first week following surgery and requiring treatment this occurred in 48 patients 197 validated met493thr substitution in hsp70hom was determined using established techniques of 244 patients genotype was determined for 242 cases the three genotypes mm mt and tt were present at frequencies of 066 031 and 003 respectively and were in hardyweinberg equilibrium in unifactorial analysis patients carrier or homozygous for 493thr mutation had significantly higher incidence of poaf pearson chi2  43 p  0037 multivariate analysis confirmed the positive association of hsp70hom with poaf or 243 p  0016 independent of age sex previous myocardial infarction number of distal anastomoses and duration of ventilation respectively serum hsp70 was ranging from 074 to 3191 ngml median 289 and was not correlated with poaf presence of 493thr mutation was also significantly correlated with higher levels of serum hsp70 p  0009              conclusions                    our data show that a mutation in hsp70hom gene is associated with higher incidence of poaf these findings are consistent with our previous results and may suggest that patients harbouring this substitution will have less endogenous myocardial protection against af in stressful situations   \n",
       "3                                                                                                                                                                                                                               relationship between the plasma proteome and changes in inflammatory markers after bariatric surgery severe obesity is a disease associated with multiple adverse effects on health metabolic bariatric surgery mbs can have significant effects on multiple body systems and was shown to improve inflammatory markers in previous shortterm followup studies we evaluated associations between changes in inflammatory markers crp il6 and tnf and circulating proteins after mbs              methods                    sequential window acquisition of all theoretical mass spectra swathms proteomics was performed on plasma samples taken at baseline presurgery and 6 and 12 months after mbs and concurrent analyses of inflammatorymetabolic parameters were carried out the change in absolute abundances of those proteins showing significant change at both 6 and 12 months was tested for correlation with the absolute and percentage  change in inflammatory markers              results                    we found the following results at 6 months there was a correlation between change in il6 and fold change in hspa4 rho  0659 p  0038 and in serpinf1 rho  0714 p  0020 at 12 months there was a positive correlation between change in il6 and fold change in the following proteinslgals3bp rho  0700 p  0036 hsp90b1 rho  0667 p  005 and ace rho  0667 p  005 we found significant inverse correlations at 12 months between change in tnf and the following proteins ephx2 and ace for both rho  0783 p  0013 we also found significant inverse correlations between change in crp at 12 months and shbg rho  0759 p  0029 l1cam rho  0904 p  0002 and ambp rho  0684 p  0042              conclusion                    using swathms we identified several proteins that are involved in the inflammatory response whose levels change in patients who achieve remission of t2dm after bariatric surgery in tandem with changes in il6 tnf andor crp future studies are needed to clarify the underlying mechanisms in how mbs decreases lowgrade inflammation   \n",
       "4                                                                                                                                                                                                                    targeted disruption of hspa4 gene leads to cardiac hypertrophy and fibrosis failure of molecular chaperones to direct the correct folding of newly synthesized proteins leads to the accumulation of misfolded proteins in cells hspa4 is a member of the heat shock protein 110 family hsp110 that acts as a nucleotide exchange factor of hsp70 chaperones we found that the expression of hspa4 is upregulated in murine hearts subjected to pressure overload and in failing human hearts to investigate the cardiac function of hspa4 hspa4 knockout ko mice were generated and exhibited cardiac hypertrophy and fibrosis hspa4 ko hearts were characterized by a significant increase in heart weightbody weight ratio elevated expression of hypertrophic and fibrotic gene markers and concentric hypertrophy with preserved contractile function in response to pressure overload cardiac hypertrophy and remodeling were further aggravated in the hspa4 ko compared to wild type wt mice cardiac hypertrophy in hspa4 ko hearts was associated with enhanced activation of gp130stat3 camkii and calcineurinnfat signaling protein blot and immunofluorescent analyses showed a significant accumulation of polyubiquitinated proteins in cardiac cells of hspa4 ko mice these results suggest that the myocardial remodeling of hspa4 ko mice is due to accumulation of misfolded proteins resulting from impaired chaperone activity further analyses revealed a significant increase in cross sectional area of cardiomyocytes and in expression levels of hypertrophic markers in cultured neonatal hspa4 ko cardiomyocytes suggesting that the hypertrophy of mutant mice was a result of primary defects in cardiomyocytes gene expression profile in hearts of 35weekold mice revealed a differentially expressed gene sets related to ion channels musclespecific contractile proteins and stress response taken together our in vivo data demonstrate that hspa4 gene ablation results in cardiac hypertrophy and fibrosis possibly through its role in protein quality control mechanism   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                              Entities  \\\n",
       "0                                                                                                                                                                                                                                 [(apg2, ORG), (five, CARDINAL), (5, CARDINAL), (two, CARDINAL), (025, CARDINAL), (2d, CARDINAL), (five, CARDINAL), (two, CARDINAL), (hsp74 grp75, PERSON), (apg2, ORG), (ie grp75, PERSON), (apg2, ORG), (apg2, ORG), (zo1, PERSON)]   \n",
       "1                                                                                                                                                                                                                                                                                                                                      [(70, CARDINAL), (four, CARDINAL), (70, CARDINAL), (70 kda, QUANTITY), (5, CARDINAL), (1, CARDINAL), (transcription, CARDINAL)]   \n",
       "2  [(70, CARDINAL), (70, CARDINAL), (met493thr, PRODUCT), (one, CARDINAL), (244, CARDINAL), (65 years 4080 years, DATE), (at least 15, CARDINAL), (first week, DATE), (48, CARDINAL), (197, CARDINAL), (met493thr, PRODUCT), (244, CARDINAL), (242, CARDINAL), (066, CARDINAL), (003, CARDINAL), (hardyweinberg, GPE), (493thr, MONEY), (43, CARDINAL), (243 p  0016, QUANTITY), (074, CARDINAL), (3191, CARDINAL), (289, CARDINAL), (493thr, CARDINAL), (0009, DATE)]   \n",
       "3                                                          [(6 and 12 months, DATE), (6 and 12 months, DATE), (6 months, DATE), (hspa4, GPE), (0659, DATE), (serpinf1, GPE), (0714 p  0020, ORG), (12 months, DATE), (0700 p  0036, LAW), (0667, DATE), (005, CARDINAL), (0667, DATE), (005, CARDINAL), (12 months, DATE), (ephx2, PERSON), (0783 p  0013, QUANTITY), (12 months, DATE), (0759, DATE), (0029, DATE), (0904 p  0002, DATE), (0684, DATE), (0042, DATE)]   \n",
       "4                                                                                                                                                                                                                                      [(hspa4, GPE), (hspa4, ORG), (110, CARDINAL), (hspa4, GPE), (hspa4 hspa4, FAC), (ko mice, PERSON), (hspa4, PRODUCT), (hspa4, ORG), (hspa4, GPE), (hspa4, FAC), (hspa4, GPE), (hspa4, ORG), (35weekold, CARDINAL), (hspa4, GPE)]   \n",
       "\n",
       "                                                                                                                                                                          Cleaned Entities  \n",
       "0                                                                           [(apg2, ORG), (hsp74 grp75, PERSON), (apg2, ORG), (ie grp75, PERSON), (apg2, ORG), (apg2, ORG), (zo1, PERSON)]  \n",
       "1                                                                                                                                                                                       []  \n",
       "2                                                                                                                       [(met493thr, PRODUCT), (met493thr, PRODUCT), (hardyweinberg, GPE)]  \n",
       "3                                                                                               [(hspa4, GPE), (serpinf1, GPE), (0714 p  0020, ORG), (0700 p  0036, LAW), (ephx2, PERSON)]  \n",
       "4  [(hspa4, GPE), (hspa4, ORG), (hspa4, GPE), (hspa4 hspa4, FAC), (ko mice, PERSON), (hspa4, PRODUCT), (hspa4, ORG), (hspa4, GPE), (hspa4, FAC), (hspa4, GPE), (hspa4, ORG), (hspa4, GPE)]  "
      ]
     },
     "execution_count": 456,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# clean the entities by removing certain types like numbers, dates, etc.\n",
    "def clean_entities(entities):\n",
    "    cleaned_entities = []\n",
    "    for entity, label in entities:\n",
    "        if label not in ['CARDINAL', 'DATE', 'TIME', 'PERCENT', 'MONEY', 'QUANTITY']:\n",
    "            cleaned_entities.append((entity, label)) \n",
    "    return cleaned_entities\n",
    "\n",
    "# Apply the clean_entities function to the 'Entities' column and concatenate the results into a single list\n",
    "important_sequences_df['Cleaned Entities'] = important_sequences_df['Entities'].apply(clean_entities)\n",
    "\n",
    "important_sequences_df.head()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 467,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAA1wAAAImCAYAAABHK4vXAAAAOXRFWHRTb2Z0d2FyZQBNYXRwbG90bGliIHZlcnNpb24zLjguMCwgaHR0cHM6Ly9tYXRwbG90bGliLm9yZy81sbWrAAAACXBIWXMAAA9hAAAPYQGoP6dpAAA/M0lEQVR4nO39eZhXdf0//t+HZVhkUdwwUTEVCEvEWBVFKd/ZoqlZueAO4gZugVoqLpjmEoqIW0C5kKS4lGFq+TY1E3FJfbul9UFBWTQIBEbW+f3hj/k2DigDc2YavN2ui+tinuf5OufxOj4G5z7nec6rpLy8vDwAAADUuAZ1XQAAAMCGSuACAAAoiMAFAABQEIELAACgIAIXAABAQQQuAACAgghcAAAABRG4AAAACiJwAdQSnzP/3+mz/rv47wbA+hC4gM+FI488Mh07dsyhhx66xjlnnHFGOnbsmHPOOadGjz1r1qwMGjQo77777mfOXblyZe66664cccQR6dmzZ3bbbbccdNBBufXWW7N06dIarau+ue6669KxY8dP/bNo0aK13t+CBQty9tln59lnn60YO/LII3PkkUdWfH3XXXflZz/7WcXX99xzTzp27JgZM2bUzJv6FFdddVV69uyZXXfdNffdd1+N7nvKlCnp2LFjpkyZst776tevX418z6zLua3u+3jooYdy/PHHZ/fdd8+uu+6a73znO7n++uuzcOHCSvPKyspyxRVXZJ999kmXLl3ywx/+MI8//ni13g/AKo3qugCA2tKgQYP87W9/y8yZM7PVVltV2lZWVpbHHnuskOM+9dRTeeyxx3L++ed/6ryysrKceOKJefHFF3PYYYdlwIABady4caZMmZKrrroqf/7zn3PDDTektLS0kDrri4kTJ65xW7NmzdZ6P6+99lruu+++HHzwwRVjw4cPrzTnhhtuSI8ePSq+3nvvvTNx4sRsscUW1ai4+v7+97/nlltuyQ9+8IN897vfzRe/+MVCj7ehW7lyZYYOHZo//OEP+d73vpfDDjssG220UV588cWMHTs2jzzySH71q1+ldevWSZJzzz03TzzxRM4666y0b98+9957b0488cTceuut6datWx2/G6C+EbiAz43OnTvnrbfeyh/+8Icce+yxlbY9+uijadKkSVq2bFlH1SWXXXZZnn/++dx2223ZddddK8b79OmTzp075/TTT88dd9xRpfbPm/88NzVtxx13/NTtbdq0SZs2bQo7/ir//ve/kyTf/va3/YBfA37xi1/kgQceyOjRo7PvvvtWjPfu3Tu9evXKYYcdluuuuy7nnXde3nnnnTz44IMZPnx4Dj/88CRJr1698vzzz2fChAn+ewDVZkkh8LnRvHnz9O3bNw8++GCVbZMnT85+++2XRo0q/x5qyZIluf7667PffvvlK1/5Sv7nf/4nN998c1auXFkxZ/r06TnppJPSs2fPiuVHf/7zn5N8vEzq3HPPTZJ87WtfW+PSq7lz52bSpEn53ve+t9pA8c1vfjPHH3982rZtWzH24Ycf5rLLLsvXv/71fOUrX8l3vvOd3H333ZVe169fv4wePTqXXXZZevbsma5du+ass87KokWLcvPNN2evvfbKV7/61QwePDjz5s1b79etWLEid9xxR/bff//ssssu2XvvvXPVVVdlyZIlFXPOOeecHHPMMZk0aVK+8Y1v5Mtf/nIOOOCAinNWEz7rGFOmTMlRRx2VJDnqqKMqlhH+55LCfv365d133829995bsdRtdcvenn322fTv3z9dunRJjx49cvbZZ2fu3LkV21euXJlrr702/fr1y5e//OX069cvP//5z7Ns2bLV1n7ddddV1HD00UenX79+Sdb+3B599NEZPnx4unXrloMOOijLly9f5/M4Y8aMDBs2LH369MnOO++c3r17Z9iwYZX+myfJsmXLMmLEiHTv3j3du3evcg7W5jx90qrlgvfcc88617+qtnHjxmWvvfaqFLZW2XXXXXP66adnp512SpK0bds2d999dw444ICKOQ0aNEijRo0+98t6gXXjChfwufKtb30rp512Wt5777184QtfSJIsXLgwjz/+eMaPH1/pPo3y8vKceOKJ+dvf/pZTTjklX/rSlzJlypRcc801mT59ei655JKsXLkygwYNyuabb54rrrgijRo1yq233pqTTz45kydPzt57752TTjopN9xwQ0aPHp2OHTuutq6//vWvWb58efbZZ5811j5s2LCKv3/00Uc5/PDD88EHH2Tw4MHZZptt8sc//jE/+clP8sEHH+TEE0+smDt+/PjsvvvuGTlyZF5++eX8/Oc/zyuvvJItt9wyl1xySf7f//t/ueKKK7LZZptVWlK3Lq+74IILct9992XAgAHp0aNHXn311Vx//fV57bXX8otf/CIlJSVJkv/7v//LnDlzMmTIkLRo0SLXXntthgwZkscff7xiWdearClANGjQIA0a/H+/R/y0Y+y888654IILcvHFF+eCCy5Iz549q+xv9OjROeGEE9K5c+ecfPLJq11GOHXq1Bx77LHp1atXrrnmmsyfPz/XXnttjjrqqNx9991p2rRpbrnlltxxxx05++yzs8022+TFF1/MyJEj07hx4wwePLjKPr///e+nTZs2FbV17dq1Wuf22WefTUlJSa677rosWrSoyi8R1lZZWVmOOuqobLLJJhk+fHhatmyZ5557Ltdff32aNGmSSy65pGLugw8+mF122SWXX3555s6dm6uuuipvv/127rzzzrU+T5+08847Z+LEidl2223Xqf5VXnnllcybN+9Tv7cGDRpU8ffS0tJ85StfSfJxWJ41a1bGjx+fd9555zOXBQOsjsAFfK7svffead68ef7whz/kuOOOS5I88sgjadOmTb761a9Wmvv444/nqaeeypVXXlnx2+499tgjTZs2zbXXXpujjz46rVu3zj/+8Y+ceOKJ6du3b5Jkl112yejRo7NkyZJst912FT8wfulLX0q7du1WW9esWbOSZI3bP+mee+7J3//+90yYMKGi7j333DPLly/PmDFjcuihh2bjjTdOkmy00UYZOXJkGjVqlN133z333ntv5syZk7vuuistW7ZM37598/TTT+f555+vdIzqvu6tt97K3XffndNPPz0nnXRSxfnaYostMmzYsDz++OMV5+jDDz/MPffcU3Fumjdvnv79++fpp5/ON77xjU997zvvvPNqxw855JBceumlFV9/1jFWLR/ccccdV7uUsHPnziktLU2bNm3WuIzx6quvzvbbb5+bbropDRs2TJJ06dIl3/72tzNp0qQcccQReeaZZ7Lzzjvne9/7XpKkR48eadasWVq0aLHafbZt27ZSbauWwq7tuV2+fHkuuuiibLfddp96Hj/LtGnT0rZt21x++eUV57BXr155+eWX88wzz1Sa26pVq/ziF7+oeE+bbLJJTjnllDz55JPp06fPWp2nT2rRokWNLB+t7vfWf7rppptyzTXXJPm4v/7zfj6AtWVJIfC50rRp0/Tr16/SssLf//73+da3vlVxhWCVZ555Jg0bNsy3vvWtSuOrwteUKVOy2WabZccdd8z555+fc845J5MnT055eXnOPffcdOjQYa3rWnVl5j+XKn6aZ555JltvvXWVkHjAAQdkyZIlefHFFyvGdtlll0pXOTbffPN88YtfrHS/2sYbb5wPP/yw0r6q+7pVP4Tvv//+lfbz7W9/Ow0bNqz0JLk2bdpUunKxaqlkWVnZZ773u+++e7V/Tj755Erz1ucYa6OsrCwvvvhi+vbtm/Ly8ixfvjzLly/PNttskx122CF/+ctfkiQ9e/bMU089lcMPPzzjx4/PP/7xj/Tv3z8HHnjgWh+rOue2adOm631VKPn4FwQTJkxIu3btMn369DzxxBMZN25c/vnPf1ZZDtm3b99KAbJfv35p3LhxnnrqqbU+T0Wp7vfWf+rXr19uv/32nHPOOXnwwQcrwi5AdbjCBXzufPOb38wpp5ySGTNmZKONNspf//rXnH766VXmzZ8/P5tsskmVJVmbb755ko+voJSUlGTcuHG54YYb8sgjj+Tee+9N48aN8/Wvfz0XXnhhxVWmz7L11lsnSd57772Ke0k+6f3336+oZ/78+dlss82qzFk1tmDBgoqx1V1JWZun+VX3dfPnz0/y/52fVRo1apRNNtmkUqD75H5Whd21+aF41XKvz7I+x1gbCxYsyMqVK3PLLbfklltuqbK9SZMmSZIBAwZko402yqRJk/Kzn/0sl19+eTp06JAf//jH6d2791odqzrndtNNN63yy4N1NX78+Nx0002ZN29eNttss+y8885p1qxZlXD+yV5s0KBBNt544yxYsGCtz1NRVn1vfdrHMsydOzcbbbRRlVpWLQHu3r17WrZsmZ/85Cd57rnnqvyiA+DTCFzA585ee+2Vli1b5qGHHkrLli3Trl27fPnLX64yr3Xr1pk3b16WL19eKXTNmTMnycfLppJkyy23zIUXXpjhw4fn9ddfzx/+8Ifccsstad26dS666KK1qqlXr15p3Lhx/vznP1csDfukQYMGpaysLA8++GBat26dt99+u8qc999/v1JttWnVvVfvv/9+peVby5Yty7x58+qkpiJttNFGKSkpyTHHHJNvf/vbVbavCnwNGjTIEUcckSOOOCL/+te/8uc//zk33nhjBg8enKeeemqtHvNfF+f2d7/7XS6//PKcddZZOeSQQyqeznjaaafl5ZdfrjT3PwN+8vEDPubNm5dNN910rc9TUb70pS9ls802y+OPP77apYtJcuGFF+bpp5/O448/nvfffz9PP/10DjjggEoBbFXQX7VEEWBtWVIIfO6Ulpbma1/7Wh5++OE8+OCDq/0hMPn4XpsVK1Zk8uTJlcZ/+9vfJkm++tWv5oUXXsjuu++el156KSUlJfnSl76UM844Ix06dKj4wew/H+SwJq1atcohhxyS3/zmN3nppZeqbH/ggQfyyiuv5Lvf/W6Sj3/j/u677+a5556rUlvjxo2zyy67fPaJqGGr7m/53e9+V2n897//fVasWPFfd1Vg1b1En+bT/tu1aNEinTt3zj//+c985Stfqfiz0047ZfTo0RXL/A499NCMGDEiycdXnw4++OAcccQR+fDDD6t84O6a1MW5fe6559KyZcuccMIJFWFr0aJFee6556pcJXzqqacqPczkoYceyvLly9OzZ8+1Pk9FadCgQY455pg89thj+dOf/lRl+9SpU/Poo4/mG9/4Rpo2bZoZM2bkvPPOy8MPP1xp3hNPPJEk6dSpU6H1AhseV7iAz6VvfetbGTRoUBo0aJDzzjtvtXP22muv9OzZM8OHD8+cOXPSuXPnPPPMM7nlllty0EEHZccdd8ySJUvStGnTDBs2LIMHD85mm22Wp556Kq+99lrFY8dbtWqV5OOHc+y1117ZYYcdVnu8M888My+//HKOPvroHHHEEenZs2eWL1+eJ554Ir/5zW+y1157ZcCAAUmSgw8+OBMmTMipp56aIUOGZJtttsmjjz6aSZMm5dRTT604Zm3acccdc9BBB2X06NH56KOP0rNnz7z22msZPXp0evbsmT333LNGjvO3v/1tjdvat2+/1ss4V92L9thjj6V169ar/UG6VatWefXVV/PMM8+sNsSeeeaZOeGEE3LWWWflgAMOyIoVKzJu3Li8+OKLFff7dO/ePePGjctmm22Wrl27Zvbs2Rk/fnx69Oix1p/pVdS5feihh/Laa69VGT/kkEOyyy675Ne//nUuv/zy7LPPPpkzZ07Gjh2bDz74oMqTJFc9LfPII4/MtGnT8vOf/zx77LFHxZLJtTlPn7Rw4cK89dZb2XbbbT/zPH3a+2jRokWOOeaYTJ06NUOGDMn3v//97L333mnQoEGeffbZ3Hbbbdlpp51y9tlnJ/k43Pbs2TOXXHJJFixYkC9+8Yt5+umnM3bs2Pzwhz9c4/cvwJoIXMDn0u67755WrVplq622WuMPUCUlJbnpppsyatSo3HrrrZk7d27atWuXM844o+LDh5s0aZJx48bl6quvzqWXXpoFCxakffv2ufjii3PwwQcn+fihCbvvvnuuvvrq/PWvf83NN9+82uO1atUqt912W26//fZMnjw5d955Z8rLy7Pddtvl3HPPzfe///2KpY3NmjXLbbfdlquvvjqjRo3KwoUL88UvfjGXXnppDjnkkALO2Nq59NJLs91222XSpEkZO3Zstthiixx55JE55ZRT1upK39r44Q9/uMZt1157bfbbb7+12s9OO+2U73znO7njjjvyxBNP5IEHHqgy57jjjstPf/rTHH/88Rk/fnyV7X369MnYsWMzevToDBkyJI0bN87OO++c8ePHVzxh77TTTktpaWkmTZqU66+/Pi1btky/fv1y1llnrd0b/v8r4tzecccdqx3/+te/noMOOigzZszIpEmTMmHChGy55Zbp27dvDj/88Jx//vl56623Kp6m+IMf/CAfffRRTjnllJSWlmb//ffP0KFDK+4lW5vz9EmvvPJKjjrqqFx22WUV30vr8j5atGiRxo0bZ8yYMZk4cWLuv//+PPjgg1m6dGnatWuXQYMG5cgjj8xGG22U5OMrn2PGjMn111+fsWPHZs6cOWnXrl1+9KMfVfwSBaA6SsrLy8vruggAAIANkXu4AAAACiJwAQAAFOS/KnCNGTMmRx555KfOmTdvXs4666x079493bt3z/nnn5/FixfXUoUAAABr778mcP3yl7/MqFGjPnPekCFDMn369Ir5f/nLX9b6c24AAABqU50/pXD27NkVn9y+/fbbf+rcF154Ic8880wmT55c8VSxiy++OAMGDMiZZ56ZLbfcsjZKBgAAWCt1foXrlVdeSevWrfPb3/42Xbp0+dS5zz77bDbffPNKj3Du0aNHSkpKqnz4JwAAQF2r8ytc/fr1S79+/dZq7uzZs7PVVltVGistLc3GG2+cmTNnrtPxX3jhhZSXl6dx48br9HoAAGDDsGzZspSUlKRr1641ts86D1zVUVZWltLS0irjTZo0yZIlS9Zpn+Xl5SkvL8/SpUvXtzwAAIBK6lXgatq06WqD0ZIlS9K8efN12mfjxo2zdOnStG/fPs2aNVvfEmGNysrKMm3aNL1G4fQatUWvUVv0GrXlzTffTIMGNXvXVb0KXG3bts0f//jHSmNLly7Nv//97/V+YEazZs3WObRBdeg1aoteo7boNWqLXqNoJSUlNb7POn9oRnV07949s2bNyttvv10xNmXKlCTJbrvtVldlAQAArNZ/deBasWJF3n///Xz00UdJki5dumS33XbLGWeckZdeeilPP/10hg8fngMPPNAj4QEAgP86/9WBa+bMmenTp08mT56c5ONLfKNHj067du1y9NFH5/TTT89ee+2VCy+8sG4LBQAAWI3/qnu4Lr/88kpft2vXLm+88UalsU033TSjRo2qzbIAAADWyX/1FS4AAID6TOACAAAoiMAFAABQEIELAACgIAIXAABAQQQuAACAgghcAAAABRG4AAAACiJwAQAAFETgAgAAKIjABQAAUBCBCwAAoCACFwAAQEEELgAAgIIIXAAAAAURuAAAAAoicAEAABRE4AIAACiIwAUAAFAQgQsAAKAgAhcAAEBBBC4AAICCCFwAAAAFEbgAAAAKInABAAAUROACAAAoiMAFAABQEIELAACgIAIXAABAQQQuAACAgghcAAAABRG4AAAACiJwAQAAFETgAgAAKIjABQAAUBCBCwAAoCACFwAAQEEELgAAgIIIXAAAAAURuAAAAAoicAEAABRE4AIAACiIwAUAAFAQgQsAAKAgAhcAAEBBBC4AAICCCFwAAAAFEbgAAAAKInABAAAUROACAAAoiMAFAABQEIELAACgIAIXAABAQQQuAACAgghcAAAABRG4AAAACiJwAQAAFETgAgAAKIjABQAAUBCBCwAAoCACFwAAQEEELgAAgIIIXAAAAAURuAAAAAoicAEAABRE4AIAACiIwAUAAFAQgQsAAKAgAhcAAEBBBC4AAICCCFwAAAAFEbgAAAAKInABAAAUROACAAAoiMAFAABQEIELAACgIAIXAABAQQQuAACAgghcAAAABRG4AAAAClLngWvlypUZNWpU9txzz3Tp0iXHHXdc3n777TXOf//993PmmWemZ8+e6dmzZ0477bTMmjWrFisGAABYO3UeuMaMGZM777wzI0aMyMSJE1NSUpKBAwdm6dKlq51/xhlnZObMmRk/fnzGjx+fWbNm5eSTT67lqgEAAD5bnQaupUuXZty4cRk8eHD69u2bTp06ZeTIkZk9e3YeeeSRKvMXLFiQqVOnZuDAgencuXM6d+6cE044Ia+88krmzZtXB+8AAABgzeo0cL3++utZtGhRevXqVTHWqlWrdO7cOVOnTq0yv0mTJmnevHnuu+++LFy4MAsXLsz999+f9u3bp3Xr1rVZOgAAwGdqVJcHX3Xv1VZbbVVpfIsttsjMmTOrzG/SpEkuvfTSXHzxxenWrVtKSkqy+eab5/bbb0+DBnW+OhIAAKCSOg1cZWVlSZLS0tJK402aNMn8+fOrzC8vL88bb7yRrl27ZsCAAVmxYkVGjhyZU045Jb/+9a/TokWL9a4FirKqx/QaRdNr1Ba9Rm3Ra9SW8vLylJSU1Og+6zRwNW3aNMnH93Kt+nuSLFmyJM2aNasy//e//30mTJiQ//3f/60IVzfeeGP22WefTJo0KUcfffQ61zJt2rR1fi1Uh16jtug1aoteo7boNWrDJy8Gra86DVyrlhLOmTMn2267bcX4nDlz0qlTpyrzn3vuuWy//faVrmS1bt0622+//Xp/A7Zv3361IQ9qSllZWaZNm6bXKJxeo7boNWqLXqO2vPnmmzW+zzoNXJ06dUqLFi0yZcqUisC1YMGCvPrqq+nfv3+V+VtttVUmT56cJUuWpEmTJkk+/gacMWNG9t9///WqpVmzZmnevPl67QPWhl6jtug1aoteo7boNYpW08sJkzp+SmFpaWn69++fq666Kn/605/y+uuv54wzzkjbtm2z7777ZsWKFXn//ffz0UcfJUkOPPDAJMnpp5+e119/vWJ+aWlpDj744Dp8JwAAAFXV+aP9hgwZkkMOOSTnnXdeDjvssDRs2DBjx45NaWlpZs6cmT59+mTy5MlJPn564YQJE1JeXp6jjz46xx57bBo3bpxf//rXadWqVR2/EwAAgMrqdElhkjRs2DBDhw7N0KFDq2xr165d3njjjUpjO+ywQ2688cbaKg8AAGCd1fkVLgAAgA2VwAUAAFAQgQsAAKAgAhcAAEBBBC4AAICCCFwAAAAFEbgAAAAKInABAAAUROACAAAoiMAFAABQEIELAACgIAIXAABAQQQuAACAgghcAAAABRG4AAAACiJwAQAAFETgAgAAKIjABQAAUBCBCwAAoCACFwAAQEEELgAAgIIIXAAAAAURuAAAAAoicAEAABRE4AIAACiIwAUAAFAQgQsAAKAgAhcAAEBBBC4AAICCCFwAAAAFEbgAAAAKInABAAAUROACAAAoiMAFAABQEIELAACgIAIXAABAQQQuAACAgghcAAAABRG4AAAACiJwAQAAFETgAgAAKIjABQAAUBCBCwAAoCACFwAAQEEELgAAgIIIXAAAAAURuAAAAAoicAEAABRE4AIAACiIwAUAAFAQgQsAAKAgAhcAAEBBBC4AAICCCFwAAAAFEbgAAAAKInABAAAUROACAAAoiMAFAABQEIELAACgIAIXAABAQQQuAACAgghcAAAABRG4AAAACiJwAQAAFETgAgAAKIjABQAAUBCBCwAAoCACFwAAQEEELgAAgIIIXAAAAAURuAAAAAoicAEAABRE4AIAACiIwAUAAFAQgQsAAKAgAhcAAEBBBC4AAICCCFwAAAAFEbgAAAAKInABAAAUROACAAAoSJ0HrpUrV2bUqFHZc88906VLlxx33HF5++231zh/2bJlufrqq7Pnnntm1113Tf/+/fPaa6/VYsUAAABrp84D15gxY3LnnXdmxIgRmThxYkpKSjJw4MAsXbp0tfMvvPDC3H333bnkkksyadKkbLzxxhk4cGA+/PDDWq4cAADg09Vp4Fq6dGnGjRuXwYMHp2/fvunUqVNGjhyZ2bNn55FHHqkyf/r06bn77rtz2WWXZe+9984OO+yQn/70pyktLc3//d//1cE7AAAAWLM6DVyvv/56Fi1alF69elWMtWrVKp07d87UqVOrzH/yySfTqlWr7LXXXpXmP/roo+ndu3et1AwAALC2GtXlwWfNmpUk2WqrrSqNb7HFFpk5c2aV+dOmTcs222yThx9+ODfffHNmz56dzp0755xzzskOO+ywXrWUlZWt1+vhs6zqMb1G0fQatUWvUVv0GrWlvLw8JSUlNbrPOg1cq75pSktLK403adIk8+fPrzJ/4cKFeeeddzJmzJgMGzYsrVq1yg033JDDDz88kydPzqabbrrOtUybNm2dXwvVodeoLXqN2qLXqC16jdrwyWyyvuo0cDVt2jTJx/dyrfp7kixZsiTNmjWrMr9x48b58MMPM3LkyIorWiNHjkzfvn1z7733ZsCAAetcS/v27Vd7TKgpZWVlmTZtml6jcHqN2qLXqC16jdry5ptv1vg+6zRwrVpKOGfOnGy77bYV43PmzEmnTp2qzG/btm0aNWpUaflg06ZNs80222TGjBnrVUuzZs3SvHnz9doHrA29Rm3Ra9QWvUZt0WsUraaXEyZ1/NCMTp06pUWLFpkyZUrF2IIFC/Lqq6+mW7duVeZ369Yty5cvz8svv1wx9tFHH2X69OnZbrvtaqVmAACAtVWnV7hKS0vTv3//XHXVVWnTpk223nrrXHnllWnbtm323XffrFixInPnzk3Lli3TtGnTdOvWLbvvvnvOPvvsXHzxxdl4440zatSoNGzYMN/97nfr8q0AAABUUecffDxkyJAccsghOe+883LYYYelYcOGGTt2bEpLSzNz5sz06dMnkydPrph/3XXXpUePHjn11FNzyCGHZOHChbn11lvTpk2bOnwXAAAAVdXpFa4kadiwYYYOHZqhQ4dW2dauXbu88cYblcZatGiRCy+8MBdeeGEtVQgAALBu6vwKFwAAwIZK4AIAACiIwAUAAFAQgQsAAKAgAhcAAEBBBC4AAICCCFwAAAAFEbgAAAAKInABAAAUROACAAAoiMAFAABQEIELAACgIAIXAABAQQQuAACAgghcAAAABRG4AAAACiJwAQAAFETgAgAAKIjABQAAUBCBCwAAoCACFwAAQEHWKXDdd999+eijj2q6FgAAgA3KOgWuH//4x9ljjz1y/vnn5/nnn6/pmgAAADYI6xS4HnvssQwaNCjPP/98Dj/88HzjG9/IzTffnNmzZ9d0fQAAAPXWOgWuLbbYIieccEJ+//vf5ze/+U123333/OpXv0q/fv0yYMCATJ48OcuWLavpWgEAAOqVRuu7g1122SW77LJLDj744Fx55ZV58skn8+STT2aTTTbJ0UcfnQEDBqRRo/U+DAAAQL2zXkloxowZ+e1vf5v7778/77zzTrbddtuceeaZ2WefffLYY4/l+uuvzz//+c9cccUVNVUvAABAvbFOgeuuu+7K/fffn+eeey5NmzbNfvvtl0svvTTdunWrmLPTTjtl7ty5ufPOO2usWAAAgPpknQLX+eefny5duuSiiy7Kt771rbRo0WK18zp27Jgf/vCH61UgAABAfbVOgeuBBx7IjjvuuMbts2bNStu2bXPggQeua10AAAD13jo9pXD//ffPSy+9tNptzz77bL75zW+uV1EAAAAbgrW+wjVu3LgsXrw4SVJeXp677rorjz/+eJV5L7zwQkpLS2uuQgAAgHpqrQPX0qVLM3r06CRJSUlJ7rrrripzGjRokJYtW+akk06quQoBAADqqbUOXCeeeGJOPPHEJEmnTp0yceLEdOnSpbDCAAAA6rt1emjG66+/XtN1AAAAbHDWOnCde+65Ofnkk7PNNtvk3HPP/dS5JSUl+elPf7rexQEAANRnax24pkyZkqOPPrri7wAAAHy6tQ5cjz766Gr/DgAAwOqt0+dwnXvuuZk+ffpqt/3zn/+seLgGAADA59laX+F67733Kv5+77335utf/3oaNmxYZd7jjz+ep556qmaqAwAAqMfWOnBdfPHF+fOf/5zk44dinHrqqaudV15enj322KNmqgMAAKjH1jpwXXTRRXnqqadSXl6eH//4xznppJOy7bbbVprToEGDtGrVKj179qzxQgEAAOqbtQ5cW265ZQ466KAkH1/h6tu3b9q0aVNYYQAAAPXdOn3w8UEHHZTy8vK8+uqrWbx4ccrLy6vM6d69+3oXBwAAUJ+tU+B66aWXctppp2XWrFlJUhG4SkpKUl5enpKSkrz22ms1VyUAAEA9tE6B66c//WkaNWqUyy67LG3btk2DBuv0dHkAAIAN2joFrldffTU///nP8/Wvf72m6wEAANhgrNOlqU033dRVLQAAgM+wTqnp8MMPz80335zFixfXdD0AAAAbjHVaUvj222/nH//4R/bYY4/stNNOadq0aaXtJSUl+dWvflUjBQIAANRX6xy4OnXqVPH1Jx8Lv7rHxAMAAHzerFPguu2229a4raysLP/85z/XuSAAAIANxVrfw9W7d++8+uqrlcZuvPHGfPDBB5XG/v73v+eQQw6pmeoAAADqsbUOXPPmzcvy5csrvl6xYkWuvfbazJ49u5DCAAAA6rv1era7e7UAAADWzIdpAQAAFETgAgAAKIjABQAAUJD1DlwlJSU1UQcAAMAGp1qfw3XKKaektLS00tiJJ56Yxo0bV3y9dOnSmqkMAACgnlvrwHXQQQcVWQcAAMAGZ60D12WXXVZkHQAAABscD80AAAAoiMAFAABQEIELAACgIAIXAABAQQQuAACAgghcAAAABRG4AAAACiJwAQAAFETgAgAAKIjABQAAUBCBCwAAoCACFwAAQEEELgAAgIIIXAAAAAURuAAAAAoicAEAABRE4AIAACiIwAUAAFCQOg9cK1euzKhRo7LnnnumS5cuOe644/L222+v1Wt/97vfpWPHjpkxY0bBVQIAAFRfnQeuMWPG5M4778yIESMyceLElJSUZODAgVm6dOmnvu7dd9/NRRddVEtVAgAAVF+dBq6lS5dm3LhxGTx4cPr27ZtOnTpl5MiRmT17dh555JE1vm7lypUZOnRodt5551qsFgAAoHrqNHC9/vrrWbRoUXr16lUx1qpVq3Tu3DlTp05d4+tuvPHGLFu2LIMGDaqNMgEAANZJo7o8+KxZs5IkW221VaXxLbbYIjNnzlzta1566aWMGzcud999d2bPnl1jtZSVldXYvmB1VvWYXqNoeo3aoteoLXqN2lJeXp6SkpIa3WedBq5V3zSlpaWVxps0aZL58+dXmb948eL86Ec/yo9+9KO0b9++RgPXtGnTamxf8Gn0GrVFr1Fb9Bq1Ra9RGz6ZTdZXnQaupk2bJvn4Xq5Vf0+SJUuWpFmzZlXmjxgxIu3bt8+hhx5a47W0b99+tceEmlJWVpZp06bpNQqn16gteo3aoteoLW+++WaN77NOA9eqpYRz5szJtttuWzE+Z86cdOrUqcr8SZMmpbS0NF27dk2SrFixIknyne98JwcccEAuvvjida6lWbNmad68+Tq/HtaWXqO26DVqi16jtug1ilbTywmTOg5cnTp1SosWLTJlypSKwLVgwYK8+uqr6d+/f5X5Dz/8cKWvX3zxxQwdOjQ333xzdthhh1qpGQAAYG3VaeAqLS1N//79c9VVV6VNmzbZeuutc+WVV6Zt27bZd999s2LFisydOzctW7ZM06ZNs91221V6/aqHbnzhC1/IpptuWhdvAQAAYI3q/IOPhwwZkkMOOSTnnXdeDjvssDRs2DBjx45NaWlpZs6cmT59+mTy5Ml1XSYAAEC11ekVriRp2LBhhg4dmqFDh1bZ1q5du7zxxhtrfG3Pnj0/dTsAAEBdqvMrXAAAABsqgQsAAKAgAhcAAEBBBC4AAICCCFwAAAAFEbgAAAAKInABAAAUROACAAAoiMAFAABQEIELAACgIAIXAABAQQQuAACAgghcAAAABRG4AAAACiJwAQAAFETgAgAAKIjABQAAUBCBCwAAoCACFwAAQEEELgAAgIIIXAAAAAURuAAAAAoicAEAABRE4AIAACiIwAUAAFAQgQsAAKAgAhcAAEBBBC4AAICCCFwAAAAFEbgAAAAKInABAAAUROACAAAoiMAFAABQEIELAACgIAIXAABAQQQuAACAgghcAAAABRG4AAAACiJwAQAAFETgAgAAKIjABQAAUBCBCwAAoCACFwAAQEEELgAAgIIIXAAAAAURuAAAAAoicAEAABRE4AIAACiIwAUAAFAQgQsAAKAgAhcAAEBBBC4AAICCCFwAAAAFEbgAAAAKInABAAAUROACAAAoiMAFAABQEIELAACgIAIXAABAQQQuAACAgghcAAAABRG4AAAACiJwAQAAFETgAgAAKIjABQAAUBCBCwAAoCACFwAAQEEELgAAgIIIXAAAAAURuAAAAAoicAEAABRE4AIAACiIwAUAAFAQgQsAAKAgAhcAAEBBBC4AAICCCFwAAAAFEbgAAAAKInABAAAUROACAAAoSJ0HrpUrV2bUqFHZc88906VLlxx33HF5++231zj/zTffzAknnJCePXumd+/eGTJkSN57771arBgAAGDt1HngGjNmTO68886MGDEiEydOTElJSQYOHJilS5dWmTtv3rwce+yx2WijjXL77bfnlltuybx58zJgwIAsWbKkDqoHAABYszoNXEuXLs24ceMyePDg9O3bN506dcrIkSMze/bsPPLII1Xm//GPf0xZWVkuv/zy7LTTTvnyl7+cK6+8Mv/4xz/y/PPP18E7AAAAWLM6DVyvv/56Fi1alF69elWMtWrVKp07d87UqVOrzO/du3euv/76NGnSpMq2+fPnF1orAABAdTWqy4PPmjUrSbLVVltVGt9iiy0yc+bMKvPbtWuXdu3aVRq76aab0qRJk3Tv3r24QgEAANZBnQausrKyJElpaWml8SZNmqzVFatbb701EyZMyLnnnptNN920RmqBoqzqMb1G0fQatUWvUVv0GrWlvLw8JSUlNbrPOg1cTZs2TfLxvVyr/p4kS5YsSbNmzdb4uvLy8lx77bW54YYbMmjQoBxzzDHrXcu0adPWex+wNvQatUWvUVv0GrVFr1EbPnkxaH3VaeBatZRwzpw52XbbbSvG58yZk06dOq32NcuWLcu5556bBx54IMOGDcvxxx9fI7W0b9/+U0MerK+ysrJMmzZNr1E4vUZt0WvUFr1GbXnzzTdrfJ91Grg6deqUFi1aZMqUKRWBa8GCBXn11VfTv3//1b5m2LBheeSRR3L11Vfn29/+do3V0qxZszRv3rzG9gdroteoLXqN2qLXqC16jaLV9HLCpI4DV2lpafr375+rrroqbdq0ydZbb50rr7wybdu2zb777psVK1Zk7ty5admyZZo2bZp77rknkydPzrBhw9KjR4+8//77FftaNQcAAOC/RZ1/8PGQIUNyyCGH5Lzzzsthhx2Whg0bZuzYsSktLc3MmTPTp0+fTJ48OUnywAMPJEmuuOKK9OnTp9KfVXMAAAD+W9TpFa4kadiwYYYOHZqhQ4dW2dauXbu88cYbFV+PGzeuNksDAABYL3V+hQsAAGBDJXABAAAUROACAAAoiMAFAABQEIELAACgIAIXAABAQQQuAACAgghcAAAABRG4AAAACiJwAQAAFETgAgAAKIjABQAAUBCBCwAAoCACFwAAQEEELgAAgIIIXAAAAAURuAAAAAoicAEAABRE4AIAACiIwAUAAFAQgQsAAKAgAhcAAEBBBC4AAICCCFwAAAAFEbgAAAAKInABAAAUROACAAAoiMAFAABQEIELAACgIAIXAABAQQQuAACAgghcAAAABRG4AAAACiJwAQAAFETgAgAAKIjABQAAUBCBCwAAoCACFwAAQEEELgAAgIIIXAAAAAURuAAAAAoicAEAABRE4AIAACiIwAUAAFAQgQsAAKAgAhcAAEBBBC4AAICCCFwAAAAFEbgAAAAKInABAAAUROACAAAoiMAFAABQEIELAACgIAIXAABAQQQuAACAgghcAAAABRG4AAAACiJwAQAAFETgAgAAKIjABQAAUBCBCwAAoCACFwAAQEEELgAAgIIIXAAAAAURuAAAAAoicAEAABRE4AIAACiIwAUAAFAQgQsAAKAgAhcAAEBBBC4AAICCCFwAAAAFEbgAAAAKInABAAAUROACAAAoiMAFAABQEIELAACgIAIXAABAQQQuAACAgghcAAAABRG4AAAAClLngWvlypUZNWpU9txzz3Tp0iXHHXdc3n777TXOnzdvXs4666x079493bt3z/nnn5/FixfXYsUAAABrp84D15gxY3LnnXdmxIgRmThxYkpKSjJw4MAsXbp0tfOHDBmS6dOn55e//GVGjRqVv/zlL7noootquWoAAIDPVqeBa+nSpRk3blwGDx6cvn37plOnThk5cmRmz56dRx55pMr8F154Ic8880wuu+yy7Lzzzundu3cuvvji3H///Zk9e3YdvAMAAIA1q9PA9frrr2fRokXp1atXxVirVq3SuXPnTJ06tcr8Z599Nptvvnl22GGHirEePXqkpKQkzz33XK3UDAAAsLYa1eXBZ82alSTZaqutKo1vscUWmTlzZpX5s2fPrjK3tLQ0G2+88Wrnr41ly5YlSd58882UlJSs0z5gbZSXlyfRaxRPr1Fb9Bq1Ra9RW5YtW1bjPVangausrCzJx6HpPzVp0iTz589f7fxPzl01f8mSJetUw6oT2qBBnd/OxgaupKRktf0LNU2vUVv0GrVFr1FbSkpKNqzA1bRp0yQf38u16u9JsmTJkjRr1my181f3MI0lS5akefPm61RD165d1+l1AAAAn6VOL+usWh44Z86cSuNz5sxJ27Ztq8xv27ZtlblLly7Nv//972y55ZbFFQoAALAO6jRwderUKS1atMiUKVMqxhYsWJBXX3013bp1qzK/e/fumTVrVqXP6Vr12t122634ggEAAKqhTpcUlpaWpn///rnqqqvSpk2bbL311rnyyivTtm3b7LvvvlmxYkXmzp2bli1bpmnTpunSpUt22223nHHGGbnwwguzePHiDB8+PAceeKArXAAAwH+dkvJVj32pIytWrMjPf/7z3HPPPfnoo4/SvXv3XHDBBWnXrl1mzJiRr33ta7nsssty8MEHJ0n+9a9/5aKLLsoTTzyRJk2aZL/99su5556bJk2a1OXbAAAAqKLOAxcAAMCGyrPQAQAACiJwAQAAFETgAgAAKIjABQAAUBCBCwAAoCACFwAAQEEELgAAgIJs8IFr5cqVGTVqVPbcc8906dIlxx13XN5+++01zp83b17OOuusdO/ePd27d8/555+fxYsX12LF1FfV7bU333wzJ5xwQnr27JnevXtnyJAhee+992qxYuqr6vbaf/rd736Xjh07ZsaMGQVXyYagur22bNmyXH311dlzzz2z6667pn///nnttddqsWLqq+r22vvvv58zzzwzPXv2TM+ePXPaaadl1qxZtVgxG4IxY8bkyCOP/NQ5NZENNvjANWbMmNx5550ZMWJEJk6cmJKSkgwcODBLly5d7fwhQ4Zk+vTp+eUvf5lRo0blL3/5Sy666KJarpr6qDq9Nm/evBx77LHZaKONcvvtt+eWW27JvHnzMmDAgCxZsqQOqqc+qe6/a6u8++67/j2jWqrbaxdeeGHuvvvuXHLJJZk0aVI23njjDBw4MB9++GEtV059U91eO+OMMzJz5syMHz8+48ePz6xZs3LyySfXctXUZ6t+1v8sNZINyjdgS5YsKe/atWv5hAkTKsbmz59fvssuu5Q/8MADVeY///zz5R06dCh/6623KsaeeOKJ8o4dO5bPmjWrVmqmfqpur/3mN78p32233co/+uijirGZM2eWd+jQofypp56qlZqpn6rba6usWLGi/LDDDis/6qijyjt06FA+ffr02iiXeqy6vfbOO++Ud+jQofx///d/K83fZ599/LvGp6pur82fP7+8Q4cO5X/6058qxv74xz+Wd+jQoXzu3Lm1UjP116xZs8qPP/748l133bV8v/32K+/fv/8a59ZUNtigr3C9/vrrWbRoUXr16lUx1qpVq3Tu3DlTp06tMv/ZZ5/N5ptvnh122KFirEePHikpKclzzz1XKzVTP1W313r37p3rr78+TZo0qbJt/vz5hdZK/VbdXlvlxhtvzLJlyzJo0KDaKJMNQHV77cknn0yrVq2y1157VZr/6KOPpnfv3rVSM/VTdXutSZMmad68ee67774sXLgwCxcuzP3335/27dundevWtVk69dArr7yS1q1b57e//W26dOnyqXNrKhs0Wudq64FVa3m32mqrSuNbbLFFZs6cWWX+7Nmzq8wtLS3NxhtvvNr5sEp1e61du3Zp165dpbGbbropTZo0Sffu3YsrlHqvur2WJC+99FLGjRuXu+++O7Nnzy68RjYM1e21adOmZZtttsnDDz+cm2++ObNnz07nzp1zzjnnVPphBT6pur3WpEmTXHrppbn44ovTrVu3lJSUZPPNN8/tt9+eBg026GsJ1IB+/fqlX79+azW3prLBBt2VZWVlST4+Mf+pSZMmq71PpqysrMrcT5sPq1S31z7p1ltvzYQJE3LmmWdm0003LaRGNgzV7bXFixfnRz/6UX70ox+lffv2tVEiG4jq9trChQvzzjvvZMyYMTnzzDNzww03pFGjRjn88MPzr3/9q1Zqpn6qbq+Vl5fnjTfeSNeuXXPHHXfkV7/6VbbeeuuccsopWbhwYa3UzOdDTWWDDTpwNW3aNEmq3HC5ZMmSNGvWbLXzV3dz5pIlS9K8efNiimSDUN1eW6W8vDzXXHNNLr300gwaNCjHHHNMkWWyAahur40YMSLt27fPoYceWiv1seGobq81btw4H374YUaOHJk+ffpkl112yciRI5Mk9957b/EFU29Vt9d+//vfZ8KECbnyyivz1a9+NT169MiNN96Yd999N5MmTaqVmvl8qKlssEEHrlWXAOfMmVNpfM6cOWnbtm2V+W3btq0yd+nSpfn3v/+dLbfcsrhCqfeq22vJx49PHjp0aG688cYMGzYsZ555ZuF1Uv9Vt9cmTZqUv/71r+natWu6du2agQMHJkm+853v5IILLii+YOqtdfl/aKNGjSotH2zatGm22WYbH0PAp6purz333HPZfvvt06JFi4qx1q1bZ/vtt8+0adMKrZXPl5rKBht04OrUqVNatGiRKVOmVIwtWLAgr776arp161Zlfvfu3TNr1qxKn/uw6rW77bZb8QVTb1W315Jk2LBh+cMf/pCrr746xx9/fG2VSj1X3V57+OGH88ADD+S+++7LfffdlxEjRiRJbr755px22mm1Vjf1T3V7rVu3blm+fHlefvnlirGPPvoo06dPz3bbbVcrNVM/VbfXttpqq7z99tuVlnSVlZVlxowZeo0aVVPZYIN+aEZpaWn69++fq666Km3atMnWW2+dK6+8Mm3bts2+++6bFStWZO7cuWnZsmWaNm2aLl26ZLfddssZZ5yRCy+8MIsXL87w4cNz4IEHusLFp6pur91zzz2ZPHlyhg0blh49euT999+v2NeqObA61e21T/7wserm9C984QvuF+RTVbfXunXrlt133z1nn312Lr744my88cYZNWpUGjZsmO9+97t1/Xb4L1bdXjvwwAMzduzYnH766RW/OLrmmmtSWlqagw8+uI7fDfVZYdlgPR5jXy8sX768/Iorrijv1atX+a677lo+cODAis+fmT59enmHDh3KJ02aVDH/gw8+KB88eHD5rrvuWt6zZ8/y4cOHV/qsJFiT6vTascceW96hQ4fV/vnPfoTVqe6/a//p6aef9jlcrLXq9tqHH35YPnz48PKePXuWd+nSpfzYY48tf/PNN+uqfOqR6vbaW2+9VT5o0KDyHj16lPfq1av81FNP9e8a1Xb22WdX+hyuorJBSXl5eXlxOREAAODza4O+hwsAAKAuCVwAAAAFEbgAAAAKInABAAAUROACAAAoiMAFAABQEIELAArgU1cASJJGdV0AAKyPl19+ObfeemumTp2auXPnZvPNN0/v3r0zaNCgbLPNNnVS05/+9Kc89NBDueKKK+rk+AD893CFC4B664477sihhx6af/3rXznrrLNyyy235MQTT8zUqVPzve99L6+88kqd1PXLX/4yM2fOrJNjA/DfpaTcmgcA6qHnnnsuRx55ZI444oj85Cc/qbRt7ty5Ofjgg9OqVav89re/rfXajjzyyCTJbbfdVuvHBuC/iytcANRLY8eOTcuWLXPmmWdW2damTZucc845+Z//+Z8sXLgwSTJ58uQcfPDB6dq1a/bYY49ccMEFmT9/fsVrrrvuunTs2LHKvjp27JjrrrsuSTJjxox07NgxDz74YIYMGZKuXbume/fu+clPfpJFixYl+ThsPfPMM3nmmWfSsWPHTJkypYi3D0A9IXABUO+Ul5fnySefTO/evdOsWbPVztlvv/1y6qmnpkWLFhkzZkzOOOOMdOnSJaNGjcopp5yShx56KEceeWQ++uijah9/+PDh2XrrrTNmzJgMGDAgkyZNyo033lixrXPnzuncuXMmTpyYnXfeeb3eKwD1m4dmAFDvzJs3L0uWLEm7du0+c+78+fNzww035Pvf/36GDx9eMd6hQ4ccccQRueeee3L44YdX6/h9+/bN2WefnSTp3bt3/vKXv+Sxxx7LWWedlR133DEtWrRIkuy6667V2i8AGx5XuACodxo0+Ph/XytWrPjMuX/729+ydOnS7L///pXGu3Xrlq233nqdlvx9Mki1bds2ixcvrvZ+ANjwucIFQL2z8cYbZ6ONNsp77723xjmLFy/O0qVLK+7T2myzzarM2WyzzfLhhx9W+/ifXMbYoEEDn7sFwGq5wgVAvdSnT59MmTIlS5YsWe32e+65J7179654PPsHH3xQZc7777+fTTbZJElSUlKSpPJVs1UPwgCAdSVwAVAvHXfccfn3v/+dkSNHVtn2r3/9K7/4xS+y3Xbb5Qc/+EFKS0vzu9/9rtKcZ599Nu+991522223JKm47+o/Pz/r+eefX6faVi15BABLCgGol3bdddecdtppueaaa/KPf/wjBx10UDbZZJO8+eabGTduXBYtWpSbb745m2yySU444YSMHj06jRs3zte+9rXMmDEj1157bXbcccccfPDBST5+EMZll12W888/PwMHDsysWbMyevTobLTRRtWurVWrVnnhhRfy17/+NZ07d07r1q1r+u0DUE/4FRwA9dZJJ52Um2++OSUlJbnssstywgkn5Lbbbstee+2V+++/Px06dEiSDB48OBdeeGGeeeaZnHjiiRk9enT222+/TJgwoeJ+rO233z4/+9nP8t577+WEE07Ir371q1xyySXZYostql3XEUcckcaNG2fgwIF5/PHHa/Q9A1C/lJS7yxcAAKAQrnABAAAUROACAAAoiMAFAABQEIELAACgIAIXAABAQQQuAACAgghcAAAABRG4AAAACiJwAQAAFETgAgAAKIjABQAAUBCBCwAAoCD/PyydxR1braXxAAAAAElFTkSuQmCC",
      "text/plain": [
       "<Figure size 1000x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Plot the most common entities for each label\n",
    "for label in candidate_labels:\n",
    "\n",
    "    # Filter sequences with the current label\n",
    "    label_sequences = important_sequences_df[important_sequences_df['Label'] == label]\n",
    "    \n",
    "    # Extract entities, skipping empty dictionaries\n",
    "    entities = [ent for ents in label_sequences['Cleaned Entities'] if ents for ent in ents]\n",
    "    \n",
    "    # Create a DataFrame\n",
    "    entities_df = pd.DataFrame(entities, columns=['Entity', 'Label'])\n",
    "    \n",
    "    # Plot the most common entities\n",
    "    plt.figure(figsize=(10, 6))\n",
    "    sns.countplot(y=\"Entity\", data=entities_df, order=entities_df['Entity'].value_counts().head(10).index, palette='viridis')\n",
    "    plt.title(f\"Most Common Entities for Label: {label}\")\n",
    "    plt.xlabel(\"Count\")\n",
    "    plt.ylabel(\"Entity\")\n",
    "    plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## The most frequent entities that are genes can be further researched and their role in the process analysed"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 478,
   "metadata": {},
   "outputs": [],
   "source": [
    "# save entities_df with the current time stamp\n",
    "filename = f\"important_entities_hspa4_{current_time}.csv\"\n",
    "entities_df.to_csv(filename, index=False)"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "base",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.0"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
